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Thesis abstract 
 
Faecal pollution regularly contaminates surface waters, introducing 
microorganisms, including bacteria and bacteria resistant to antibiotics, to coastal 
waters. People can come into contact with these potentially harmful microbes 
when they enjoy recreational activities in the sea. Understanding the risk to 
bathers of acquiring infections from the sea is important for developing effective 
intervention strategies to protect human health.  
This thesis consists of four original studies which aim to answer the question ‘are 
bacteria in the coastal zone a threat to human health’? First, we describe a 
systematic review on the risk of acquiring infections from recreational use of 
coastal waters. Synthesising risk estimates of reporting various symptoms of ill 
health, we quantify this risk as well as appraise the evidence that these infections 
are acquired from bathing in coastal waters. The results of the second study - a 
large online survey - corroborate these findings and provide updated estimates 
of risk for UK bathers. Third, we assess the risk of ingesting antibiotic resistant 
bacteria among UK coastal water users. In the final study, we measured the 
prevalence of faecal carriage of antibiotic resistant bacteria among a highly 
exposed group – surfers, and in an unexposed group (non-surfers).  
We conclude that despite improvements made to the collection, treatment and 
discharge of sewage, and initiatives to communicate water quality to members of 
the public in recent years, people who bathe in coastal waters are still at an 
increased risk of adverse health outcomes, whether this is experiencing 
symptoms of ill health, or exposure to and colonisation by antibiotic resistant 
bacteria.  
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Definitions 
Term Definition  
Antibiotics A type of antimicrobial used to kill or prevent the 
reproduction of bacteria.  
Antibiotic resistance The ability of a bacterium to survive and/or multiply in 
the presence of an antibiotic to which it was previously 
susceptible.   
Antibiotic resistance 
gene 
A gene (section of DNA) that encodes for a protein, 
whose action protects the bacterial cell from the 
bactericidal or bacteriostatic effects of antibiotics. 
Antimicrobial A compound that kills or prevents the reproduction of 
living microorganisms, including bacteria, fungi, 
protozoa and viruses.  
Antimicrobial 
resistance 
The ability of a microorganism to survive and/or 
multiply in the presence of an antimicrobial to which it 
was previously susceptible.  
Bacteria A large group of prokaryotic microorganisms, 
differentiated from eukaryotes (see below) by the 
absence of membrane-bound organelles. 
Bactericidal A bactericidal antibiotic is one that causes bacterial cell 
death.  
Bathing Swimming or spending time in the water. 
Bathing season Time of year during which large numbers of bathers 
can be expected.  
Citation chasing A method used to identify additional publications by 
searching the reference sections and related citations 
of each paper identified. 
Commensal flora Microorganisms (bacteria, fungi, etc.) that live on or in 
a healthy person or animal.  
Confidence interval A measure of precision around a point estimate. These 
are usually calculated using standard error, and any 
level of precision may be chosen. E.g. 95% confidence 
21 
 
intervals provide the range of values in which we can 
be 95% certain that the true point estimate lies.  
Conjugation One of three mechanisms by which bacteria can 
acquire new genetic material. Conjugation involves the 
exchange of mobile genetic elements (e.g. a plasmid) 
between two bacteria that make contact by forming a 
conjugal pilus between themselves through which 
genetic material can be passed from one to the other.  
Confounding 
variable (also called 
a confounder) 
A variable that is related to both the exposure of 
interest and the outcome of interest. They can bias or 
confound a relationship between an exposure and an 
outcome. 
Department of 
Environment, Food 
and Rural Affairs  
(DEFRA) 
Department of the UK government which is responsible 
for the environment, food and rural affairs. 
Enteric Relating to or occurring in the intestines. 
Eukaryotes Taxonomic group of organisms characterised by the 
cells containing membrane-bound organelles. These 
are considered separate from the prokaryotic taxons 
Bacteria and Archaea.   
Extended-spectrum 
beta-lactamase 
An enzyme produced by bacteria which hydrolyses and 
inactivates most beta-lactam antibiotics, including most 
penicillins and cephalosporins. 
Faecal indicator 
bacteria 
Subgroup of faecal indicator organisms (see below). 
These are bacteria typically found in large numbers in 
the intestinal tract of animals, including humans. Their 
presence signify the occurrence of faecal pollution. 
Faecal indicator 
organisms 
Organisms typically found in large numbers in the 
intestinal tract of animals, including humans. Their 
presence signify the occurrence of faecal pollution, and 
therefore of pathogens transmitted by the faecal-oral 
route. 
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Genotype/ 
genotypic 
A genetic aspect of an organism that, if expressed, is 
responsible for some phenotypic (see below) 
characteristic(s) observed. 
Gram-negative 
bacteria 
A group of bacteria that have thin peptidoglycan cell 
walls between the cell membrane and bacterial outer 
membrane. They give a negative result in a Gram stain 
test. 
Gram-positive 
bacteria 
A group of bacteria that have thick peptidoglycan cells 
walls and no bacterial outer membrane. They give a 
positive result in a Gram stain test. 
Grey water Relatively clean water from baths, sinks, washing 
machines.  
Incubation period The time between exposure to an infection and the 
onset of symptoms. 
I2 statistic The I-squared statistic quantifies the amount of 
statistical heterogeneity across the studies included in 
a meta-analysis.  It is the percentage of the variation 
across study estimates that is due to heterogeneity as 
opposed to within-study variability. 
Minimum inhibitory 
concentration 
The lowest concentration of antibiotic or antimicrobial 
at which the growth of bacteria is prevented. This 
varies according to the species of bacteria, and to the 
class of antibiotic.  
Mobile genetic 
element 
Segments of DNA that encode proteins that mediate 
the movement of DNA within genomes or between 
bacterial cells, for example plasmids, transposons, and 
introns. 
Nosocomial 
infection 
An infection occurring in a hospital or other healthcare 
facility, when the infection was not present or 
incubating at time of admission. 
Odds ratio A measure of relative effect, odds ratios are one way to 
measure an association between an exposure and an 
outcome. It is the ratio of the odds of an outcome in an 
exposed group of subjects compared to the odds of the 
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outcome in an unexposed group. An odds ratio of one 
indicates exposure has no effect on the risk of the 
outcome, values greater than one indicate an increase 
in risk, and values less than one indicate a decrease in 
risk.  
Opportunistic 
pathogen 
A pathogen (see below) which does not cause disease 
in healthy individuals, but does in people with 
suppressed immune systems. 
Pathogen A microorganism (bacterium, fungus, protozoan, virus) 
which can cause disease. 
Plasmid Typically a small, circular piece of DNA, which is 
separate to chromosomal DNA, and which can 
replicate independently of chromosomal DNA. 
Polymerase chain 
reaction (PCR) 
A technique to multiply DNA exponentially to a quantity 
at which it can be detected. 
Phenotype/ 
phenotypic 
The physical characteristics of an organism that are 
observed as a result of the interaction between its 
genotype and the environment.  
Primary pathogen A pathogen which causes disease if it gains entry into 
the body, even in healthy individuals.  
Resistome A collection of resistance genes present in the 
members of a microbial community.  
Risk A term often used for the probability that an adverse 
outcome will develop.   
Risk ratio (or 
relative risk) 
A measure of relative effect, risk ratios are another way 
to measure an association between an exposure and 
an outcome. It is the ratio of the proportion (i.e. risk) of 
an outcome in an exposed group of subjects compared 
to the risk of the outcome in an unexposed group. A 
risk ratio of one indicates exposure has no effect on 
the risk of the outcome, values greater than one 
indicate an increase in risk, and values less than one 
indicate a decrease in risk.  
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Risk difference  The difference in the risk observed in two groups. The 
importance of a risk difference will depend upon the 
underlying risk.  
Shedding The process by which microorganisms are expelled 
from the body, such as from the respiratory tract, skin, 
and intestinal tract. 
Transduction One of three mechanisms by which bacteria can 
acquire new genetic material. Transduction requires 
that a bacteriophage (a virus) transfers genes from one 
host bacterium to another. 
Transformation One of three mechanisms by which bacteria can 
acquire new genetic material. Transformation is when 
a bacterium takes up free DNA in its environment and 
incorporates it into its own genome.  
Water sports Sports or recreational activities played or practised in 
or on water. 
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Abbreviations 
Abbreviation Definition 
AFRI Acute febrile respiratory illness 
AMR Antimicrobial resistance 
ARB Antibiotic resistant bacteria 
ARG Antibiotic resistance gene 
bp Base pair 
CI Confidence interval 
CFU Colony forming unit 
CTX-M Cefotaximase-Munich 
DEFRA Department for the Environment, Food and Rural Affairs 
DNA Deoxyribonucleic acid 
DPSEEA Drivers, Pressures, State, Exposure, Effect, Action 
EA Environment Agency 
ECDC European Centre for Disease Prevention and Control 
EFTEC Economics for the Environment Consultancy  
ESBL Extended-spectrum beta-lactamase 
EU European Union 
EUCAST The European Committee on Antimicrobial Susceptibility 
Testing 
FIB Faecal indicator bacteria 
FIO Faecal indicator organism 
GBDVS Great Britain Day Visits Survey 
HCGI Highly credible gastrointestinal infection 
HEPE Health and Environment Public Engagement group 
HGT Horizontal gene transfer 
IMP Imipenemase  
KPC Klebsiella pneumoniae carbapenemase 
MeSH Medical Subject Headings 
MGE Mobile genetic element 
MIC Minimum inhibitory concentration 
MRSA Methicillin resistant Staphylococcus aureus 
NDM New Delhi metallo-beta-lactamase 
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NEC Non-Escherichia coli coliforms 
NJSDH New Jersey State Department of Health 
NR Not reported 
NZ New Zealand 
OECD Organisation for Economic Co-operation and Development  
OXA Oxacillinase 
PCR Polymerase chain reaction 
RCT Randomised controlled trial 
SAS Surfers Against Sewage 
SHV Sulfhydryl variable 
UK United Kingdom 
UNEP United Nations Environment Programme 
US United States 
US EPA United States Environment Protection Agency 
UTI Urinary tract infections 
VIM Verona imipenemase 
WHO The World Health Organization 
WWTP Waste water treatment plant 
3GC Third-generation cephalosporin 
3GCREC Third-generation cephalosporin resistant Escherichia coli 
4GC Fourth-generation cephalosporin 
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Chapter 1: Thesis Introduction 
 
1.1 Bacteria and antibiotic resistance 
1.1.1 Biology 
Bacteria are a diverse group of organisms, inhabiting a plethora of different 
environments on this planet: from subglacial lakes in the Antarctic (Christner et 
al., 2014) to acidic hot springs (Brock and Darland, 1970), as well as being found 
in all animals including the human body. With microbial communities inhabiting 
many regions of the body, such as the upper respiratory tract, digestive tract, 
skin, and urogenital tract, there are at least as many bacterial cells in the human 
body as there are human ones (Sender et al., 2016). The human intestinal tract, 
in particular, harbours huge numbers of very diverse bacteria, including 
commensal bacteria, opportunistic pathogens and, occasionally, primary 
pathogens. Most bacteria in this part of the body are harmless or beneficial for 
human health, outcompeting pathogenic bacteria for space and nutrients, as well 
as synthesising essential compounds like vitamin B (Martin et al., 2013, LeBlanc 
et al., 2013). However, some species of bacteria, for example Vibrio cholerae, 
cause serious disease in humans.  
The role that bacteria and other microorganisms, such as viruses, fungi, protozoa 
and helminths, play in human disease has only been understood since the mid-
19th century, and much of that early work stems from the endeavours of a few 
notable scientists, such as Robert Koch, Louis Pasteur and John Snow (Bynum 
and Porter, 2013). Since then, the prevention and treatment of infectious 
diseases has been an important aspect of medicine and veterinary work 
(Department of Health Antimicrobial Resistance Strategy Analytical Working 
Group, 2015). The discovery and clinical use of compounds that kill or prevent 
the growth of microorganisms causing disease (antimicrobials and antibiotics) 
during the 20th century revolutionised medicine. However, even as early as 1940, 
several years before the introduction of penicillin as a therapeutic agent to treat 
wound infections sustained in the Second World War, resistance to penicillin was 
observed (Abraham and Chain, 1940). Abraham & Chain (1940) reported their 
discovery of bacteria that were once susceptible to penicillin resisting the effects 
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of the bactericidal compound. They suggested that these penicillin resistant 
bacteria produced an enzyme called penicillinase that deactivated penicillin. 
Following the widespread clinical use of penicillin, bacteria that were resistant to 
it became prevalent. To prevent the deactivating action of penicillinase, penicillin 
underwent modifications by chemically adding and removing chemical groups 
(Davies and Davies, 2010). Since then, as new antibiotics have been discovered 
and deployed clinically, resistance to antibiotics among bacterial pathogens has 
been increasingly observed, leading to the need to introduce modifications or 
alterations to improve antibacterial activity (Clatworthy et al., 2007).  
While resistance to antibiotics is an ancient phenomenon pre-dating the use of 
antibiotics by humans (D'Costa et al., 2011), there is little doubt that the extensive 
use (and misuse) of antibiotics, and antimicrobials in general, by mankind has 
accelerated the development of antibiotic resistance and antimicrobial resistance 
(AMR) among bacteria and other microorganisms. The natural ability of bacteria 
to transfer antibiotic resistance genes (ARGs) carried on mobile genetic elements 
(MGEs), to other bacteria has undoubtedly facilitated the rapid and wide 
dissemination of antibiotic resistant bacteria (ARB) around the world. Since many 
treatments in modern medicine, such as surgery, cancer treatments, organ 
transplants, among many other procedures, rely on the efficacy of antibiotics and 
antimicrobials for the prevention and successful treatment of a range of 
conditions, the failure of essential antibiotics to treat or prevent infections caused 
by ARB presents a serious problem (Smith and Coast, 2013). This threat is 
exacerbated by the decline in the rate of discovery and development of new 
antibiotics in recent years. With only a limited number of antibiotics remaining to 
which multi-resistant bacteria may still be susceptible, antibiotic resistance has 
been described as “one of the greatest health threats faced today”, and was 
added to the UK National Risk Register in 2015, alongside other threats such as 
terrorism, climate change, and influenza pandemics (Cabinet Office, 2015, Taylor 
et al., 2014). Not only does the failure of antibiotics result in increased risk of 
mortality, there are high costs associated with treating patients with resistant 
infections. These costs arise through prolonged hospital stays, loss of bed days 
through ward closures, extra or more costly antibiotic treatment, additional 
investigations, and reduction in quality of life in addition to a reduction in 
economic activity (Taylor et al., 2014, Smith and Coast, 2013). Smith and Coast 
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(2013) estimated that these additional costs amount to between less than $5 to 
more than $55,000 per patient episode. Currently, it is estimated that globally, 
700,000 people die each year from antimicrobial resistant infections. If current 
trends continue, experts predict that by the year 2050, this will reach 10 million 
deaths each year. This burden is likely to hit low- and middle-income countries 
hardest, but even in countries that are members of the Organisation for Economic 
Co-operation and Development (OECD) the cumulative loss of economic output 
by 2050 will amount to between $20 and $35 trillion. Global estimates indicate 
that between 2014 and 2050, AMR could cost the world up to $100 trillion (Review 
on antimicrobial resistance, 2014). 
1.1.2 Mechanisms of resistance 
Understanding how resistance develops and spreads, is therefore key to 
developing effective strategies to mitigate the impact ARB have on human health. 
There are three main mechanisms of resistance by which bacteria counteract the 
action of antibiotics: 1) Enzymatic degradation of the antibiotic; 2) Modification of 
the molecule or protein that the antibiotic targets; 3) Changes in cell permeability 
to antibiotics (Iredell et al., 2016). Bacteria become resistant to antibiotics when 
they possess the necessary gene (or genes) to express one or more proteins 
which deliver these resistance mechanisms. Some bacteria are intrinsically 
resistant to some groups of antibiotics, although bacteria can also either develop 
resistance de novo via mutation of existing genes, or they might acquire these 
genes from another bacterium. One way they can do this is to inherit this DNA 
from their parental bacterium (via vertical gene transfer), and they can also 
acquire resistance genes from a bacterium that is not their parent via horizontal 
gene transfer (HGT). Horizontal gene transfer mediated predominantly by 
conjugation, but also by transformation and transduction, has facilitated the wide 
and rapid spread of antibiotic resistance observed worldwide (von Wintersdorff et 
al., 2016).   
Interestingly, HGT events do not have to occur between two bacteria of the same 
species. Studies have found that bacteria are able to mobilise MGEs, such as 
plasmids, even between distantly related species of bacteria. Transference of 
MGEs has been observed to occur between bacteria and eukaryotes (non-
bacterial cells) (Heinemann and Sprague, 1989, Grillot-Courvalin et al., 1998, 
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Department of Health Antimicrobial Resistance Strategy Analytical Working 
Group, 2015, Gaze et al., 2011).  
Conjugational transfer of plasmids is considered to be the most important 
mechanism by which ARGs spread among bacterial communities. Not only are 
plasmids self-replicating (they can initiate their own replication independently of 
the host bacterium), some have a broad host range, and can carry genes 
encoding resistance to multiple antibiotics.  
1.1.3 Extended-spectrum beta-lactamase-producing Enterobacteriaceae 
One group of resistant bacteria that is of particular concern are extended-
spectrum beta-lactamase (ESBL)-producing Enterobacteriaceae (Iredell et al., 
2016). Enterobacteriaceae is a large family of Gram-negative bacteria, and 
includes several genera, including Escherichia and Klebsiella. Some members of 
the Enterobacteriaceae are important human pathogens, such as Escherichia coli 
and Klebsiella pneumoniae.  
Extended-spectrum beta-lactamases are a group of enzymes with a similar 
function. ESBLs deactivate beta-lactam antibiotics by hydrolysing the beta-
lactam chemical group of these drugs, which include a wide range of clinically 
useful medicines such as the penicillins and cephalosporins. Bacteria harbouring 
and expressing genes for these enzymes are therefore able to deactivate the 
antibiotic, and survive and grow in its presence. Plasmid-borne ESBLs are 
commonly harboured by members of the family Enterobacteriaceae. There are 
several classes of genes encoding ESBLs, although cefotaximase-Munich (CTX-
M) enzymes are the predominant type of ESBL globally and confer greater activity 
against extended-spectrum beta-lactams, such as the third-generation 
cephalosporins (3GCs). These antibiotics, for example cefotaxime, are described 
by the World Health Organization as “essential medicines”. This means that they 
are the only (or one of a limited number of alternatives) for treating serious human 
infections (Collignon et al., 2009). The emergence and spread of resistance to 
these antibiotics is a significant international public health concern due to the 
limited number of treatments available for treating infections caused by bacteria 
resistant to these antibiotics. A group of antibiotics called carbapenems are 
usually indicated for the treatment of infections caused by ESBL-producing 
bacteria, including blaCTX-M-bearing Enterobacteriaceae. However, resistance to 
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even these has emerged and the prevalence of infections caused by 
Enterobacteriaceae that are resistant to carbapenems is rising. This spread is 
likely to be due to the wide variety of mobile ARGs conferring resistance to 
carbapenems, such as the gene families beta-lactamase (bla) imipenemase 
(blaIMP), Verona imipenemase (blaVIM), Klebsiella pneumoniae carbapenemase 
(blaKPC), and New Delhi metallo-beta-lactamase (blaNDM) (Iredell et al., 2016).  
Carbapenem resistant infections pose a significant threat as available treatment 
options are limited to a few classes of last-resort antibiotics, such as colistin (a 
polymyxin), which can have neurotoxic or nephrotoxic side-effects (Review on 
antimicrobial resistance, 2015, van Duin et al., 2013). Worryingly, a plasmid-
borne gene, mcr-1, conferring resistance to colistin has been reported very 
recently in Enterobacteriaceae isolated from humans and animals in China (Liu 
et al., 2016). This ARG has very rapidly spread throughout the globe (McGann et 
al., 2016, Grami et al., 2016, Kluytmans-van den Bergh et al., 2016). 
1.1.4 Sources of antibiotic resistant bacteria 
Identifying key transmission routes by which people acquire resistant infections 
is essential for developing successful interventions to reduce or prevent such 
infections. The mechanisms of transmission that apply to susceptible bacteria 
also apply to ARB and, depending on the bacterial species in question, might 
require direct contact with infected individuals (person-to-person or animal-to-
person transmission) (Smith et al., 2013, Lewis et al., 2008). Indirect contact with 
infectious individuals also plays a role in the transmission of many bacterial 
pathogens, including ARB (Public Health Agency of Canada, 2015). Contact with 
contaminated objects (fomites), and consumption of contaminated food and 
drinking water have also been shown to play a role in the dissemination of ARB 
to people (Sydnor and Perl, 2011, Grandjean et al., 2015, Coleman et al., 2012).  
Environmental sources of antibiotic resistance bacteria 
A great deal of research has unsurprisingly focused on healthcare environments, 
where large numbers of vulnerable individuals, use of invasive devices and 
frequent person-to-person contact occurs, creates an ideal environment for the 
transmission of infectious agents and ARB (Hunter et al., 2008). More recently 
however, community-acquired infections have become increasingly prevalent, 
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and the natural environment has been recognised as a potential, but under-
studied, setting in which members of the community may come into contact with 
ARB (Ashbolt et al., 2013, Rogers et al., 2011). Using culture-based and 
metagenomic studies, natural environments such as soil and water have been 
shown to harbour a diverse population of bacteria hosting a wide range of ARGs 
(resistome) (Chen et al., 2013b). One particular natural environment that is the 
focus of this thesis, is the coastal zone. The coastal zone is an under-studied and 
complex environment, which is affected by human activities. With approximately 
40% of the world’s population living within 100 km of the coast, this is a suitable 
environment to permit bacteria-human interaction as there is a high probability of 
people coming into contact with bacteria of anthropogenic and zoonotic origins in 
this environmental compartment (Agardy et al., 2005). 
The Driver, Pressure, State, Exposure, Effect, Action (DPSEEA) model provides 
a framework in which to consider the factors affecting human health with respect 
to a variety of public health problems, with a view to identifying mitigation 
strategies that might take effect at any of the stages from Driver through to Effect 
(Gentry-Shields and Bartram, 2014). The stages of DPSEEA are described as 
follows: 
 Drivers: These are factors that are associated with human health and the 
environment. Driving forces can act at a local or global scale, and include 
societal issues (e.g. population growth, technological advancements), 
economic, and political issues. 
 Pressures: Drivers may have knock-on effects which cause pressure to be 
exerted on the environment, for example, through the generation of various 
types of pollution.  
 State: The introduction, spread and accretion of pollutants in terrestrial and 
aquatic environments, as well as air pollution, reduces the quality of the 
environment.  
 Exposure: People interacting with polluted environments come into direct 
contact with pollutants through ingestion or inhalation of polluted media.   
 Effects: These pollutants might have a number of health effects on humans. 
These may range from “minor, subclinical effects (i.e. effects that have not yet 
manifested in overt symptoms) to illness and death, depending on the intrinsic 
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harmfulness of the pollutant, the severity and intensity of exposure and the 
susceptibility of the individuals exposed.”(von Schirnding, 2002).  
 Actions: Strategies and activities can be developed to act at various stages of 
the framework to protect human health. They can take a variety of forms, 
including the development or adaptation of policies to reduce environmental 
pollution, as well as introducing or improving health education, and medical 
treatment of people affected.  
Figure 1 is a DPSEEA model that simplifies the complex interactions between 
bacteria, including ARB, the coastal environment and humans that can impact 
upon human health.  
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Figure 1: Drivers, Pressures, State, Exposures, Effects and Actions (DPSEEA) model for water-borne bacterial infections in the coastal 
zone.  
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The information populating Figure 1 is discussed further: 
 
1.2 Drivers 
Humans, and other animals, eliminate waste in the form of urine and faeces.  
Faecal matter contains the remains of food, water, dead cells, and microbes. 
Indeed, with 4 x1011 bacteria per gramme, bacteria make up a significant 
proportion of the dried mass of human faeces (Stephan and Cummings, 1980). 
Other components of waste are metabolites produced by the liver, gut and 
kidneys. This is particularly important when considering antibiotics. When 
antibiotics are given, the percentage of the dose that is absorbed and eliminated 
depends on the pharmacokinetic properties of the drug, as well as the method of 
administration. Any unabsorbed antibiotics (between 70% and 90% of the dose) 
and their metabolites, which may still possess antimicrobial properties, are 
excreted in faeces and urine (Levison and Levison, 2009, Review on antimicrobial 
resistance, 2015). Furthermore, the selective pressure that the administered 
antibiotic exerts on the microflora of the treated individual can result in the 
selection and increased abundance of resistant bacteria, which will also be 
eliminated (Gaze et al., 2008). 
Three major driving forces affecting the amount of waste produced, as well as 
antimicrobial usage, are an increasing world population, climate change, and the 
inappropriate disposal of antimicrobial compounds (Gentry-Shields and Bartram, 
2014, Review on antimicrobial resistance, 2015). The world population is 
expected to grow to between 9.4 billion and 10 billion people in the year 2050 
(United Nations et al., 2015). A larger population will produce larger volumes of 
waste to be treated, and more land will be used for food production (crops and 
livestock) to sustain a larger number of people. A greater abundance of livestock, 
and a greater reliance upon intensive farming methods will also contribute to the 
volume of waste produced, as well as the volume of antimicrobials used for 
disease prevention.  
Climate change models predict the occurrence of more frequent and more 
extreme weather events (flash storms, increased precipitation, and flooding), 
which would result in greater volumes of storm water transporting faecal waste 
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from terrestrial environments into waterways (see Pressures below) (DEFRA, 
2009).  
Anthropogenic antibiotic use is the predominant driver of the emergence of 
resistant genotypes and phenotypes around the world (Iredell et al., 2016). In 
addition to their use in human medicine for treating and preventing infections, a 
wide range of antimicrobial products are used in agriculture and aquaculture for 
disease treatment, disease prevention and, in some regions of the world, for 
growth promotion (Review on antimicrobial resistance, 2015). Several studies 
have concluded that agricultural use of antibiotics drives the emergence of 
resistance in human pathogens. Estimates of the global antibiotic consumption 
revealed an increase of 36% between 2000 and 2010 (Van Boeckel et al., 2014). 
While the quantities used vary greatly between different countries, this overall 
trend is expected to continue. In addition to un-metabolised antibiotics and 
residues being excreted by humans and animals receiving treatment, the 
inappropriate disposal of antimicrobial compounds by manufacturers, industry 
and individuals contributes to the quantities of antimicrobials in natural 
environments. These micropollutants exert a selective pressure on bacteria in 
these environments to acquire and maintain resistant genotypes (Review on 
antimicrobial resistance, 2015). 
1.3 Pressures 
Treated and untreated wastewater, containing microbes (including pathogens 
and ARB) and antimicrobial residues, are discharged into surface waters. 
Significant expenditure devoted to the collection and treatment of human sewage 
in the past 50 years in the developed world have reduced the amount of human 
waste entering the environment (Fewtrell and Kay, 2015). Currently, in many 
developed nations like the UK, excrement (faecal matter and urine) is collected 
from domestic, industrial and commercial properties, by sewer systems which 
transport untreated sewage to wastewater treatment plants (WWTPs) 
(Department for Environment Food & Rural Affairs, 2012). At WWTPs, waste 
goes through successive levels of treatment to improve the quality of the final 
effluent discharged into the environment. This is achieved through removing 
gross solids, reducing the levels of nutrients (primarily nitrates and phosphates), 
and destroying or inactivating pathogenic microorganisms such as bacteria, 
viruses, protozoa, fungi and helminths remaining in the final effluent (Gerardi and 
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Zimmerman, 2005). While the overall abundance of microbes is significantly 
reduced during treatment, bacteria are present in the final effluent, and several 
studies have reported evidence that WWTPs provide favourable conditions for 
the HGT of ARGs between bacteria (Rizzo et al., 2013). This has resulted in the 
observation that a higher proportion of bacteria in waters downstream of WWTPs 
is resistant to multiple antibiotics and contain clinically important mobile ARGs, 
compared to bacteria found in waters upstream of WWTPs (Amos et al., 2014a, 
Amos et al., 2014b, Zhang et al., 2009, Ferreira da Silva et al., 2006, Uyaguari et 
al., 2011, Gaze et al., 2008).  
In addition to collecting sewage, a type of sewerage system called “combined 
sewers” also collect storm water in built-up areas via drains. During periods of 
high rainfall, large volumes of storm water enter these combined sewers, and if 
the combined volume of sewage and storm water exceeds the capacity of the 
sewer, then raw, untreated sewage is discharged into waterways (see Figure 2). 
These overflows are called combined sewer outfall (CSO) spills, and their 
purpose is to prevent untreated sewage from backing up and flooding streets and 
properties, or overwhelming WWTPs (DEFRA, 2012).   
 
 
Figure 2: Illustration of a combined sewer system. In dry conditions, wastewater 
is diverted to wastewater treatment plants for treatment. High rainfall can trigger 
combined sewer outfalls (Kidwell-Ross, 2016). 
Another means by which pathogenic microbes and ARB can enter surface waters 
is in land runoff. Manure produced by livestock is applied to land as an organic 
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fertiliser, or left in fields after grazing. It is here that interactions may occur 
between environmental bacteria already present in the soil and the introduced 
bacteria, resulting in the exchange of mobile ARGs (Gaze et al., 2008). During 
heavy rainfall, this manure (containing nutrients, microbes, and antimicrobial 
residues), is washed into nearby waterways (Dufour et al., 2012). Additionally, 
waste from wild animals, such as rats and seabirds, which are also zoonotic 
reservoirs of some human pathogens (Table 1, p. 40), enter coastal waters 
(Dufour et al., 2012, Sinigalliano et al., 2010).  
Bacteria that have adapted to living in or on humans can also enter coastal waters 
as a result of bather shedding (Gerba, 2000). Shedding refers to the process by 
which microorganisms present on the skin, in the gut, or inhabiting mucosal 
membranes (for example in the nose) are expelled. Gerba (2000) estimated that 
the average bather sheds 0.14 g of faecal material, and bather shedding has 
been shown to have an impact upon the levels of bacteria detected in coastal 
waters (Elmir et al., 2007).  
The relative contribution of each of these routes is likely to vary from region to 
region. For example, the amount of untreated waste making its way into surface 
waters might be greater in low- and middle-income countries which lack the 
infrastructure and resources to collect and treat waste. Regardless of region, both 
treated and untreated wastewater, containing bacteria and other pathogens, as 
well as compounds with antimicrobial properties regularly contaminate coastal 
waters.  
1.4 State 
Although the wastewater treatment processes reduce the overall abundance of 
microorganisms, final effluent and raw sewage entering the environment can still 
contain microbes and antimicrobial residues (Hendricks and Pool, 2012, Dufour 
et al., 2012, Ferreira da Silva et al., 2006). Several biotic and abiotic factors affect 
the survival and transport of organisms in coastal waters that have adapted to 
living in or on an animal host. A decrease in temperature, higher salinity, more 
oxygen, fewer nutrients, solar radiation, as well as predation by and competition 
with the autochthonous microbial community affect the rate of survival among 
allochthonous microorganisms (Enns et al., 2012). Despite these hostile 
conditions, some hardy microorganisms survive and persist. For example, some 
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enteric bacteria have been shown to enter a reversible viable but non-culturable 
state in marine waters (Gerardi and Zimmerman, 2005, Troussellier et al., 1998). 
Upon encountering more favourable conditions, these inactivated bacteria may 
reactivate and become a potential source of infection if they reach a suitable host.  
Coastal waters are also influenced by complex hydrological processes, such as 
ocean currents, riverine inputs, and tides, which affect the dispersal of bacteria 
by mixing and re-suspending marine sediments to the water column (Dufour et 
al., 2012, Papatheodoulou et al., 2013). Sediments, which offer a more sheltered, 
stable environment for microorganisms, have been found to contain much higher 
densities of bacteria (including ARB) compared to the water column above 
(Dufour et al., 2012). Vigorous wave action can re-suspend these sediments, re-
seeding the water column with bacteria and other microorganisms. 
It is unsurprising therefore, that large temporal and spatial fluctuations occur in 
the levels of bacteria found in coastal waters (Enns et al., 2012). Nevertheless, 
pathogenic microorganisms, including bacteria have been detected in coastal 
waters. Table 1 presents a selection of water-borne pathogens, the types of 
disease they commonly cause, along with the infective dose, important routes of 
transmission and known hosts and reservoirs. The presence and relative 
abundance of each pathogen will largely depend on the prevalence of carriage in 
the catchment populations, which may include livestock and wild animals, as well 
as the level of treatment applied to wastewater before discharge by WWTPs, and 
the factors affecting the fate and transport within marine waters. 
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Table 1: Examples of autochthonous and allochthonous water-borne pathogens that have been detected in surface waters. Adapted from 
(Gerardi and Zimmerman, 2005, World Health Organization, 2003, Payment, 2003, Public Health Agency of Canada, 2015).  
Organism  Hosts and reservoirs4 Type of illness commonly 
caused 
Mode of transmission 
4 
Infective 
dose4 
Incubation 
period 4 
Bacteria 
Campylobacter 
sp, e.g. C. 
jejuni1 2 
 
Hosts: humans, animals 
Reservoirs: infected humans, 
wild and domestic animals 
Gastrointestinal illness 2, 3 
(Severe infections can cause 
febrile convulsions, Guillain-
Barre syndrome, meningitis)4 
Faecal-oral <500  Days 1 day 
to 10 days 
Leptospira 
interrogans1, 
 
Hosts: humans, animals 
Reservoir: wild and domestic 
animals 
Leptospirosis (Weil’s disease) 
causes flu-like symptoms such 
as fever, chills, headaches, 
malaise, nausea and vomiting, 
conjunctivitis, cough, rash 2,3,4  
Ingestion, inhalation 
or direct contact with 
contaminated water 
or soil 
Not 
known  
2 days to 
30 days 
Vibrio cholerae 
servovar 011,2 
Hosts: humans, aquatic animals 
Reservoirs: seawater, infected 
humans, aquatic animals 
Gastrointestinal illness 3 Faecal-oral 102 – 
>106  
5 
A few 
hours to 5 
days 
  Viruses 
Adenovirus, 
e.g. 
1,2,3,4,5,71,2 
Hosts: Humans  
Reservoirs: humans and 
mammals 
Respiratory disease, 
gastrointestinal illness, urinary 
tract infections, hepatitis, 
conjunctivitis 4 
Faecal-oral, 
inhalation, fomite  
5 – 150  1 day to 14 
days 
Noroviruses 1 Hosts: humans 
Reservoirs: humans, shellfish, 
water 
Gastroenteritis 4 Faecal-oral  18 12 to 48 
hours 
                                                          
1 Gerardi and Zimmerman (2005), 2 World Health Organization (2003) 3 Payment (2003) 4 Public Health Agency of Canada (2015) 5 World Health Organization (2005) WORLD HEALTH ORGANIZATI ON & FOOD A ND AGRI CULTURE ORGANIZATION OF THE UNITED NATI ONS 2 005. Ri sk assessme nt of chol eragenic Vibrio 
cholerae 01 and 0 139 in war m-water shrimp i n international trade . Interpretive summary and techni cal report. Microbiologi cal Ri sk Assessment Series. 
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Organism  Hosts and reservoirs Type of illness commonly 
caused 
Mode of transmission Infective 
dose 
Incubation 
period  
Fungi 
Candida 
albicans 1 
Hosts: humans 
Reservoirs: humans 
Infection of skin or mucous 
membranes 
Severe infections can cause 
ulcers in the gastrointestinal 
tract or bladder lesions in 
kidney, spleen, lung, liver, eye, 
brain 4 
Autoinfection, direct 
contact  
Not 
known 
Unknown  
Protozoans 
Cryptosporidiu
m parvum 1,2 
Hosts: humans and animals  
Reservoir: infected humans, 
domestic animals, environment 
Gastrointestinal illness 
(diarrhoea, cramping, nausea, 
vomiting, fever) 1 
Faecal-oral, direct 
contact, inhalation 
  
1 - 132 7 days to 
10 days 
Giardia 
lamblia1,2  
  
Hosts: humans, wild and 
domestic animals 
Reservoir: humans, wild and 
domestic animals 
Gastrointestinal illness1. 
Infections are asymptomatic in 
most individuals4.  
Faecal-oral route, 
direct contact 
10  1 day to 25 
days  
Helminths 
Ascaris 
lumbricoides 
1,2 
Hosts: Humans, domestic 
animals 
Reservoirs: infected humans, 
swine, soil 
Infection of small intestine, 
pulmonary manifestations may 
occur 4 
Faecal-oral Unknown 6 weeks to 
8 weeks 
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Bacteria that are resistant to antibiotics have also been isolated from coastal 
waters. Table 25 (p. 185 in Appendix I) presents a selection of papers that have 
reported a variety of bacteria with phenotypic resistance to many different classes 
of antibiotics in coastal regions all around the world.  
1.5 Exposures 
Exposure to pathogens can occur via direct contact, as well as indirect contact 
(via vehicles or vectors). While there are other ways that humans can be exposed 
to microbes in the coastal zone2, in this thesis, the focus is primarily on exposure 
to microorganisms (specifically bacteria) during recreational exposure in coastal 
waters. While enjoying recreational activities, people are exposed to 
microorganisms in seawater if they accidentally swallow seawater, if they inhale 
airborne water droplets, or if the microorganisms in seawater cross the skin or 
mucosal membranes (World Health Organization, 2003, Gerardi and 
Zimmerman, 2005). There is a whole spectrum of exposures that are possible 
with recreational use of coastal waters from low levels of exposure (such as 
fishing from the shore, or walking on the beach) to whole body contact (such as 
swimming and surfing), where immersion of the head and face, and ingestion of 
water is likely to occur (World Health Organization, 2003).  
Considering that the popularity of many water sports has increased recently, and 
is expected to continue to do so in the future, the number of events during which 
people are exposed to microbes in surface waters during recreational activities is 
likely to increase (Pond, 2005, Dufour et al., 2012).  
1.6 Effects  
Once exposed, in order to have an effect on their host, the invading 
microorganism must attach to a target cell and multiply (Gerardi and Zimmerman, 
2005). Some pathogens that achieve this cause damage, producing symptoms 
in the infected host. However, some microorganisms might colonise their host 
without causing harm, or symptoms of the disease. The successful colonisation, 
or the production of symptoms, is determined by several factors. First, a sufficient 
                                                          
2 One important way that humans can be exposed to bacteria in the coastal zone is through the 
consumption of contaminated shellfish. Shellfish, such as muscles and oysters filter bacteria 
and viruses from their surrounding environment and concentrate these microorganisms in their 
tissues. Ingestion of raw or partially cooked shellfish carrying bacteria, including those 
harbouring mobile resistance genes, could introduce these bacteria to humans. 
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number of the invading microbe must be present (i.e. the infective dose). This 
varies from microbe to microbe, and might be very small (e.g. between one and 
100 cells for E. coli O157:H7 (Paton and Paton, 1998), or very large (e.g. millions 
of Yersinia enterocolitica cells). Second, the microbe must overcome the host’s 
immune system. People with compromised immune systems, such as infants, the 
elderly, and people receiving immunosuppressive treatments, might become 
symptomatic with a lower infective dose of the pathogen. Finally, in order to cause 
a symptomatic infection, the microbe must be virulent (cause damage).  
A variety of mild, self-limiting infections are associated with bathing in seawater, 
and there is evidence that gastrointestinal symptoms, such as diarrhoea, are 
caused by the ingestion of pathogenic organisms present in faecally 
contaminated coastal waters (Pruss, 1998). In 2003, Shuval reported that over 
120 million cases of gastrointestinal illness occur worldwide due to bathing in 
marine waters polluted by faecal waste. However, as Table 1 shows, there are 
pathogens present in coastal waters which are not transmitted by the faecal-oral 
route, and which cause non-enteric illnesses. Many epidemiological studies 
conducted over the past 60 years have explored the relationship between bathing 
in coastal waters and the occurrence of other symptoms of infections with short 
incubation periods, for example respiratory infections, skin ailments, and 
symptoms of ear and eye diseases (Yau et al., 2009). However, the causal 
association between recreational exposure and these non-enteric illnesses has 
not been assessed as rigorously, and many experts still debate whether 
recreational use of the coastal zone continues to pose a health threat to water 
users (Shuval, 2003b, Payment, 2003, King et al., 2014). Comparatively little 
research has been done on the association between recreational exposure to 
coastal waters and the risk of infection by pathogens with long incubation periods, 
such as hepatitis A and hepatitis E. The most likely explanation for this is the 
large number of zoonotic and environmental reservoirs for some of the 
aetiological agents, and the long incubation period making it more difficult to 
pinpoint the exposure that resulted in infection. In regard to exposure to ARB 
present in coastal waters, while there is a biologically plausible route of 
transmission in this setting, no epidemiological studies have been conducted to 
assess whether recreational exposure to resistant bacteria in coastal waters has 
an impact on water users’ health.  
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1.7 Actions 
The purpose of implemented actions should be to protect people from harmful 
pathogens in coastal waters, and thus protect and improve health. The actions 
currently being adopted in the UK and wider European Union (EU) are considered 
under four broad themes: risk assessment, surveillance, modification of the 
environment, and public awareness and risk communication.  
1. Risk assessment   
Risk assessment involves evaluating the potential risks to health of recreational 
exposure to coastal waters: both the magnitude of the effect and the likelihood of 
the effect occurring. To understand these risks, several pieces of information are 
needed, which include hazard identification (see effects), exposure assessment 
(see state and exposure), and the dose-response relationship. Conducting risk 
assessments helps to identify feasible intervention strategies and areas where 
further research is needed (Ashbolt et al., 2013).  
Table 1 gives an insight into the variety of human pathogens present in 
wastewater and seawater. Measuring the densities of these individual infective 
agents in seawater, as well as identifying infection or colonisation of bathers is 
costly and time-consuming. In addition, many of these pathogens have zoonotic 
and environmental reservoirs, making it even more difficult to pinpoint bathing in 
coastal waters as the causative route of exposure. Therefore, despite multiple 
studies demonstrating an association between bathing and illness, some experts 
argue that there is insufficient evidence to prove that recreational exposure 
causes illness, mentioning that Hill’s criteria of causality have not always been 
met (Hill, 1965). Nevertheless, much research has been conducted into the dose-
response relationships between faecal indicator bacteria (FIB) and the risk of 
illness in bathers. Measuring FIB in bathing waters has been adopted widely, and 
can be used to estimate the risk of infections to the bathing population caused by 
pathogens transmitted by the faecal-oral route.   
2. Monitoring  
Despite the lack of consensus among the scientific and policy-making 
communities that recreational exposure to coastal waters poses a risk to bather 
health, the precautionary principal has been adopted widely. As exposure to 
faecally contaminated water is strongly suspected to cause gastrointestinal 
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illness in bathers, it is recommended that bathing waters are monitored for levels 
of FIB, and are expected to achieve a certain level of these bacteria to reduce 
the risk that bathers face of developing symptomatic infections (World Health 
Organization, 2003, Wade et al., 2003).  Since the 1970s, some nations, including 
many European countries, have monitored selected beaches for levels of faecal 
pollution. In Europe this was done in accordance with the European Commission 
Bathing Water Directive, 76/160/EEC, which directed that designated bathing 
waters be monitored for the FIB total coliforms and faecal coliforms on a regular 
basis during peak bathing times of the year (Council of the European Union, 
1975). However, in 2006, the Bathing Water Directive was revised. Changes 
made in Directive 2006/7/EC included changing the FIB measured at beaches 
from total and faecal coliforms to E. coli and intestinal enterococci, as well as the 
methods used to categorise waters into excellent, good, satisfactory and poor 
(European Parliament Council of the European Union, 2006). These were 
changed due to the acquisition of a larger body of evidence that E. coli and 
intestinal enterococci were more strongly correlated with the risk of 
gastrointestinal illness compared to the previous indicators (Wade et al., 2003, 
Kay et al., 1994, Pruss, 1998).  
Currently, coastal waters and other aquatic environments are not routinely 
monitored for the presence or density of ARB. This is due to the paucity of 
evidence of the risk of exposure to ARB present in bathing waters and whether 
they may have an adverse impact upon human health (Ashbolt et al., 2013).  
3. Modification of the environment  
In many developed countries, efforts are made to reduce the extent to which 
untreated waste enters the aquatic environment. This has so far been achieved 
by improving the collection and treatment of waste, and modifying agricultural 
practices.  
Improvements in the collection, treatment and disposal of waste include:  
 Although not mandatory, some WWTPs treat waste to the highest degree 
(using chlorination or ultraviolet lamps), particularly when effluent is 
discharged into sensitive areas, including bathing waters  
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 Repairing sewage misconnections. Misconnections can result in 
wastewater getting into surface water system, and rainwater entering the 
sewer which can cause flooding.  
Agricultural practices can have a significant impact on coastal water quality via 
diffuse pollution (land runoff). Responsible agencies have proposed several 
modifications to farming practices that will reduce faecal loading from farms into 
surface waters. First, it is recommended that fences are erected to prevent 
livestock from accessing waterways. In addition to preventing animals from 
directly contaminating nearby rivers, farmers can grow certain crops and plant 
grasses (buffer zones) adjacent to waterways to prevent runoff and natural 
drainage to surface waters (Natural England, 2009). The application of manure 
to crops as a fertiliser is still encouraged, but there are guidelines for the storage 
and application of this. For example, manure must not be stored within 10 m of 
any surface waters (DEFRA and Environment Agency, 2015), it must undergo 
treatment before it is applied to agricultural lands (Environment Agency, 2013), 
and the application of manure should not exceed crop nutrient requirements. 
Additionally, in 2006, the European Commission imposed an EU-wide ban on the 
use of antibiotics as growth promoters in animal feeds in an attempt to reduce 
selection for ARB in animals and levels of antibiotic residues in manures (The 
European Parliament and the Council of the European Union, 2003).  
4. Public awareness and risk communication  
Raising awareness by communicating effectively the health risks of bathing in 
coastal waters to members of public can modify bather behaviour and thus play 
a role in preventing infections.  
Besides providing direction on the monitoring of bathing waters, the revised 
Bathing Water Directive dictates that timely and accurate information on the water 
quality at individual bathing waters must be made publically available using 
appropriate media and technologies. Generally, this means making the results of 
water quality monitoring efforts available, displaying water quality classification 
each bathing water site has been awarded, as well as any advice against bathing 
due to short- or long-term pollution events affecting that beach. Beach signs, 
websites, and mobile device applications have recently been introduced to 
disseminate this information to people visiting bathing waters.   
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Too little is known about the impact of ARB in coastal waters on human health to 
be able to advise the public about the risks of bathing.  
 
1.8 Thesis overview 
The work in this PhD thesis focuses on the exposure and effect aspects of the 
DPSEEA model described above, which have been marked by red dotted lines 
in Figure 1 (p.34). While recreational use of coastal waters can be beneficial to 
human health by increasing physical activity (Pond, 2005), understanding the 
detrimental impacts on health will help policy-makers to make evidence-based 
decisions about implementing interventions to improve public health. This 
information will also help members of the public to understand better the risks 
they face when they bathe, and allow them to make informed decisions about 
whether or not they wish to expose themselves to potential hazards.   
A brief description of each data chapter and the knowledge gaps that it addresses 
is given: 
- Chapter 2: A systematic review on the risk of acquiring infections from 
recreational exposure to coastal waters (p. 50) 
The evidence that recreational exposure to coastal waters causes non-enteric 
illnesses and infections with long incubation periods has not been rigorously 
assessed. The aim of this chapter is to quantify the risks to bathers of acquiring 
various infections, and to assess the evidence that there is a causal association 
between bathing and these types of infections. The results are compared to the 
risk of enteric illnesses, which is strongly suspected to be caused by bathing in 
faecally contaminated waters. 
Individual contribution: I led this review, formulating the research questions, 
developing and conducting the search strategies, retrieving the titles, abstracts 
and full texts. I also devised the selection criteria, screened all the titles and 
abstracts and full texts, designed the data extraction form, and completed all the 
data extraction, quality appraisal, syntheses and meta-analyses. Second 
reviewers screened titles and abstracts for inclusion as well as the full texts, and 
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double checked the accuracy of my data extraction and quality appraisal. I wrote 
the chapter, which will be submitted to a peer-reviewed journal for publication.  
- Chapter 3: The beach user health survey (p. 91) 
In addition to the implementation of the revised Bathing Water Directive in 2015, 
improvements in the UK have been made recently to the collection and treatment 
of wastewater, as well as the introduction of initiatives aimed at communicating 
water quality data to the public. In this cross-sectional study, we collected 
exposure and health information from sea bathers and non-bathers using an 
online survey. We use this information to assess whether these various actions 
have resulted in a reduction in self-reported illnesses among bathers compared 
to non-bathers. In addition, water quality data at beaches in England and Wales 
were obtained from various sources, and used to assess whether bathers 
exposed to polluted waters are at a greater risk of experiencing symptoms of ill 
health.  
Individual contribution: Using my knowledge of the literature on this topic, I 
designed this study. This included developing the questionnaire and information 
for participants, applying for approval from the Research Ethics Committee, and 
compiling data on coastal bathing water quality from the Environment Agency 
and Surfers Against Sewage. I was also responsible for data collection, data 
cleaning and analysis, and I wrote the study up and intend to submit it to a peer-
reviewed journal for publication.  
- Chapter 4: Human recreational exposure to antibiotic resistant bacteria in 
coastal waters (p. 119) 
This chapter describes an exposure risk assessment to quantify the extent to 
which water users are exposed to ARB in coastal waters, specifically to third-
generation cephalosporin resistant E. coli. This involved enumeration of resistant 
E. coli from coastal waters using culture-based methods to estimate the 
prevalence of E. coli that are resistant to 3GCs. This data was combined with 
publically available E. coli density data in coastal bathing waters, and a review of 
the volumes of water that people ingest during a variety of water sports. This 
allowed us to identify specific populations and conditions during which 
recreational coastal water users would be most at risk of ingesting ARB.  
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Individual contribution: Water samples were collected by the Environment 
Agency and the laboratory work was conducted by Lihong Zhang and Andrew 
Balfour. I devised a search strategy to find various estimates of the volumes of 
water that people ingest while swimming, and expanded the search to find reports 
of the volumes of water people ingest during other watersports. I incorporated a 
quality appraisal aspect to this literature review, appraising the quality of the 
research supporting each estimate, and performed all the data analyses. I also 
wrote the manuscript for publication.  
- Chapter 5: The beach bum survey (p. 143) 
Having identified water users who are at the greatest risk of ingesting ARB in 
seawater, we set out to test the hypothesis that ingestion of ARB in seawater 
results in gut colonisation by ARB. A cross-sectional survey was conducted to 
assess whether there is an association between ingestion of seawater and faecal 
carriage of ARB.  
Individual contribution: Using my knowledge of the literature and experience from 
designing the Beach User Health Survey, I designed this final study. This involved 
developing the questionnaire, instructions and information sheets for participants, 
applying for ethical approval from the Research Ethics Committee, and designing 
the laboratory protocol. I did all of the laboratory work and performed all of the 
data cleaning and analyses. Finally, I wrote the study up and intend to submit it 
for publication to a peer-reviewed journal. 
- Chapter 6: Discussion and conclusions (p. 173) 
In the final chapter of this thesis, the results from all the chapters are considered 
as a body of evidence, and recommendations made for actions that can be 
implemented to protect human health, as well as potential avenues for future 
research.   
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Chapter 2: A systematic review on the risk of 
acquiring infections from recreational use of 
coastal waters 
 
Review team: Anne Leonard (AL), Ruth Garside (RG), Andrew Singer (AS), 
Obioha Ukoumunne (OU), William Gaze (WG) 
 
2.1 Introduction 
The association between bathing in recreational waters and the risk of infection 
has been the subject of many epidemiological studies since the 1950s. A large 
number of these investigations report that exposure to water contaminated with 
faecal material increases a person’s risk of illness, particularly symptoms of 
gastrointestinal illness and skin ailments (Yau et al., 2009, Wade et al., 2003, 
Pruss, 1998). However, not all studies report such results (Harwood et al., 2013), 
and the evidence that bathing increases a person’s risk of illness is still uncertain. 
Faecal material (of both human and animal origin) contains numerous 
microorganisms, some of which can infect and cause disease in humans. These 
infectious agents may be introduced to natural waters if treated effluent from 
wastewater treatment plants (WWTP) enter waterways. Untreated sewage 
discharged into bathing waters by combined sewer overflow spills, and land runoff 
can also carry high densities of microorganisms. Faecal contamination of waters 
can be detected by measuring the abundance of faecal indicator organisms 
(FIOs). These are microorganisms associated with the presence of pathogens 
transmitted by the faecal-oral route (World Health Organization, 2003).  
In an attempt to develop evidence-based guidelines for “safe” bathing waters 
where it is believed bathers have a low risk of becoming ill, many studies have 
examined the relationship between the density of these FIOs in natural waters 
and the risk of illness in bathers. In 2003, a systematic review and meta-analysis 
of 27 epidemiological studies demonstrated that the FIOs, Escherichia coli and 
enterococci, were better correlated with the risk of developing gastrointestinal 
illness in bathers after exposure to natural waters compared to other FIOs that 
had been studied (Wade et al., 2003).  
51 
 
Most developed nations now monitor bathing waters for these two faecal indicator 
bacteria (FIB) to make sure that levels of faecal contamination are not high 
enough to pose an excess risk to bather health. However, the cost of this activity 
restricts the agencies responsible for monitoring bathing waters to testing 
samples taken from a limited number of bathing waters (designated bathing 
waters) during periods of high use (commonly called ‘the bathing season’). In 
most cases, a few water samples are taken from each bathing water every month 
of the bathing season (European Parliament Council of the European Union, 
2006, Health Canada, 2012). Due to the large spatial and temporal fluctuations 
in FIB densities that occur in natural waters, weekly (or even daily) measurements 
are unlikely to capture high levels of faecal pollution that occur in between 
samples (Enns et al., 2012, World Health Organization, 2003). Indeed, a recent 
study reported that even in bathing waters that were considered to be of good 
quality (according to regular monitoring efforts), bathers were still at an increased 
risk of experiencing gastrointestinal illness, as well as respiratory infections, and 
ear and eye ailments (Papastergiou et al., 2012). Even in England and Wales, 
where water quality is considered to be ‘sufficient’ or better at 95% of designated 
beaches (European Environment Agency, 2016), 3,616 CSO spills were reported 
by water companies between 2014 and 2015, nearly half of these (1,769) 
occurring during the bathing season. However, it is estimated that only 11% of 
those that occurred during the bathing season were detected by current sampling 
methods (Surfers Against Sewage, 2016). Given this, it is useful to know what 
risk of illness people face when they bathe in natural waters, regardless of the 
timing or quantity of FIB levels.  
Current methods of assessing bathing water quality thresholds are limited to the 
evidence base which has largely focused on the risk of gastrointestinal illnesses 
among swimmers. Gastrointestinal symptoms are the most commonly 
investigated adverse health outcome in epidemiological studies conducted, but 
other illnesses and indicators of infection have been reported to be associated 
with bathing in natural waters, such as respiratory infections, skin ailments, eye 
infections, and ear infections, ((World Health Organization, 2003, Zmirou et al., 
2003, Pruss, 1998, Yau et al., 2009). Furthermore, bathing is an umbrella term 
for swimming or spending time in the water, encompassing many different 
activities. Individuals who enjoy other high-exposure activities, such as surfing, 
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may be at greater risk of acquiring an infection, since they usually have a greater 
number of unexpected head submersions and are more likely to ingest water 
accidentally (WHO, 2001).  
Systematic reviews aim to provide an unbiased synthesis of the knowledge that 
exists on a defined topic or research question. The results of these types of 
reviews are considered to be less biased compared to traditional reviews, and 
provide a sound basis on which to assess risks, interventions or treatments, and 
can help to identify knowledge gaps (Higgins and Green, 2011).  
In this systematic review, we aimed to gather, appraise and synthesise the 
evidence in order to answer the following research questions: 
1. Is there an increase in the risk of acquiring infections following recreational 
use of natural water?  
2. Does this risk change with the extent of exposure to the water (i.e. with 
water sport or recreational activity)? 
Having good-quality evidence of the risks of infection from using natural waters 
for recreation is important for communicating to the public the variety of illnesses 
they might experience after bathing in natural waters, and if certain behaviours 
(such as doing low-contact water sports) will reduce the risk of acquiring 
infections. Understanding these risks will allow members of the public to make 
informed decisions about their bathing and sporting habits in recreational waters. 
It is hoped that the results of this systematic review will also help policy-makers, 
beach managers, and water companies to make evidence-based decisions to 
improve public health.   
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2.2 Methods 
In August 2013 a protocol for this review was registered with the Prospero 
database (http://www.crd.york.ac.uk/PROSPERO/ registration number 
CRD42013005307), in which the research questions, search strategy, rationale 
for the review, and methods to be used in the data synthesis were outlined. The 
characteristics of the studies (PECO) that would be included in the review were 
also defined, and used to form the basis of the search strategy and selection 
criteria for studies: 
2.2.1 Inclusion criteria 
Populations (P): This review considers all studies that involved healthy human 
subjects. 
Exposures (E): Any water sport (any recreational activity done in or on water) 
involving contact with natural waters. Natural waters were considered to be 
bodies of water that are not disinfected, such as the sea, rivers, ponds, and 
lakes. 
Comparators (C): The main comparator group of interest in this review are non-
bathers (people who have not had contact with natural waters). However, in 
order to explore the effect of exposure to polluted water, additional comparator 
groups included were water users exposed to unpolluted water bodies, or 
bathers with a lower degree of exposure to natural waters.  
Outcomes (O): The health outcomes of interest are symptoms of infections 
caused by infectious microorganisms present in natural waters, particularly 
microorganisms introduced to these waters in sewage. Symptoms include, but 
are not restricted to, gastrointestinal illnesses, respiratory, skin, eye, throat, and 
ear infections. In addition, we also consider papers reporting other indicators 
of infection, such as identification of the infective organism in stool samples, 
and the detection of antibodies to infective agents in the body (serology).  
Studies were restricted according to the selection criteria listed and rationalised 
in Table 28 (Appendix I, p.193). Briefly, only studies published in English after 
1961 were included. Study designs included were limited to observational 
epidemiological studies and randomised exposure trials, where the health 
outcome(s) under investigation had been reported in a suitable comparator 
(control) group. Studies that were conducted in countries that were not members 
of the Organisation for Economic Co-operation and Development were excluded, 
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as were studies that did not investigate health outcomes related to microbial 
pollution of natural waters.  
2.2.2 Information sources 
A search strategy was developed with the help of Information Specialists3, in 
order to identify relevant published and unpublished literature for inclusion in the 
systematic review. This involved identifying relevant MeSH and free text terms to 
systematically search electronic databases, hand searching pertinent journals, 
asking an expert in the area to suggest articles we might have missed, looking 
for unpublished articles on the internet, and forward- and reverse-citation 
chasing. Each of these approaches is described in more detail below. 
In July 2013, six electronic databases (Table 2) were searched for published 
articles. Two of these databases, BIOSIS and Medline, were searched again in 
June 2015 to identify any relevant literature published since the last search. 
Medline was selected to be searched again because it had the largest number of 
relevant reports, and BIOSIS had the lowest number of hits that were duplicates 
of those identified by Medline.  
Table 2: Electronic databases searched.  
Database name Specialism Dates of coverage Dates searched 
Medline Biomedical 
sciences 
1946 to present 5/7/13 
Updated 22/6/15 
Embase  Biomedical 
sciences 
1947 to present 5/7/13 
BIOSIS Biosciences 1926 to present 5/7/13 
Updated 22/6/15 
Web of Science Biosciences 1900 to present 5/7/13 
Greenfile Environmental 
sciences 
1910 to present 5/7/13 
Environment 
complete 
Environmental 
sciences 
1902 to present 5/7/13 
 
                                                          
3 Morwenna Rogers and Chris Cooper at PenCLAHRC (Exeter) were consulted on the search strategy 
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These electronic databases were searched for appropriate articles using three 
categories of search terms: 
1) Type of water pollution: exposure to waste water, or sewage or microbial 
pollution; 
2) Types of bathing waters: beaches or marine or sea or coastal or lake or 
pond or river; 
3) Type of recreation: swimming or bathers or surfing.   
These three categories of search terms were combined with the Boolean operator 
AND, and results were limited to records published about humans, and to records 
published in English.  A copy of the search strategy developed for use in Medline 
has been included in Appendix I (Table 26, p. 191). This was modified for use in 
the other five online databases.  
In July 2013, the peer-reviewed journal, “Water Quality, Exposure and Health” 
was hand-searched for suitable literature. This particular journal was chosen for 
hand searching because in 2009 it published a systematic review of the risk of 
experiencing skin ailments after recreational exposure to natural waters (Yau et 
al., 2009) and it was not indexed by any of the electronic databases listed in Table 
2.  
It was agreed that the results of unpublished studies should be included in the 
review, and information sources that would yield unpublished results of studies 
were incorporated into the search strategy. In July 2013 we contacted an expert 
in this field, Dr Nick Ashbolt (United States Environment Protection Agency), and 
asked for a list of key papers on illnesses associated with recreational exposure 
to natural waters. Furthermore, in August 2013, the websites of 11 relevant 
environment and health authorities, for example the United States Environment 
Protection Agency, were searched using the phrases “bathing water quality” and 
“human health” (see Table 27, p. 192 in Appendix I for the full list of websites 
searched). Results were sorted by relevance and only the first 50 hits were 
evaluated for their suitability for the review. The web-based search engine 
www.google.com was used in a similar way to identify additional published and 
unpublished epidemiological studies that would be appropriate for the review. 
Finally, the reference sections of identified reports and reviews were searched, 
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as well as the list of papers that had cited included studies, for further related 
studies that might meet the systematic review’s selection criteria.  
2.2.3 Study selection  
After removing duplicated records, selection criteria were used to screen titles 
and abstracts identified by the search strategy for inclusion in the review (Table 
28, p. 193). Independent double screening was shared among four members of 
the review team (AL, RG, AS and WG). Disagreements about which records 
should be retrieved for full text review were discussed, and if a decision could not 
be reached, the record was discussed by all members of the review team. 
Full texts for the records identified in the first round of screening were obtained 
where possible, and were screened using these same selection criteria for 
inclusion in the review. Independent double screening was shared among four 
members of the review team (AL, RG, AS and WG). Any discrepancies were 
discussed, and if a decision could not be reached the record was discussed by 
all members of the review team.  
2.2.4 Data extraction and quality appraisal 
Data extraction forms for four different study designs were drafted and piloted on 
a selection of different study designs: randomised controlled trials, cohort studies, 
cross-sectional studies, and case-control studies (for an example of a data 
extraction form, see Appendix II, p. 241). The following data were extracted, 
where available, from each record: 
Description of the study: the study location, year(s) the study was conducted, 
study design, and study size.  
Study population: eligibility criteria, and methods of recruitment.  
Exposure assessment: the type of recreational exposure and how this was 
defined and assessed, the control group and how this was defined and assessed. 
Where available, the faecal indicator organisms measured, methods of 
enumeration, and their densities at the study site were extracted.  
Outcome assessment: the health outcomes investigated in the study (any illness, 
ear ailment, eye ailment, gastrointestinal illness, other illness, skin ailment, 
respiratory illness, urogenital infections, and infections caused by a specific 
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organism), how this information was collected, and how these outcomes were 
diagnosed. The symptoms and illnesses considered in each of these categories 
are available in Appendix II (p. 238). Where studies relied upon symptomatology, 
case definitions were categorised as being i) sensitive case definitions (the case 
definition required the reporting of just one symptom out of multiple possible 
symptoms), ii) single symptom (the case definition required the reporting of just 
one symptom), iii) specific case definitions (the case definition required the 
reporting of at least two symptoms together), and iv) case definition not reported 
(authors did not report the symptoms included in the diagnosis of a case).  
The numbers of cases among exposed and unexposed individuals were 
extracted, or were calculated if enough data was provided to do so. This 
information was used to calculate a crude odds ratio and 95% confidence 
intervals using STATA statistical analysis software (StataCorp, 2013) for each 
illness within each category of exposure reported. If available, adjusted odds 
ratios and 95% confidence intervals were also extracted, as well as the 
confounding variables that had been used to adjust the odds ratio. In papers 
where numbers of cases in each exposure group or a crude or adjusted odds 
ratio was not available, other risk metrics (for example, crude and adjusted risk 
ratios and adjusted odds ratios along with 95% confidence intervals) were 
extracted for completeness. Where available, data for separate locations (e.g. 
beach names), study years, and populations (e.g. children) were extracted, as 
well as data which had been combined by location, year and population, to ensure 
that individuals were not double-counted within studies.  
Where articles had not provided enough information to adequately appraise the 
quality of the study, authors of the reports were contacted in order to get 
additional information about their investigation. Final and technical reports, as 
well as results from pilot studies, were obtained where possible and used to fill in 
information where it was missing in peer-reviewed, published records.  
Each study was assessed for quality and sources of bias using a relevant version 
of the CASP tool (Critical Appraisal Skills Programme). Studies were recorded as 
being of high quality (the design and methods of the study were sufficient to make 
the results reliable), moderate quality (the design and methods of the study were 
sufficient to make the results fairly reliable) and poor quality (the design and 
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methods of the study were insufficient to make the results reliable). A quality 
appraisal tool interpretation instrument was developed to ensure the same 
assessment criteria were applied to all studies included in the review (see 
Appendix II, p. 246). Data extraction and quality appraisal were conducted by one 
reviewer (AL) and the accuracy was double-checked by one of three members of 
the review team (AS, RG, and WG). Any disagreements were discussed and if a 
decision couldn’t be made, the paper was discussed as a team.  
Due to time restrictions, studies regarding freshwater studies were not data 
extracted or quality appraised. The remainder of this chapter focuses on the risks 
of incident cases of the following four health outcomes among bathers exposed 
to coastal waters compared to non-bathers: 1) cases of any illness, 2) ear 
ailments, 3) gastrointestinal illness and 4) illnesses caused by specific organisms. 
Incidence was chosen over prevalence because incidence is more useful for 
understanding disease aetiology, and fulfils one of Hill’s criteria for causation: 
time-sequence (that exposure precedes outcome) (Hill, 1965). Also the number 
of studies reporting on incidence was much greater. The selected outcome 
categories were chosen in order to: 1) get a sensitive measure of the risk of illness 
by meta-analysing the risk of experiencing any illness, 2) investigate an outcome, 
ear infection, which has not been systematically reviewed and meta-analysed 
before, 3) compare these risks to an outcome, gastrointestinal illness, that has 
been reviewed before, and 4) get an insight into some of the specific pathogens 
that might be causing some of these symptoms, as well as infections with longer 
incubation periods.  
2.2.5 Data synthesis and meta-analysis 
Information from the included studies were synthesised in order to answer the 
following research questions: 
1. What is the risk of acquiring an infection from recreational use of natural 
waters?  
The odds ratios and 95% confidence intervals comparing the risk of infection in 
bathers to the risk of infection in non-bathers were used. Random-effects meta-
analyses were conducted for outcome using a single odds ratio estimate per 
included study (DerSimonian and Laird, 1986). For studies that stratified their 
results by location, year, population (e.g. age, gender), or whether or not bathers 
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were exposed to high or low levels of FIB, data from each strata were combined 
into one odds ratio for the study. This was done using raw data if available, and 
fixed-effect meta-analysis if the raw data were not available but odds ratios and 
95% confidence intervals had been reported (Mantel and Haenszel, 1959). For 
studies that stratified results by the extent of immersion in the water (for example, 
any water contact, paddling, water up to the waist, head immersion, or swallowed 
water), the most inclusive definition was used (i.e. any water contact). 
Heterogeneity among combined studies was assessed using the I2 statistic 
(Higgins and Green, 2011, Higgins et al., 2003).  
The results of meta-analyses were interpreted as being statistically significant at 
the 5% level (P ≤ 0.05) or if the lower bound of the 95% confidence interval was 
greater than the null value, one, or the upper bound of the 95% confidence 
interval was less than one.  
2. Are some recreational activities associated with a greater risk of acquiring 
an infection than others?  
Recreational exposures reported by studies were categorised into three groups 
based on how the authors defined exposure: 1) any water contact, which was 
also considered to be exposures that were either not defined in the study, and 
those which encompassed many different exposures including getting the head 
wet and not getting the head wet; 2) exposures involving body immersion but not 
head immersion; and 3) exposures where the bathers got their head or face wet. 
Whereas the meta-analysis described above combined data from the most 
inclusive definitions of water contact (i.e. any water contact), the impact of high 
levels of contact – head immersion – were also assessed. Similar methods to the 
first analysis were used.  
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2.3 Results 
A total of 6,919 identified titles and abstracts were screened for relevance. Of the 
285 selected for full text review, 148 were excluded. Sixty-five records for 
inclusion were put aside because they reported the results of studies conducted 
in fresh water sites. This left 72 full texts pertaining to 40 separate studies for 
inclusion in the coastal water review (Figure 3). A reference list of the articles 
pertaining to the 40 included studies has been included in Appendix I (Table 29, 
p. 196). 
 
Figure 3: PRISMA flow chart of the number of records considered at each stage 
of the systematic review.   
2.3.1 Description of the included studies 
Location: Nearly half of the all studies (19/40) included in the whole coastal 
waters review were conducted in the United States. Eight studies were done in 
the United Kingdom, four in Australia, two in New Zealand, two in Spain, and one 
each in Denmark, Greece, Mexico, Norway and Turkey (Figure 4).   
Study size: The size of the 40 studies ranged from 25 subjects to 26,686.   
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Study designs: Four major study designs were identified among the included 
studies: two randomised control trials (RCTs), 25 cohort studies (24 prospective 
cohort and one retrospective cohort), six cross-sectional studies and seven case-
control studies. 
Study ID 
 
Location Sample 
size 
Health outcome categories reported 
   A E G I O R S U Sp 
Randomised controlled trials 
Kay 1994 UK 1216          
Fleisher 2010 US 1303          
Prospective cohort studies 
Alexander 1992 UK 703          
Arnold 2013 US 5674          
Balarajan 1991 UK 1460          
Bonilla 2007 US 1491          
Cabelli 1982 US 26686          
Colford 2005 US 8797          
Colford 2012 US 9525          
Corbett 1993 Australia 2968          
Fewtrell 1994 UK 450          
Fleming 2004 US 208          
Haile 1999 US 11686          
Harrington 1993 Australia 1529          
Kocasoy 1995 Turkey  3661          
Lepesteur 2006 Australia 340          
McBride 1998 NZ 3884          
Morens 1994 US  2556          
Nelson 1997 UK NR          
NJSDH 1988 US 11447          
Papastergiou 2011 Greece 4377          
Prieto 2001 Spain 1805          
UNEP 1991 Spain 9691          
Wade 2010 US  6350          
Wade 2013 US 11159          
Yau 2014 US 6165          
Retrospective cohort studies 
Harder-Lauridsen 2013 Denmark 1769           
Cross-sectional studies 
Brown 1987 UK 1903          
Dale 2009 Australia 2794          
Dwight 2004 US 1873          
Gammie 1997 UK 353          
Harding 2015 US 510          
Reed 2006 US 447          
Case-control studies 
Calderon 1982 US 58          
Charoenca 1995 US 106          
Hoque 2002 NZ 519          
Roy 2004 US 772          
Soraas 2013 Norway 290          
Case-control studies of outbreaks 
Begier 2008 Mexico 25          
Ihekweazu 2006 UK 33          
Total   10 21 28 20 19 25 19 5 9 
Figure 4: Summary of key characteristics of the included studies. Health 
outcomes investigated include A = any illness, E = ear ailment, G= 
Gastrointestinal illness, I = eye ailment, O= other illness, R = respiratory illness, 
S = skin ailment U = urogenital ailment, Sp = infections caused by a specific 
organism. UK= United Kingdom, US = United States, NZ=New Zealand, NR=Not 
reported. Colour-coding: Green = good-quality studies, orange = moderate-
quality studies, red = poor-quality studies. 
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2.3.2 The quality of studies 
The CASP tool was used to assess the presence of various types of bias in the 
included studies, including misclassification bias, attrition bias, sampling bias, 
and analytical bias. The overall quality of a study was evaluated by posing the 
question: Are the results reliable? To which the answer could be yes (good 
quality), partially (moderate quality) and no (poor quality). The overall quality of 
each study has been illustrated in Figure 4. Good quality studies (green) were 
found among the prospective cohort studies and RCTs. Reasons for receiving 
moderate or poor ratings among prospective cohort studies tended to be the 
presence of significant attrition bias, misclassification bias, and failure to collect 
and analyse potential confounding factors. Other study designs (cross-sectional 
and case-control studies) were generally found to be of moderate or poor quality. 
The major limitations identified in these studies were small sample sizes, failure 
to collect and adjust for potential confounding factors, different methods of 
assessing the exposure or outcome among all the subjects, and recall periods 
that were of unsuitable duration to capture potential infections with longer 
incubation periods. All studies were limited to some extent by self-selection bias 
and misclassification bias.  
The quality assessment tool also considered how well each study was able to 
demonstrate a causal relationship between exposure and the outcomes 
investigated. These were based upon Hill’s criteria for causation (Hill, 1965). 
None of the studies met all of the criteria, a major limitation among all studies 
being lack of demonstrable specificity (causation is likely if a specific population 
at a specific site and disease with no other likely explanation).  Not all studies 
succeeded in identifying the organisms causing symptoms of ill health, as well as 
isolating the causal organisms from sea water at the time of exposure.   
2.3.3 Risk of infections  
We summarised all of the studies reporting data on each of the following four 
outcomes: 1) any infections, 2) ear infections, 3) gastrointestinal infections, and 
4) infections caused by specific organisms. Due to the size of the review, we 
focused on summarising the quantitative data on the risk of experiencing incident 
cases of these infections among bathers compared to non-bathers. Furthermore, 
we investigated the effect head immersion while bathing has on the risk of these 
infections.  
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1) Infections resulting in symptoms of any illness 
Ten studies reported the outcome ‘any’ illness (Figure 4).   
Study population: All of the studies recruited people at a beach or were self-
reported beach-goers. Seven recruited both adults and children (Balarajan 1991, 
UNEP 1991, Nelson 1997, Prieto 2001, Fleming 2004, NJSDH 1988, Kocasoy 
1995). The three remaining studies recruited only adults (Corbett 1993, 
Harrington 1993, Dwight 2004).  
Exposure assessment: All studies relied upon participants self-reporting their 
exposure to coastal bathing waters. Only one study (UNEP 1991) also had study 
investigators validate participants’ responses by observing whether the 
participants had wet bathing suits or wet hair during the initial interview.  
Comparator groups: In eight of the studies, the comparator group comprised 
beach-going non-bathers (Corbett 1993, Harrington 1993, Kocasoy 1995, Nelson 
1997, Prieto 2001, Balarajan 1991, NJSDH 1988 and UNEP 1991). Three of 
these (Corbett 1993, Kocasoy 1995, and UNEP 1991) also compared bathers 
exposed to polluted bathing waters to bathers exposed to comparatively 
unpolluted waters. In the study conducted by Fleming et al. (2004), bathers 
exposed to historically poor quality bathing waters were compared to bathers 
exposed to bathing waters with historically good quality water. Dwight et al. 
(2004) compared surfers who were exposed to coastal waters affected largely by 
urban runoff to surfers who went in coastal waters affected by diffuse pollution 
from rural runoff.  
Outcome assessment: All of the studies investigating ‘any illness’ relied upon the 
participants themselves, or the parents or guardians of under-age participants, 
self-reporting symptoms of illness. The definition of any illness varied across the 
studies, counting a case as the occurrence of one or more of a list of symptoms. 
The number of possible symptoms people could report to be counted as a case 
ranged from three (Nelson 1997) to 16 (Fleming 2004, Kocasoy 1995, Prieto 
2001), and included symptoms of gastrointestinal infection, as well as non-enteric 
symptoms, such as skin infections and respiratory illness. Most of the studies 
collected health information during a follow-up interview conducted over the 
telephone three to 15 days after exposure. The exceptions to this were Harrington 
et al. (1993) who asked participants to record daily diaries over a period of two 
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months, and Dwight et al. (2004) who used an online questionnaire to collect 
information on symptoms of illness that participants had experienced in the past 
three months.   
The risk of experiencing incident cases of any infection among bathers compared 
to non-bathers  
Four studies reporting the risk of any illness could not be included in this meta-
analysis because it was either not possible to obtain an odds ratio and 95% 
confidence interval from the data reported (Harrington 1993, Nelson 1997), or the 
comparator group consisted of people who had reported contact with coastal 
water (Dwight 2004, Fleming 2004). This left six studies providing data that were 
suitable for pooling in a meta-analysis. The results of the random-effects meta-
analysis show that there is a statistically significant increase in the risk of bathers 
that report any kind of contact with seawater of experiencing any illness 
compared to non-bathers (odds ratio = 2.00, 95% CI 1.38 to 2.90, P < 0.01) 
(Figure 5). There was considerable heterogeneity between the included studies 
(I2 = 93.3%). However, all the studies included in this analysis report a similar 
result: that bathers are at an increased risk of experiencing symptoms of any 
illness compared to non-bathers. The most plausible reasons for the high I2 value 
are differences in study designs and locations, particularly the differences in the 
microbiological quality of the bathing water (Yau et al., 2009, Pruss, 1998, Wade 
et al., 2003).  
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Figure 5: Result of a random-effects meta-analysis to examine the risk of 
bathers reporting any illness compared to non-bathers. The P-value is derived 
from a Cochran χ2 test.  
 
Four studies reported the risk of experiencing symptoms of any illness among 
bathers who immersed their heads in seawater: Balarajan 1991, Corbett 1993, 
NJSDH 1988 and Prieto 2001. There is also a statistically significant increase in 
the risk of experiencing any symptoms of illness among bathers who immerse 
their heads compared to non-bathers (odds ratio = 1.77, 95% CI 1.19 to 2.64, P 
< 0.01: Figure 6). Broadly, the odds ratio reported for bathers who immersed their 
heads compared to non-bathers was smaller than the odds ratios reported for 
bathers reporting any kind of contact compared to non-bathers (Figure 5). Despite 
considerable heterogeneity across the studies included in this meta-analysis (I2 
= 93.4%), all the studies report similar findings: that bathers who immerse their 
heads are at a greater risk of experiencing any symptoms compared to non-
bathers.  
NOTE: Weights are from random effects analysis
Overall  (I-squared = 93.3%, p = 0.000)
Study
Kocasoy 1995
ID
Balarajan 1991
Prieto 2001
Corbett 1993
NJSDH 1988
UNEP 1991
2.00 (1.38, 2.90)
1.69 (0.72, 3.96)
ES (95% CI)
1.30 (1.19, 1.42)
1.30 (0.69, 2.45)
2.38 (1.94, 2.92)
1.95 (1.62, 2.34)
4.17 (3.02, 5.77)
100.00
%
9.95
Weight
20.37
12.87
19.39
19.60
17.83
  
1.173 5.77
Odds ratio
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Figure 6: Result of a random-effects meta-analysis to examine the risk of bathers 
who reported immersing their heads in seawater reporting any illness compared 
to non-bathers. The P-value is derived from a Cochran χ2 test. 
 
2) Infections resulting in symptoms of ear infections 
Twenty one studies collected and reported data on the risk of experiencing 
symptoms of ear infections (Figure 4).  
Study population: 18 of these studies recruited people while at the beach 
(Alexander 1992, Arnold 2013, Cabelli 1982, Colford 2005, Colford 2012, Corbett 
1993, Dwight 2004, Fleisher 2010, Fleming 2004, Haile 1999, Kay 1994, NJSDH 
1988, Papastergiou 2011, Prieto 2001, UNEP 1991, Wade 2010, Wade 2013, 
Yau 2014). Other sources of participants described were from a health clinic 
(Calderon 1982), and online (Harding 2015). Brown et al. (1987) did not report 
the methods they used to recruit participants to their study. Thirteen recruited 
both children and adults as participants, two recruited only children (Alexander 
1992 and Calderon 1982), and five studies recruited only adults (Corbett 1993, 
Dwight 2004, Fleisher 2010, Harding 2015 and Kay 1994). Brown et al. (1987) 
did not report the characteristics of their participants.  
Exposure assessment: In the RCTs (Fleisher 2010 and Kay 1994), participants 
were randomly assigned a bathing status. Bathers were asked to go in the water 
for at least 10 or 15 minutes and immerse their heads completely three times. 
NOTE: Weights are from random effects analysis
Overall  (I-squared = 93.4%, p = 0.000)
ID
NJSDH 1988
Prieto 2001
Study
Balarajan 1991
Corbett 1993
1.77 (1.19, 2.64)
ES (95% CI)
2.29 (1.89, 2.77)
1.23 (0.64, 2.35)
1.29 (1.16, 1.43)
2.38 (1.94, 2.92)
100.00
Weight
27.46
16.54
%
28.77
27.22
  
1.342 2.92
Odds ratio
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Non-bathers stayed on the beach and had no contact with the water, and study 
investigators supervised the participants to ensure people adhered to their 
assigned exposures. In the remaining studies, participants self-reported their 
exposure to the sea. If children were included, parents or guardians reported on 
their behalf. In the studies UNEP 1991 and Haile 1999, investigators also 
observed and confirmed participants’ activities in the water.  
Comparator group: 16 studies recruited beach-going non-bathers as the control 
group (Alexander 1992, Arnold 2013, Brown 1987, Cabelli 1982, Colford 2005, 
Colford 2012, Corbett 1993, Fleisher 2010, Kay 1994, NJSDH 1988, 
Papastergiou 2011, Prieto 2001, UNEP 1991, Wade 2010, Wade 2013, and Yau 
2014).  The comparator group in the Calderon 1982 study were children who had 
no recent history of going into the sea, which might include those who had not 
been to the beach. To investigate the effect of poor water quality on the risk of 
illness among bathers, five of these studies (Colford 2005, Colford 2012, Corbett 
1993, Papastergiou 2011, and UNEP 1991) and five others (Brown 1987, Dwight 
2004, Fleming 2004, Haile 1999, Yau 2014) compared the risk of ear infections 
in bathers exposed to polluted bathing waters to those who bathed in relatively 
unpolluted waters. Harding et al. (2015) recruited surfers to their study and 
investigated the impact different surfing behaviours had on their risk of 
experiencing symptoms of infections.  
Outcome assessment: Nearly all (20 out of 21) studies relied upon participants 
(or parents or guardians of under-age subjects) self-reporting symptoms of ear 
infections. This information was usually collected by investigators during a 
telephone interview three to 14 days after exposure. In the Calderon 1982 study, 
a physician diagnosed cases of otitis externa and asked about exposure to sea 
water in the past week. Dwight et al. (2004) used an online questionnaire to 
collect information on symptoms of illness that participants had experienced in 
the past three months. Cases of ear infection were defined in a variety of ways: 
some definitions required the reporting of a single symptom to be counted as a 
case of ear infection (single symptom case definitions), some case definitions 
were more sensitive, requiring at least one of a list of multiple symptoms to be 
counted as a case (sensitive case definitions). One study (Papastergiou 2011) 
had a case definition for ear infection that required at least two of a list of four 
possible symptoms of ear infections to be reported together to be counted as a 
68 
 
case (specific case definition). Six studies did not report case definitions for ear 
infection (Alexander 1992, Calderon 1982, Corbett 1993, NJSDH 1988, Prieto 
2001, and UNEP 1991).   
The risk of experiencing incident cases of ear infections among bathers 
compared to non-bathers  
Eight studies reporting the risk of ear infection could not be pooled in a meta-
analysis because the comparator group comprised people who had reported 
contact with coastal water (Dwight 2004, Fleming 2004, Haile 1999, Yau 2014), 
or prevalence was measured (Alexander 1992, Brown 1987, Dwight 2004, 
Harding 2015), or there were too few cases or non-cases to calculate an odds 
ratio (Brown 1987, Calderon 1982). The 13 remaining studies reported data that 
were suitable for pooling in a meta-analysis in order to estimate the risk of 
experiencing incident cases of ear infections among bathers compared to non-
bathers.  
Sensitive case definitions: Among bathers there is a statistically significant 
increase in the risk of experiencing ear infections that require the reporting of one 
or more of a list of multiple possible symptoms compared to non-bathers (odds 
ratio = 1.97, 95% 1.50 to 2.59, P < 0.01) (Figure 7). There is a statistically 
significant increase in the risk of experiencing this type of ear infection among 
bathers who immersed their heads in seawater compared to non-bathers (odds 
ratio = 2.12, 95% CI 1.66 to 2.69, P < 0.01) (Figure 8). Generally, the estimated 
odds ratio is higher among bathers who immerse their heads compared to 
bathers who reported doing any kind of activity. The results reported by all studies 
were reasonably consistent, and measures of heterogeneity were relatively low 
in these meta-analyses: I2 values were between 0 and 25% (Higgins et al., 2003) 
(Figure 7 and Figure 8).  
Single symptom case definitions: Bathers reporting any kind of contact with 
seawater are also at a statistically significant increased risk of experiencing 
earache compared to non-bathers (odds ratio = 1.91, 95% 1.18 to 3.07, P < 0.01) 
(Figure 7). There is also a statistically significant increase in the risk of 
experiencing earache among bathers who reported immersing their heads in 
seawater compared to non-bathers (odds ratio = 1.95, 95% CI 1.19 to 3.19, P < 
0.01) (Figure 8). The estimated odds ratio for bathers reporting head immersion 
was greater than the odds ratio for bathers reporting any contact with seawater. 
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Again, the point estimates reported by all the included studies were greater than 
one, although I2 values indicated moderate heterogeneity (I2 values were 
between 66.2 and 73.2%). 
Only one study reported an estimate of risk for the reporting of ear discharge 
among bathers compared to non-bathers (Colford 2005). This study estimated 
that bathers are at a decreased risk of experiencing ear discharge compared to 
non-bathers, although the reduction in risk is not considered to be statistically 
significant (odds ratio = 0.60, 95% CI 0.29 to 1.23). This study also reported that 
bathers who immersed their heads were at a decreased risk of experiencing ear 
discharge compared to non-bathers (odds ratio = 0.61, 95% CI 0.28 to 1.34). 
Again, this reduction in risk is not considered to be statistically significant.  
Case definition not reported: The risk of experiencing ear infections, where the 
case definition is not reported, is higher among bathers compared to non-bathers, 
although this increase is not statistically significant (odds ratio = 1.89, 95% CI 
0.60 to 5.91, P = 0.27) (Figure 7). The results of the studies included in this meta-
analysis were inconsistent: Half of the studies reported that the risk of this 
outcome was insignificantly reduced in bathers, and half reported that the risk 
was significantly higher in bathers. The I2 value indicates moderately high 
heterogeneity (66.2%) (Higgins et al., 2003). Among bathers who immersed their 
heads, however, the risk of experiencing these types of ear infections is greater 
compared to non-bathers, and this increase is statistically significant (odds ratio 
= 2.55, 95% CI 1.48 to 4.40, P < 0.01) (Figure 8). The point estimate is also higher 
than that reported for the risk among bathers engaging in any kind of water 
activity. The two studies included in this meta-analysis reported similar results, 
and heterogeneity between the two studies was moderate (I2 = 44.2%).  
Sources of heterogeneity are most likely to be due to differences in study 
populations, study methods and locations, particularly the differences in the 
microbiological quality of the water in which bathers went.  
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Figure 7: Results of random-effects meta-analyses to examine the risk of 
bathers reporting symptoms of ear infections compared to non-bathers. Results 
have been grouped according to how cases of ear infections were defined. The 
most sensitive case definitions were chosen if a study reported more than one 
sensitive case definition, and the most specific case definitions were chosen if a 
study reported more than one specific case definition. The P-value is derived 
from a Cochran χ2 test.  
NOTE: Weights are from random effects analysis
.
.
.
.
Earache (single symptom case definition)
Arnold 2013
Colford 2005
Colford 2012
Papastergiou 2011
Subtotal  (I-squared = 66.2%, p = 0.031)
Ear infection (sensitive case definition)
Cabelli 1982
Fleisher 2010
Kay 1994
Papastergiou 2011
Wade 2010
Wade 2013
Subtotal  (I-squared = 25.0%, p = 0.247)
Ear infection (case definition not reported)
Corbett 1993
NJSDH 1988
Prieto 2001
UNEP 1991
Subtotal  (I-squared = 77.5%, p = 0.004)
Ear discharge (single symptom case definition)
Colford 2005
Subtotal  (I-squared = .%, p = .)
ID
Study
3.11 (1.65, 5.87)
1.28 (0.93, 1.75)
1.75 (1.19, 2.56)
14.32 (0.95, 216.78)
1.91 (1.18, 3.07)
1.95 (1.40, 2.70)
2.01 (0.37, 10.84)
3.06 (1.67, 5.61)
20.05 (1.33, 302.20)
1.44 (0.90, 2.29)
1.85 (1.18, 2.90)
1.97 (1.50, 2.59)
3.60 (1.80, 7.20)
0.91 (0.52, 1.60)
0.54 (0.08, 3.76)
18.21 (1.15, 287.26)
1.89 (0.60, 5.91)
0.60 (0.29, 1.23)
0.60 (0.29, 1.23)
ES (95% CI)
25.04
37.37
34.71
2.89
100.00
34.51
2.49
15.56
0.98
22.68
23.78
100.00
34.14
35.72
18.26
11.89
100.00
100.00
100.00
Weight
%
Earache
Earache
Earache
Ear pain
Earache or runny ears
Ear
Ear ailments
Ear
Earache
Earache
Ear symptoms
Ear infection
Ear
Otitis
Ear discharge
Outcome_paperreported
  
1.00331 302
Odds ratio Increase in riskDecrease in risk
71 
 
 
Figure 8: Results of random-effects meta-analyses to examine the risk of bathers 
who immersed their heads in seawater reporting symptoms of ear infections 
compared to non-bathers. Results have been grouped according to the 
specificity/sensitivity of case definitions. The P-value is derived from a Cochran 
χ2 test.  
 
3) Infections resulting in symptoms of gastrointestinal illness 
Twenty eight studies reported the risk of symptoms of gastrointestinal illness 
(Figure 4).   
Study population: 24 of the studies recruited people at a beach or were self-
reported beach-goers. Three studies recruited subjects from the community (Dale 
2009), during a water sports event (Harder-Lauridsen 2013) or online (Harding 
2015). Brown et al. (1987) did not report their participant recruitment methods. 
Seven studies recruited only adults (Corbett 1993, Dwight 2004, Fleisher 2010, 
Harder-Lauridsen 2013, Harding 2015, Harrington 1993, Kay 1994). Eighteen of 
the studies recruited both adults and children. Alexander et al. (1992) recruited 
just children, and two studies (Bonilla 2007 and Brown 1987) did not report 
whether their participants were adults or children.  
NOTE: Weights are from random effects analysis
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Exposure assessment: In the RCTs (Fleisher 2010 and Kay 1994), participants 
were randomly assigned a bathing status. Bathers were asked to go in the water 
for at least 10 or 15 minutes and immerse their heads completely three times. 
Non-bathers stayed on the beach and had no contact with the water, and study 
investigators supervised the participants’ exposures. One study recruited people 
who had taken part in an Ironman triathlon (Harder-Lauridsen 2013). In the 
remaining studies, participants self-reported their exposure. If children were 
included, parents or guardians reported the child’s activities on their behalf. In the 
studies UNEP 1991 and Haile 1999, investigators also observed and confirmed 
participants’ activities in the water.  
Comparator group: 21 studies recruited beach-going non-bathers as the 
comparator group (Alexander 1992, Arnold 2013, Balarajan 1991, Brown 1987, 
Cabelli 1982, Colford 2005, Colford 2012, Corbett 1993, Fleisher 2010, 
Harrington 1993, Kay 1994, Kocasoy 1995, McBride 1998, Morens 1994, NJSDH 
1988, Papastergiou 2011, Prieto 2001, UNEP 1991, Wade 2010, Wade 2013, 
and Yau 2014). Seven of these studies (Brown 1987, Colford 2005, Colford 2012, 
Corbett 1993, Papastergiou 2011, UNEP 1991 and Yau 2014) and three others 
(Fleming 2004, Haile 1999, and Harder-Lauridsen 213) recruited bathers who 
had been exposed to relatively unpolluted coastal water as a comparator group. 
Two studies recruited non-bathers who had not necessarily visited a beach 
(Bonilla 2007 and Dale 2009). Both Dwight 2004 and Harding 2015 recruited 
surfers via an online questionnaire. Dwight 2004 compared the risk of 
experiencing gastrointestinal symptoms among surfers who go surfing at 
beaches affected by urban pollution to those surfers who reported going to 
beaches affected by rural runoff. Harding et al. (2015) recruited surfers to their 
study and investigated the impact different surfing behaviours had on their risk of 
experiencing symptoms of infections. 
Outcome assessment: All of the studies relied upon the participants themselves, 
or the parents or guardians of under-age participants, self-reporting symptoms of 
illness. The definition of gastrointestinal illness varied across the studies.  As with 
symptoms of ear infections, four types of case definitions were found in the 
included studies for gastrointestinal infection: sensitive case definitions, single 
symptom case definitions, specific case definitions and outcomes where the case 
definition was not reported. Most of the studies collected health information during 
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a follow-up interview three to 14 days after exposure conducted over the 
telephone, postal questionnaire or in a face-to-face interview. The exceptions to 
this were Harrington et al. (1993) who asked participants to record daily diaries 
over a period of two months, Dale et al. (2009) who asked participants to keep a 
weekly diary for two weeks. Two studies used online questionnaires to collect 
health information from participants:  Dwight et al. (2004) asked participants to 
report symptoms of illness that they had experienced in the past three months, 
and Harder-Lauridsen et al. (2013) asked participants to report symptoms to 
illness that they had experienced two weeks to one month after the triathlon.  
The risk of experiencing incident cases of gastrointestinal infections among 
bathers compared to non-bathers  
Eighteen studies reported data that was suitable for combining in a meta-analysis 
to estimate the risk of experiencing incident cases of gastrointestinal illness 
among bathers compared to non-bathers.  
Sensitive case definitions: There is an increased risk of bathers experiencing 
gastrointestinal illness (where a case is defined as reporting one or more of 
multiple symptoms) compared to non-bathers, which is statistically significant 
(odds ratio = 1.31, 95% CI 1.13 to 1.51, P < 0.01) (Figure 9). Nearly all of the 
separate studies that were pooled to derive this estimate make the same 
observation: bathers are at an increased risk of experiencing gastrointestinal 
illness. However, the results reported by Bonilla et al. (2007) are noticeably 
different from the rest of the studies, reporting that bathers are at a significantly 
reduced risk of experiencing gastrointestinal symptoms compared to non-
bathers. This is most likely due to the control group recruited in this study being 
members of the general population who did not go to the beach, rather than (as 
is the case with the other studies) being beach-goers who did not go in the water. 
The control group in the Bonilla 2007 study could consist of people with poorer 
health overall, experiencing higher rates of illness than people who chose to go 
to the beach. This could be partly responsible for the high heterogeneity observed 
in this meta-analysis (I2 = 75.6%), although differences in study populations, 
methods and locations are likely to contribute to the large I2 value.   
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Figure 9: Result of a random-effects meta-analysis to examine the risk of 
experiencing gastrointestinal infections that were defined as at least one of 
several symptoms (sensitive) among bathers compared to non-bathers. Where 
more than one sensitive definition was reported by a study, the most sensitive 
was selected for analysis. The P-value is derived from a Cochran χ2 test. 
 
Bathers who immersed their heads in seawater are also at a significantly higher 
risk of experiencing symptoms of gastrointestinal illness compared to non-
bathers (odds ratio = 1.57, 95% CI 1.33 to 1.86, P < 0.01) (Figure 10). Generally, 
the odds ratio reported for bathers who immersed their heads compared to non-
bathers were greater than the odds ratios reported for bathers reporting any kind 
of contact compared to non-bathers. Heterogeneity was somewhat lower for this 
meta-analysis compared to that reported in Figure 9, but the I2 value was still 
moderately high (I2=71.7%).  
 
NOTE: Weights are from random effects analysis
Overall  (I-squared = 75.6%, p = 0.000)
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Figure 10: Results of a random-effects meta-analysis to examine the risk of 
experiencing gastrointestinal infections that were defined as at least one of 
several symptoms (sensitive) among bathers who immersed their heads in 
seawater compared to non-bathers. Where more than one sensitive definition 
was reported by a study, the most sensitive was selected for analysis. The p-
value is derived from a Cochran χ2 test.  
 
Single symptom case definitions: Bathers are at a significantly increased risk 
compared to non-bathers of reporting diarrhoea (odds ratio = 1.37, 95% CI 1.19 
to 1.57, P < 0.01), stomach ache (odds ratio = 1.30, 95% CI 1.14 to 1.48, P < 
0.01) and vomiting (odds ratio = 1.29, 95% CI 1.05 to 1.59, P = 0.02) (Figure 11). 
Bathers who immersed their heads in seawater are also at a significantly 
increased risk of reporting these symptoms compared to non-bathers: odds ratio 
for diarrhoea = 1.45 (95% CI 1.25 to 1.69, P < 0.01), odds ratio for stomach ache 
= 1.32 (95% CI 1.16 to 1.49, P < 0.01), and odds ratio for vomiting = 1.36 (95% 
CI 1.11 to 1.67, P < 0.01) (Figure 12). The odds ratios reported for bathers who 
immersed their heads were greater than the odds ratios reported for bathers 
reporting any kind of contact.  
Bathers are also at a higher risk compared to non-bathers of reporting nausea 
(odds ratio = 1.02, 95% CI 0.88 to 1.19, P = 0.76), although the increase in risk 
is not statistically significant. This risk of nausea among bathers who immersed 
their heads in seawater compared to non-bathers is still increased, though not 
NOTE: Weights are from random effects analysis
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significantly so (odds ratio = 1.12, 95% CI 0.96 to 1.31, P = 0.16), and the point 
estimate is larger than that reported for bathers reporting any kind of water 
contact.  
One study (Kay 1994) reported that the risk of experiencing “loose motions” was 
higher in bathers compared to non-bathers (odds ratio 1.83, 95% CI 0.83 to 4.04: 
Figure 11, Figure 12). Another, Papastergiou 2011, reported that the risk of 
experiencing dysphagia (pain on swallowing) was not significantly higher in 
bathers compared to non-bathers (odds ratio = 3.11, 95% CI 0.54 to 17.87). While 
bathers are at an increased risk of experiencing both of these symptoms as 
compared to non-bathers, it was not possible to include them in a meta-analysis, 
but they have been presented in Figure 11 and Figure 12 below for completeness.  
The results reported by all studies for each outcome were reasonably consistent, 
in that they generally report odds ratios greater than one. I2 values reported for 
these meta-analyses were generally low, ranging from 0.0% to 37.0%. Sources 
of heterogeneity are likely to be differences in study design, study location and 
study population.  
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Figure 11: Results of random-effects meta-analyses to examine the risk of 
experiencing single symptoms of gastrointestinal illness among bathers 
compared to non-bathers. The P-value is derived from a Cochran χ2 test. 
 
NOTE: Weights are from random effects analysis
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Figure 12: Results of random-effects meta-analyses to examine the risk of 
experiencing single symptoms of gastrointestinal illness among bathers who 
immersed their heads in seawater compared to non-bathers. The P-value is 
derived from a Cochran χ2 test. 
 
Specific case definitions: Bathers are at a significantly increased risk compared 
to non-bathers of reporting gastrointestinal illnesses that require two or more 
symptoms to be reported together (odds ratio = 1.96, 95% CI 1.01 to 3.78, P = 
0.05) (Figure 13). Only one study (Colford 2005) reported the risk of “highly 
credible gastrointestinal illness” among bathers who immersed their heads in 
seawater compared to non-bathers. There was an increased risk of these bathers 
experiencing highly credible gastrointestinal illness compared to non-bathers, 
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which was statistically significant, odds ratio = 2.18, 95% CI 1.25 to 3.80 (not 
shown). The latter odds is larger than that reported for bathers having any contact 
with seawater. The results of the studies included in this meta-analysis were 
broadly consistent, and heterogeneity was low (I2=18.2%). 
 
Figure 13: Result of a random-effects meta-analysis to examine the risk of 
experiencing specific cases of gastrointestinal illness among bathers compared 
to non-bathers. The P-value is derived from a Cochran χ2 test. 
 
Case definition not reported: Results from studies that did not give a case 
definition for gastrointestinal illness were also pooled in a meta-analysis (Figure 
14). There is an increased risk of bathers experiencing these types of 
gastrointestinal illnesses compared to non-bathers, which is statistically 
significant (odds ratio = 1.41, 95% CI 1.11 to 1.79, P < 0.01). Bathers who 
immersed their heads in seawater were also at a significantly higher risk of 
experiencing these types of gastrointestinal illness compared to non-bathers 
(odds ratio = 1.56, 95% CI 1.04 to 2.35, P = 0.03) (Figure 15). Generally, the odds 
ratio for bathers reporting head immersion experiencing gastrointestinal illness 
was greater than the odds ratio for bathers who reported any kind of contact with 
water. All the studies included in the first meta-analysis (Figure 14) report similar 
results, and the level of heterogeneity is moderately low (I2=35.5%). Again, the 
results of the studies included in the second meta-analysis (Figure 15) report 
fairly similar results, but heterogeneity is much higher (I2=75.6%). Sources of 
heterogeneity are likely to be differences in study populations, study location, 
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methods for assessing the health outcome, and microbiological quality of the 
water to which bathers were exposed.  
 
Figure 14: Results of a random-effects meta-analysis to examine the risk of 
experiencing undefined cases of gastrointestinal illness among bathers 
compared to non-bathers. The P-value is derived from a Cochran χ2 test. 
 
 
Figure 15: Results of a random-effects meta-analysis to examine the risk of 
experiencing undefined cases of gastrointestinal illness among bathers who 
immersed their heads in seawater compared to non-bathers. The P-value is 
derived from a Cochran χ2 test. 
NOTE: Weights are from random effects analysis
Overall  (I-squared = 35.5%, p = 0.199)
Balarajan 1991
ID
Kay 1994
Prieto 2001
Cabelli 1982
Study
1.41 (1.11, 1.79)
1.46 (1.27, 1.67)
ES (95% CI)
1.84 (1.13, 3.01)
5.07 (0.32, 79.26)
1.04 (0.71, 1.52)
100.00
56.01
Weight
17.86
0.76
25.36
%
Gastrointestinal illness
Outcome_paperreported
Gut
Gastrointestinal illness
Severe gastrointestinal illness
  
1.0126 79.3
Odds ratio Increase in riskDecrease in risk
NOTE: Weights are from random effects analysis
Overall  (I-squared = 75.6%, p = 0.017)
Study
Kay 1994
Cabelli 1982
Balarajan 1991
ID
1.56 (1.04, 2.35)
1.84 (1.13, 3.01)
1.04 (0.71, 1.52)
1.94 (1.58, 2.39)
ES (95% CI)
100.00
%
27.25
32.36
40.39
Weight
Gut
Severe gastrointestinal illness
Gastrointestinal illness
Outcome_paperreported
  
1.332 3.01
Odds ratio Increase in riskDecrease in risk
81 
 
 
4) Infections caused by specific organisms  
The above results have focused on the reporting of symptomatic infections 
without identifying the causative agent. However, nine studies reported on the 
risks of infections caused by specific organisms, including those caused by 
bacteria, viruses and protozoans (Table 3).  
Study population: Four of the studies recruited only adults (Gammie 1997, 
Harder-Lauridsen 2013, Hoque 2002, and Soraas 2013), two recruited only 
children (Ihekweazu 2006 and Charoenca 1995), and the remaining three 
recruited both adults and children (Begier 2008, Reed 2006, Roy 2004). Three 
studies recruited people who had visited clinics (Hoque 2002, Charoenca 1995, 
and Soraas 2013). Two studies recruited subjects who had taken part in a water 
sport event (Gammie 1997, Harder-Lauridsen 2013). Two studies recruited 
holiday makers who had visited a particular beach resort (Begier 2008 and 
Ihekweazu 2006). Two studies recruited people from local communities (Reed 
2006, Roy 2004). 
Exposure assessment: All of the studies relied upon participants self-reporting 
their recent exposure to coastal waters. The recall period (the period of time for 
which people were asked to recall their exposure to coastal waters) for the case-
control studies ranged from 10 days (Charoenca 1995) to a year (Soraas 2013). 
One study did not report a recall period (Ihekweazu 2006).   
Comparator group: Eight studies recruited non-bathers as a control group, 
although, as they were not recruited at the beach, their exposure to the beach is 
unclear (Begier 2008, Charoenca 1995, Gammie 1997, Hoque 2002, Ihekweazu 
2006, Reed 2006, Roy 2004, Soraas 2013). Begier et al. (2008) also compared 
bathers who had immersed their heads to other bathers who had not, in order to 
investigate the effect of this increased intensity of exposure. One study did not 
have non-bathers as a comparator group; Harder-Lauridsen et al. (2013) 
compared swimmers exposed to polluted water in 2010 to swimmers exposed to 
relatively unpolluted waters in 2011.  
Outcome assessment: Because these infections were caused by specific 
organisms, outcome assessments utilised either laboratory methods (Harder-
Lauridsen 2013, Hoque 2002, Begier 2008, Gammie 1997, Reed 2006, Roy 
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2004, Ihekweazu 2006, Soraas 2013) or were diagnosed by physicians 
(Charoenca 1995_ENREF_167). Table 3 reports the pathogens identified by the 
included studies.  
Due to the variety of infections reported, it was not possible to combine the results 
of any of these studies in a meta-analysis. Instead, we describe the quantitative 
results presented by the individual papers and present these, uncombined, in a 
forest-plot (Figure 16). Studies investigating prevalence (Gammie 1997, Harder-
Lauridsen 2013, and Reed 2006) have not been included in this summary. 
Table 3: Infections caused by specific organisms, sorted by type of causative 
agent. 
Health outcome Study ID 
Bacterial pathogens 
Campylobacter infections, E. coli infections 
(diarrheagenic E. coli, enteropathic E. coli, 
enterotoxigenic E. coli) 
Harder-Lauridsen 
2013  
Community-acquired urinary tract infections 
caused by ESBL-producing E. coli or Klebsiella 
pneumoniae 
Soraas 2013 
E. coli O157 infections Ihekweazu 2006 
Mycobacterium avium complex infection Reed 2006 
Staphylococcal skin infections Charoenca 1995 
Protozoan pathogens 
Cryptosporidium infections Roy 2004 
Giardia infections Hoque 2002, 
Harder-Lauridsen 
2013 
Viral pathogens 
Echovirus infection Begier 2008 
Hepatitis A Gammie 1997 
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The risk of experiencing incident cases of infections caused by specific organisms 
among bathers compared to non-bathers  
Three studies (Gammie 1997, Reed 2006 and Harder-Lauridsen 2013) reported 
prevalence, and so were not included in this synthesis. Figure 16 displays the 
results reported by individual papers that compared the odds of infections caused 
by specific organisms in bathers compared to non-bathers. Generally, point 
estimates for odds ratios were greater than one (indicating an increase in risk). 
The precision of the odds ratios reported varied greatly. Two of these studies 
reported a statistically significant increase in the odds of acquiring bacterial 
infections among bathers compared to non-bathers. These were staphylococcal 
skin infections (Charoenca 1995), and community-acquired (CA) urinary tract 
infections (UTI) caused by the antibiotic resistant bacteria, extended-spectrum 
beta lactamase (ESBL)-producing E. coli or Klebsiella pneumoniae (Soraas 
2013).  
One study investigated the impact that immersing the head had upon the risk of 
acquiring an infection compared to non-bathers. Begier et al. (2008) reported that 
the risk of acquiring an echovirus infection among this group of bathers was 5.00, 
95% CI 0.21 to 314 (not shown). This point estimate of 5.00 is somewhat lower 
than that reported in Figure 16.  
 
Figure 16: Forest plot with the outcomes of studies investigating the risk of 
infections caused by specific organisms (outcome) associated with recreational 
exposure to coastal waters. A pooled estimate is not reported. 
Begier 2008
Charoenca 1995
Hoque 2002
Roy 2004
Soraas 2013
ID
Study
5.33 (0.14, 207.87)
3.78 (1.57, 9.12)
1.23 (0.68, 2.24)
1.78 (0.77, 4.09)
1.99 (1.16, 3.42)
ES (95% CI)
Echovirus infection (viral)
Staphylococcal skin infection (bacterial)
Giardia infection (protozoan)
Cryptosporidium infection (protozoan)
ESBL-producing CA UTI E. coli or K. pneumoniae (bacterial)
Outcome
  
1.00481 208
Odds ratio Increase in riskDecrease in risk
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2.3.4 Overall 
Figure 17 summarises the results of the meta-analyses conducted to compare 
the effect sizes associated with the different outcomes investigated above. As 
can be seen, all the pooled odds ratios are greater than one, indicating an 
increase in the risk of illness among bathers compared to non-bathers. 
Furthermore, the 95% confidence intervals surrounding the reported odds ratios 
indicate that the increases in risk are statistically different. Only the risk of nausea 
was not significantly increased in bathers compared to non-bathers.  
 
 
Figure 17: Forest plot of the pooled estimates for each outcome that underwent 
random-effects meta-analysis. An overall estimate has not been calculated, and 
results from single studies have not been presented.  
 
Of all the outcomes investigated, bathers who participate in any type of activity in 
seawater are at a greater risk of experiencing symptoms of any illness compared 
to non-bathers (odds ratio = 2.00, 95% CI 1.38 to 2.90). In nearly every health 
outcome (with the exception of any illness) there is a trend towards higher point 
estimates of risk with head immersion.  
Any illness
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Ear infection (not reported)
Ear infection (not reported)
Gastrointestinal infection (sensitive)
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Diarrhoea (single)
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Contact involving head immersion
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1.77 (1.19, 2.64)
1.97 (1.50, 2.59)
2.12 (1.67, 2.70)
1.91 (1.18, 3.08)
1.95 (1.19, 3.19)
1.41 (1.11, 1.79)
1.56 (1.04, 2.34)
1.34 (1.15, 1.56)
1.57 (1.33, 1.86)
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85 
 
2.4 Discussion 
This is the first study that has systematically reviewed the literature reporting on 
the association between non-enteric illnesses and recreational exposure to 
coastal waters. We found that among bathers there is a statistically significant 
increase in the risk of experiencing any symptoms of illness (odds ratio= 2.00, 
95%CI 1.38 to 2.90, P < 0.01) and ear infections (odds ratio = 1.97, 95% CI 1.50 
to 2.59, P < 0.01) among bathers compared to non-bathers, including symptoms 
such as ear ache (odds ratio = 1.91, 95% CI 1.18 to 3.08, P < 0.01). In addition, 
we systematically reviewed and meta-analysed the risk of acquiring 
gastrointestinal illness among bathers compared to non-bathers. There is a 
statistically significant increase in the risk of experiencing gastrointestinal 
symptoms (odds ratio = 1.31, 95% CI 1.13 to 1.51, P < 0.01), including symptoms 
such as diarrhoea (odds ratio = 1.37, 95% CI 1.19 to 1.57, P < 0.01), stomach 
ache (odds ratio = 1.30, 95% CI 1.14 to 1.48, P < 0.01) and vomiting (odds ratio 
= 1.29, 95% CI 1.05 to 1.59, P = 0.02). The reporting of more specific case 
definitions of gastrointestinal illness (such as highly credible gastrointestinal 
illness) was also significantly higher among bathers compared to non-bathers 
(odds ratio = 1.96, 95% CI 1.01 to 3.78, P = 0.05).  
While the risk of gastrointestinal illness among bathers has received a lot of 
attention, there are no reviews that have produced a pooled estimate of studies 
reporting the risk of gastrointestinal illness in bathers compared to non-bathers. 
Pruss (1998) reported that the risk ratio for reporting gastrointestinal illness 
among bathers exposed to relatively clean water compared to non-bathers 
commonly lay between 1.0 and 2.5 (representing an increase in risk to bathers), 
although the precision of these risk ratios were not commented upon. In contrast, 
a recently published non-systematic review of the epidemiological literature 
conducted since 2003, reported that while most papers report an increase in the 
odds of gastrointestinal illness among bathers at marine beaches compared with 
non-bathers, there is little evidence of a true difference (King et al., 2014). The 
most plausible reason for the contradictory results of this review is that the 
assessment conducted by King et al. was limited to reviewing studies that had 
been published from 2003 onwards, and a pooled estimate was not produced as 
the authors considered their included studies too heterogeneous to combine. 
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Excluding studies published before 2003 did not make a large difference to our 
findings on the risk of acquiring ear infections or some gastrointestinal infections: 
the risk of earache and ear infection remained significantly higher in bathers, with 
little difference to the overall estimates (see Appendix I Figure 28, p. 198), and 
the risk of experiencing gastrointestinal infections, including diarrhoea and 
vomiting also remained significantly elevated in bathers compared to non-bathers 
(Appendix I Figure 30, p. 200). While the risk of experiencing vomiting and the 
risk of experiencing sensitive cases of gastrointestinal illness remained elevated 
in bathers, the 95% confidence intervals around these point estimates included 
one, suggesting that there is not a statistically significant increase in risk for these 
health effects (see Appendix I Figure 29 and Figure 30, p. 199). All of the studies 
reporting on the risk of experiencing symptoms of any illness were conducted 
prior to 2003.  
The results of the random-effect meta-analysis to estimate the risk of 
experiencing nausea indicated that the risk of this particular symptom was 
elevated in bathers compared to non-bathers. However the increased risk of 
reporting nausea was not statistically significant (odds ratio = 1.02, 95% CI 0.88 
to 1.19, P = 0.76). The rates of nausea in the bathing and non-bathing groups 
were generally very low (<3%), and the differences in the rate of nausea between 
the two groups were very small. Detecting such a small increase in the reporting 
of an uncommon symptom requires large studies. However, most of the studies 
included in the meta-analysis were very large, and all were of excellent or 
moderate quality. It is worth noting that most studies included in this meta-
analysis reported an insignificant increase in the risk of nausea among bathers 
compared to non-bathers, with the exception of the two Colford studies (Colford 
2005 and Colford 2012), which reported an insignificant reduction in the risk of 
experiencing nausea among bathers compared to non-bathers (Figure 11, p. 77). 
The reason for the lack of consistent findings among the studies could be the way 
each study measured the symptom of nausea, as well as the symptom itself, 
which is a sensation, lacking a “clinically observable event” (Stern et al., 2011b). 
Therefore this particular symptom, which has a wide range of potential causes 
(such as, pregnancy, anxiety, motion sickness), is susceptible to risk perception 
and recall biases, and is therefore often under-reported by sufferers (Stern et al., 
2011a).  
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This is also the first review to conduct a meta-analysis to examine the effect that 
head immersion in seawater has upon the risk of experiencing illness. The point 
estimates of risks for symptoms of ear infections and gastrointestinal illness were 
higher in bathers who immersed their heads in seawater, increasing the odds 
ratio between 1.54% and 34.9% (stomach ache and ear infection (case definition 
not reported), respectively). However, the precision of these estimates were poor, 
meaning that there are a large range of values that the true odds ratio could be. 
The exception to this trend was any illness. Bathers who immersed their heads 
were still at a significantly increased risk of experiencing any illness compared to 
non-bathers, but the odds ratio decreased by 11.5% by excluding bathers who 
had not immersed their heads in seawater. A possible reason for this slight 
reduction in effect size is that the head immersion analysis did not include two 
studies that had been conducted in seawater with high levels of FIB (Kocasoy 
1995 and UNEP 1991). Therefore greater weight was given to studies such as 
NJSDH 1988, which were conducted at beaches with low levels of FIB, where 
presumably the risk of experiencing symptoms of ill health was lower.   
This is also the first time that the literature reporting on the association between 
acquiring infections caused by specific organisms and recreational exposure to 
coastal waters has been systematically reviewed. We found that bathers are at 
an increased risk of acquiring certain bacterial, viral and protozoan infections. 
Although all the included studies reported an odds ratio of greater than one, the 
magnitude of risk (effect size) and in the precision of these risk estimates varied 
greatly, with some of the 95% confidence intervals reported including a value of 
one (Figure 16, p. 83). Due to the variety of different organisms reported among 
the identified papers, it was not possible to pool estimates from these studies into 
a meta-analysis. Despite this, it is worth noting that among the infections caused 
by specific organisms, the only infections that were significantly increased in 
bathers compared to non-bathers were caused by bacteria (Charoenca 1995 and 
Soraas 2013).  
Most of the studies were limited by selection bias: beach-goers who elect to go 
into the sea might comprise a different population of beach-goers to those who 
choose to stay out of the sea, and people who volunteer in a health study might 
be different from those who choose not to. Therefore, any observed health effects 
might be due to some other, unmeasured factor, rather than exposure to 
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seawater (dos Santos Silva, 1999). Differences in rates of attrition in the exposed 
and unexposed groups could be another source of selection bias in the included 
studies, but this was rarely reported. Ethically speaking, these biases are very 
difficult to eliminate in epidemiological studies with human subjects.  
Misclassification bias was another potential source of bias identified in many of 
the studies. Most relied upon participants to self-report their exposure and 
outcomes, the accuracy of which may be influenced by interviewer bias, recall 
bias and response bias (dos Santos Silva, 1999). Another potential source of 
misclassification bias is the methods used by the included studies to measure 
water quality and how water quality values were applied to bathers.  
While viruses, such as norovirus, are widely believed to be the most common 
cause of gastrointestinal illness among bathers (Maunula, 2007, Maunula et al., 
2004, Sinclair et al., 2009, Harwood et al., 2013), none of the studies included in 
the systematic review assessed norovirus, as the causative agent of symptomatic 
illness. In fact, many of the included studies did not identify the pathogen 
responsible for the observed health outcome. This is because there are so many 
entities in addition to microbes in seawater that can cause symptoms of illness, 
and similar symptoms can be caused by a variety of pathogens (Table 1, p. 40). 
While we excluded studies that specifically investigated exposure to poisons 
present in natural waters (pesticides, heavy metals) and harmful algal blooms, if 
these entities are in seawater, they might be responsible for the observed 
symptoms rather than sewage. To address this we recommend that, where 
possible, future studies collect specimens from subjects and the environment to 
try to identify the pathogenic microorganisms. The advancement and reduced 
cost of culture-independent metagenomics techniques should permit the 
detection and identification of pathogens (Miller et al., 2013).  
There are a few limitations inherent in this systematic review that must be 
considered. First, our selection criteria for studies excluded those conducted 
before 1961, and those that were not published in English. One study identified 
by our search was published before 1961, and three studies were not written in 
English. Publication bias was assessed using funnel plots (see Appendix I Figure 
32, p. 202). There are few studies occupying the southwest corner of the funnel 
plot, indicating an under-representation of smaller studies reporting negative 
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findings (odds ratios of less than one). We anticipated the potential for publication 
bias and tried to reduce this by including in the search strategy methods to identify 
grey literature (study results that have not been published in academic journals), 
and did not place limits on the size of the studies that could be included in the 
review. Nevertheless, the paucity of small studies reporting negative findings 
might influence the pooled estimates reported. We also excluded studies that 
were conducted in countries that were (at the time) not members of the OECD. 
This means that the results reported by this systematic review are not necessarily 
applicable to coastal waters in developing countries.  
Studies were excluded from the meta-analyses if they did not report an odds ratio 
and 95% confidence intervals or sufficient raw data for this summary statistic to 
be calculated. Therefore studies reporting other relative effect measures (e.g. risk 
ratios), or studies where at least one of the cells of the 2 x 2 tables contained 0, 
were not included in the random-effects meta-analysis as the necessary statistics 
were not calculable. For example, Ihekweazu 2006 reported that none of children 
who had not played in the sea were found to be infected with E. coli O157. Odds 
ratios and 95% CI were undefined, and therefore were excluded from analyses. 
These kinds of results are more frequent in small studies, where low-risk illnesses 
are less likely to be observed.  
 
It is our intention to synthesise the data for the other health outcomes that were 
extracted and double checked (eye, other, respiratory, skin, urogenital) in the 
future. These outcomes are beyond the scope of this thesis given the size of the 
review. It would also be beneficial to update this review in a few years’ time to 
investigate the impact the revised Bathing Water Directive (2006/7/EC), as an 
intervention, has had upon the risk of illness among bathers, by comparing 
studies conducted in European countries after 2015 to those conducted before. 
A review of the revised Bathing Water Directive is planned between 2018 and 
2020, and this type of analysis could be extremely useful evidence to submit to 
such a consultation. It was also our intention, as stated in the published protocol, 
to evaluate the effect of microbiological water quality on the risk of illness by 
comparing bathers exposed to coastal bathing waters with high levels of FIB to 
bathers exposed to coastal bathing waters with low levels of FIB. Due to the time 
available, this wasn’t completed, but it is my intention to do so in the future.   
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Conclusions 
This is the first systematic review to evaluate the evidence that bathers are at risk 
of acquiring infections from exposure to seawater, and to quantify this risk relative 
to non-bathers. We report that bathers are at a significantly higher risk of 
experiencing a variety of symptoms of ill health compared to non-bathers, 
including symptoms of ear infections, gastrointestinal infection and symptoms of 
any illness. Recreational exposure to coastal waters is likely to cause these 
infections, although future epidemiological studies should aim to address the 
issue of specificity.  
 
 
Based on the studies identified in this systematic review, it has been 10 years 
since an observational epidemiological study was conducted in the UK. The 
quality of bathing waters in England and Wales is widely reported to have 
improved in recent years, and therefore an updated estimate of the risk of illness 
in England and Wales would be useful. In the next chapter, we describe a cross-
sectional study that we conducted in England and Wales on the risk of sea 
bathers experiencing illness.  
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Chapter 3: The beach user health survey 
3.1 Introduction 
Seawater contains a variety of microbial organisms, many of which are normal 
members of the marine microbial community (World Health Organization, 2003). 
However, faecal pollution of aquatic environments introduces pathogens to 
coastal waters. There are several ways that waterways become contaminated by 
human and animal faecal matter. Wastewater treatment plants discharge treated 
effluent directly into the sea or into rivers that empty into coastal waters. While 
wastewater treatment reduces the abundance of pathogenic and non-pathogenic 
microorganisms, final effluent discharged to the environment can still contain high 
numbers of microbes. Untreated (raw) sewage can also enter coastal waters 
during periods of high rainfall. Rainwater produces runoff from agricultural lands, 
flushing livestock manure from fields into waterways. Rain can also trigger 
combined sewer overflow (CSO) spills, which discharge a mixture of storm water, 
grey water and raw sewage into the aquatic environment.  
The introduction and survival of faecal pathogens in sea water poses a health risk 
to people who use these waters for recreation. Many studies around the world, 
including the UK, have reported an association between recreational exposure to 
pathogens in the sea and an increase in the risk of a range of illnesses, such as 
gastrointestinal, respiratory, skin, ear, and eye infections (Wade et al., 2003, 
Pruss, 1998). The most commonly investigated and reported illness associated 
with bathing in coastal water is gastrointestinal illness (see Chapter 1 Results, p. 
61). In 2003, Shuval reported that every year over 120 million cases of 
gastrointestinal illness are caused by swimming and bathing in polluted coastal 
waters worldwide (Shuval, 2003b). The most recent estimate for the number of 
gastrointestinal cases in England and Wales caused by bathing in faecally 
contaminated coastal waters was produced in 2001 and estimated that 1.75 
million cases of gastrointestinal illness occur each year (Georgiou and Langford, 
2002). However, due to their mild and self-limiting nature, illnesses acquired from 
recreational use of marine bathing waters are likely to be significantly under-
reported (World Health Organization, 2003). 
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A range of measures have been taken in recent years to protect the health of 
water users by improving the communication of water pollution risks to the public, 
as well as improving bathing water quality. For example, several UK water 
companies warn the Environment Agency and other organisations when a CSO 
is discharging at a designated beach, so that members of the public can be 
notified when their local bathing waters are affected by pollution. In mid-July 
2014, the Environment Agency started issuing Pollution Risk Forecasts, which 
are daily predictions of water quality at selected beaches freely available on their 
website (http://environment.data.gov.uk/bwq/explorer/index.html). Additionally, 
designated bathing waters in Europe are regularly monitored to assess levels of 
faecal contamination by measuring the densities of faecal indicator bacteria (FIB): 
bacteria that are found in high numbers in faecal material, and are therefore used 
as a proxy for the presence of pathogens transmitted by the faecal-oral route 
(Pruss, 1998). In 2012 the FIB measured transitioned from faecal coliforms and 
total coliforms to E. coli and intestinal enterococci, under the procedures of the 
revised European Bathing Water Directive 2006/7/EC (European Parliament 
Council of the European Union, 2006). In 2015 the revised Bathing Water 
Directive was fully implemented in the UK, which grades bathing waters as 
excellent, good, sufficient, or poor according to the densities of E. coli and 
intestinal enterococci measured in weekly water samples (Environment Agency, 
2016). In England and Wales, water samples are taken from designated bathing 
waters approximately 20 times over the course of the bathing season, which runs 
from 15 May to 30 September (Department for Environment Food & Rural Affairs, 
2013). Table 4 reports the upper density thresholds for each indicator for each 
water quality grade under the Directives in operation in A) 2014 and B) 2015 
onwards.  
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Table 4: Water quality indicators used in the monitoring of designated coastal 
bathing waters and density limits for classifying bathing waters.  
 Parameter 
(CFU/100 ml) 
Excellent 
(Guideline) 
Good Sufficient 
(Mandatory) 
Poor  
(Fail) 
A Intestinal 
enterococci 
100 - - - 
E. coli 100  2000 >2000 
B Intestinal 
enterococci 
100 (*) 200(*) 185(**) 10% or more of 
samples exceeded 185 
E. coli 250(*) 500(*) 500(**) 10% or more of 
samples exceeded 500 
*95-percentile evaluation, **90-percentile evaluation. All units are colony-forming units 
per 100 ml 
However, academics, public health professionals, politicians and special interest 
groups debate the effectiveness of monitoring bathing water quality in this way. 
A major concern being that FIB densities vary significantly throughout the course 
of the day and week, and vary along the length of a beach (Enns et al., 2012), 
and therefore that current sampling efforts fail to capture major pollution events. 
For example, it is estimated that only 11% of water samples taken by the 
responsible agencies are done at times that would detect increases in FIB 
following CSO spills (Andy Cummins, Campaigns Director at Surfers Against 
Sewage, personal communication). The most recent epidemiological study to be 
conducted in the UK was a small case-control study in 2004, involving 33 
subjects, in response to an outbreak of highly virulent E. coli O157 (Ihekweazu et 
al., 2006). Playing in the sea was reported to be a significant risk factor for 
developing infection. The last large-scale study to be conducted in the UK was in 
the early 1990s (Kay et al., 1994, Fleisher et al., 1996), which collected data from 
1,216 adults in the first ever randomised controlled trial of its kind. The primary 
aim of the current study is to assess whether water users are still at risk of 
experiencing illnesses commonly associated with bathing in faecally 
contaminated seawater following changes imposed by the revised Bathing Water 
Directive (2006/7/EC). We also assess whether available water quality data can 
predict a high risk of illness among bathers.  
To the best of our knowledge, the acquisition of infections via the inhalation of 
airborne water droplets in coastal zones has not been investigated before. 
Therefore, another aim of this survey was to investigate whether there is an 
association between visiting beaches and reporting symptoms of respiratory 
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illness, assuming that the majority of respiratory illnesses are caused by airborne 
pathogens.  
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3.2 Methods  
This cross-sectional study involved an online survey to collect information from 
adults in England and Wales on their exposure to coastal waters in these 
countries, as well as on their health, dietary, and behavioural habits in the 
previous two weeks. To ensure a range of conditions were sampled, the 
questionnaire was made available at four points throughout a one year period; 
twice during the bathing season, and twice outside the bathing season. Each time 
it was available for two weeks for people to participate. Respondents who 
reported going into the sea in the previous two weeks were compared to people 
who reported not going into the sea in the same period to assess whether there 
is an association between recreational use of coastal waters and risk of self-
reported symptoms of illness. A sampling strategy was pursued that allowed us 
to investigate the impact of poor water quality at beaches visited by participants 
upon the risk of experiencing ill health.  
3.2.1 Planning 
Prior to conducting the survey, the materials given to participants, such as the 
information sheet and the survey questions, were piloted by members of staff at 
Surfers Against Sewage, as well as by a number of people who do not regularly 
go to the beach (students and staff at the University of Exeter). This was to ensure 
that questions and information were clear and meaningful to potential 
participants. Amendments were made to the materials based on feedback from 
the pilots. Approval for the study was sought from and granted by the University 
of Exeter Medical School Research Ethics Committee (reference number 
14/02/039).  
3.2.2 Eligibility criteria 
People were eligible to take part in this study if they were adults (aged 18 and 
above) who lived in England and Wales.  
3.2.3 Sample size calculation 
It was estimated that 957 bathers and 957 non-bathers would need to be recruited 
to the beach user health survey to detect a difference of five percentage points 
(15% versus 10%, respectively) in the rate of illness with 90% power at the 5% 
(2-tailed) level of significance. The background rate of 10% of gastrointestinal 
illness among non-bathers was obtained from Kay and colleagues (1994). These 
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parameters were chosen in order to detect the same difference as reported by 
the randomised controlled exposure studies conducted in the UK in the 1990s.   
3.2.4 Participant recruitment  
Working with Surfers Against Sewage (SAS), an environmental charity based in 
Cornwall, we recruited participants to the survey via SAS’s membership email list 
(approximately 40,000 email addresses), and by advertising for participants on 
social media (Facebook, and Twitter). Messages and adverts, which included a 
link to the live survey, were only sent out when the survey was available for 
people to participant in. Subjects self-selected for each wave of data collection 
by visiting the survey, and informed consent was assumed to be given by 
participants if they submitted the online questionnaire.  
Since we expected high rainfall to reduce bathing water quality by triggering CSO 
spills, in order to maximise the chance that we collected data from people 
exposed to bathing waters affected by faecal pollution as well as bathing waters 
unaffected by pollution, the questionnaire was made available four times in a 12-
month period. The survey was released twice during the bathing season: for two 
weeks after a period of low rainfall in June 2014, and for two weeks after a period 
of high rainfall in August 2014. Sampling outside the bathing season was 
conducted in a similar manner: the survey was available for two weeks following 
a period of high rainfall in November 2014, and again for two weeks after a 
relatively dry period in April 2015 (Table 5). This provided us with 16 weeks’ worth 
of data on volunteers’ recent exposures to the sea and their health.  
 
Table 5: Dates that the survey were made available to the public, and the period 
of time to which their data related. The total rainfall that fell in England and 
Wales during the dates of recall were estimated from publically available data 
provided by the Met Office data (Met Office, 2016)  
Wave  Dates survey was 
available 
Dates of recall Total 
rainfall in 
England 
and Wales 
(mm)  
1 02/06/2014 to 15/06/2014 19/05/2014 to 14/06/2014 93.9  
2 19/08/2014 to 01/09/2014 04/08/2014 to 30/08/2014 104.9 
3 10/11/2014 to 23/11/2014 27/10/2014 to 22/11/2014 124.7 
4 13/04/2015 to 26/04/2015 30/03/2015 to 25/04/2015 28.6  
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3.2.5 The online survey 
Participants were asked to complete a short survey, which was hosted online by 
Bristol Online Surveys (https://www.survey.bris.ac.uk/). Information about the 
study and a consent form preceded the survey questions. The questionnaire 
collected some demographic information (gender, age, and a measure of 
socioeconomic status), data on recent visits to beaches and recent exposure to 
the sea, whether respondents experienced symptoms of ill health in either of the 
weeks for which they were providing data. Additionally, information on various 
risk factors and potential confounders thought to be associated with the outcomes 
under investigation, such as consumption of food that might cause 
gastrointestinal ailments, were also collected. Questions in the survey were 
based on those in similar surveys investigating health effects following exposure 
to coastal water (Kay et al., 1994, Fleisher et al., 1993, Fleisher et al., 1996, 
Fleisher et al., 2010). The questionnaires were anonymous, but participants were 
asked to provide an email address at the end of the questionnaire. This was so 
that individuals participating in multiple rounds of data collection could be 
identified as repeat responders; another potential confounder. A copy of the 
online questionnaire has been included in Appendix II, (p. 271).  
3.2.6 Data analysis 
Data collected during all four waves were combined into one dataset. People 
were excluded from the survey if they reported going into the sea anywhere other 
than in England or Wales. A new variable was created that identified in which 
wave of data collection each individual participated, based on the date they 
submitted their response. A total of 503 responses were identified as being 
submitted by ‘repeat responders’: individuals who submitted responses for more 
than one wave of the survey. These individuals were identified by matching up 
email addresses provided in each round. Email addresses were then removed 
from the database to preserve participant anonymity. Results were imported into 
STATA v13 (STATACorp, 2013) for further analysis.  
 
Exposure definitions  
Participants were categorised by their reported exposure to seawater and to the 
beach: 
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 “Bathers” were people who reported going into the sea in the past two weeks4; 
 “Beach-going non-bathers” were people who reported visiting the beach in the 
past two weeks but reported not going into the sea in this time; 
 “Community controls” were people who reported not going to the beach nor 
going into the sea in the previous two weeks. 
Additionally, bathers were categorised based upon their reported exposure to 
designated bathing waters that had been affected by pollution. Respondents 
were asked to name the beaches that they had visited in the first and second 
week of the previous two weeks. Water quality information was obtained for 
designated beaches to assess whether people visiting the beach could have been 
exposed to faecally polluted water during the week they reported visiting the 
beach. These data were acquired from two sources: 
1. The density of FIB for each water sample taken at designated beaches in 
2014 by the Environment Agency (EA) were obtained from the 
Environment Agency’s DataShare service (Environment Agency, 2014).  
2. Surfers Against Sewage shared a database of CSO spill notifications from 
the developers of their Safer Seas Service.  
Bathers were considered to have been exposed to faecally polluted bathing 
waters if they visited a beach in the same week as high densities of E. coli or 
intestinal enterococci (>500 CFU/100 ml and >185 CFU/100 ml respectively, as 
defined by the revised Bathing Water Directive 2006/7/EC) were reported, and/or 
a notification of a CSO spill was issued for that beach.  
Case definitions 
Participants were asked to self-report any symptoms of ill health they had 
experienced in the first as well as the second week of the previous two weeks. 
We measured six major health outcomes: gastrointestinal illness, acute febrile 
respiratory infection (AFRI), skin ailments, ear ailments, eye ailments, and any 
illness. Cases of these matched definitions used in a previous UK-based 
epidemiological study (Kay et al., 1994, Fleisher et al., 1996), and are defined as 
follows: 
                                                          
4 Regardless of whether or not they reported visiting a beach in the past two 
weeks. 
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 Gastrointestinal illness – any of vomiting or diarrhoea or nausea with fever or 
indigestion with fever. 
 AFRI – at least one of the following from each category: 1) fever, 2) headache 
or body aches or unusual fatigue or loss of appetite, 3) sore throat or runny 
nose or dry cough or productive cough. 
 Skin ailments – at least one of the following: skin rash or skin ulcer or skin 
irritation accompanied by itching.  
 Ear ailments – ear ache with or without concurrent discharge. 
 Eye ailments – red or painful eye with or without concurrent discharge.  
 Any symptom – occurrence of at least one of the symptoms investigated, 
including symptoms of illnesses other than these that participants reported 
experiencing.   
Combining data 
The main analyses used logistic regression to compare the odds of the symptom 
occurrences (outcome variable) between the exposed and unexposed groups 
(exposure status is the predictor variable). The extent to which the main 
relationship of interest (exposure to bathing water and illness) differed across the 
four waves of data collection was examined by testing for the modifying effect 
that wave had on each major health outcome under investigation.   
 Wave 1: bathing season, low rainfall 
 Wave 2: bathing season, high rainfall 
 Wave 3: out of season, high rainfall 
 Wave 4: out of season, low rainfall  
As there was little evidence of moderation (the P-values yielded by the tests of 
interaction between exposure and outcome were all above 0.1), data from all four 
waves were pooled for the logistic regression.  
 
While data were collected that would allow the prevalence of these outcomes to 
be estimated, this measure is less useful than incidence in assessing risk 
differences that are likely to be due to the exposure of interest. Prevalence 
measures the existing cases at a given time point, and any differences between 
bathers and non-bathers might not be due to exposure to coastal waters. 
Therefore, the number of new cases in the second week (the incidence) of these 
outcomes were counted and crude risk ratios and crude odds ratios for each 
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outcome were estimated by comparing the incidence of health outcomes in the 
following exposure groups: 
1. Bathers were compared to people who reported not going into the sea 
(beach-going non-bathers were pooled with community controls). 
 
Analyses were done to assess whether there were any differences 
between the reporting of health outcomes in beach-going non-bathers 
compared to community controls (see Appendix I Table 32, p. 207). There 
was little difference, and it was agreed that by combining these two 
‘unexposed’ groups, that this would increase the power to detect 
differences between bathers and people who did not go into the sea.  
We also investigated the effect of head immersion on the risk of illness by 
comparing the health outcomes reported by bathers who immersed their 
heads in seawater to people who reported not going into the sea. 
2. For the outcome AFRI, beach-going non-bathers were compared to 
community controls because it was suspected that inhalation of aerosolised 
seawater could cause symptoms of respiratory illness. 
3. Bathers exposed to bathing waters known to be affected by pollution were 
compared to bathers not exposed to polluted bathing waters. 
 
Crude odds ratios were adjusted for confounding factors using logistic regression 
to give adjusted odds ratios. A limit was set on the number of confounders that 
each odds ratio could be adjusted for. The maximum number of confounders that 
could be adjusted for was ≤10% of the total number of cases (or non-cases, 
depending on which number was the smaller of the two). The confounders used 
to adjust for each outcome were prioritised in terms of their mechanistic 
importance as well as by the frequency of their appearance in the literature as a 
confounder. These lists of confounders were reviewed by a clinician (personal 
communication, Dr K. Harrop-Griffiths), and have been included in Appendix I 
(Table 33, p. 210). 
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The prevalence of the outcomes under investigation have been reported in 
Appendix II (p. 282) for completeness.   
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3.3 Results 
3.3.1 Recruitment 
Between June 2014 and April 2015, a total of 2,644 respondents completed the 
survey: 769 in the first wave of data collection, 492 in the second, 546 in the third, 
and 837 in the final wave (Figure 18). Thirteen people (0.5%) were excluded 
because the beaches they had visited were not in England or Wales, leaving 
2,631 responses for analysis. 
   Total participation = 2,644 
Wave 1  (June 2014) = 769 
Wave 2 (August 2014) = 492 
Wave 3 (November 2014) = 546 
Wave 4 (April 2015) = 837 
   
      
Eligible participation = 2,631 (99.5%) 
Wave 1 = 769 (99.2%) 
Wave 2 = 489 (99.4%) 
Wave 3 = 546 (100%) 
 Wave 4 = 833 (99.5%)  
        
          
Bathers = 1,693   Beach-going non-
bathers = 412 
  Community controls = 
526 
Wave 1 = 493    Wave 1 = 104    Wave 1 = 166  
Wave 2 = 385    Wave 2 = 34    Wave 2 = 71  
Wave 3 = 313    Wave 3 = 92    Wave 3 = 141  
Wave 4 = 502    Wave 4 = 182    Wave 4 = 149  
Figure 18: Participant flow diagram. 
We successfully achieved our target of recruiting 957 bathers. However, despite 
efforts to recruit non-bathers to the study, the number of non-bathers (938) fell 
slightly short of our target of 957 non-bathers.  
3.3.2 Population description 
Participants were self-selecting, and this meant that certain demographic 
variables (especially gender) were not well-balanced between the exposed group 
(bathers) and the unexposed groups (beach-going non-bathers and community 
controls) (Table 6). Men and women were equally represented among all 
participants, however, a higher percentage of bathers were males, and a higher 
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proportion of unexposed participants were females. Conversely, the distribution 
of age and socioeconomic status were fairly similar in all the exposure groups, 
with the majority of people taking part in the survey being aged 25 to 45, and 
holding a Bachelor’s degree or equivalent or higher qualifications.  
Table 6: Number (%) of bathers and non-bathers belonging to each demographic 
group. 
Demographic 
variables 
Total (2,632) Bathers 
(1,693) 
Non-bathers 
(412) 
Community 
controls (526) 
Males 1,326 (50.4%) 979 (57.8%) 127 (30.8%) 220 (41.8%) 
Age 
18 – 24  
25 – 34  
34 – 44  
45 – 54  
55 – 64  
65+ 
 
436 (16.6%) 
753 (28.6%) 
735 (27.9%) 
458 (17.4%) 
196 (7.4%) 
54 (2.1%) 
 
276 (16.3%) 
483 (28.5%) 
490 (28.9%) 
309 (18.3%) 
105 (6.2%) 
30 (1.8%) 
 
51 (12.4%) 
123 (29.9%) 
102 (24.8%) 
72 (17.5%) 
50 (12.1%) 
14 (3.4%) 
 
109 (20.7%) 
147 (27.9%) 
142 (27.0%) 
77 (14.6%) 
41 (7.8%) 
10 (1.9%) 
Level of 
education 
No formal 
qualifications 
Level 1* 
Level 2* 
Apprenticeship 
Level 3* 
Level 4* 
Other  
 
 
 
19 (0.7%) 
66 (2.5%) 
137 (5.2%) 
45 (1.7%) 
489 (18.6%) 
1,727 (65.6%) 
149 (5.7%) 
 
 
 
13 (0.8%) 
34 (2.0%) 
97 (5.7%) 
34 (2.0%) 
343 (20.3%) 
1092 (64.5%) 
80 (4.7%) 
 
 
 
2 (0.5%) 
15 (3.6%) 
17 (4.1%) 
4 (1.0%) 
61 (14.8%) 
284 (68.9%) 
29 (7.0%) 
 
 
 
4 (0.8%) 
17 (3.2%) 
23 (4.4%) 
7 (1.3%) 
85 (16.2%) 
350 (66.5%) 
40 (7.6%) 
*Level 1: 1-4 GCSEs or equivalent; Level 2: 5 or more GCSEs or equivalent; 
Level 3: 2 or more A-levels or equivalent; Level 4: Bachelor’s degree or 
equivalent, higher qualifications. 
 
3.3.3 Risk of illness among bathers compared to people not going into the 
sea 
The incidence of illnesses (new cases of illness in the second week of recall) was 
estimated for bathers and people not going in the sea (Table 7). A greater 
proportion of bathers reported symptoms compared to people not going in the 
sea for all investigated health outcomes. Adjusted odds ratios were significantly 
higher for incident cases of gastrointestinal illness, skin ailments, ear ailments, 
and any symptoms of illness. These increases in risk were statistically significant 
at the 5% level of significance. The risk of experiencing AFRI and eye ailments 
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was increased among bathers compared to non-bathers, but the P-values 
reported in Table 7 indicate that these increases are not statistically significantly.  
Estimates of risk of illness were also estimated separately for data collected 
during the bathing season and outside the bathing season. During the bathing 
season there was an increased risk of experiencing incident cases of ear ailments 
and any symptoms of illness among bathers compared to non-bathers. These 
increases in risk were statistically significant at the 5% level of significance. For 
gastrointestinal illness, skin ailments, and eye ailments, the odds ratios presented 
were above one, indicating a possible increase in risk among bathers of reporting 
these health effects. However, the P-values reported in Table 7 indicate that 
these are non-significant increases in the risk of illness among bathers compared 
to non-bathers. Outside the bathing season, however, the bathing population is 
at an increased risk of experiencing a greater number of health outcomes. The 
risk of experiencing gastrointestinal illness, skin ailments, ear ailments, and any 
symptoms of illness were significantly higher in bathers compared to non-bathers. 
The only health outcomes that were not significantly higher among bathers 
compared to non-bathers were AFRI and eye ailments. For completeness, results 
for each separate wave have been reported in Table 34, p. 211 in Appendix I, as 
well as for individual symptoms (Appendix I Table 35, p. 213).  
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Table 7: Number (%) of incident cases of health outcomes among bathers and participant who reported not going into the sea. 
Health outcome  Bathers 
(1,693) 
Participants who did not 
go into the sea (938) 
Crude 
risk ratio  
Crude 
odds ratio 
Adjusted odds ratio (95% 
CI), P-value 
Gastrointestinal illness 
All waves 80 (5.1%) 25 (2.8%) 1.84 1.89 1.70 (1.02 to 2.84), P = 0.04 
Bathing season  42 (5.2%) 10 (2.8%) 1.88 1.93 1.54 (0.72 to 3.30), P = 0.27 
Outside the bathing season  38 (5.0%) 15 (2.8%) 1.80 1.84 2.08 (1.06 to 4.11), P = 0.03 
Acute febrile respiratory infection 
All waves 21 (1.3%) 5 (0.5%) 2.32 2.34 2.33 (0.87 to 6.20), P = 0.18 
Bathing season  8 (0.9%) 0 (0%) . 1 (undefined) 
Outside the bathing season  13 (1.6%) 5 (0.9%) 1.79 1.80 1.81 (0.64 to 5.09), P = 0.51 
Skin ailments 
All waves 36 (2.3%) 9 (1.0%) 2.30 2.33 2.37 (1.14 to 4.96), P = 0.02 
Bathing season  15 (1.8%) 3 (0.8%) 2.19 2.21 2.27 (0.65 to 7.91), P = 0.20 
Outside the bathing season  21 (2.8%) 6 (1.1%) 2.53 2.57 2.63 (1.05 to 6.57), P = 0.04 
Ear ailments 
All waves 58 (3.7%) 9 (1.0%) 3.80 3.91 3.39 (1.59 to 7.23), P < 0.01 
Bathing season  28 (3.5%) 2 (0.5%) 6.54  6.74 5.68 (1.29 to 25.1), P < 0.01 
Outside the bathing season  30 (3.9%) 7 (1.3%) 3.06 3.15 3.62 (1.45 to 9.01), P = 0.02 
Eye ailments 
All waves 32 (2.0%) 6 (0.6%) 3.08 3.12 2.12 (0.81 to 5.53), P = 0.13 
Bathing season  17 (2.1%) 2 (0.5%) 3.78 3.84 3.80 (0.87 to 16.5), P = 0.08 
Outside the bathing season  15 (1.9%) 4 (0.7%) 2.70 2.73 2.77 (0.91 to 8.39), P = 0.07 
Any symptoms of illness 
All waves 258 (24.0%) 54 (7.2%) 3.33 4.07 3.82 (2.69 to 5.42), P < 0.01 
Bathing season  128 (24.1%) 26 (8.9%) 2.70 3.24  3.20 (1.90 to 5.37), P < 0.01 
Outside the bathing season  130 (23.9%) 28 (6.1%) 3.92 4.83 4.75 (2.87 to 7.87), P < 0.01 
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We also investigated the effect of head immersion on the risk of illness by 
comparing the risk of experiencing health outcomes in bathers who immersed 
their heads in seawater to people who reported not going into the sea. Figure 19 
presents the results in a forest plot, along with data reported in Table 7 (this data 
can also be found in Table 37 in Appendix I, p. 215). The odds ratio estimates for 
experiencing gastrointestinal illness and ear ailments among bathers immersing 
their heads in seawater were slightly higher than those estimated for bathers 
reporting any activity. However, the estimated odds ratios of experiencing AFRI, 
skin ailments, eye ailments and any symptoms of illness among bathers reporting 
head immersion were smaller than the odds ratios estimated for bathers who 
reported any contact with seawater.  
 
Figure 19: Forest plot of the odds ratio and 95% confidence intervals comparing 
the risk of experiencing illness in bathers compared to people who did not go 
into the sea. Results from bathers doing any activity in the sea are presented 
alongside bathers who immersed their head in seawater.  
 
3.3.4 Risk of respiratory illness among beach-going non-bathers compared 
to community controls 
The incidence of respiratory illness was estimated for beach-going non-bathers 
and community controls (Table 8). The reporting of AFRI was uncommon, and 
Gastrointestinal illness
Gastrointestinal illness
AFRI
AFRI
Skin ailments
Skin ailments
Ear ailments
Ear ailments
Eye ailments
Eye ailments
Any symptoms of illness
Any symptoms of illness
outcome
Health
Any type of contact
Contact involving head immersion
Any type of contact
Contact involving head immersion
Any type of contact
Contact involving head immersion
Any type of contact
Contact involving head immersion
Any type of contact
Contact involving head immersion
Any type of contact
Contact involving head immersion
Type of contact
1.70 (1.02, 2.84)
1.85 (1.09, 3.14)
2.33 (0.87, 6.22)
2.09 (0.78, 5.58)
2.37 (1.14, 4.94)
2.15 (1.03, 4.49)
3.39 (1.59, 7.23)
3.46 (1.57, 7.63)
2.12 (0.81, 5.54)
1.84 (0.70, 4.83)
3.82 (2.69, 5.42)
3.59 (2.52, 5.11)
ES (95% CI)
  
1.131 7.63
Odds ratio Increase in riskDecrease in risk
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indeed absent among beach-going non-bathers and community controls during 
the bathing season. Outside the bathing season, a greater proportion of beach-
going non-bathers reported symptoms that indicated a case of AFRI compared 
to community controls. However, there was not a statistically significant increase 
in the risk of illness in beach-going non-bathers compared to community controls.   
Table 8: Number (%) of incidence cases of acute febrile respiratory illness in 
beach-going non-bathers and community controls. 
 Beach-
going non-
bathers 
n=412  
Community 
controls 
(526) 
Crude risk 
ratio  
Crude odds ratio 
(95% confidence 
interval), P-value 
All waves 3 (0.7%) 2 (0.4%) 1.93 1.94 (0.32 to 11.6),  
P = 0.47 
Bathing 
season  
0 (0%) 0 (0%) . 1 (undefined) 
Outside the 
bathing 
season  
3 (0.7%) 2 (0.4%) 1.93 1.94 (0.32 to 11.6),  
P = 0.47 
 
3.3.5 Impact of known pollution of bathing waters on the risk of illness 
among bathers 
Bathers who reported visiting designated beaches in the same week as a known 
pollution event (CSO spill or failure of the revised Bathing Water Directive’s 
standards for satisfactory water quality) were considered to be exposed to 
polluted water, and rates of illness reporting in this group were compared to rates 
reported by bathers who were not known to have been exposed to polluted water 
(and were therefore assumed to have not been exposed to polluted water). A 
small proportion (approximately 13%) of bathers (220 of 1,693) was exposed to 
a known pollution event in either week 1 or week 2 of the period of recall (Table 
9).  
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Table 9: Number (%) of bathers who visited beaches during weeks when there 
was a known pollution event. 
 Week 1 Week 2 Either week 1 or 
week 2 of recall 
(% of bathers) 
Bathers affected by CSO 
spills  
164 80 220 (13.0%) 
Wave 1 (93.9 mm rain) 86 30 105 (21.3%) 
Wave 2 (104.9 mm rain) 50 13 57 (14.8%) 
Wave 3 (124.7 mm rain) 21 25 40 (12.8%) 
Wave 4 (28.6 mm rain) 7 12 18 (3.6%) 
Bathers affected by EA 
failures 
2 1 3 (0.2%) 
Wave 1 (93.9 mm rain) 2 1 3 (0.6%) 
Wave 2 (104.9 mm rain) 0 0 0 (0%) 
Wave 3 (124.7 mm rain) Not monitored Not monitored Not monitored 
Wave 4 (28.6 mm rain) Not monitored Not monitored Not monitored 
Bathers affected by 
pollution  
164 81 221 (13.0%) 
Wave 1 (93.9 mm rain) 86 31 106 (21.5%) 
Wave 2 (104.9 mm rain) 50 13 57 (14.8%) 
Wave 3 (124.7 mm rain) 21 25 40 (12.8%) 
Wave 4 (28.6 mm rain) 7 12 18 (3.6%) 
 
The incidence of investigated health outcomes were estimated for bathers 
exposed to bathing waters known to be polluted and compared to the prevalence 
of investigated outcomes reported by bathers who were not known to be exposed 
to polluted bathing waters (Table 10). Mostly, bathers exposed to polluted waters 
were at an insignificantly lower risk of experiencing symptoms of ill health, except 
in the case of AFRI and skin ailments, for which the risk was higher among 
bathers exposed to bathing waters affected by known pollution events. However, 
none of the P-values reported in were significant at the 5% level. Therefore, 
known pollution events had no significant impact upon the risk of illness among 
bathers.  
Inspecting these risks during the bathing season, similar trends to those 
described above were observed for all the major health outcomes. Outside the 
bathing season, however, the risks of gastrointestinal illness or any symptoms of 
illness were higher among bathers exposed to known pollution when compared 
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to bathers not exposed to known pollution events, although the P-values indicate 
that this increase in risk is not statistically significant.   
110 
 
Table 10: Number (%) of incident cases of illness reported by bathers exposed to known pollution compared to bathers not exposed to 
known pollution 
Health outcome  Bathers exposed to 
known pollution  
(221) 
Bathers not 
exposed to known 
pollution (1,472) 
Crude 
risk ratio  
Crude 
odds ratio 
Adjusted odds ratio (95% 
confidence interval), P-value 
Gastrointestinal illness 
All waves 8/211 (3.8%) 72/1361 (5.43%) 0.72 0.71 0.67 (0.31 to 1.43), P = 0.30 
Bathing season  4/156 (2.6%) 38/651 (5.8%) 0.44 0.42 0.40 (0.14 to 1.14), P = 0.09 
Outside the bathing season  4/55 (7.3%) 34/710 (4.8%) 1.52 1.56 1.43 (0.47 to 4.34), P = 0.53 
Acute Respiratory Febrile Illness 
All waves 4/218 (1.8%) 17/1455 (1.2%) 1.57 1.58 1.58 (0.53 to 4.74), P = 0.42 
Bathing season  2/161 (1.2%) 6/706 (0.8%) 1.46 1.47 (0.29 to 7.34), P = 0.64 
Outside the bathing season  2/57 (3.5%) 11/749 (1.5%) 2.39 2.44  2.39 (0.52 to 11.1), P = 0.27 
Skin ailments 
All waves 8/205 (3.9%) 28/1379 (2.0%) 1.92 1.96 1.96 (0.88 to 4.39), P = 0.10 
Bathing season  5/150 (3.3%) 10/676 (1.5%) 2.25 2.30 2.22 (0.74 to 6.60), P = 0.15 
Outside the bathing season  3/55 (5.5%) 18/703 (2.6%) 2.13 2.20 2.35 (0.66 to 8.32), P = 0.19 
Ear ailments 
All waves 7/195 (3.6%) 51/1363 (3.7%) 0.96 0.96 0.95 (0.42 to 2.13), P = 0.90 
Bathing season  5/140 (3.6%) 23/650 (3.5%) 1.01 1.01 0.98 (0.37 to 2.65), P = 0.97 
Outside the bathing season  2/55 (3.6%) 28/713 (3.9%) 0.93 0.92 0.92 (0.21 to 4.01), P = 0.91 
Eye ailments 
All waves 2/204 (1.0%) 30/1402 (2.1%) 0.45 0.46 0.45 (0.11 to 1.91), P = 0.28 
Bathing season  1/149 (0.7%) 16/678 (2.4%) 0.28 0.28 0.29 (0.04 to 2.20), P = 0.23 
Outside the bathing season  1/55 (1.8%) 14/724 (1.9%) 0.94 0.94 0.96 (0.12 to 7.49), P = 0.97 
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Health outcome  Bathers exposed to 
known pollution  
(220) 
Bathers not 
exposed to known 
pollution (1,472) 
Crude 
risk ratio  
Crude 
odds ratio 
Adjusted odds ratio (95% 
confidence interval), P-value 
Any symptoms of illness 
All waves 30/130 (23.1%) 228/945 (24.1%) 0.96 0.94 0.97 (0.61 to 1.56), P = 0.92 
Bathing season  21/92 (22.8%) 107/439 (24.4%) 0.94  0.92 0.94 (0.52 to 1.71), P = 0.84 
Outside the bathing season  9/38 (23.7%) 121/506 (23.9%) 0.99 0.99 1.16 (0.49 to 2.74), P = 0.73 
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3.4 Discussion 
This is the first study conducted in the UK into the risk recreational water use 
poses to bathers’ health following the transition to the revised Bathing Water 
Directive (2006/7/EC) in 2012. Our primary objective was to assess whether 
bathers are still at an increased risk of experiencing illness compared to non-
bathers. Our results demonstrated that a higher proportion of people who 
reported having been into the sea in the previous two weeks (bathers) reported 
symptoms of illness, compared to people reported not going into the sea. There 
was an increased risk of experiencing incident cases of gastrointestinal illness 
among bathers that was statistically significant (adjusted odds ratio 1.70, 95% 
confidence interval 1.02 to 2.84, P = 0.04), as was the risk of experiencing skin 
ailments (adjusted odds ratio 2.37, 95% confidence interval 1.14 to 4.96, P = 
0.02), ear ailments (adjusted odds ratio 3.39, 95% confidence interval 1.59 to 
7.22, P < 0.01), and any symptoms of illness (adjusted odds ratio 3.82, 95% 
confidence interval 2.69 to 5.42, P < 0.01). While a higher proportion of bathers 
reported incident cases of AFRI and eye ailments compared to people who had 
not been into the sea recently, the P-values indicate that the increase in risk for 
bathers was not statistically significant.  
 
These results agree with those reported previously in a similar study population 
(Kay et al., 1994, Fleisher et al., 1996), showing that health risks haven’t been 
noticeably lowered since the 1990s, despite efforts to improve water quality. From 
1989 to 1992, several randomised controlled exposure trials were conducted in 
the UK, which compared the incidence of illness in adult bathers and adult non-
bathers in the week after the trial. They reported that bathers were at a 
significantly higher risk of experiencing incident cases of gastrointestinal illness 
(odds ratio 1.66, 95% confidence interval 1.21 to 2.29), as well as ear ailments 
(odds ratio 3.06, 95% confidence interval 1.70 to 5.71), and eye ailments (odds 
ratio 2.06 95% confidence interval 1.01 to 4.25). They also reported that a higher 
proportion of bathers reported symptoms of AFRI and skin ailments compared to 
non-bathers, but that the increase in risk to bathers was not significant. One 
plausible explanation for the lack of an association between recreational use of 
coastal waters and incidence of AFRI in these studies could be that the case 
definition for AFRI is too specific, and not sensitive enough. This definition, which 
maps on to the International Classification of Diseases, as well as on to 
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respiratory illnesses reported in previous research, requires that people report at 
least three symptoms at the same time to be considered a case. One of these 
symptoms must be fever, which people are especially poor at self-diagnosing 
(Nguyen et al., 2010). A larger sample size would be required to detect a 
significant difference between the two exposure groups of such a rare outcome.  
 
 
Figure 20: A forest plot displaying the results of the randomised controlled trial 
conducted in the UK in the 1990s alongside the results of the beach user health 
survey. 
 
The results from the randomised controlled trials conducted in the UK in the 
1990s (Kay 1994) have been plotted in a forest plot (Figure 20) along with the 
results obtained in the current study in order to display the similarities between 
the two studies. Comparing the magnitude of the point estimates of the risks 
between the studies demonstrates that for every outcome, except eye ailments, 
they were greater in the present study. A possible explanation for the elevated 
risk is that we pooled data from all four waves of data collection, which included 
times when bathing water quality was likely to be poorer because of a higher risk 
of faecal contamination due to rainfall. However, the test of interaction indicated 
that wave was not a major factor influencing the association between wave and 
health outcomes. The estimates reported by the UK trials conducted in the 1990s 
Gastrointestinal illness
Gastrointestinal illness
AFRI
AFRI
Skin ailments
Skin ailments
Ear ailments
Ear ailments
Eye ailments
Eye ailments
outcome
Health
Kay 1994
Beach user health survey
Kay 1994
Beach user health survey
Kay 1994
Beach user health survey
Kay 1994
Beach user health survey
Kay 1994
Beach user health survey
Study
1.66 (1.21, 2.28)
1.70 (1.02, 2.84)
1.68 (0.89, 3.18)
2.33 (0.87, 6.22)
1.31 (0.83, 2.06)
2.37 (1.14, 4.94)
3.06 (1.67, 5.61)
3.39 (1.59, 7.23)
2.15 (1.03, 4.47)
2.12 (0.81, 5.54)
ES (95% CI)
  
1.138 7.23
Odds ratio Increase in riskDecrease in risk
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were from data collected during the summer months (during the bathing season) 
only. Restricting the analysis to data collected during separate waves showed 
similar trends: that for the majority of outcomes, a higher proportion of bather 
reported health outcomes compared to non-bathers during each wave. However, 
the small sample size in each wave meant that in most instances, the risk could 
not be estimated precisely. The extent to which the main relationship of interest 
(exposure to bathing water and illness outcomes) differed across the four waves 
of data collection was examined by testing for the modifying effect each wave 
had on each major outcome under investigation. This revealed little evidence of 
interaction for all the outcomes under investigation, so pooling the data from 
separate waves was justified to increase the statistical power in order to detect 
differences between the exposure groups. Even pooling together data from 
waves that were conducted during the bathing season only, the risk of 
experiencing incident cases of ear ailments or any symptoms remained 
significantly higher for bathers compared to people who did not go into the sea.  
 
Exploring the impact head immersion has on the risk of experiencing illness 
among bathers revealed similar results to those reported in Chapter 2 (p. 50). 
The risk of experiencing gastrointestinal illness and the risk of experiencing ear 
ailments were both increased among bathers who reported head immersion, and 
the risk of experiencing any symptoms of illness was reduced in this group.  
Neither result was statistically significant at the 5% level, however.  
 
For the outcome, AFRI, beach-going non-bathers were compared to community 
controls because it was suspected that inhalation of pathogens in aerosolised 
seawater could cause symptoms of respiratory illness. The risk of experiencing 
incident cases of AFRI was higher among beach-going non-bathers compared to 
community controls (adjusted odds ratio 1.94, 95% confidence interval 0.32 to 
11.6, P = 0.47), although the P-value suggests that this is not a statistically 
significant association. If an association does exist between visiting the beach 
and experiencing symptoms of respiratory illness, a larger sample size would be 
necessary to detect a sufficient number of cases. Inspecting Table 38 in Appendix 
I (p. 216), the risk of experiencing cough (either dry or productive) was higher in 
beach-goers compared to community controls but not significantly so. For all 
other symptoms of respiratory illness (e.g. sore throat, runny nose), the risks of 
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experiencing these were lower in beach-goers compared to community controls. 
Again, this association was not statistically significant, except in the case of 
reporting body aches.  
 
The second research question was whether bathers visiting beaches in the same 
week as a known pollution event were at greater risk of experiencing symptoms 
of ill health compared to bathers visiting beaches not known to have been 
affected by a pollution event in the week they were visited. Contrary to our 
expectation that bathers exposed to polluted bathing waters would report higher 
rates of illness compared to bathers not exposed to pollution in bathing waters, 
we found that a lower proportion of bathers exposed to polluted bathing waters 
reported cases of the health outcomes under investigation, except for the 
incidence of AFRI and skin ailments (Table 10). However, after adjusting for 
confounders, none of these differences remained statistically significant. The 
evidence reported in the literature is contradictory: Some studies report that 
exposure to bathing waters affected by point or diffuse pollution has no 
statistically significant impact on the risk of illness (Fleming et al., 2004, Kocasoy, 
1995). Others report that exposure to polluted water increases the risk of some 
illnesses (Dwight et al., 2004, Papastergiou et al., 2011, UNEP and WHO, 1991, 
Haile et al., 1999, Harder-Lauridsen et al., 2013, Harding et al., 2015). These 
inconsistent results reported by different studies are most likely due to the 
different definitions studies use for exposure to polluted bathing waters. 
Approaches used have included defining “polluted” water as those with current 
or historically high levels of faecal indicator organisms in the water, proximity to 
a source of pollution, or the origin (type) of pollution. In the present study, the lack 
of a demonstrable association between bathing in waters affected by pollution 
and ill health could be due to the small number of bathers known to be exposed 
to pollution, which is a product of the fact that the water quality data available for 
analysis was of poor resolution. Water quality data provided by the Environment 
Agency comes from water samples which are taken from designated beaches 
during the bathing season only. Therefore more than half of the bathers would 
not have any FIB density information if they went into the sea outside the bathing 
season (during waves 3 or 4), or if they visited undesignated beaches which are 
not monitored for their water quality. Although CSO spill notifications were 
available year-round, only a few water companies supply these notifications year-
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round for all their assets. A handful of water companies provide data at certain 
times of year (mostly in the bathing season), or only for a fraction of their assets 
(David Smith, Campaigns Officer at Surfers Against Sewage, personal 
communication). This would result in misclassification bias if bathers classified as 
unexposed were actually exposed to polluted bathing waters. It was assumed 
that people visiting undesignated beaches were not exposed to pollution (since 
there is no data available on water quality or CSO spills at undesignated 
beaches). Apart from sparse water quality information, another explanation for so 
few bathers being exposed to polluted waters could be that they were warned of 
the CSO spills or poor water quality by either the Environment Agency or SAS’s 
Safer Seas Service, and therefore avoided beaches they knew would be polluted. 
However, we did not ask bathers if they accessed water quality information prior 
to their beach visits.  
 
Our sampling strategy collected information from participants after periods of high 
rainfall in England and Wales, which we anticipated would be a good proxy for 
poor water quality, even at times and places that are not monitored for pollution. 
We predicted that the greatest increase in risk of illness would be observed during 
the wave with the highest rainfall (wave 3), and the lowest increase in risk would 
be observed during the wave with the lowest rainfall (wave 4). While the greatest 
increases in risk of experiencing gastrointestinal illness, skin, or any illness was 
indeed observed in wave 3, this was not the case for ear ailments or eye ailments 
(see Table 34, p.211). The lowest risks of illness for gastrointestinal illness, skin 
ailments, ear ailments, and any ailments were actually observed during wave 2, 
the period during which the second highest amount of rain fell. The risk of 
experiencing eye ailments was lowest during wave 3.  
 
Aside from misclassification bias, there are a number of limitations involved with 
this study. First, the information provided by participants has been self-reported, 
and could be inaccurate due to the presence of recall and self-report biases. We 
attempted to reduce the effects of recall bias by asking respondents about their 
exposures and health in the recent past (the previous two weeks). Self-reporting 
of symptoms provides a subjective measure of health, which could be influenced 
by various factors, such as the level of the participants’ education and risk 
perception. Controlling for these potential confounders in the analysis where 
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possible, should reduce the impacts of these factors on the odds ratios reported 
(Fleisher and Kay, 2006). 
 
Second, the population that we sampled may not be representative of the general 
population, limiting the generalisability of these findings to the wider population. 
For example, the majority (>65%) of participants were educated to a Bachelor’s 
degree level or higher (Table 6). This is a much higher proportion compared to 
the  27% of the population of England and Wales holding a degree (Office for 
National Statistics, 2014). Furthermore, Surfers Against Sewage is an 
environmental charity with a remit to improve the marine environment: People 
self-selecting for this study might either be more aware about the potential health 
risks of swimming in water polluted by sewage, or have a motive to over-report 
symptoms of ill health in an attempt to provide evidence that cleaner sea water is 
needed. However, by using social media, the survey had the potential to be 
circulated not just to SAS members, but more widely outside this group of people 
with a special interest in the topic. Furthermore, we expected that controlling for 
risk perception bias (knowledge of the health risks associated with bathing) would 
ameliorate this. Therefore, sampling Surfers Against Sewage members, as well 
as people who follow them on social media, is adequate for the purposes of this 
study as we expect to receive responses from a wide range of people who are 
highly exposed to seawater, as well as people who are not. In addition, the survey 
was only available online, limiting the respondents to those with access to the 
internet, although we suspect this is not something that will limit the vast majority 
of UK residents.  
Finally, due to the nature of data collection, we were not able to establish that 
exposure to seawater always preceded the onset of symptoms. Bathers were 
defined as people who reported going into the sea in the past two weeks, and the 
major outcome of interest was the incidence of illness in the second week of 
recall. It is possible that a small proportion of respondents reported new cases of 
illness in the second week, and only went bathing once they felt well again later 
in the second week. Nevertheless, we expect that for the majority of bathers’ 
responses, the exposure in either week one or week two preceded the onset of 
reported symptoms in week two.  
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Conclusions 
We have demonstrated that bathers are still at an increased risk of experiencing 
illness following recreational exposure to coastal waters in the UK compared to 
people who have not recently been in the sea. There have been recent 
improvements made to coastal catchments to make coastal bathing waters safer 
for water users. The results presented here might indicate that water treatment 
and catchment management strategies at the time of conducting the survey were 
insufficient at protecting bather health. It is worth noting that the stricter 
microbiological criteria of the revised Bathing Water Directive (2006/7/EC) were 
only fully implemented in the 2015 bathing season. These results are important 
in terms of communicating health risks to members of the public so that they can 
make informed decisions about whether or not to bathe in UK coastal waters.  
Although we attempted to show that known pollution events at affected beaches 
were responsible for an increased risk to bather health, data on known pollution 
events were too limited to demonstrate this. Further studies into this phenomenon 
are required, and these studies should collect more detailed information from 
bathers about the dates of their visits to beaches, as well as collecting better 
information from water companies on CSO spills.  
 
 
In the previous two chapters, we have provided evidence that bathers are at risk 
of acquiring infections from bathing in coastal waters, including infections caused 
by bacterial agents. We identified in the systematic review one study that 
investigated sea bathing as a risk factor for infection by ARB. Antibiotic resistance 
is a massive threat to human health, and natural environments that support 
human activities could be an important exposure route to resistant bacteria. In 
the next chapter we demonstrate that the ingestion of ARB while participating in 
water sports in coastal waters is not only possible, but in certain situations, highly 
likely.   
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Chapter 4: Human recreational exposure to 
antibiotic resistant bacteria in coastal 
bathing waters 
 
The contents of this chapter is almost identical to the published version of this 
paper: Leonard et al. (2015). Human recreational exposure to antibiotic resistant 
bacteria in coastal bathing waters. Environment International, 82, p92-100. A 
copy of this paper has been included in Appendix II (p. 286). 
 
4.1 Introduction 
The widespread use and misuse of antibiotics in clinical and veterinary medicine 
for the treatment and prevention of bacterial infections has contributed to the 
emergence and spread of antibiotic resistance genes (ARGs) among bacteria 
(Blaak et al., 2011, Marti et al., 2014). Antibiotic resistant bacteria (ARB) are 
recognised as a serious threat to human health globally because once easily 
treatable infections are becoming harder and more expensive to treat, exerting a 
burden on healthcare services worldwide (Finley et al., 2013). With limited 
treatment options on the horizon, global rates of morbidity and mortality from 
infections caused by resistant bacteria are expected to increase (Ashbolt et al., 
2013, de Kraker et al., 2011a, World Health Organization, 2014). 
 
Extended-spectrum β-lactamase (ESBL)-producing Enterobacteriaceae are ARB 
of particular concern. ESBL enzymes inactivate β-lactam antibiotics, a large 
group of clinically important antibiotics which includes penicillins and 
cephalosporins (Nordmann et al., 2012). There are a variety of plasmid-mediated 
ESBLs (such as CTX-M, TEM, SHV, and OXA), which disseminate among 
bacteria by the transfer of these mobile genetic elements (MGEs), often 
conferring resistance to multiple antibiotics (Livermore and Hawkey, 2005). The 
rapid emergence and spread, particularly of the CTX-Ms, poses a significant 
public health threat, as infections caused by ESBL-producing bacteria are 
unresponsive to essential frontline drugs such as third-generation cephalosporins 
(3GCs). Carbapenems are the recommended treatment for severe infections 
caused by ESBL-producers. Although not widespread, resistance to 
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carbapenems among Enterobacteriaceae has already been observed (Montezzi 
et al., 2014). 
 
Escherichia coli are members of the Enterobacteriaceae family and are often 
harmless commensals found in large numbers in the intestines of warm-blooded 
animals, including healthy humans (Blaak et al., 2014, Georgiou and Langford, 
2002). However, some types are pathogenic and can cause serious diseases 
such as urinary tract infections and bacteraemia (European Centre for Disease 
Prevention and Control, 2014a). E. coli is a leading cause of bloodstream 
infections, causing nearly 100-times as many infections as methicillin resistant 
Staphylococcus aureus (MRSA) in England in 2013 (Public Health England, 
2014b, Public Health England, 2014a). Increasing numbers of infections caused 
by third-generation cephalosporin resistant E. coli (3GCREC) in recent years in 
the UK (and elsewhere) present a threat to public health. In particular vulnerable 
people (e.g. the elderly, immunocompromised, and hospitalised) are at risk of 
developing life-threatening opportunistic infections caused by 3GCREC that are 
difficult to treat. Another characteristic of E. coli that makes them a considerable 
threat is their ability to acquire MGEs, which can be transferred to other members 
of the enteric microbial community, including transient pathogens (Winokur et al., 
2001). 
 
There are a few transmission routes by which humans are thought to be infected 
by ARB: person-to-person contact and the ingestion of contaminated food and 
drinking water have been implicated, with exposure possible within healthcare 
settings and in the wider community (Coleman et al., 2012, Kennedy and 
Collignon, 2010, Valverde et al., 2008). However, the natural environment has so 
far received little attention as a potentially significant setting in which people are 
exposed to ARB. 
Natural environments, such as soils, sediments and surface waters (e.g. the sea, 
rivers), have complex microbial communities and diverse metagenomes (Amos 
et al., 2014a, Gaze et al., 2013), and are increasingly being recognised as a 
reservoir of clinically important ARB and ARGs. Human activities, for instance the 
application of sewage sludge and animal slurry to farmland (Byrne-Bailey et al., 
2009, Byrne-Bailey et al., 2011), and disposal of wastewater to surface waters 
(Amos et al., 2014a, Young et al., 2013), introduce bacteria harbouring a large 
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array of ARGs, along with biologically active antimicrobial residues to these 
environments (Ash et al., 2002, Gaze et al., 2008, Servais and Passerat, 2009). 
Consequently, there is likely to be exchange of ARG occurring between 
environmental bacteria, and human and animal commensals and pathogens 
(Forsberg et al., 2012, Gaze et al., 2011). This increases the chance of clinically 
relevant pathogens acquiring genes conferring resistance to essential frontline 
antibiotics from the environmental metagenome (Alm et al., 2014, Maravic et al., 
2014). Coastal waters polluted by faecal matter may be a critical point of contact 
where people are exposed to ARB while participating in sports or recreational 
activities played or practised on or in water (hereafter referred to as water sports) 
(Department of Health et al., 2014, Turgeon et al., 2012). 
To limit the spread of antibiotic resistance, data on the magnitude of transmission 
in different settings are needed. The popularity of many water sports has 
increased in recent years (Pond, 2005), and with millions of people visiting 
coastal waters (Great Britain Day Visits Survey, 2013), the potential exists for 
large numbers of people to be exposed to 3GCREC in coastal water. It is 
hypothesised that E. coli resistant to 3GCs are present in coastal waters in 
England and Wales, and that ingestion of seawater whilst participating in water 
sports is a route by which large numbers of people in England and Wales may be 
exposed. 
 
The aim of this research was to establish if seawater is a medium through which 
humans encounter ARB. The prevalence of 3GC resistance among E. coli 
isolates in coastal bathing waters, and associated rivers discharging into bathing 
waters was determined. The extent to which people were directly exposed via the 
ingestion of seawater during various water sports was estimated. In addition, a 
population-level estimate of exposure was calculated to demonstrate the scale of 
this exposure. 
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4.2 Methods 
The mean proportion of E. coli isolated from surface water samples that were 
resistant to 3GCs (prevalence of 3GC-resistance) was determined using culture-
based methods. This was combined with the density of E. coli in designated 
coastal waters around England and Wales, along with estimates of the volumes 
of water ingested during different water sports taken from the literature to 
calculate the mean number of 3GCREC ingested by people participating in a 
number of different high- and low-contact water sports. 
4.2.1 Estimating the prevalence of 3GC-resistance in E. coli 
Water samples were taken by the Environment Agency from surface waters 
associated with coastal bathing waters around England and Wales between July 
and September 2012 as part of their routine monitoring (Jonathan Porter, 
personal communication). Samples were kept at 4°C overnight and 97 of these 
were selected and transported on ice to our laboratory for immediate processing. 
Water samples were centrifuged at 8000 rpm (11,899 g) for 10 min at 4°C, and 
after discarding the supernatant, the pellet was resuspended in 2 ml of sterilised 
saline (0.85% NaCl). 100 μl of the resulting cell suspension was spread onto three 
Chromocult® Coliform Agar Enhanced Selectivity (Merck) plates supplemented 
with 2 μg/ml cefotaxime, 4 μg/ml ceftazidime (clinically relevant concentrations 
for these antibiotics (EUCAST, 2014) and no antibiotics respectively, using Easy 
Spiral Automatic Plater (Interscience). Plates were incubated at 37°C overnight 
(18–20 h) and colony forming units (CFUs) of E. coli were counted. 
4.2.2 Density of E. coli in coastal waters of England and Wales 
E. coli are used to monitor faecal contamination of designated bathing waters as 
a proxy for the occurrence of pathogens transmitted by the faecal–oral route. In 
2012, data on the density of E. coli in designated bathing waters during the 
bathing season (15 May–30 September) were collected by the Environment 
Agency to ensure compliance with the revised EU Bathing Water Directive 
2006/7/EC (European Parliament Council of the European Union, 2006). E. coli 
density data for 507 designated coastal bathing waters around England and 
Wales were obtained from the Environment Agency (Environment Agency, 2014). 
4.2.3 Volume of seawater ingested during recreational activities 
Medline, Google, and websites of relevant organisations (e.g. the World 
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Health Organization, United States Environment Protection Agency) were 
searched for records reporting volumes of water that people ingest while 
undertaking various water sports. Additional records were also identified by 
reviewing the reference sections and related citations of each paper identified 
(citation chasing). The estimates reported by primary research were reviewed 
and the quality of evidence supporting these estimates was appraised, based on 
aspects such as the suitability of the methods used, likely sources of error and 
bias, and overall reliability of the results, using an adapted version of a rapid 
assessment tool devised by the US EPA (United States Environmental Protection 
Agency, 2011). 
4.2.4 Data analysis 
The number of CFUs on plates amended with 3GC antibiotics was divided by the 
number of CFUs on the non-selective agar plate for each water sample to give a 
prevalence of 3GC-resistance (i.e. the proportion of E. coli that are phenotypically 
resistant to 3GCs). Seven water samples were removed from the dataset for 
calculating the mean prevalence of 3GC-resistance because the density of E. coli 
colonies on the non-selective plates was too high (>2000 CFU) to be counted 
accurately. A further two samples were excluded from the analysis because the 
water samples were taken from surface waters not associated with coastal 
waters. Data were entered into Microsoft Excel 2010, and imported into STATA 
v13.0 for analysis (StataCorp, 2013). 
Water quality data from the Environment Agency were cleaned (data from 
designated freshwaters removed, and data for 2012 selected). The E. coli 
densities of these water samples were positively skewed. Therefore each sample 
was categorised based on E. coli density into samples that met guideline levels 
(indicating excellent quality), mandatory levels (minimum water quality that all 
coastal bathing waters should achieve) and water samples that failed to meet the 
minimum standard. Two different sets of limits were used to categorise water 
quality (see Table 11).  
 
A) E. coli density limits used during 2012, when bathing water monitoring was 
transitioning from the previous Bathing Water Directive (76/160/EEC) to the 
revised Directive (2006/7/EC) (European Environment Agency, 2008). 
  
124 
 
B) E. coli density limits stated in the revised Bathing Water Directive (2006/7/EC), 
applied to designated waters as of 2015 (European Parliament Council of the 
European Union, 2006). 
 
Table 11: E. coli density limits for designated coastal bathing waters A) in the 
transition period (2012–2014), and B) as specified by the revised Bathing Water 
Directive 2006/7/EC. 
 Water quality indicator Guideline Mandatory Fail 
A) Escherichia coli (CFU/100 ml) 0–100 101–2000 >2000 
B) Escherichia coli (CFU/100 ml) 0–250 251–500 >500 
 
4.2.5 Exposure to 3GCREC 
The mean number of 3GCREC ingested was calculated for each water sample 
reported by the Environment Agency using the formula: 
P x D x V 
Where P is the mean prevalence of 3GC-resistance among E. coli isolated from 
surface water samples provided by the Environment Agency, D is E. coli density 
(CFU/ml) reported in designated coastal bathing waters around England and 
Wales, and V is the mean volume of water ingested (ml) during a particular water 
sport. 
The mean number (and 95% confidence intervals) of 3GCREC ingested per 
session of water sport was calculated for each category of water quality. 
4.2.6 Population estimate 
To derive a population-level estimate, similar methods to those described by 
Georgiou and Langford (2002) were used. In 2001, Economics for the 
Environment Consultancy (EFTEC) conducted a survey on coastal bathing 
behaviour for a representative sample of the adult population of England and 
Wales (EFTEC, 2002). Each participant was asked about the number of times 
they enjoyed various activities in the past year, and the average number of 
sessions of each activity per person per year was then calculated (Table 17, 
p.135). The number of times the activity was reported to have been done in the 
year based on survey responses was divided by the sample size. To calculate 
the number of sessions that took place for each activity during 2012, the average 
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number of sessions of activity per person per year was multiplied by the estimated 
population by age of England and Wales in mid-2012 (Office for National 
Statistics, 2013b). An even distribution of people visiting designated beaches in 
England and Wales was assumed. Using the proportions of water samples 
meeting each water quality standard at bathing beaches in 2012 as reported in 
Table 12, the number of different water sport sessions taking place in seawater 
of high, minimum, and failing quality was calculated. The number of water sport 
session where one or more 3GCREC was ingested was then calculated 
(Appendix I Table 40, p. 221 ). 
 
Table 12: Number (%) of water samples from designated coastal bathing waters 
in each water quality category according to the density of E. coli A) in the 
transition period (2012 – 2014), and B) as specified by the revised Bathing Water 
Directive 2006/7/EC. 
 Water quality indicator 
(CFU/100 ml) 
Water quality category 
  Guideline Mandatory Fail 
A) Escherichia coli  8391 (83.3%) 1553 (15.4%) 134 (1.3%) 
B) Escherichia coli  9238 (91.7%) 388 (3.8%) 452 (4.5%) 
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4.3 Results 
4.3.1 Estimating the prevalence of 3GC-resistance in E. coli 
Fifteen of the 97 (15.46%) surface water samples contained 3GC resistant E. coli. 
However, the mean prevalence of 3GC-resistance in E. coli in these samples was 
low at 0.12% (standard deviation = 0.46). The mean density of E. coli in these 
water samples was estimated to be 233.3 CFU/100 ml (standard deviation = 
409.5). 
4.3.2 Density of E. coli in designated coastal bathing waters of England and 
Wales 
The Environment Agency reported the density of E. coli in 10,078 water samples 
from around 507 designated coastal bathing waters in 2012. The mean density 
of E. coli in these water samples was found to be 138.0 CFU/100 ml (standard 
deviation = 632.5). In the context of the range of E. coli densities reported in 
coastal waters (between 0 and >10,000 CFU/100 ml), the difference between the 
water samples used for estimating the prevalence of 3GC-resistance in E. coli 
and those used to monitor water quality at designated beaches is considered to 
be small. Therefore, the samples used to estimate the prevalence of 3GC-
resistance in E. coli are assumed to be reasonably representative of designated 
coastal bathing waters in England and Wales. 
The number and percentage of water samples from designated coastal bathing 
waters in each water quality criterion for the transition period (from 2012 to 2014) 
and for the limits stated in Directive 2006/7/EC are presented in Table 12. 
4.3.3 Volume of seawater ingested during recreational activities 
Twenty-three relevant papers, reporting volumes and rates of water ingestion 
during water sports were obtained (see Table 39 in Appendix I, p. 217). Nineteen 
papers were retrieved that stated volumes of water ingested while swimming or 
bathing (Allen et al., 1982, Boland et al., 1993, Dorevitch et al., 2011, Dufour et 
al., 2006, Eisenberg et al., 1996, Evans et al., 2006, Georgiou and Langford, 
2002, Haas et al., 1999, Marino et al., 1995, Philipp et al., 1985, Rijal et al., 2011, 
Schets et al., 2011, Shuval, 2003b, Staley et al., 2012b, United States 
Environmental Protection Agency, 1995, United States Environmental Protection 
Agency, 1989, United States Environmental Protection Agency, 2003, Westrell, 
2004, World Health Organization, 2003). Only four of these provided detailed 
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methods used to derive these estimations (Allen et al., 1982, Dorevitch et al., 
2011, Dufour et al., 2006, Schets et al., 2011). Other records stating volumes of 
water ingested did not report methods used to derive the estimates, or did not 
provide enough information for an adequate appraisal of the quality of evidence 
supporting the estimate.  
 
Two different methods were described to quantify the ingestion of water whilst 
swimming. The first, used by Allen et al. (1982) and Dufour et al. (2006), used 
objective methods to accurately quantify the amount of cyanuric acid (a 
compound used in swimming pools to extend the bactericidal activity of chlorine, 
which is barely absorbed through the skin) in pool swimmers' urine to estimate 
the volume of chlorinated water ingested. The second method described in the 
literature, employed by Dorevitch et al. (2011) and Schets et al. (2011) used 
subjective measures where participants completed questionnaires to self-report 
how much water they believe they ingested when swimming, using reference 
volumes (e.g. a mouthful) to help respondents estimate quantities. 
 
Five estimates were identified that reported the volume of water ingested during 
water sports other than swimming (Department of Environmental Affairs, 2012, 
Department of Water Affairs and Forestry, 1996, Dorevitch et al., 2011, Schijven 
and de Roda Husman, 2006, Steyn et al., 2004, Stone et al., 2008b). Two of 
these stated volumes ingested during unspecified water sports which were not 
substantiated by empirical evidence (Department of Environmental Affairs, 2012, 
Department of Water Affairs and Forestry, 1996).  The other three papers used 
subjective methods (self-completed questionnaires similar to those described by 
Schets et al. (2011) to collect responses from different water users on how much 
water they ingest during specified activities. Schijven and de Roda Husman 
(2006) quantified the volume of water ingested by divers during diving sessions. 
Stone et al. (2008) estimated the volume of water ingested while surfing, and 
Dorevitch et al. (2011) estimated the mean volumes of water ingested while 
participating in a number of different activities that involve a low risk of head 
immersion (boating, rowing, canoeing, kayaking, fishing, and wading) in surface 
waters. 
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Exposure to 3GCREC during swimming sessions 
Point estimates reported by Dufour et al. (2006) were used to calculate the mean 
number of 3GCREC ingested by adults and non-adults while swimming in 
designated coastal bathing waters (Table 13). Dufour et al. (2006) estimated that 
the average adult (over the age of 18) ingests on average 16 ml water per 45-
minute swimming session, and non-adults (aged 18 or under) ingest 37 ml per 
45-minute session. These estimates were chosen because estimates derived 
from objective measurements are more reliable than those obtained from 
subjective methods (Figure 21). 
 
Table 13: Mean number (95% confidence intervals) of 3GCREC ingested per 
swimming session by adults and non-adults in designated coastal bathing waters 
of different quality as defined by A) the transition period (2012 – 2014), and B) 
the revised Bathing Water Directive 2006/7/EC. 
 Sub-
population 
Guideline Mandatory Fail 
A) Adults 0.004  
(0.004 to 0.004) 
0.073  
(0.069 to 0.076) 
0.891  
(0.807 to 0.975) 
Non-adults 0.009  
(0.009 to 0.010) 
0.168  
(0.160 to 0.177) 
2.061  
(1.867 to 2.255) 
B) Adults 0.007  
(0.006 to 0.007) 
0.070  
(0.068 to 0.071) 
0.397  
(0.358 to 0.436) 
Non-adults 0.015  
(0.015 to 0.016) 
0.161  
(0.158 to 0.164) 
0.918  
(0.828 to 1.009) 
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Figure 21: Mean number of 3GCREC ingested per swimming session by adults and non-adults in designated coastal bathing waters of 
different quality as defined by A) the transition period (2012 – 2014), and B) the revised Bathing Water Directive 2006/7/EC. Error bars 
indicate the 95% confidence intervals associated with each estimate.  
Non-adults (<18 years old) 
Adults (≥ 18 years old) 
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Ingestion of 3GCREC during surfing sessions 
Stone et al. (2008) used questionnaire responses from adult surfers to estimate 
that they ingest a mean volume of 170.6 ml of water per day. Using this value, 
the following estimations of the mean number of 3GCREC ingested per day were 
calculated (Table 14). 
 
Table 14: Mean number (95% confidence intervals) of 3GCREC ingested per 
surfing session by adults in designated coastal bathing waters of different quality 
as defined by A) the transition period (2012 – 2014), and B) the revised Bathing 
Water Directive 2006/7/EC. 
 Activity Guideline Mandatory Fail 
A) Surfing 0.044  
(0.043 - 0.045) 
0.777  
(0.739 - 0.815) 
9.504  
(8.610 - 10.398) 
B) Surfing 0.070  
(0.068 - 0.072) 
0.743  
(0.729 - 0.757) 
4.234  
(3.817 - 4.652) 
 
Ingestion of 3GCREC during diving sessions 
Schijven and de Roda Husman (2006) also used questionnaire responses from 
sport divers to estimate that divers (wearing normal masks) diving in coastal 
waters ingest on average 9.9 ml water per session. Using this value, the following 
estimates of the mean number of 3GCREC ingested per diving session were 
derived (Table 15). From these estimates of ingestion for high-contact water 
sports (swimming, surfing and diving), it is evident that of these three water 
sports, surfers ingest greater numbers of 3GCREC per session compared to 
swimmers and divers ( Figure 22). 
 
Table 15: Mean number (95% confidence intervals) of 3GCREC ingested per 
diving session by adults in designated coastal bathing waters of different quality 
as defined by A) the transition period (2012 – 2014), and B) the revised Bathing 
Water Directive 2006/7/EC. 
 Activity Guideline Mandatory Fail 
A) Diving 
(Adults) 
0.003  
(0.002 - 0.003) 
0.045  
(0.043 - 0.047) 
0.306  
(0.500 - 0.603) 
B) Diving 
(Adults) 
0.004  
(0.004 - 0.004) 
0.043  
(0.042 - 0.044) 
0.246  
(0.221 - 0.270) 
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Figure 22: Mean number of 3GCREC ingested by adults when participating in high-contact water sports in designated coastal bathing 
waters of different quality as defined by A) the transition period (2012 – 2014), and B) the revised Bathing Water Directive 2006/7/EC. Error 
bars indicate the 95% confidence intervals associated with each estimate. 
Swimming (adults) 
Surfing (adults) 
Diving (adults) 
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Ingestion of 3GCREC during low-contact water sports  
Dorevitch et al. (2011) also estimated the volumes of water ingested during a 
variety of low-contact water sports (boating, canoeing, fishing, rowing, kayaking, 
and wading/splashing) using responses to a questionnaire. 
The volumes of water reported for each activity respectively were 3.7 ml, 3.9 ml, 
3.6 ml, 3.5 ml, 3.8 ml and 3.7 ml respectively. The average numbers of 3GCREC 
ingested per session for each of these activities are reported in Table 16 and 
displayed in Figure 23. 
 
Table 16: Mean number (95% confidence intervals) of 3GCREC ingested per 
session by adults participating in low-contact water sports in designated coastal 
bathing waters of different quality as defined by A) the transition period (2012 – 
2014), and B) the revised Bathing Water Directive 2006/7/EC. 
 Activity Guideline Mandatory Fail 
A) Boating 0.001  
(0.001 to 0.001) 
0.017 
(0.016 to 0.018) 
0.206  
(0.187 to 0.226) 
 Canoeing 0.001  
(0.001 to 0.001) 
0.018 
(0.017 to 0.019) 
0.217  
(0.197 to 0.238)  
 Fishing 0.001  
(0.001 to 0.001) 
0.016  
(0.016 to 0.017) 
0.201  
(0.182 to 0.219) 
 Kayaking 0.001  
(0.001 to 0.001) 
0.017  
(0.016 to 0.018) 
0.212  
(0.192 to 0.232) 
 Rowing 0.001  
(0.001 to 0.001) 
0.018  
(0.017 to 0.019) 
0.217  
(0.197 to 0.238) 
 Wading/ 
splashing 
0.001  
(0.001 to 0.001) 
0.017  
(0.016 to 0.018) 
0.206  
(0.187 to 0.226) 
B) Boating 0.002  
(0.001 to 0.002) 
0.016  
(0.016 to 0.016) 
0.092  
(0.083 to 0.101) 
 Canoeing 0.002  
(0.002 to 0.002) 
0.017  
(0.017 to 0.017) 
0.097  
(0.087 to 0.106) 
 Fishing 0.001  
(0.001 to 0.002) 
0.016  
(0.015 to 0.016) 
0.089  
(0.081 to 0.098) 
 Kayaking 0.002  
(0.002 to 0.002) 
0.017  
(0.016 to 0.017) 
0.094  
(0.085 to 0.104) 
 Rowing 0.002  
(0.001 to 0.002) 
0.017  
(0.017 to 0.017) 
0.097  
(0.087 to 0.106) 
 Wading/s
plashing 
0.002  
(0.002 to 0.002) 
0.016  
(0.016 to 0.016) 
0.092  
(0.083 to 0.101) 
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Figure 23: Mean number of 3GCREC ingested per session by adults during low-contact water sports in designated coastal bathing waters 
of different quality as defined by A) the transition period (2012 – 2014), and B) the revised Bathing Water Directive 2006/7/EC. Error bars 
indicate the 95% confidence intervals associated with each estimate.   
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4.3.4 Population-level estimate of 3GCREC ingestion  
Using these individual-level values of 3GCREC ingestion, a population-level 
estimate of recreational exposure to 3GCREC was calculated (Table 17). In the 
case of swimming, the EFTEC report combined people reporting going for a swim 
and people going for a dip into the same category. As people going for a dip were 
expected to ingest less water compared to swimmers participating in the 
investigation conducted by Dufour et al., people reporting swims or dips in the 
EFTEC report that did not involve head immersion were excluded from the 
number of water sport sessions per person per year. Other categories of activities 
reported in the EFTEC report combined multiple water sports: the category 
‘surfing’ also includes those people reporting windsurfing and water-skiing, 
people reporting snorkelling sessions were grouped with those who went diving, 
and jet-skiing sessions were grouped with canoeing. In these cases, similar 
volumes of water are assumed to be ingested during activities that are in the 
same category. It was expected that people participating in these activities do so 
once a day (such that the amount of water ingested per day equates to the 
amount of water ingested per session). Furthermore, due to the lack of data on 
the average number of sessions of water sports children participate in annually, 
it was assumed that children engage in these water sports as frequently as adults. 
Details of calculations are provided in Table 40 in Appendix I (p. 221). 
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Table 17: Number of water sport sessions occurring in 2012 resulting in the 
ingestion of at least one 3GCREC. 
Activity Average number of 
water sport sessions 
per person per year  
(reported by (EFTEC, 
2002) 
Number of sessions 
occurring in England 
and Wales per year 
Number of 
sessions 
resulting in 
ingestion of 
3GCREC 
Swimming 1.2 67,881,360 2,085,187 
Surfing 0.4 22,627,120 3,830,998 
Diving 0.2 11,313,560 151,681 
Boating 0.5 28,283,900 173,352 
Canoeing 0.2 11,313,560 72,701 
Fishing Not reported -  -  
Kayaking Not reported -  -  
Rowing Not reported -  -  
Wading/ 
splashing 
Not reported -  -  
Total  164,046,620 6,313,919 
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4.4 Discussion 
Third-generation cephalosporin resistant E. coli were detected in coastal surface 
waters in England and Wales, implicating this environmental compartment as a 
setting in which humans can be exposed to clinically important ARB. The 
prevalence of 3GCREC isolates was found to be low (0.12%), and this is similar 
to estimates reported elsewhere (Blaak et al., 2014, Maravic et al., 2014). 
However, due to the fact that only one resistance phenotype was investigated in 
E. coli, the prevalence of antibiotic resistance among E. coli is expected to be 
greater than this. Blaak et al. (2014) also used culture-based methods to 
investigate the prevalence of antibiotic resistant E. coli isolated from rivers in the 
Netherlands. They reported that on average, 27.6% of E. coli were resistant to at 
least one of six different types of antibiotics tested. Elsewhere, a much higher 
prevalence (42%) of E. coli isolated from the Seine River, France, were reported 
to be resistant to one or more of 16 antibiotics tested (Servais and Passerat, 
2009). However, even these are expected to underestimate the true prevalence 
of antibiotic resistance among bacteria in natural aquatic environments since 
these studies only measure resistance in one group of culturable bacteria that 
are capable of colonising the human gut. Other bacteria present in natural waters 
will also harbour ARGs, and therefore contribute to the reservoir of ARGs in this 
environmental compartment.  
 
The mean number of 3GCREC ingested during swimming sessions in designated 
coastal bathing waters was estimated (Table 13). These estimates are lower than 
those reported by a recently published study (Harris et al., 2013), which predicted 
that bathers ingest 30 3GCREC per swimming session, and up to 193 antibiotic 
resistant E. coli per swimming session. The difference in this estimate may be 
explained by the fact that 3GC-resistance prevalence estimates reported by 
Harris et al. (2014) were not derived from measurement of actual coastal bathing 
water samples, but from bacteria in final wastewater treatment plant (WWTP) 
effluent, and bacterial die-off in the environment and heterogeneity between 
multiple WWTP were not accounted for. Furthermore, this study used the World 
Health Organization’s estimate of bathers ingesting 100 ml of water per swimming 
session, which is considerably higher than the volumes used in this study. 
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In addition to swimming, the mean numbers of 3GCREC ingested during surfing 
(Table 14), diving (Table 15), and boating, canoeing, fishing, kayaking, rowing, 
and wading/splashing (Table 16) were calculated. This is the first paper to use 
volumes of water ingested during these ‘special interest’ activities to estimate 
human exposure to ARB. Higher rates of water ingestion were reported for 
swimming, surfing, and diving. This is probably due to the fact that these activities 
involve a high degree of contact with water and frequent head immersion 
compared to low-contact water sports such as fishing. Despite the same being 
true of diving, the mean volume of water ingested by divers was considerably 
lower than that for swimmers and surfers. This may be because wearing masks 
and breathing apparatus reduces or prevents the intake of large volumes of 
water, or because head immersion in this activity is more controlled than during 
surfing and swimming.  
 
Besides the type of water sport being undertaken, several other factors influence 
an individual's likelihood of ingesting seawater containing 3GCREC. Sex, age, 
and duration of swimming affect the volume of water ingested by individuals: both 
Dufour et al. (2006) and Schets et al. (2011) reported that males tend to ingest 
greater volumes of water than females, and that children ingested more water 
compared to adults. Schets et al. (2011) also found that children reported greater 
frequency of swimming in the sea, and longer duration of swimming than adults. 
Therefore, children may be at greater risk of ingesting clinically important ARB 
when swimming in coastal bathing waters. Another variable affecting the total 
number of 3GCREC ingested during water sports in the coastal zone is the 
density of E. coli in coastal bathing waters. Apart from the source and extent of 
pollution, spatial and temporal fluctuations in faecal indicator bacteria (FIB) 
density are caused by numerous factors, for example, local topography, rainfall, 
temperature, ultraviolet radiation, and wind speed (Crowther et al., 2001, World 
Health Organization, 2003). Rainfall in the 2012 bathing season was unusually 
high (Met Office 2012), so FIB density in surface waters is likely to have been 
higher than in other years. The strategy of sampling designated bathing waters 
in England and Wales, which involves taking one water sample from one location 
along the length of a beach approximately once a week for five months of a year, 
does not detect changes in FIB levels in between samples, or at different points 
along the length of a beach. Therefore people bathing at designated coastal 
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beaches in between samples, or at beaches which are not monitored for water 
quality, or bathing in coastal waters outside the bathing season are exposed to 
unknown levels of E. coli. Indeed, Blaak et al. (2011) reported that E. coli density 
and the prevalence of antibiotic resistance among bacteria in surface waters was 
higher at all sites sampled outside the bathing season, compared to samples 
taken during the bathing season. Therefore people may ingest greater numbers 
of 3GCREC (and other ARB) whilst participating in water sports at times of year 
outside the bathing season. 
 
In order to demonstrate the extent to which people in England and Wales are 
exposed to 3GCREC when participating in water sports in designated coastal 
bathing waters, the number of water sport sessions that took place at beaches in 
2012 that were likely to result in the ingestion of at least one 3GCREC was 
estimated. Over 164 million water sport sessions are estimated to have occurred 
in or on coastal waters in England and Wales in 2012, and of these over 6.3 
million resulted in the ingestion of at least one 3GCREC (Table 17). This is likely 
to be an underestimate of true recreational exposure to antibiotic resistant E. coli 
in designated coastal waters because only resistance to 3GCs was investigated. 
Using the prevalence of antibiotic resistance in E. coli (27.6%) as reported by 
Blaak et al. (2011) as a conservative estimate, this population-level estimate 
increases to over 109 million sessions occurring in 2012 that resulted in the 
ingestion of at least one E. coli resistant to one or more antibiotics, with many 
sessions involving the ingestion of hundreds of ARB (see Table 41 and Table 42 
in Appendix I, p.222 and p. 223). 
 
There are a number of assumptions made in the calculation of these estimates 
and limitations associated with the data that means these results should be 
interpreted with caution. Principally, the methods used to quantify the volumes of 
water ingested by people participating in various water sports may produce 
variable estimates of 3GCREC ingestion during water sports in coastal waters. 
The mean volumes of water ingested while swimming in a swimming pool 
reported by Dufour et al. (2006) were used to estimate the mean number of 
3GCREC ingested by sea swimmers. These were thought to be the most 
appropriate estimate available given that the objective methods of quantification 
used would be subject to fewer biases (e.g. recall bias) that are hard to avoid 
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when using subjective methodologies to collect data. However, the methods used 
by Dufour et al. (2006) could have marginally overestimated the volume of water 
ingested by swimmers. Allen et al. (1982) reported that a very small quantity of 
cyanuric acid was extracted from the urine of people who soaked in swimming 
pool water for 2 hours, indicating minimal dermal absorption. Nevertheless, in a 
45-minute swimming session, any dermal absorption is likely to have contributed 
little more than 1 ml to the estimation of the volumes of water ingested. It was 
assumed that the volume of water ingested by people swimming in the sea is 
similar to the volume ingested by people swimming in an outdoor chlorinated 
pool. However, conditions in natural bodies of water and people's bathing 
behaviour may be very different to those in an outdoor swimming pool. Although 
Schets et al. (2011) found that respondents generally reported swallowing larger 
volumes of water whilst swimming in swimming pools compared to seawater, 
under certain conditions (for example, greater wave activity) unexpected head 
immersions may be more frequent, resulting in more accidental water ingestion. 
 
The second approach to quantifying the volume of water ingested during water 
sports relies on accurate recall of study participants estimating how much water 
they believe they swallowed. Although Dorevitch et al. (2011) reported good 
agreement between self-reported estimates for volumes of water ingested and 
estimates derived using the objective measurement of cyanuric acid in urine, self-
reported estimates for these activities as well as other water sports varied widely 
and are likely to be subject to various biases as a consequence of the subjective 
methods used for their measurement. Dufour et al. (2006) also reported a large 
range of volumes of water ingested, so the large variation in estimates reported 
by all papers (even those using subjective measures) can be partially explained 
by the differences in individual behaviour during these activities as discussed 
previously. Despite the subjective nature of the methodology relying on 
questionnaire responses, the lack of adequate marker chemicals in seawater 
(and other natural water bodies) that can be measured in natural conditions 
means that obtaining objective measures of water ingested in realistic settings 
during water sports is extremely difficult. In addition, very few of the identified 
papers investigated the volumes of water ingested by children undertaking water 
sports. It was therefore assumed that the data reported for adults also applied to 
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children. However, it is highly likely that (as with swimming) children doing these 
activities ingest more water than adults doing the same activity. 
 
The data on the number of sessions per person per year as reported by EFTEC 
are based on a small number of adults' responses to a survey that was conducted 
over 10 years ago. The average number of water sport sessions per child per 
year was not estimated, and so it was assumed that the data reported for adults 
applied to children. However, it is possible that (as with swimming) children 
participate in some of these water sports more often than adults, meaning that 
this population-level approximation of exposure is an underestimate. Furthermore 
the popularity of many water sports has increased in recent years, so it is likely 
that the number of sessions of recreational activities involving intake of 3GCREC 
in 2012 is greater than reported here. The average duration of water sport 
sessions in England and Wales are assumed to be similar to those reported in 
the literature (e.g. a sea swimming season lasts approximately 45 minutes 
(Dufour et al., 2006, Evans et al., 2006), although the duration of many of these 
activities could be influenced by other factors, such as fitness levels, or air and 
water temperature. Additional data is needed to estimate more accurately 
population-level exposure to ingestion of 3GCREC. For example, the volume of 
water ingested or the number of sessions per person per year has not been 
reported for some water sports, such as kitesurfing, which are becoming 
increasingly popular. 
 
It was assumed that people enjoying water sports in coastal waters have an equal 
probability of visiting any designated beach, such that 83.3% of the population 
visited bathing waters meeting the higher water quality standards, and the 
remainder visited bathing waters meeting or failing the mandatory water quality 
standards in the same proportions as reported in Table 12. In reality, beaches 
regularly reporting high water quality develop a good reputation and therefore 
attract more people, so a greater proportion of the population than 83.3% may 
have been exposed to waters meeting the higher standard for water quality. 
 
Despite these limitations, the results reported here are significant in terms of 
public health, as 3GCs are essential for the treatment of serious Gram-negative 
bacterial infections in humans, including infections commonly caused by E. coli, 
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such as urinary tract infections, and bacteraemias (World Health Organization, 
2014). There is some evidence to suggest that consuming water containing 
antibiotic resistant E. coli is associated with human intestinal colonisation by 
antibiotic resistant bacteria. Furthermore, Kennedy and Collignon (2010) reported 
that human colonisation by antibiotic resistant commensal bacteria can persist 
for several months, and horizontal gene transfer of ARGs on MGEs can take 
place in vivo between ARB and transient and resident intestinal bacteria (Blake 
et al., 2003). These MGEs often carry multiple ARGs, conferring resistance to 
multiple antibiotics to recipient microbes (Turgeon et al., 2012). Therefore, 
ingestion of 3GCREC in coastal waters could result in asymptomatic human gut 
colonisation by bacteria that are resistant to multiple antibiotics. Consequently, 
asymptomatic carriers could pass on these bacteria to members of the 
community that are vulnerable to infection (e.g. the elderly, the very young, the 
immunocompromised), or go on to develop infections in the future that are difficult 
to treat. 
 
The health risks of ingestion of 3GCREC in the coastal zone are difficult to 
quantify due to the current lack of data on a number of variables that would enable 
predictions of the burden of disease caused by 3GCREC (and ARB more 
generally) acquired in natural environments. These include demonstrating that 
exposure to ARB in natural environments results in gut colonisation, determining 
the dose required to cause gut colonisation (or symptomatic infections), 
pathogenicity of the ingested bacteria, pathogenicity of bacteria that acquire 
ARGs in the gut, the rates of ARG transfer between bacteria in the gut, and the 
persistence of various ARGs among intestinal bacteria in the absence of selective 
pressure from antimicrobials (Ashbolt et al., 2013, Blaak et al., 2011). 
 
This study has considered one type of exposure to ARB in the coastal zone: 
ingestion of 3GCREC present in seawater. However, ARB could colonise people 
enjoying recreational activities in seawater by means not involving water 
ingestion. For example, bacteria distributed in the water and adsorbed to marine 
sediments or sand could colonise bathers' skin or mucosal membranes, 
contaminate open wounds, or be inhaled if airborne (Attias et al., 1995). These 
routes of exposure are difficult to quantify, so the contribution they make to 
142 
 
recreational exposure to ARB is currently unknown, although it is expected that 
ingestion is the major route of exposure.  
 
Future research 
To assess the public health risk posed by ARB in coastal waters, further research 
needs to be done to estimate the prevalence of resistance to different classes of 
antimicrobials in coastal waters, and other coastal compartments (e.g. in streams 
that cross beaches), and to expand this to other groups of bacteria. Other 
knowledge gaps that need to be addressed include quantifying the volumes of 
water ingested by different populations during other popular water sports, 
estimating the exposure to ARB in coastal waters that does not involve 
swallowing water, as well as understanding the extent to which the public use 
coastal waters outside the bathing season, and at undesignated waters. Since 
we expect that ingestion of ARB in seawater could result in gut colonisation, 
future research should aim to examine the association between recreational 
exposure to ARB in coastal waters and gut colonisation by ARB.  
 
Conclusions 
To limit the spread of antibiotic resistance, it is important to understand the 
magnitude of all routes of transmission so that effective strategies can be 
developed and implemented. It has been demonstrated that there were over 6.3 
million exposures to 3GCREC in 2012 through the recreational use of designated 
bathing waters in England and Wales. This is the first study to use volumes of 
water ingested during a variety of different water sports to estimate human 
exposure to ARB. Actual exposure to ARB during water sports in coastal waters 
is likely to be much greater than reported here. Although this represents just one 
of many human exposure routes, the contribution the natural environment makes 
to the transmission of ARB deserves further research to enable a full human 
health risk assessment to be conducted. 
 
Having demonstrated that water users, in particular surfers, are at risk of 
ingesting ARB, the next chapter of this thesis aims to investigate the hypothesis 
that recreational exposure to ARB in coastal waters is associated with gut 
colonisation by ARB.  
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Chapter 5: The beach bum survey 
5.1 Introduction 
The widespread use of antibiotics for the treatment and prevention of bacterial 
infections has contributed to the emergence of antibiotic resistance among 
bacteria (Blaak et al., 2011). Resistance mechanisms can be acquired by 
mutation or horizontal transfer of antibiotic resistance genes (ARGs) on mobile 
genetic elements (MGEs) such as plasmids, from one bacterium to other 
members of a bacterial community. Recipients of these ARGs express resistant 
phenotypes, and are able to survive and multiply in the presence of antibiotics. 
With the resulting failure of essential antibacterial agents to treat diseases caused 
by resistant bacteria, and only a limited number of antibiotics to which they may 
still be susceptible remaining, resistance has been described as “one of the 
greatest health threats faced today” (Davies et al., 2011). The European Centre 
for Disease Prevention and Control (ECDC) estimated that in 2007 more than 
386,000 bloodstream infections were caused by ARB in Europe, resulting in over 
25,000 deaths and costing more than €1.5 billion (European Centre for Disease 
Prevention and Control and European Medicines Agency, 2009). If current trends 
continue, rates of morbidity and mortality from infections caused by ARB are 
predicted to increase (de Kraker et al., 2011a, World Health Organization, 2014, 
de Kraker et al., 2011b).  
Extended-spectrum β-lactamase (ESBL)-producing Enterobacteriaceae are ARB 
of particular concern. ESBL enzymes deactivate a large group of clinically 
important antibiotics called the β–lactams. This group, which includes the 
penicillins and cephalosporins, is used widely to treat a variety of Gram-negative 
infections, such as urinary tract infection (UTIs) (Nordmann et al., 2012). 
Plasmids carrying ESBLs, such as CTX-Ms, disseminate among bacteria, often 
conferring resistance to multiple antibiotics, for example β-lactams, 
fluoroquinolones, aminoglycosides and trimethoprim-sulfamethoxazole 
(Livermore and Hawkey, 2005, Department of Health Antimicrobial Resistance 
Strategy Analytical Working Group, 2015, Johnson et al., 2010). Although there 
are a number of different plasmid-borne ESBLs (including TEM, SHV, OXA), 
CTX-Ms (and particularly CTX-M-15) represent nearly 80% of ESBLs in clinical 
isolates (Amos et al., 2014a, Hawkey and Jones, 2009, Lartigue et al., 2007). 
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Worryingly, their prevalence is increasing outside healthcare settings 
(Wickramasinghe et al., 2012, Amos et al., 2014a). The rapid emergence and 
spread of ESBLs, particularly of the CTX-Ms, poses a significant public health 
threat, as infections caused by ESBL-producing bacteria are unresponsive to 
multiple antibiotics, including essential frontline drugs such as third-generation 
cephalosporins (3GCs) (Collignon et al., 2009). Resistant infections are therefore 
much more difficult and expensive to treat, resulting in lengthy and costly hospital 
stays and an increased risk of death (de Kraker et al., 2011a, de Kraker et al., 
2011b). Carbapenems are one of the few classes of antibiotics recommended for 
the treatment of serious infections caused by ESBL-producing bacteria, and while 
E. coli resistant to carbapenems have been detected in a UK river, resistance in 
the clinic remains low in the UK (Amos et al., 2014a, European Centre for Disease 
Prevention and Control, 2014b, Department of Health Antimicrobial Resistance 
Strategy Analytical Working Group, 2015, Rogers et al., 2011). Genes encoding 
carbapenemase production can also be embedded in MGEs, and their spread, 
particularly of KPC, among members of the Enterobacteriaceae has been 
observed (Queenan and Bush, 2007). Temocillin is one of a limited number of 
last resort antibiotics which can be used to treat infections caused by 
carbapenemase-producing bacteria (van Duin et al., 2013). 
Escherichia coli are members of the Enterobacteriaceae family with a complex 
phylogenetic substructure. Some (notably those belonging to phylogroups A and 
C) are usually harmless commensals inhabiting the intestines of healthy animals, 
including humans (Georgiou and Langford, 2002, Blaak et al., 2014, Clermont et 
al., 2009, Dufour et al., 2012). However, some types are associated with intestinal 
and extra-intestinal infections. The phylogenetic group B2 and group D contain 
numerous extra-intestinal pathogenic E. coli which can cause serious infections 
when they enter certain areas of the body. E. coli is the predominant pathogen 
responsible for community-acquired urinary tract  infections (UTIs), and can also 
cause meningitis and bloodstream infections (European Centre for Disease 
Prevention and Control, 2014a, Clermont et al., 2009, Johnson, 2011). The 
mortality rate associated with bloodstream infections caused by resistant E. coli 
in the UK is twice that of infections caused by susceptible E. coli (Davies et al., 
2011). Recently, the dissemination of a CTX-M-15-producing E.coli O25b-ST131 
clone, belonging to the B2 phylogenetic group, has been reported worldwide. 
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With a high virulence potential and resistance to multiple antibiotics, this extra-
intestinal pathogen represents an emerging public health problem (World Health 
Organization, 2014, Nordmann et al., 2012, Blaak et al., 2014, European Centre 
for Disease Prevention and Control, 2014a, Department of Health Antimicrobial 
Resistance Strategy Analytical Working Group, 2015, Clermont et al., 2009, 
Rogers et al., 2011).  
Another characteristic of E. coli that make them a considerable threat to human 
health is their ability to acquire MGEs, which can be transferred to other members 
of the enteric microbial community, including transient pathogens (Winokur et al., 
2001, Nordmann et al., 2012). This ability makes them “the perfect vehicles for 
the dissemination” of CTX-Ms and other MGEs encoding resistance to 
carbapenems and other last-resort antibiotics “out of hospitals and establishing 
them in community settings” (page 15 of (Department of Health Antimicrobial 
Resistance Strategy Analytical Working Group, 2015). 
The mechanisms by which people acquire ARB have been the subject of much 
research. Person-to-person contact and the consumption of contaminated food 
and water have been implicated as transmission routes for ESBL-producing 
Enterobacteriaceae and other ARB to humans (Sorensen et al., 2001). Exposure 
occurs in many settings, such as within the healthcare environment, at home and 
during international travel (Coleman et al., 2012, Kennedy and Collignon, 2010, 
Valverde et al., 2008, Paltansing et al., 2013, Department of Health et al., 2014). 
However, the natural environment has so far received little attention as a potential 
setting in which people may acquire these important ARB.  
Natural environments, for example soils and water, are increasingly being 
recognised as a reservoir of ARGs and ARB (Mesa et al., 2006, Ashbolt et al., 
2013). Not only do these environments have their own complex microbial 
communities, but they are frequently contaminated by anthropogenic pollutants. 
Manure applied as fertiliser to crops, and wastewater effluent discharged into 
waterways introduce faecal matter to coastal waters. Faecal matter carries large 
numbers of harmful pathogens and commensal bacteria carrying a diverse range 
of MGEs into this environmental compartment. Sewage also carries compounds 
that select for resistant phenotypes and genotypes (Blaak et al., 2014, Amos et 
al., 2014a, Amos et al., 2014b). Furthermore, with seaside and coastal locations 
in Great Britain receiving 160 million visits in 2014 (Great Britain Day Visits 
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Survey, 2014), coastal bathing waters may be an important setting in which 
people come into direct contact with ARB, particularly when participating in water 
sports. In 2012, third-generation cephalosporin resistant E. coli (3GCREC) were 
isolated from coastal waters in the UK and the majority were found to harbour 
blaCTX-M  (unpublished manuscript, (Zhang and Gaze, 2016). These E. coli, which 
were resistant to 3GCs, were found in high enough concentrations to suggest 
that multiple ARB are ingested during high-contact recreational activities, and that 
surfers, in particular, are at the greatest risk of swallowing ARB (Leonard et al., 
2015) (see Chapter 3, p. 119). There is some evidence to suggest that ingestion 
of water containing antibiotic resistant E. coli is associated with gut colonisation 
by these bacteria (Coleman et al., 2012). Furthermore, human colonisation by 
antibiotic resistant commensals has been shown to persist for several months 
(Kennedy and Collignon, 2010), and horizontal gene transfer of ARGs can take 
place in vivo between ARB and transient and resident intestinal bacteria (Blake 
et al., 2003). Therefore, the ingestion of ARB in coastal waters by recreational 
water users could result in asymptomatic gut colonisation by ARB and contribute 
to the prevalence of ARB in the community. A higher prevalence of ARB, 
particularly those harbouring plasmid-borne ARGs, in the community poses a risk 
to public health, as ARB can spread via person-to-person contact including to 
people who are predisposed to develop infections (for example the 
immunocompromised, and the elderly), who could go on to develop infections 
that are difficult to treat.   
We hypothesise that recreational use of coastal bathing waters exposes water 
users to ARB, and that ingestion of seawater can result in gut colonisation by 
ARB. It is expected that, if such a relationship exists, a higher proportion of people 
who frequently use seawater for recreational purposes will be colonised by 
enteric bacteria that are resistant to antibiotics as against people who do not have 
regular contact with seawater. As surfers were shown to be at a particularly high 
risk of swallowing ARB, we decided to study this population as the exposure 
group. This is the first study to explore the relationship between recreational use 
of coastal waters and gut colonisation by ARB.  
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5.2 Methods 
This cross-sectional study aimed to investigate regular surfers and body boarders 
(hereafter referred to as ‘surfers’) as the group exposed to coastal waters, 
alongside people with very little exposure to seawater as the ‘control’ group. 
Participants were asked to collect their own rectal swab and these were submitted 
within 48 hours to our laboratory for analysis. Gut bacteria collected on these 
swabs were tested for their resistance to three clinically important antibiotics 
(cefotaxime, meropenem and temocillin), as an indication of gut colonisation by 
ARB among surfers and controls. Resistant colonies were screened for ARGs 
commonly responsible for their resistance phenotypes.  
5.2.1 Planning 
Prior to conducting the study, the Health and Environment Public Engagement 
(HEPE) group was consulted to discuss the feasibility of such a study. Over a few 
discussions, HEPE provided feedback on the proposed methods, as well as on 
materials for participants (the information sheet, consent form, questionnaire, and 
instructions for participants). Approval for the study was sought from the 
University of Exeter Medical School Research Ethics Committee (reference 
number 15/02/067). All materials and protocols were amended following 
feedback from both HEPE and the Ethics Committee.  
5.2.2 Sample size calculation 
We estimated that 150 surfers and 150 matched controls would be needed to 
detect a difference of 15 percentage points (25% versus 10%, respectively) in the 
prevalence of gut colonisation by ESBL-producing E. coli with 90% power at the 
5% (2-tailed) level of significance. The prevalence of gut colonisation in the wider 
community (10%) was obtained from Wickramasinghe and colleagues 
(Wickramasinghe et al., 2012). 
5.2.3 Eligibility criteria 
People were only eligible to take part in this study if they met the following criteria:  
 Aged 18 or over; 
 Lived in England, Wales or Northern Ireland5; 
                                                          
5 people living in Scotland or the Channel Islands were ineligible to participate in 
order for the study to comply with the Human Tissue Act (2004) regulations 
regarding import and export of human tissue 
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 Did not have any underlying chronic conditions that made them 
susceptible to infection or required frequent visits to hospital;  
 Had not travelled outside Europe in the previous six months;  
 Had not spent the night in a healthcare facility in the past six months;  
 Had not received treatment involving a course of antibiotics in the past six 
months;  
 Had not participated in water sports outside the UK in the past six months. 
Surfers who met the definition of regular surfer (surfer or body boarder who goes 
at least 3 times per month) were asked to recruit their own matched control. 
Participants were instructed that matched controls should be a person of the 
same sex, same age (+/- five years) who lived in the same part of the county as 
the recruiting surfer, who did not surf or body board, and who had very little 
exposure to the sea (going in the sea on average less than once per month). As 
described below, we had to change these criteria to ensure we achieved a 
sufficient sample size. 
In order to avoid likely person-to-person transmission, controls were not eligible 
to take part if they lived in the same house as the surfer, or were a recent sexual 
partner (in the past six months) of their recruiting surfer. 
5.2.4 Participant recruitment 
Working with Surfers Against Sewage (SAS), an environmental charity based in 
Cornwall, we originally aimed to recruit our sample size of 150 surfers using 
SAS’s network of regional representatives (Reps). These individuals were asked 
to communicate the existence and purpose of the study to surfers in their area, 
and to recruit interested people to the study. Following extensive local, national, 
and global media coverage of the survey in June 2015, many volunteers 
contacted SAS to express interest in taking part. An employee of SAS sent 
interested individuals further information on the study (including the information 
sheet for participants) and screened them for eligibility. Once confirmed as 
eligible, volunteers were sent kits containing information about the study, a 
consent form, a rectal swab (Medical wire, Fecal Transwab Cary Blair Media), 
along with illustrated instructions to help participants safely and hygienically 
collect their specimens, and a short questionnaire (copies of the materials sent 
to participants have been included in Appendix II, p. 295). Participants were 
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instructed to complete the questionnaire, sign the consent form and return these 
along with their rectal swab by first class post to the laboratory as soon as 
possible. Participants were reimbursed for the cost of postage. 
Surfers Against Sewage also posted advertisements on social media (Facebook, 
Twitter and Instagram) asking for volunteers to come forward.  
  
Figure 24: Example of study announcement made by SAS on social media: 
“NON SURFING VOLUNTEERS NEEDED!!!!!!! We are in the last month of the 
Beach Bums study and we urgently need lots of lovely non surfers to support 
our study. Contact david@sas.org.uk or call 01872 555 950 to help SAS and 
the European Centre for the Environment and Human Health investigate the 
prevalence of antibiotic resistant bacteria in the marine environment.”  
Volunteers who had been sent packs were sent polite prompts via email to remind 
them to complete the survey, or asked, if they were no longer able to take part, 
to return any unused kits.  
Eight months into data collection, the desired sample size had not been achieved, 
and SAS introduced a reward scheme for their reps whereby they were rewarded 
with merchandise from Finisterre for recruiting people to the study. Reps were 
reminded to follow previous guidelines for recruitment, which instructed that 
people had to be volunteers, and that they were allowed to leave the study at any 
time. Further recruitment efforts were made at the Eden Project (October 2015), 
as well as at the Newquay Marine Group (November 2015), and Plymouth Marine 
Laboratory (November 2015).  
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5.2.5 The questionnaire and materials for participants 
The short anonymous questionnaire collected some demographic information 
(sex, age, ethnic group, in which part of the UK they lived, a measure of 
socioeconomic status), recent exposure to the sea, surfer risk behaviours (for 
example, how much time they usually spend in water, whether they surf in water 
that they know is affected by pollution), and information on various risk factors 
(such as consumption of meat and contact with animals), which are thought to be 
associated with gut colonisation by ARB. Questions in the survey were based on 
those in similar surveys investigating exposure to coastal water, as well as those 
used in Public Health England’s research study on bacteria in the gut of GP 
patients (personal communication, (Hawkey, 2015 ) . All the materials given to 
participants (e.g. the information sheet, consent form, instructions for taking 
swabs, and the questionnaire) were piloted by surfers (from SAS) as well as by 
a number of non-surfers (members of the HEPE group). Minor amendments were 
made to the materials based on feedback from people who piloted them before 
being approved by the Ethics Committee (reference number 15/02/067).  
5.2.6 Laboratory work 
Questionnaires were marked with a unique identifying number, which was 
transcribed onto the accompanying Fecal Transwab Tube. The questionnaire 
was kept separate from the laboratory work after this so that the investigator was 
blinded to the exposure status of the individual from whom the swab came. 
Methods used in the laboratory are briefly described here. Full details of the 
methods and validity and quality control checks are described in Appendix I 
(Table 43, p. 224).  
Enrichment  
Samples of the liquid Cary Blair medium from the Fecal Transwab tubes were 
enriched in LB broth (Miller) containing 50 mg/L ampicillin. These were incubated 
overnight (18 - 20 h) at 37oC.  
Selective culture  
The enrichments were plated out onto Coliform Chromocult Enhanced Selectivity 
agar (Merck) of four different types:  
1) agar amended with a third-generation cephalosporin (3GC), cefotaxime (1 
mg/L), to isolate ESBL-producing colonies; 
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2) agar amended with a carbapenem, meropenem (4 mg/L), to isolate 
carbapenemase-producing colonies; 
3) agar amended with a beta-lactamase resistant penicillin, temocillin (4 mg/L), 
to isolate OXA-48-producing colonies; 
4) agar amended with no antibiotics.  
The concentrations of antibiotics used were half the minimum inhibitory 
concentrations reported by the European Committee on Antimicrobial 
Susceptibility Testing (EUCAST, 2014). This concentration was chosen in order 
to isolate intermediately resistant bacteria as well as bacteria that are resistant to 
clinically relevant concentrations of the antibiotics. Samples were recorded as 
being positive for enteric bacteria that were resistant to any of the antibiotics 
investigated if presumptive E. coli colonies (blue) or presumptive non-E. coli 
coliforms (NEC) colonies (pink) grew in the presence of these antibiotics, 
regardless of the number of colonies of each type growing.  
Colony PCR and gel electrophoresis 
A maximum of five presumptive E. coli and a maximum of five presumptive NEC 
colonies were selected from each plate and spotted onto LB agar (Miller) plates 
containing the corresponding antibiotic (at half the MIC) to which they were 
resistant. These were left to incubate overnight at 37oC.  
Cefotaxime resistant colonies underwent PCR to identify those harbouring blaCTX-
M genes. The primer sequences used in this study have been reported in Table 
44 in Appendix I, p. 232). Temocillin resistant colonies underwent PCR to identify 
colonies harbouring blaOXA-48 genes. Meropenem resistant isolates were sent to 
the Public Health England Reference Laboratory for characterisation of 
resistance mechanisms responsible for the observed phenotype.  
CTX-M PCR products were run on 1.0% agarose gel at 100V for 45 minutes with 
a Gene Ruler 1Kb Plus DNA ladder (Thermo Scientific). Samples that produced 
bands of about 909 base pairs (bp) in size were considered to contain blaCTX-M. 
OXA-48 PCR products were run under the same conditions, and samples that 
produced bands of about 740 bp in size were considered to contain blaOXA-48. 
The presence or absence of the genes of interest was transcribed into the results 
spreadsheet. 
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Characterisation of CTX-M genes 
A maximum of three CTX-M-producing presumptive E. coli and a maximum of 
three CTX-M-bearing presumptive NEC per subject were picked for further 
analysis. PCR for the CTX-M gene was performed on CTX-M-producing E. coli 
and NEC colonies. PCR products were purified using the NucleoSpin® Gel and 
PCR Clean-up kit (Macherey-Nagel) according to the manufacturer’s instructions. 
These were sent for bidirectional sequencing at a commercial firm (Macrogen, 
Europe) using the primers used for amplification. Sequences obtained from 
colonies isolated from individuals were trimmed in order to remove low-quality 
reads. These were then aligned using ClustalW in MEGA7 software (Kumar et 
al., 2015) in order to obtain a single sequence. This was compared against 
BLAST to confirm that the genes amplified were indeed blaCTX-M. These 
sequences were used, along with published sequences of known blaCTX-M genes, 
to generate a phylogenetic tree using the maximum likelihood method and 
Tamura-Nei model. The statistical robustness and reliability of the branching 
order within each phylogenetic tree were confirmed by applying bootstrap 
resampling (n = 500 replicates). 
Characterisation of resistant colonies 
The identities of CTX-M-producing colonies, as well as colonies resistant to 
meropenem, were investigated: 
Investigating the identities of Non-E. coli coliforms  
PCR for the dnaJ gene was performed as described by Pham et al. (2007) on 
CTX-M-producing NEC and meropenem resistant NEC (Pham et al., 2007). PCR 
products were purified using the NucleoSpin® Gel and PCR Clean-up kit 
(Macherey-Nagel) according to the manufacturer’s instructions. Amplicons of the 
dnaJ gene were sent for bidirectional sequencing by Macrogen. Nucleotide 
sequences were compared to known sequences using BLAST. A number of 
presumptive NEC were identified as being E. coli, and these isolates were 
analysed along with presumptive E. coli as described below. 
Since a number of CTX-M-producing presumptive NEC were revealed through 
sequence analysis to be E. coli, cefotaxime resistant NEC that did not harbour 
the CTX-M gene were further characterised. This was done by performing qPCR 
amplification of the E. coli-specific gene uidA (Srinivasan et al., 2011), as 
sequencing dnaJ genes was prohibitively expensive and time-consuming. A 
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range of CT values for known E. coli isolates were derived from positive controls, 
and a range of CT values for known NEC were derived from negative controls). 
These CT values were used to develop threshold values that could be used to 
differentiate between E. coli and NEC among the unknown samples. Isolates with 
CT values less than 21.9 were classified as being E. coli. Isolates with CT values 
greater than 28 were classified as being NEC.  
E. coli phylogroup typing 
Quadruplex PCR as described by Clermont et al. (2013) was performed on CTX-
M-producing E. coli in order to assign each colony to one of eight E. coli 
phylogenetic groups (Clermont et al., 2013). Those found to belong to phylogroup 
B2 were screened by PCR to identify members of the highly virulent ST131 clone 
as described previously (Johnson et al., 2009). 
Laboratory methods were approved by Professor Peter Hawkey (at the University 
of Birmingham), and peer-reviewed as part of the process for applying for 
approval from the University of Exeter Medical School Research Ethics 
Committee. The Designated Individual for the University of Exeter Human Tissue 
Act Licence at St. Lukes’ and Streatham campus was also consulted on the 
methods. They agreed that, as the protocol involved the isolation and analysis of 
bacterial cells and not human cells, the regulations surrounding the storage of 
human tissues did not apply to these samples (personal communication, 
(Whatmore, 2015 ) . People submitted signed informed consent forms along with 
their sample. All laboratory work was conducted, and the samples stored, in a 
secure laboratory.  
5.2.7 Data analysis 
Information from returned questionnaires was transcribed into a password-
protected Microsoft Excel spreadsheet stored on a secure server at the University 
of Exeter. Where respondents had not answered a question, or had marked more 
than one of the response options for a question, these were coded as missing 
data. Laboratory results from each swab were transcribed into this spreadsheet. 
Individual samples were marked as positive or negative for the presence of 
bacteria that were resistant to the antibiotics tested. Hard copies of completed 
questionnaires were securely stored in a locked filing cabinet in a secure office 
along with the signed consent forms. 
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The data were entered into STATA v13. (STATACorp, 2013) for analysis, and 
people who did not meet the study’s eligibility criteria (see Participant recruitment) 
were excluded from the main analysis: 
The exposure of interest was a dichotomous variable: recreational exposure to 
coastal waters or not. This was determined by whether or not the respondents 
self-identified as a regular surfer or body boarder, or as a control subject. The risk 
ratio and test-based 95% confidence interval were estimated for the presence of 
ARB, along with the risk difference and accompanying 95% confidence intervals.   
This study was approved by the University of Exeter Medical School Research 
Ethics committee (reference number 15/02/067).  
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5.3 Results 
5.3.1 Recruitment 
Seven hundred and seventy six swab kits were sent out to participants who had 
requested them. Two hundred and ninety four (37.9%) of these were returned 
between 27th April and 2nd December 2015. However, 21 swabs of 294 (7.1%) 
were submitted by people who were not eligible to participate (Figure 25), and 
were thus excluded from the main analysis.  
389 people contacted SAS to volunteer 
  
308 were eligible (met study inclusion criteria) 
  
776 kits were given out 
(includes kits given to control subjects) 
  
294 swabs and consent forms were returned 
154 from surfers 
137 from controls 
3 missing exposure data  
  
273 swabs were analysed (143 surfers, 130 controls) 
Reasons for excluding 21 samples: 
 3 missing data 
 18 returned paper work indicating they did not meet eligibility criteria 
for the study 
Figure 25: Participant flow diagram.  
This left 273 swabs and questionnaires available for analysis: 143 from surfers, 
and 130 controls from controls.  
5.3.2 Population description 
Surfers volunteering to participate in the survey were asked to identify a suitable 
control subject (a non-surfer with very little exposure to the sea) that was matched 
by age, sex and county of residence. After several months of very few samples 
being returned from controls (29 were returned in the first 6 months), the matching 
criteria were relaxed in order to achieve the required sample size. This meant 
that certain demographic variables (especially age and sex) were not well-
balanced between the exposed group (surfers) and the unexposed group 
(controls) (Table 18).  
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Table 18: Number (%) of surfers and control subjects belonging to each 
demographic group.  
Demographic variable Surfers  
N=143  
Controls  
N=130  
Sex 
Male 
Female 
Missing 
 
98 (68.5%) 
43 (30.1%) 
2 (1.4%) 
 
50 (38.5%) 
79 (60.8%) 
1 (0.8%) 
Age 
18-24 
25-34 
35-44 
45-54 
55-64 
≥65 
Missing 
 
39 (27.3%) 
38 (26.6%) 
50 (35.0%) 
6 (4.2%) 
7 (4.9%) 
3 (2.1%) 
0 (0%) 
 
33 (25.4%) 
30 (23.1%) 
20 (15.4%) 
23 (17.7%) 
14 (10.8%) 
10 (7.7%) 
0 (0 %) 
Ethnic group 
English/Welsh/Scottish/Northern Irish/British 
Irish 
Any other White background 
White and Asian 
Any other Mixed/ Multiple ethnic background 
Any other Asian background 
Missing 
 
133 (93.0%) 
2 (1.4%) 
6 (4.2%) 
0 (0%) 
1 (0.7%) 
0 (0%) 
1 (0.7%) 
 
120 (92.3%) 
0 (0%) 
7 (5.4%) 
1 (0.8%) 
1 (0.8%) 
1 (0.8%) 
0 (0%) 
Education 
Level 1: 1-4 GCSEs or equivalent 
qualifications    
Level 2: 5 or more GCSEs or equivalent  
Apprenticeship  
Level 3: 2 or more A-levels or equivalent  
Level 4: Bachelor’s degree or equivalent, 
higher  
Other qualification 
Missing 
 
6 (4.2%) 
 
5 (3.5%) 
3 (2.1%) 
31 (21.7%) 
84 (58.7%) 
3 (2.1%) 
11 (7.7%) 
0 (0%) 
 
2 (1.5%) 
 
6 (4.6%) 
1 (0.8%) 
35 (26.9%) 
73 (56.2%) 
4 (3.1%) 
9 (6.9%) 
0 (0%) 
 
 
5.3.3 Resistance among enteric coliforms 
Escherichia coli and non-E. coli coliforms collected on rectal swabs were tested 
for their phenotypic resistance to three antibiotics separately: cefotaxime, 
meropenem and temocillin.  
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Prevalence of cefotaxime-resistance 
A slightly lower proportion of surfers was colonised by cefotaxime resistant 
enteric coliforms (18.2%) compared to controls (18.5%), but the precision of the 
estimated risk ratio was not high enough to conclude that the surfing population 
is at a significantly lower risk of being colonised by cefotaxime resistant bacteria 
(risk ratio = 0.98, 95% confidence interval 0.60 to 1.63, P = 0.95) (Table 19). A 
similar trend was observed in resistance among NEC (risk ratio = 0.61, 95% 
confidence interval 0.31 to 1.20, P = 0.15). However, a higher proportion of 
surfers (9.7%) was colonised by E. coli resistant to cefotaxime as against controls 
(3.1%). The risk ratio and 95% confidence intervals indicate that surfers are at a 
greater risk of being colonised by E. coli that are resistant to cefotaxime than are 
controls (risk ratio = 3.18, 95% confidence interval 1.15 to 8.81, P = 0.03), and 
this increase in risk is statistically significant.  
Table 19: The number (%) of surfers and controls who submitted swabs 
containing enteric coliforms phenotypically resistant to cefotaxime (1 mg/L).  
 Surfers 
N = 
143 
Controls 
N =130 
Risk ratio 
(95% CI) 
P-
value 
Risk difference 
(95% CI) 
Presence of 
enteric coliforms 
(either E. coli or 
NEC) resistant to 
cefotaxime 
26 
(18.2%) 
24 
(18.5%) 
0.98  
(0.60 to 
1.63) 
0.95 -0.3% 
(-9.5% to 
8.9%) 
Presence of E. 
coli resistant to 
cefotaxime 
14 
(9.7%) 
4  
(3.1%) 
3.18 
(1.15 to 
8.81) 
0.03 6.7%  
(0.8% to 
12.6%) 
Presence of NEC 
resistant to 
cefotaxime 
12 
(8.4%) 
18 
(13.8%) 
0.61  
(0.31 to 
1.20) 
0.15 -5.4%  
(-12.9% to 
2.0%) 
 
Prevalence of blaCTX-M 
Two hundred and forty four resistant enteric coliforms (76 E. coli and 168 NEC) 
were picked to undergo colony PCR to identify which colonies were carrying 
blaCTX-M. Forty-nine (20 %) of these colonies tested positive for blaCTX-M: Of the 
76 cefotaxime resistant E. coli colonies, 66% harboured blaCTX-M (50/76), 
whereas 0% of cefotaxime resistant NEC harboured blaCTX-M (0/168). Comparing 
the carriage rate among surfers and controls, a higher proportion of surfers was 
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colonised by cefotaxime resistant E. coli bearing blaCTX-M (6.29%) than in the case 
of controls (1.54%) (Table 20). Surfers were at a significantly greater risk of being 
colonised by E. coli harbouring blaCTX-M than was the control group (risk ratio = 
4.09, 95% confidence interval 1.02 to 16.4, P = 0.05).  
Table 20: The number (%) of surfers and controls who submitted swabs 
containing enteric coliforms bearing blaCTX-M.  
 Surfers 
N = 
143 
Controls 
N =130 
Risk ratio 
(95% CI) 
P-
value 
Risk 
difference 
(95% CI) 
Presence of 
enteric coliforms 
(either E. coli or 
NEC) producing  
CTX-M 
9 
(6.3%) 
2  
(1.5%) 
4.09 
(1.02 to 
16.4) 
0.05 4.8% 
(0.1% to 
9.4%) 
Presence of E. 
coli producing 
CTX-M 
9 
(6.3%) 
2  
(1.5%) 
4.09 
(1.02 to 
16.4) 
0.05 4.8% 
(0.1% to 
9.4%) 
 
CTX-M typing and identities of bacteria producing CTX-M  
The phylogenetic analysis of blaCTX-M sequences failed to demonstrate clustering 
of our sequences with known blaCTX-M gene sequences (see Figure 33 in 
Appendix I, p. 234). However, all were confirmed, using BLAST, as being blaCTX-
M. Nine surfers and two controls were colonised by blaCTX-M -bearing E. coli. Of 
these surfers, six were colonised by blaCTX-M -bearing E. coli belonging to the 
phylogenetic group B2 and all of these were identified as being ST131. One 
member of the control group was colonised by CTX-M-producing E. coli typed as 
group B2, which was also ST131, and the other was colonised by E. coli 
belonging to the phylogenetic group D. Three surfers were colonised by blaCTX-M 
-bearing E. coli belonging to phylogenetic groups, A, B1, C and F. 
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Table 21: The number (%) of surfers and controls colonised by pathogenic blaCTX-
M-bearing E. coli. 
  Surfers 
N = 143 
Non-
surfers 
N =130 
Risk ratio 
(95% CI) 
P-value Risk difference 
(95% CI) 
Presence 
of 
phylogroup 
B2 or D E. 
coli 
producing 
CTX-M 
6 
(4.2%) 
2 (1.5%) 2.73  
(0.60 to 12.4) 
0.19 2.7%  
(-1.4% to 6.7%) 
CTX-M-
producing 
ST131 E. 
coli 
6 
(4.2%)  
1 (0.8%) 5.45  
(0.85 to 35.1) 
0.07 3.4%  
(-0.3% to 7.2%) 
 
A higher proportion of surfers was colonised by blaCTX-M-bearing pathogenic E. 
coli than in the case of non-surfers. There is an increased risk of surfers being 
colonised by highly resistant pathogenic E. coli ST131 compared to non-surfers, 
but this is not statistically significant (risk ratio = 5.45, 95% CI 0.85 to 35.1, P = 
0.07).  
Meropenem resistance 
Resistance to meropenem among enteric coliforms was rare: two meropenem 
resistant NEC colonies were isolated from a surfer and four from a control. A 
slightly higher proportion of controls were colonised by meropenem resistant 
NEC compared to surfers, but the estimated reduction in risk to surfers was not 
significant (Table 22). 
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Table 22: The number (%) of surfers and controls who submitted swabs 
containing enteric coliforms phenotypically resistant to meropenem (4 mg/L).  
 Surfers 
N = 143 
Controls 
N =130 
Risk ratio 
(95% CI) 
P-
value 
Risk difference 
(95% CI) 
Presence of 
enteric coliforms 
(either E. coli or 
NEC) resistant 
to meropenem 
1  
(0.7%) 
1  
(0.8%) 
0.91  
(0.06 to 
14.4) 
0.95 -0.1% 
(-2.1% to 2.0%) 
Presence of E. 
coli resistant to 
meropenem 
0  
(0%) 
0  
(0%) 
Undefined  0% 
(Undefined) 
Presence of 
NEC resistant to 
meropenem 
1  
(0.7%) 
1  
(0.8%) 
0.91  
(0.06 to 
14.4) 
0.95 -0.1% 
(-2.1% to 2.0%) 
 
In addition, the identity of NEC that were phenotypically resistant to meropenem 
were investigated by sequencing the dnaJ gene. Meropenem resistant colonies 
from both the surfer and the control were found to be Enterobacter cloacae. 
Characterisation of the mechanisms responsible for meropenem resistance is 
ongoing.  
Temocillin resistance and prevalence of blaOXA48 
A large number of enteric coliforms phenotypically resistant to temocillin were 
recovered from swabs submitted by participants at the beginning of the study. 
Three hundred and forty-seven temocillin resistant colonies (93 NEC and 270 E. 
coli) were selected to undergo PCR for the presence of blaOXA-48. However, all 
were negative and, in order to conserve time and resources, screening for 
resistance to this antibiotic was discontinued. Results obtained until this cut-off 
have been presented in Table 23.  
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Table 23: The number (%) of surfers and controls who submitted swabs 
containing enteric coliforms phenotypically resistant to temocillin (4 mg/L).  
 Surfers 
N = 70 
Controls 
N =32 
Risk ratio 
(95% CI) 
P-
value 
Risk 
difference 
(95% CI) 
Presence of enteric 
coliforms (either E. 
coli or NEC) 
resistant to 
temocillin 
42  
(60.0%) 
23 
(71.9%) 
0.83  
(0.61 to 
1.14) 
0.25 -11.9% 
(-32.1% to 
8.3%) 
Presence of E. coli 
resistant to 
temocillin 
34  
(48.7%) 
18 
(56.3%) 
0.86 
(0.58 to 
1.29) 
0.47 -7.7% 
(-28.7% to 
13.3%) 
Presence of NE-
coliforms resistant 
to temocillin 
14  
(20.0%) 
6 (18.9%) 1.07  
(0.45 to 
2.52) 
0.88 1.3% 
(-15.4% to 
17.9%) 
 
Risk factor analysis for surfers 
Surfers were asked five additional questions about their surfing behaviour that 
might explain any observed differences in the risk of carrying ARB among the 
surfing group. The results of this analysis are reported for cefotaxime resistant or 
CTX-M-producing E. coli among the surfing group (Table 24). The prevalence of 
faecal carriage of cefotaxime resistant E. coli was highest among surfers 
spending, on average, more than three hours in the sea each time they go surfing 
(20.0%), and lowest among surfers spending, on average, less than one hour in 
the sea when they surf (0%). A similar trend was seen for the prevalence of CTX-
M-producing E. coli. The reverse was observed when considering how many 
times per month surfers went surfing: the prevalence of colonisation by 
cefotaxime resistant E. coli was lowest (7.5%) among surfers who go surfing most 
frequently (more than seven times in the past month) and highest (11.1%) among 
surfers who go surfing less frequently (less than once in the past month). Again, 
a similar trend was seen for the prevalence of colonisation by CTX-M-producing 
E. coli coliforms. 
No trend in colonisation by resistant E. coli was observed for information-seeking 
behaviours, although a higher proportion of surfers who tend to avoid going in 
bathing waters that they know to be affected by pollution was colonised by CTX-
M-producing E. coli (24%), compared to surfers who reported never avoiding 
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waters that they know to be affected by pollution (0%). Due to the small numbers 
of surfers colonised by resistant E. coli, it is not possible to comment on the 
significance of these observed trends.   
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Table 24: Responses from surfers asked about their surfing behaviour that might 
indicate factors that increase the risk of colonisation by cefotaxime resistant or 
CTX-M-producing E. coli. 
 Surfers  
N = 143 
Number (%) of 
surfers colonised 
by cefotaxime 
resistant E. coli 
N= 14 
Number (%) of surfers 
colonised by CTX-M-
bearing E. coli  
N = 9 
1. In which UK County do you usually go surfing/body boarding? 
England 109 11 (10.1%) 6 (5.5%) 
“England” 7 0 (0%) 0 (0%) 
North England6  4 0 (0%) 0 (0%) 
Southeast 
England 
8 1 (12.5%) 1 (12.5%) 
Southwest 
England 
90 10 (11.1%) 5 (5.6%) 
Wales 16 2 (12.5%) 2 (12.5%) 
Northern Ireland 17 1 (5.9%) 1 (5.9%) 
Missing 1 0 (0%) 0 (0%) 
2. How much time do you spend in the water (on average) each time you go 
surfing/body boarding? 
< 1 hour 
 1-3 hours 
 >3 hours 
Missing  
13 
120 
10 
0 
0 (0%) 
12 (10.0%) 
2 (20.0%) 
0 (0%)  
0 (0%) 
7 (5.8%) 
2 (20.0%) 
0 (0%) 
3. How many times have you been surfing/body boarding in the past month?  
<3 times 
3-7 times 
>7 times 
Missing 
36 
54 
53 
0 
4 (11.1%) 
6 (11.1%) 
4 (7.5%) 
0 (0%) 
3 (8.3%) 
4 (7.4%) 
2 (3.8%) 
0 (0%) 
4. How often do you look for information* on the water quality at beaches before 
you go surfing/body boarding?  
*Information on the water quality at beaches can be found on water quality 
apps, beach signs, news, social media, online, word of mouth, etc. 
Always 
Often 
Rarely 
Never 
Missing 
6 
27 
64 
46 
0 
0 (0%) 
2 (7.4%) 
10 (15.6%) 
2 (4.35%) 
0 (0%) 
0 (0%) 
1 (3.7%) 
7 (10.9%) 
1 (2.2%) 
0 (0%) 
5. Do you avoid surfing/body boarding at beaches if you know warnings are in 
place that the water is polluted? 
Always 
Often 
Rarely 
Never 
N/A 
Missing 
42 
33 
45 
10 
13 
0 
5 (11.9%) 
4 (12.1%) 
5 (11.1%) 
0 (0%) 
0 (0%) 
0 (0%) 
4 (9.5%) 
3 (9.1%) 
2 (4.8%) 
0 (0%) 
0 (0%) 
0 (0%) 
                                                          
6 Only one surfer reported surfing in the Northwest of England, and so surfers from 
the Northeast and Northwest were combined to preserve the anonymity of the 
surfer from the Northwest. 
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5.4 Discussion 
We set out to test the hypothesis that surfers regularly using coastal waters in the 
UK are at an increased risk of being colonised by antibiotic resistant bacteria 
when compared to people who are not exposed to coastal waters. We found that 
surfers were approximately three times more likely to be colonised by E. coli that 
were phenotypically resistant to cefotaxime at half the MIC, compared to non-
surfers (risk ratio = 3.18, 95% CI 1.15 to 8.81, P = 0.03). We also demonstrated 
an association between recreational use of coastal waters and gut colonisation 
by E. coli bacteria harbouring the plasmid-borne antibiotic resistance gene blaCTX-
M. People who regularly surf or body board were four times more likely (risk ratio 
= 4.09, 95% CI (1.04 - 16.6), P = 0.05) to be colonised by E. coli harbouring this 
gene compared to healthy people who do not surf. A risk difference of 4.8% (95% 
CI 0.1% to 9.4%) was found in the carriage rates of CTX-M-bearing E. coli 
between surfers and controls (Table 20), meaning that out of every 21 regular 
surfers, one will become a faecal carrier of CTX-M-producing E. coli as a result 
of surfing activity (the 95% confidence intervals suggests that the true number of 
people that need to be exposed to surfing before one is colonised as a result 
could be anywhere between 11 and 1000).  
These findings are of public health significance: CTX-Ms are plasmid-borne 
extended-spectrum beta-lactamases (ESBLs), encoding resistance to multiple 
beta-lactam antibiotics, such as penicillins and cephalosporins. Cephalosporins, 
including third-generation cephalosporins, have been classed as essential 
medicines by the World Health Organization, as they are “the sole therapy or one 
of a few alternatives to treat serious human disease” (Collignon et al., 2009).  
Furthermore, we have shown that the bacteria harbouring these mobile 
resistance elements are not necessarily harmless commensal E. coli. Indeed, of 
the 11 people colonised by CTX-M-producing E. coli, seven were colonised by E. 
coli belonging to the phylogenetic group B2, all of which were found to be the E. 
coli sequence type 131 (ST131). ST131 is a highly virulent strain of E. coli. Its 
rapid spread has been observed globally, commonly causing urinary tract 
infections (ranging from cystitis to pyelonephritis), but it has also been found to 
cause respiratory tract infections, intra-abdominal abscesses, osteoarticular 
infections and bacteraemia (Rogers et al., 2011, Clermont et al., 2009, Vigil et 
al., 2010).  
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While surfers colonised by potentially pathogenic ARB may not display any 
symptoms of infection, gut bacteria have been shown to be a major source of 
infection, particularly for antibiotic resistant infections in hospital settings (Asir et 
al., 2015).  Furthermore, they may be contributing to the overall carriage of ARB 
in the community, and may, through person-to-person contact, spread ARB 
among the wider population (Smith et al., 2005, Lietzau et al., 2006, Valverde et 
al., 2008). A higher community carriage of ARB puts vulnerable people 
(immunocompromised people, hospitalised patients, people in care homes) at 
increased risk of acquiring ARB through person-to-person contact. This 
constitutes a serious threat to the health of these susceptible individuals, who 
may subsequently develop infections that are hard to treat.   
The prevalence of CTX-M carriage in our study subjects, and the difference 
between the two groups, was lower than expected. There is no routine 
surveillance of faecal carriage of CTX-M-producing E. coli (or indeed other groups 
of bacteria) in the general population. However, previous European studies have 
reported that between 1.4% and 11.1% of the non-hospitalised population were 
colonised by CTX-M-producing E. coli. Our estimate of 1.5% in our control group 
(4.0% among surfers and controls combined) is within this range, but towards the 
lower end. The most plausible explanation for the low prevalence observed in our 
sample is the strict eligibility criteria we imposed on participants. These were 
imposed for both health and safety and legal reasons, but also because 
international travel, use of antibiotics in the recent past and recent hospitalisation 
are known risk factors for gut colonisation by ESBL-producing bacteria (Kennedy 
and Collignon, 2010). We wanted to eliminate people with these exposures so 
that we could be more confident that any differences observed between surfers 
and controls in terms of faecal carriage of ARB was due to recreational exposure 
to coastal waters. Furthermore, we suspect that the low prevalence of 
colonisation by CTX-M-producing E. coli may be due to nearly half of the 
participants being from regions in the Southwest of England (a large proportion 
of subjects reported living in Cornwall), where there are lower population 
densities and less immigration; factors which are thought to impede the spread 
of ARB among members of rural communities (Wickramasinghe et al., 2012, 
Rienzo and Vargas-Silva, 2014, Office for National Statistics, 2013a). True faecal 
carriage of CTX-M-producing Gram-negative bacteria is therefore likely to be 
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higher in the wider non-surfing and surfing populations than we have reported. 
However, we expect that the difference in risk between surfers and non-surfers 
will be similar to those reported here. Using estimates of CTX-M-production in E. 
coli reported in the literature as a conservative estimate for CTX-M-production in 
enteric coliforms within the community, we can predict the proportion of the 
surfing community likely to be colonised. These have been reported in Table 45 
in Appendix I (p. 235). If the prevalence of faecal carriage of CTX-M producing E. 
coli in the wider community were to reach 25%, theoretically 100% of surfers 
would be colonised by CTX-M-producing enteric bacteria.  
Understanding the direction and magnitude of this risk will be useful to help policy 
makers in this area to develop effective mitigation strategies to reduce the 
dissemination of ARB in the wider community. Our risk ratio of 4.01 is greater 
than estimated risk ratios for other studied routes of transmission, such as 
hospitalisation (Table 46 in Appendix I, p. 236). However, studies investigating 
the impact of international travel report larger differences in the prevalence of gut 
colonisation by CTX-M-producing Enterobacteriaceae between pre-travel and 
post-travel measurements (Kennedy and Collignon, 2010). Nevertheless, 
recreational exposure to coastal waters could be a more important transmission 
route than previously thought. 
Our hypothesis is that surfers are acquiring ARB harbouring MGE after 
swallowing coastal waters while surfing. Not only is this transmission pathway 
biologically plausible, but previous research by Coleman et al. (2012) has 
demonstrated that people with water supplies contaminated by antibiotic resistant 
E. coli  are at a greater risk of being colonised by antibiotic resistant E. coli. 
Furthermore, these results are consistent with those reported by Soraas et al. 
(2013), who reported that recreational sea swimming was a significant risk factor 
for community-acquired urinary tract infections caused by ESBL-producing E. coli 
or Klebsiella pneumoniae. The Beach Bum Survey has also demonstrated that 
there is a moderately strong association between regular recreational exposure 
to coastal waters and faecal carriage of enteric coliforms harbouring blaCTX-M. 
However, further criteria need to be met before a causal relationship between this 
exposure of interest and outcome can be inferred (Hill, 1965). One such criterion 
would be clear evidence that surfers were not colonised by CTX-M-producing 
bacteria before their exposure and that colonisation occurs following exposure. 
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As the Beach Bum Study is a cross-sectional survey, we have not been able to 
demonstrate this temporal aspect in the link between surfing or body boarding 
and faecal carriage of ARB. A prospective cohort study (ideally randomised 
exposures) would be the best way of determining whether faecal carriage of CTX-
M-producing bacteria occurs following surfing in coastal waters. Nevertheless, it 
will be extremely difficult to prove that bacteria or resistance genes were acquired 
from the environment and transmitted within a community. This is due mostly to 
“the complexity of bacterial population biology and genetics” as well as to the 
multitude of environments in which ARB can be found (Smith et al., 2005).  
Another criterion would be the existence of a dose-response relationship between 
the exposure and outcome. Surfers were asked five additional questions about 
their surfing behaviours so that we might be able to demonstrate whether 
increased exposure to coastal waters, or to polluted coastal waters, is associated 
with an increased risk of being colonised by ARB. We would expect people who 
surf for longer periods or more frequently to have a higher risk of having the 
condition (colonisation by blaCTX-M-bearing E. coli). However, the results 
presented in Table 24 were inconclusive. In line with our prediction, prevalence 
of the condition was highest among surfers spending more than three hours in 
the water and lowest among surfers spending less than one hour in the water. By 
contrast, the highest prevalence among surfers were who surfed on average less 
than three times per month, compared to those going three to seven or more than 
seven times in the past month. We also asked surfers whether they researched 
water quality at the beach which planned on visiting before going, and whether 
they avoided surfing at beaches they know to have been affected by pollution. 
We would expect people who do not look for water quality information, or who do 
not avoid beaches known to be polluted to be at greater risk of having the 
condition. The results presented in Table 24 were, again, inconclusive. No clear 
pattern emerged from consideration of the different prevalence among people 
researching water quality before their visits. Contrary to our expectations, it 
appeared that the prevalence was highest among surfers who always avoid 
surfing at beaches where they know the water quality is compromised, and the 
lowest among those who never avoid beaches where they know the water quality 
is compromised. These inconsistent results are probably due to the small number 
of people harbouring CTX-M-bearing E. coli (n=11), and the overall number of 
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surfers taking part in the study, and we cannot therefore explicitly rule out the 
existence of a dose-response relationship.  
Apart from the fact that a smaller number of people than required were recruited, 
there are a few limitations with the Beach Bum Survey that mean the results 
should be interpreted with caution. First, this study was concerned with detecting 
one group of culturable bacteria (Enterobacteriaceae) that are resistant to 
representatives of three groups of clinically important antibiotics (cefotaxime, 
meropenem and temocillin) used to treat Gram-negative infections. The benefit 
of this approach is that we can elucidate the identities of living bacteria expressing 
resistance genotypes. However, this does not allow for the detection of other 
bacteria, such as Gram-positive bacteria and unculturable bacteria, nor of 
bacteria (including Enterobacteriaceae) that are resistant to other classes of 
antibiotics, such as quinolones. Second, we have relied upon participants to 
identify themselves accurately as not only being suitable to take part in the study 
(i.e. that they met all its eligibility criteria) but also as surfers or controls in 
accordance with our definition. If people identifying themselves as surfers in 
reality go less often than three times per month, we might have underestimated 
the prevalence of surfers carrying CTX-M-producing enteric coliforms, as well as 
the magnitude of risk to surfers of having this condition. Likewise, we assumed 
that the control group accurately identified themselves as people with no/minimal 
exposure to seawater. We also relied upon the validity of the laboratory methods 
used. The rectal swabs collected a small sample of the participants’ bacteria from 
the end of the intestinal tract. Different areas of the gut harbour different 
communities of bacteria, so it is possible that ARB in other regions of the 
alimentary canal were not detected. Early stages of colonisation might occur 
higher up in the alimentary canal, and therefore people more recently colonised 
might not have been identified as having the condition of interest. However, this 
rate of error is likely to be consistent in both the surfer and the control group so 
that the size of our relative risk estimate would not be affected.   
A third limitation of this study is that subjects may not be representative of the 
wider population, a factor which would compromise the external validity of the 
study findings. Despite efforts to ensure that all surfers and body boarders were 
made aware of the study and given the opportunity to participate, those taking 
part in the survey may not be representative of all surfers and body boarders. 
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Similarly the controls may not be representative of all non-surfers. This is partly 
due to the large number of exclusion criteria limiting participation, but it is also 
likely that many people were deterred by the invasive nature of sample collection, 
and/or the effort involved in participation: recruiting a suitable matched control, 
requesting data collection kits, completing the kit, and returning completed kits 
via post. Therefore, those who did volunteer to participate may differ in ways from 
those who chose not to participate, creating bias in our estimated risks. In order 
to assess whether the sampled surfers could be considered to be representative 
of surfers in general, we can compare some characteristics of surfers taking part 
in the Beach Bum Survey to those who took part in a recent study to assess the 
economic impact of surfing in the UK (Mills and Cummins, 2013). The two studies 
reported similar distributions of demographic variables (age and education) 
among the UK adult surfing population: between 93% and 95% of surfers were 
aged between 18 and 54, and between 59% and 64% hold higher degrees. 
However, comparing the results of these two studies involving surfers revealed 
that a much higher proportion of surfers participating in the Beach Bum Survey 
reported surfing in Cornwall or Northern Ireland compared to those taking part in 
the study conducted by Mills and Cummins (2013). All the regions in which surfers 
reported going surfing had the vast majority (>80%) of their designated bathing 
waters classified as either good or excellent quality in 2015 (Department of the 
Environment, 2015, Environment Agency, 2015, Natural Resources Wales, 
2015). We expect that if a higher proportion of surfers taking part in the Beach 
Bum Study had used coastal waters in areas with poor water quality, particularly 
beaches affected by urban waste-water, the observed prevalence of gut 
colonisation by ARB among surfers would be higher.    
 
Finally, there were a few other problems with participant recruitment. We had 
hoped to eliminate a number of potential confounders at the design stage of the 
study by having participating surfers and body boarders match themselves by 
age, sex and county of residence to a person with minimal exposure to coastal 
waters. These matching criteria were dropped in favour of achieving an adequate 
sample size in the remaining time. Therefore, the distribution of a few potential 
confounding variables among the surfer group and control group were noticeably 
different (Table 18). Overall, there was a roughly equal number of men and 
women participating in the study. However, the majority of surfers were male 
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(68.5%), whereas the majority of controls were female (60.8%). Furthermore, 
nearly 90% of surfers were between 18 and 45, whereas 64% of controls were 
under the age of 45. The differences in the measured prevalence of ARB carriage 
between the two groups of participants might be affected by these differences in 
potential confounders. However, because a small number of subjects were found 
to be colonised by CTX-M-producing enteric coliforms, the risk ratio estimates 
could not be adjusted for these potential confounders. Furthermore, the majority 
of subjects (81.8%) participated after the end of the bathing season (30th 
September), which coincides with surfers’ peak use of UK coastal waters (Mills 
and Cummins, 2013). In 2012, we estimated that surfers swallow approximately 
four 3GCREC each time they go surfing during the bathing season in designated 
bathing waters that fail the revised European Bathing Water Directive (Leonard 
et al., 2015). Of these, at least two (67%) would be harbouring blaCTX-M (Zhang 
and Gaze), although after the end of the bathing season (1st October onwards), 
we expect that this number would be similar or greater, even if surfers used 
coastal waters that were classified as good during the bathing season. Water 
quality is expected to be poorer outside the bathing season, when faecal 
contamination of bathing waters is not monitored, compared to during the bathing 
season. This is because higher rainfall leads to greater amounts of land runoff 
from agricultural lands and CSO spills, introducing faecal material to coastal 
waters.  
Although prevalence was extremely low (less than 1%) in both groups, 
meropenem resistant Enterobacter cloacae were isolated from members of the 
study population. Enterobacter cloacae is a normal member of the gut microflora, 
but can be an opportunistic pathogen, causing wound infections and, urinary tract 
infections (among others), especially in vulnerable populations (Fraser et al., 
2015). Further research efforts will include the elucidation of the mechanisms 
responsible for the observed phenotypes in these isolates to discover whether 
the meropenem resistance genes are found on mobile elements or are 
chromosomally encoded. However, it is worth mentioning that we did not identify 
a significant association between surfing and gut colonisation by meropenem 
resistant isolates. Nevertheless, monitoring the presence of bacteria that are 
resistant to last-resort antibiotics such as carbapenems and polymyxins, will be 
valuable, and should be prioritised in future studies.  
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Further research needs to be done in order to understand ARB survival in the 
human alimentary canal and various factors affecting gut colonisation, such as 
the effect of stomach acid levels, and antacids on ARB survival. Additionally, the 
derivation of dose-response estimates for human gut colonisation by ARB is 
information that is necessary for risk assessments, as is the measurement of the 
rates of transfer of ARGs among human gut microbiota. It would also be beneficial 
to test the susceptibility of the enteric coliforms that were phenotypically resistant 
to half the MIC in this study at the full MIC to confirm the clinical relevance of the 
results presented in Table 19 (p.157).  
 
Conclusions 
We report that regular surfers and body boarders in the UK are at a significantly 
higher risk of colonisation by cefotaxime resistant E. coli when compared to 
healthy adults who do not have much contact with seawater. Surfers were also 
at a significantly increased risk of being colonised by CTX-M-producing E. coli 
compared to the control group. CTX-M ESBLs confer resistance to multiple beta-
lactam antibiotics, including medicines essential for the treatment of serious, life-
threatening infections. In addition, the majority of E. coli harbouring these 
important mobile resistance genes were found to be extra-intestinal pathogenic 
E. coli of the pandemic sequence type 131. Although healthy adults may remain 
asymptomatic during colonisation by ARB, they may also be making a 
contribution to the overall prevalence of carriage of ARB in the wider population. 
This represents a risk for members of the community who are vulnerable to 
developing infections (the immunocompromised, the elderly, and the very young), 
where the acquisition of resistant infections through person-to-person contact is 
more likely. Further work needs to be done to investigate whether this association 
is causal. Regardless of the nature of the association, surfers are significantly 
more likely than non-surfers to be faecal carriers of E. coli producing CTX-M 
ESBLs. Therefore, communication with the surfing community about their 
increased risk of harbouring ARB and the consequences of transmitting these to 
vulnerable members of the community is essential. The suggestion of measures 
to prevent person-to-person transmission, such as vigilant hand hygiene 
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particularly when in contact with potentially vulnerable populations, of these ARB 
to the wider public could help reduce the spread of such ARB in the community.
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Chapter 6: Thesis discussion 
6.1 Summary of results 
The four novel studies presented in this thesis provide evidence that indicates 
that people who bathe in coastal waters are at an increased risk of adverse health 
outcomes, whether this involves experiencing symptoms of ill health, or exposure 
to and colonisation by antibiotic resistant bacteria.  
Linking the Exposure and Effect stages of the DPSEEA model, the results of the 
Systematic Review (Chapter 2, p. 50) and the Beach User Health Survey 
(Chapter 3, p. 91) both quantified the risk of experiencing symptoms of ill health 
among bathers. The results of these two studies confirm that bathers are at a 
significantly higher risk than non-bathers of reporting a variety of symptoms of ill 
health following exposure to marine waters. In the first systematic review of its 
kind, the meta-analyses pooling together the results of multiple studies indicated 
that bathers are at a significantly higher risk of experiencing a variety of 
gastrointestinal symptoms, including diarrhoea, vomiting and stomach ache, as 
well as symptoms of ear infection (in particular earache), and any symptoms of 
illness. Despite improvements in recent years in the levels of faecal indicator 
bacteria found in UK and European designated bathing waters (DEFRA et al., 
2015, European Environment Agency, 2015), bathers are still at risk of 
experiencing these symptoms. This is evidenced by pooling data from studies 
published from 2003 onwards, as well as by the result of the Beach User Health 
Survey (Chapter 3). This online survey, conducted in England and Wales from 
2014 to 2015, found that bathers are at a significantly higher risk of experiencing 
symptoms of gastrointestinal illness, skin ailments, ear complaints and any 
symptoms of illness, compared to non-bathers. Furthermore, the magnitude of 
these risks was comparable to those reported by a survey conducted over 20 
years ago in the UK by Kay et al. (1994). Comparing the risks reported in the 
beach user health survey (Chapter 3) to those in the systematic review (Chapter 
2), odds ratio estimates were generally larger but less precise (larger 95% 
confidence intervals: Figure 26), as might be expected for a smaller study size. 
There were no large differences between the results of these two studies, 
suggesting that the results of the Beach User Health Survey are reasonably 
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consistent with the findings of previous studies. The exception to this was in 
relation to the single symptom, nausea, for which the risk was significantly higher 
among bathers compared to non-bathers in the Beach User Health Survey, 
although it was not significantly higher in the Systematic Review. As the figure 
below shows, the 95% confidence intervals surrounding the risk estimates for 
nausea from these two studies do not overlap, indicating that different results on 
the risk of nausea were obtained in the Systematic Review and Beach User 
Health Survey. 
 
Figure 26: Forest plot of the pooled estimates from the systematic review and the 
results of the beach user health survey for selected health outcomes that are 
directly comparable.  
 
The results from these first two data chapters indicate that bathers are still at an 
increased risk of experiencing symptoms of ill health when compared to non-
bathers. Previous reviews have focused on the relationship between the density 
of faecal indicator organisms and gastrointestinal illness and skin ailments 
(Pruss, 1998, Wade et al., 2003, Yau et al., 2009). However, Chapter 2 is the first 
systematic review to meta-analyse the risk of a variety of different health 
outcomes following bathing in coastal waters. Current monitoring methods have 
been shown to be ineffective at capturing some acute pollution events, such as 
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CSO spills, as well as some diffuse pollution, for example land runoff, in addition 
to the fluctuations in bacterial densities that occur naturally (Andy Cummins, 
Campaigns Director at Surfers Against Sewage, personal communication). 
Therefore bathers are at risk of being exposed to polluted waters, even at 
beaches that are monitored for faecal pollution and are classified as satisfactory. 
Understanding the potential risk of experiencing ill health that bathers face when 
they enjoy recreational activities in coastal waters will enable beach-goers to 
make reasoned decisions about whether or not they want to bathe in coastal 
waters. However, it is uncertain whether bacteria are responsible for the adverse 
health effects reported. In Chapter 2, several studies were included that had 
identified the organisms causing ill health in people. The two studies that 
investigated bacterial agents revealed a significant association between bathing 
in coastal waters and infection by bacterial pathogens (Charoenca and Fujioka, 
1995, Soraas et al., 2013). Although many experts believe that viral agents are 
the predominant cause of illness among bathers, this has yet to be confirmed in 
the coastal environment (Sinclair et al., 2009).   
 
There are extremely few studies examining the State – Exposure – Effect stages 
of the DPSEEA model with regards to ARB in natural environments (Ashbolt et 
al., 2013). Chapters 4 and 5 focused on the potential threat that the ARB, 
extended-spectrum beta-lactamase (ESBL)-producing Enterobacteriaceae, pose 
to water users via the ingestion of seawater during water sports. Chapter 4 (p. 
119) was the first study to use volumes of water ingested during a variety of 
different water sports to estimate human exposure to ARB. In doing this, we 
demonstrated that water users are at risk of being exposed to third-generation 
cephalosporin resistant E. coli that are present in UK coastal waters. We 
estimated that in 2012 there were over six million water sports sessions that 
theoretically resulted in the ingestion of at least one of these resistant E. coli; and 
that surfers, in particular, were found to be a group at the greatest risk of exposure 
to resistant bacteria. In the first study to investigate the link between recreational 
exposure to coastal waters through regular surfing, and faecal carriage of third-
generation cephalosporin resistant E. coli, the results of Chapter 5 (p. 136) 
demonstrate that surfers are at a significantly higher risk than non-surfers of being 
colonised by cefotaxime resistant E. coli. Further analysis of these resistant E. 
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coli showed that not only were a large proportion carrying the MGE, blaCTX-M, 
which confers resistance to multiple beta-lactam antibiotics, but also that many 
of these E. coli were the highly virulent, pandemic sequence type 131 (ST131), 
which commonly causes urinary tract infections. These results are consistent with 
those reported by Soraas et al. (2013), who found that sea swimming was 
significantly associated with community-acquired urinary tract infections caused 
by ESBL-producing E. coli or K. pneumoniae.  
While we have focused on resistance to a few antibiotics among select members 
of the Enterobacteriaceae, the findings of this research are significant and novel. 
If recreational exposure to coastal waters is a transmission route by which ARB 
colonise humans, the implications could be far-reaching. First, the magnitude of 
the risk was found to be greater than the risk of colonisation reported in previous 
studies investigating healthcare settings (Munday et al., 2004, Valverde et al., 
2004). Using the estimates reported in this thesis, as well as estimates available 
elsewhere, we estimate the number of individuals colonised by blaCTX-M-bearing 
E. coli that are contributed to the wider community by surfing and compare this 
value to the number contributed by an important setting in which transmission 
occurs: Healthcare settings (Figure 27). Methods used to derive these values 
were based on methods described by Smith et al. (2005), and have been 
described in detail in Appendix I (Figure 34, p. 237).  
 
Figure 27: Estimation of the number of individuals newly colonised by CTX-M-
producing E. coli through surfing, compared to the number of individuals newly 
colonised by CTX-M-producing E. coli through hospitalisation.  
It seems that surfing alone contributes approximately less than 25% of the 
number of newly colonised individuals to the community than do healthcare 
settings. However, as the results presented in Chapter 4 show, swimmers, and 
other water users are also at risk of exposure to ARB through the ingestion of 
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seawater. With cumulatively much larger numbers of people enjoying other water 
sports and recreational activities in coastal environments, recreational exposure 
to coastal waters could potentially be contributing to overall community carriage 
as well. More information is required in order to understand how the numbers 
contributed by recreational exposure in coastal waters in general compares to the 
numbers contributed by healthcare settings, including up-to-date estimates of the 
rates of gut colonisation in hospitals, and data on various ARB. Nevertheless, 
intestinal colonisation with resistant Enterobacteriaceae might serve as a 
reservoir for autoinfection (Zerr et al., 2014). In addition, these bacteria may be 
passed to other members of the community via person-to-person transmission. 
A further threat to human health posed by surfing in coastal water is the 
acquisition by surfers of novel resistance variants (Smith et al., 2005, Ashbolt et 
al., 2013). The phylogenetic analyses of the blaCTX-M genes isolated from the 
Beach Bum Survey participants were inconclusive, because the sequences we 
obtained did not cluster with sequences of known blaCTX-M variants (Appendix I 
Figure 33, p. 234). Although this is most likely due to sequencing error, it is also 
possible that the blaCTX-M genes isolated from surfers represent new variants of 
this gene. To find out if this is the case, the blaCTX-M DNA from resistant colonies 
will be amplified, purified and sequenced again as described in Chapter 5 on 
order to get more accurate sequence data for these isolates.  
6.2 Recommendations 
As Professor Dame Anne Johnson recently said, “we need to rethink how to 
prevent disease, promote good health and harness new technologies to secure 
the health of the public. New research partnerships, methods and tools are critical 
in making this vision a reality” (The Academy of Medical Sciences, 2014). While 
advising people against bathing in coastal waters could be a potential action to 
prevent some diseases, such a recommendation might be detrimental in some 
ways to the health and wellbeing of the public. Coastal ecosystems and 
recreational activities within these environments provide valuable services in 
terms of human health. For example, physical activity increases aerobic and 
cardiovascular fitness, improves strength and flexibility (Janssen and Leblanc, 
2010), and many water sports, such as swimming and boating, are low impact, 
reducing the risk of wear-and tear on joints (Alkatan et al., 2016). Additionally, 
recent research has shown a correlation between interacting specifically with 
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coastal environments and self-reported indicators of well-being, such as stress-
relief (Ashbullby et al., 2013, White et al., 2013).  
Therefore it is important to acquire more information on effective measures 
(actions) that individuals can take to reduce their exposure to pathogenic agents 
in coastal bathing waters, thereby reducing the risk of adverse health effects, 
while gaining the benefits of bathing in coastal waters. Despite attempts to identify 
factors that affect the risk of experiencing adverse health effects, such as head 
immersion, and microbiological water quality, the results presented here have 
been inconclusive. Head immersion had no significant impact upon the risks of 
any of the illnesses investigated, and the avoidance of polluted waters did not 
appear to reduce the risk of illness or colonisation in participants.  
It was curious to observe, from the Beach Bum Survey, that the largest proportion 
of colonised surfers were those who avoided going in waters that they knew were 
affected by pollution (Table 24, p.163). It was also interesting that only 30% of 
the surfers that participated in the survey reported looking up the water quality at 
beaches in advance of their visit. This opens up a new and interesting avenue of 
research. Responsible agencies spend time and money to make the results of 
their monitoring publically available, along with (in the case of the Environment 
Agency) predictions of poor water quality based on recent rainfall 
(http://environment.data.gov.uk/bwq/explorer/index.html/). However, it seems 
that a large proportion of water users are not accessing this information or, if they 
are, are not changing their behaviour after being given this information. 
Qualitative research methodologies could provide answers to the questions: Why 
are people not accessing water quality information for the beaches at which they 
intend to bathe? And why do people still choose to go in water that they know has 
been affected by pollution? Knowledge of the answers to these questions will 
improve the effectiveness of communicating health-promoting advice to the 
public.  
6.3 Future research 
Aside from these, other knowledge gaps have been identified in this thesis, and 
summarised below, along with suggestions for approaches to answer these 
questions.  
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1. What pathogens are bathers acquiring from coastal waters? 
Very few of the studies identified in the systematic review attempted to identify 
the agents responsible for bather illness. This has largely been due to the fact 
that in the past, the detection and identification of pathogens, including bacteria 
and viruses, have been limited to culture-dependent techniques and 
serodiagnostics, requiring a priori knowledge of the infecting agent. Many experts 
believe that viruses are largely responsible for the symptoms reported by sea 
bathers (Maunula, 2007, Maunula et al., 2004, Harwood et al., 2013, Sinclair et 
al., 2009), although hitherto proof has been limited by the available technologies. 
In recent years however, sequencing technologies and computational techniques 
have advanced. These new techniques could be used in this field of study to 
enable understanding of the diversity of microorganisms in environmental 
samples (metagenomics), and the detection of their presence in humans (Li et 
al., 2016, Greninger et al., 2015, Baquero, 2012). Similar approaches are being 
used to enable understanding of the diversity of AMR (including ARB) genotypes 
in natural environments.  
2. How are coastal waters and water quality information used by members of 
the public?  
Very few studies have investigated the risk of experiencing adverse health effects 
among people who bathe in the sea outside the bathing season, as it is assumed 
that few people go into the sea between October and May (European Parliament 
Council of the European Union, 2006). In Chapter 3 we collected health data from 
bathers outside the bathing season. Not only did we find that people in England 
and Wales bathe outside the bathing season, but nearly as many bathers were 
recruited during this period as were recruited during the bathing season (Figure 
18, p.102). It is therefore important to know their risk of experiencing ill health 
from bathing in coastal waters outside the bathing season. The risk of illness was 
slightly higher outside the bathing season, but a larger sample size would be 
required in order to detect significant differences between the two seasons. The 
information gained from such a study could be communicated to members of the 
public so that they can make informed decisions about bathing out of season. In 
the same study we attempted to link water quality information with health risk 
among bathers, but this data is extremely scarce between October and May. 
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Further research would be needed to understand what water quality is like outside 
the bathing season, including data on FIB levels, and CSO spills. We were unable 
to demonstrate in Chapters 3 and 5 that exposure to polluted coastal waters is 
associated with an increase in the risk of experiencing illness, or an increase in 
the risk of being colonised by ARB. This is likely due to small sample sizes. 
Nevertheless, we found that bathers are exposed to coastal waters affected by 
pollution.  
Qualitative research studies should be conducted in order to find out how bathers 
access water quality information at the beaches they intend to visit, what they 
understand are the risks of being exposed to seawater with high levels of 
bacteria, and what factors influence their decision to expose themselves to 
polluted seawater. 
3. Has the revised Bathing Water Directive (2006/7/EC) reduced the risk of 
bathers developing symptomatic illness? 
Performing an updated systematic review that pools together the results of 
epidemiological studies conducted from 2015 onwards might give an insight into 
whether or not the revised Bathing Water Directive (2006/7/EC) has had a 
significant impact upon reducing the risk of bathers developing symptoms of ill 
health. Likewise, similar methods to those used in the Beach User Health Survey 
may be used in the future for the rapid and cheap collection of information from 
a large sample of people. The survey could be modified so that only the health 
effects associated with bathing in designated bathing waters during the bathing 
season were investigated.  
4. What other types of illnesses are bathers at risk of experiencing?  
In Chapter 2, we focused on meta-analysing the risk of bathers experiencing any 
illness, ear ailments, and gastrointestinal illnesses. Further work in this field will 
involve a summary of the evidence that bathers are at an increased risk of 
experiencing symptoms of eye infections, respiratory infections and urinary tract 
infections. It would also be interesting to compare the results of these analyses 
with the risk of these illnesses being experienced after bathing in freshwater.  
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5. Antibiotic resistance in the environment and their impact upon human 
health 
In this context, the topic about which we know the least, but which poses the 
greatest threat to human health globally, is the role played by coastal 
environments in the dissemination of ARB. In this thesis we have focused on 
recreational exposure to coastal waters, but other exposures, such as contact 
with sand, and the consumption of shellfish, could also be important transmission 
routes for resistant bacteria to colonise humans (Solo-Gabriele et al., 2016). Still, 
additional research must be conducted to confirm the acquisition of ARB from 
coastal waters. Conducting prospective cohort studies would demonstrate that 
gut colonisation by ARB follows exposure, and randomised controlled trials would 
provide the best evidence that resistant bacteria are acquired from bathing in 
coastal waters. Yet this is just part of the picture. The long-term health 
consequences of gut colonisation by ARB are yet to be elucidated fully, although 
recent research suggests that colonisation by ARB is a risk factor for developing 
clinical infections (Young et al., 2014). For example, one study reported that 86% 
of patients colonised by methicillin resistant Staphylococcus aureus (MRSA) 
developed clinical infections within 6 months of becoming colonised by MRSA 
(Balm et al., 2013). With regards to Gram-negative bacteria, only 8.5% of patients 
colonised by ESBL-producing E. coli developed a subsequent bloodstream 
infection caused by ESBL-producing E. coli (Reddy et al., 2007), and 3% of 
patients colonised by ciprofloxacin resistant E. coli before a transrectal 
ultrasound-guided prostate biopsy developed “infectious complications” after this 
procedure, compared to 0% of patients colonised by ciprofloxacin susceptible E. 
coli (Steensels et al., 2012). However, the link between gut colonisation and 
infection is less well described for non-hospitalised individuals. Longitudinal 
studies, or prospective cohort studies with long follow-up periods, will be useful 
in the assessment of correlations between gut colonisation by ARB in healthy 
populations, such as surfers, and serious health effects experienced by these 
populations, including clinical infections caused by ARB. 
More information is also needed to determine the infective dose that is required 
to initiate gut colonisation after ingesting water containing ARB, as well as the 
rate of transfer in the human gut of ARG between invading ARB and resident gut 
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microflora. Such information would be extremely useful data for performing 
quantitative microbial risk assessments for ARB specifically (Ashbolt et al., 2013).   
In this thesis we have focused on a small, but clinically important, group of ARB. 
The range of ARB investigated will need to be expanded in order for us to have 
a more complete understanding of the threat that various ARB in the coastal zone 
pose to human health. It will be extremely important, given recent developments, 
for the spread of resistance to last-resort antibiotics (such as colistin), among 
bacteria to be monitored; not just in patients, but also in environmental reservoirs.  
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6.4 Conclusions 
Altogether, the evidence presented in this thesis indicates that people who bathe 
in coastal waters are at an increased risk of adverse health outcomes, whether 
this involves experiencing symptoms of ill health, or exposure to and colonisation 
by antibiotic resistant bacteria. Further research is required to elucidate whether 
the agents causing symptomatic infections are bacterial. There should also be an 
assessment of interventions to protect bather health. Antibiotic resistant bacteria 
are one of the greatest threats facing mankind. We have demonstrated that 
recreational exposure to coastal waters is a plausible transmission route for 
people to become infected by clinically important bacteria that are resistant to 
essential antibiotics. Furthermore, there is a statistically significant association 
between regular surfing and faecal carriage of these antibiotic resistant bacteria.  
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Table 25: Antibiotic resistant bacteria found in coastal waters (sea water and estuarine waters). 
Species or genus of bacteria Class of antibiotics bacteria were 
resistant to (or mechanisms found 
provides resistance to an antibiotic 
within this class)  
Resistance 
determinants 
identified 
Country  Reference 
     
Not reported Macrolides, sulphonamides, 
tetracyclines  
ermB, ermC, 
suI1, sul2, tetA, 
tetM, tetO, tetQ, 
tetW, tetX,  
China (Niu et al., 2016) 
Vibrio sp Macrolides, penicillins Not reported Malaysia (You et al., 2016) 
E. coli Aminoglycosides, macrolides, others*, 
penicillins, penicillin combinations, 
tetracyclines  
Not reported Brazil (Andrade Vda et al., 
2015) 
Vibrio vulnificus, V. chlorae Carbapenems, others, penicillins  No isolates 
carried any of 
the genes 
expected for the 
observed 
resistance 
Germany (Bier et al., 2015) 
V. parahaemolyticus Aminoglycosides, others, penicillins, 
quinolones, tetracyclines, 
sulphonamides, 3GCs  
Not reported Mexico (de Jesus Hernandez-
Diaz et al., 2015) 
186 
 
Species or genus of bacteria Class of antibiotics bacteria were 
resistant to (or mechanisms found 
provides resistance to an antibiotic 
within this class)  
Resistance 
determinants 
identified 
Country  Reference 
Escherichia, Pelagibacter, 
Prochlorococcus, 
Roseobacter, Parvibaculum, Fl
avobacterium, 
Rhodobacteracea, Vibrio, 
Ruegeria,  Roseovarius, 
Octadecabacter, 
Dinoroseobacter 
Silicibacter 
Nitrofurans, penicillins, tetracyclines, 
sulphonamides 
TEM-1, tetC, 
tetA, marA, 
tet41, matE, 
Bcr, sul2, sul1, 
sul3, RosB, 
pbp2, vanE, 
vanSD, vanXD 
vanHD 
US (Hatosy and Martiny, 
2015) 
E. coli Aminoglycosides, monobactams, 
penicillins, penicillin combinations, 
quinolones, sulphonamides, 1GCs, 
2GCs, 3GCs, 4GCs 
Int1, Int2 Poland (Kotlarska et al., 2015) 
Enterococcus including  
En. faecalis, En. faecium 
Others, quinolones, tetracyclines Not reported Iran (Alipour et al., 2014) 
E. coli Aminoglycosides, carbapenems, other, 
penicillins, penicillin combinations, 
quinolones, sulphonamides, 
tetracyclines, 1GCs, 3GCs 
TEM, sul1, sul2, 
tetA tetB, CTX-
M-1, SHV-12, 
qnrS1, qnrB19 
Portugal (Alves et al., 2014) 
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Species or genus of bacteria Class of antibiotics bacteria were 
resistant to (or mechanisms found 
provides resistance to an antibiotic 
within this class)  
Resistance 
determinants 
identified 
Country  Reference 
E. coli Aminoglycosides, other penicillins, 
quinolones, sulphonamides, 
tetracyclines, 3GCs 
CTX-M-1, CTX-
M-2, CTX-M-3, 
CTX-M-9, CTX-
M-14, CTX-M-
15, CTX-M-27, 
CTX-M-32, 
SHV-12, TEM-
52, OXA 
The 
Netherlands 
(Blaak et al., 2014) 
Enterobacteriaceae: E. coli, 
Enterobacter cloacae, 
Klebsiella pneumoniae 
Aminoglycosides, carbapenems, 
penicillins, quinolones, sulphonamides, 
tetracyclines,  3GCs 
TEM1, SHV-12, 
CTX-M-15 
Croatia (Maravic et al., 2014) 
Klebsiella sp. Citrobacter sp, 
Kluyvera sp, Enterobacter sp, 
Aeromonas sp  
Aminoglycosides, carbapenem, 
monobactams, penicillins, penicillin 
combinations, quinolones, 2GCs 
3GCs, 4GCs  
CTX-M-9, CTX-
M-14, GES-5, 
GES-16, KPC-2, 
TEM-1, SHV-
like, qnrB-like, 
qnrA-like 
Brazil (Montezzi et al., 2014) 
E. coli Aminoglycosides, carbapenems, 
others, penicillins, penicillin 
combinations, quinolones, 
sulphonamides, tetracyclines, 1GCs, 
3GCs 
Int1, Int2 Portugal (Moura et al., 2014) 
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Species or genus of bacteria Class of antibiotics bacteria were 
resistant to (or mechanisms found 
provides resistance to an antibiotic 
within this class)  
Resistance 
determinants 
identified 
Country  Reference 
Vibrio cholerae  Penicillins Not reported US (Dobbs et al., 2013)  
Not reported Tetracyclines tetB, tetC, tetM, 
tetO, tetW 
China (Chen et al., 2013a) 
Enterococci Aminoglycosides, macrolides, others, 
penicillins, quinolones, tetracyclines 
 
Not reported Malaysia (Dada et al., 2013)  
Salmonella sp  
 
Aminoglycosides, penicillins, penicillin 
combinations, quinolones, 
tetracyclines, 2GCs 
 
Not reported  
 
Greece 
 
(Economou et al., 2013) 
Clostridium difficile Glycopeptides, lincosamides, 
quinolones 
Not reported  UK (Hargreaves et al., 2013) 
Vibrio cholerae Quinolones, tetracyclines Not reported Georgia (Kokashvili et al., 2013) 
Vibrio parahaemolyticus Penicillins, 1GCs Not reported Morocco (Malainine et al., 2013) 
Escherichia coli Aminoglycosides, carbapenems, 
others, penicillins, penicillin 
combinations, quinolones, 
sulphonamides, tetracyclines, 1GCs, 
3GCs 
TEM, sul2, sul1, 
Intl1, Intl2 
Portugal (Pereira et al., 2013) 
Staphylococcus aureus Penicillins tetM, tetK, erm 
A, msrA, aadD, 
ermC 
United 
States 
(Roberts et al., 2013) 
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Species or genus of bacteria Class of antibiotics bacteria were 
resistant to (or mechanisms found 
provides resistance to an antibiotic 
within this class)  
Resistance 
determinants 
identified 
Country  Reference 
Enterococcus Glycopeptides, tetracyclines  tetM, vanA Puerto Rico (Santiago-Rodriguez et 
al., 2013) 
Not reported Sulphonamides sul1, sul2, sul3 Philippines  (Suzuki et al., 2013) 
Not reported Not reported Integrons (class 
1, 2 and 3) 
United 
States 
(Uyaguari et al., 2013) 
Pseudomonas fluorescens Carbapenems, monobactams, 
tetracyclines, 3GCs 
Chromosomal 
TEM-116  
Croatia  (Maravic et al., 2012a) 
Burkholderia cepacia Aminoglycosides, carbapenems, 
others, monobactams, penicillins, 
penicillin combinations, polypeptides, 
quinolones, sulphonamides, 
tetracyclines, 3GCs, 
Chromosomal 
TEM-116  
Croatia (Maravic et al., 2012b) 
Acinetobacter sp 
Aeromonas sp 
B. cepacia,  
Chryseobacterium indologenes, 
Citrobacter sp, Enterobacter sp, E.  
coli, Flavimonas oryzihabitans, 
Klebsiella sp, Pantoea agglomerans, 
Pasteurella multocida, Proteus 
penneri, Pseudomonas aeruginosa, 
Salmonella sp, Serratia sp, Shigella 
sp, Sphingomonas paucimobilis, 
Vibrio sp, Yersinia sp 
Aminoglycosides, carbapenems, 
nitrofurans, others, penicillins, 
quinolones, sulphonamides, 
tetracyclines, 1GCs, 2GCs,  3GCs, 
4GCs. 
Not reported Turkey (Matyar, 2012) 
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Species or genus of bacteria Class of antibiotics bacteria were 
resistant to (or mechanisms found 
provides resistance to an antibiotic 
within this class)  
Resistance 
determinants 
identified 
Country  Reference 
Acinetobacter sp, Psychrobacter sp, 
Pseudomonas sp, Rheinheimera sp, 
Alishewanella sp, Shewanella, sp, 
Photobacterium sp 
Listonella anguillarum, Marinomonas 
sp, Paracoccus, Methylarcula sp, 
Micrococcus, Arthrobacter, 
Rathayibacter, Microbacterium  
Aminoglycosides, macrolides, other, 
quinolones, tetracycline  
Not reported Poland (Moskot et al., 2012) 
E. coli, Vibrio sp, Salmonella 
sp, Enterococcus sp 
Aminoglycosides, glycopeptides, 
macrolides, other, penicillins, 
quinolones, tetracycline  
Not reported India (Vignesh et al., 2012) 
Not reported Quinolones qnrA United 
States 
(Cummings et al., 2011) 
E. coli Penicillins M-1 United 
States 
(Uyaguari et al., 2011) 
Not reported Aminoglycosides, others, penicillins, 
quinolones tetracyclines 
Not reported Sweden (Hermansson et al., 
1987) 
Coliforms Aminoglycosides, others, tetracyclines Not reported United 
States 
(Sizemore and Colwell, 
1977) 
The group ‘penicillin combinations’ included penicillin antibiotics coupled with a beta-lactamase inhibitor, such as piperacillin with 
tazobactam, and amoxicillin with clavulanic acid. *Antibiotics belonging to the class ‘other’ tended to be chloramphenicol and 
streptomycin, although there were also antibiotics used for treating mycobacteria e.g. rifampicin. 1GCs = first-generation cephalosporins; 
2GCs = second-generation cephalosporins; 3GCs = third-generation cephalosporins; 4GC = fourth-generation cephalosporins. 
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Table 26: Search strategy used in Medline (run 5/7/13). 
 
Database: Ovid MEDLINE(R) In-Process & Other Non-Indexed Citations and 
Ovid MEDLINE(R) <1946 to Present> 
Search Strategy: 
-------------------------------------------------------------------------------- 
1     (water adj3 (untreat* or contaminat* or pollut*)).ti,ab. (11997) 
2     water quality.ti,ab. (9802) 
3     water pollution.ti,ab. (1512) 
4     exp water pollution/ or exp water quality/ (18861) 
5     water microbiology/ (27613) 
6     microbiological.ti,ab. (32775) 
7     microbial.ti,ab. (87329) 
8     (bacteri* and water).ti,ab. (27650) 
9     exp waste water/ or exp sewage/ae, mi, ps, st, vi (20722) 
10     or/1-9 (198348) 
11     seawater/ae, mi, ps, vi (5934) 
12     bathing beaches/mi, st (146) 
13     (beach or beaches).ti,ab. (4040) 
14     exp fresh water/an, mi, ps, st, vi (10073) 
15     river*.ti,ab. (34065) 
16     lake*.ti,ab. (21905) 
17     (stream or streams).ti,ab. (30054) 
18     estuar*.ti,ab. (7290) 
19     (sea or seawater).ti,ab. (58553) 
20     ocean*.ti,ab. (18265) 
21     (water* and (risk* or hazard*) and (infect* or disease* or illness*)).ti,ab. 
(8432) 
22     (coast or coasts or coastal).ti,ab. (30299) 
23     marine.ti,ab. (48585) 
24     exp fresh water/ or exp lakes/ or exp ponds/ or exp rivers/ (35036) 
25     ((upstream or downstream) and water and (health or disease* or 
illness*)).ti,ab. (417) 
26     recreation* water*.ti,ab. (640) 
27     ((bathing or swimming) and water).ti,ab. (5232) 
28     or/11-27 (230862) 
29     swimm*.ti,ab. (19086) 
30     exp Swimming/ae, st [Adverse Effects, Standards] (1319) 
31     (diver or divers or diving).ti,ab. (6392) 
32     (water adj3 (contact or expos* or activit* or sport* or recreation)).ti,ab. 
(13935) 
33     (surfer* or surfing).ti,ab. (666) 
34     (bather* or bathing).ti,ab. (8546) 
35     exp Environmental Exposure/ae, an, cl, lj, pc, st [Adverse Effects, 
Analysis, Classification, Legislation & Jurisprudence, Prevention & Control, 
Standards] (45618) 
36     windsurf*.ti,ab. (60) 
37     snorkel*.ti,ab. (193) 
38     (sailing or sailor*).ti,ab. (1121) 
39     (triathl* or pentathl*).ti,ab. (1016) 
40     waterski*.ti,ab. (23) 
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41     (rafter* or rafting).ti,ab. (205) 
42     kayak*.ti,ab. (253) 
43     canoe*.ti,ab. (303) 
44     or/29-43 (95367) 
45     10 and 28 and 44 (2559) 
46     exp animals/ not humans.sh. (3996986) 
47     45 not 46 (2193) 
48     limit 47 to english language (1874) 
 
*************************** 
 
 
Table 27: List of websites searched, dates searched and number of items found 
by the search. Only the first 50 titles were screened.  
Organisation Date searched Number of hits 
Centre for Disease Control and Prevention 
(CDC) 
19/08/2013 833 
Environment Canada 19/08/2013 7 
European Centre for Disease Prevention 
and Control (ECDC) 
15/08/2013 508 
European Environment Agency (EEA) 15/08/2013 94 
Health Protection Agency (HPA) – 
renamed Public Health England (PHE) 
15/08/2013 61 
Medical Research Council (MRC) 14/08/2013 0 
Umweltbundesamt (UBA) 14/08/2013 1,700,000 
United Nations Environment Programme 
(UNEP) 
13/08/2013 468 
United Nations Environment Programme 
Mediterranean Action Plan (UNEP MAP) 
14/08/2013 4 
United States Environment Protection 
Agency (US EPA) 
15/08/2013 1,700 
World Health Organization (WHO) 14/08/2013 532 
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Table 28: The selection criteria used to screen titles and abstracts, how these criteria were applied and the rationale for each criterion.  
Selection criteria  How it was applied Rationale  
1. The study measures 
health outcomes in 
humans 
Exclude reviews, studies that model or predict 
outcomes, commentaries, and studies investigating 
health outcomes in non-human subjects. Include 
physician-diagnosed and lab-diagnosed infections 
as well as self-reported symptoms of ill health. 
The systematic review’s population of interest is restricted 
to humans, and to the risk of acquiring infections among 
bathers.  
2. The study does not 
restrict the study 
population to people 
with a pre-existing 
medical condition 
Exclude studies if the study population was 
restricted to patients or subjects with conditions 
such as HIV/AIDS. Include case-control studies 
retrospectively investigating waterborne diseases.  
While the general population will contain people with such 
conditions, restricting the study population to people with 
conditions that compromise the immune system is likely 
to result in an over-estimate the risk of illness in the wider 
population. 
3. The study has been 
conducted in a 
developed country (a 
country that is a 
member of the 
Organisation for 
Economic Co-
operation and 
Development) 
(OECD) 
Exclude studies conducted before 1961. Exclude 
studies conducted in countries that aren’t members 
of the OECD. The countries belonging to the 
OECD and the dates they joined are available 
online (OECD, 2016). Exclude studies conducted 
in countries that weren’t members on the dates 
they were conducted. Exclude countries that are 
territories of member countries (e.g. Puerto Rico, 
the Virgin Islands).  
The OECD was started in 1961, and this is when the first 
members of the OECD joined. Endemic levels of illness, 
particularly diarrhoeal diseases, are much higher in low- 
and middle-income countries compared to those in 
developed countries, due partially to a lack adequate 
sanitation. Therefore an association between bathing in 
natural waters and the risk of infection will be harder to 
attribute to bathing. Developed nations also have more 
resources to dedicate to monitoring bathing water quality.  
4. The study examines 
exposure to natural 
(untreated) waters 
Exclude studies conducted in swimming pools, 
spas, hot tubs, even if the disinfection mechanism 
was found to be faulty. 
Natural, untreated waters are the focus of this systematic 
review.  
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Selection criteria  How it was applied Rationale  
5. The study explores 
recreational 
exposure to natural 
waters 
Exclude studies investigating adverse health 
effects in occupational divers, health effects 
associated with domestic exposure (e.g. washing 
or drinking) to natural waters. 
Recreational exposure is the focus of this review. 
Furthermore, occupational and domestic exposures are 
likely to be greater (of a longer duration) than recreational 
exposures, biasing the effect size.  
6. The study reports 
the investigated 
health outcome in a 
control group 
Exclude case studies, case series, and summaries 
of outbreaks where a case-control study design 
has not been carried out.  
In order to estimate the direction and magnitude of the 
risk of infection associated with an exposure, the rate of 
illness in a control group (unexposed group) must be 
known.  
7. The study 
investigates health 
outcomes caused by 
exposure to 
microbial agents 
Exclude studies investigating health risks in 
humans of water contamination by heavy metal 
and other poisons, drowning, injuries caused by 
animals (e.g. wounds caused by corals, jellyfish 
stings, shark attacks).  
This review is concerned with the health outcomes 
caused by microbes in natural waters, particularly those 
that are carried in sewage polluting natural waters. 
8. Study does not 
investigate health 
outcomes caused by 
exposure to 
cyanobacteria, to 
helminths, or those 
requiring a vector or 
intermediate host 
Excluded studies investigating risk of illness after 
exposure to bathing waters affected by harmful 
algal blooms, cyanobacteria, dinoflagellates. 
Excluded studies investigating health risks in 
humans of exposure to parasitic helminths (e.g. 
nematodes, trematodes). Excluded studies 
investigating infections requiring a vector or 
intermediate host, such as malaria, tularaemia, and 
schistosomiasis. 
Toxins produced by algae, cyanobacteria, dinoflagellates 
are produced outside the host, and these organisms do 
not need to infect the human body in order to cause ill 
health. Infection caused by helminths are a problem in 
areas where sanitation is poor, and are therefore not 
highly endemic in most developed countries. The 
incidence of pathogenic infections requiring an 
intermediate host or vector in order to infect humans 
depend upon the population of their intermediate host or 
vector, rather than upon the extent of sewage pollution.  
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Selection criteria  How it was applied Rationale  
9. The study is 
available in English 
Exclude studies that are not available in English. Limited time and resources to have records translated 
into English.  
10. The study has not 
combined data 
collected from 
participants exposed 
to freshwater with 
participants exposed 
to marine waters 
Exclude studies if they have pooled results from 
seawater and freshwater. 
This reviewed aimed to assess the risk of infections from 
marine waters and freshwaters separately.  
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Table 29: Reference list of publications in each included study. 
Study ID References 
1. Alexander 1992 (Alexander et al., 1992) 
2. Arnold 2013 (Arnold et al., 2013) 
3. Balarajan 1991 (Balarajan et al., 1991, Pike, 1994, Pike, 1992, Pike, 1990) 
4. Begier 2008 (Begier et al., 2008) 
5. Bonilla 2007 (Bonilla et al., 2007, Esiobu et al., 2013) 
6. Brown 1987 (Brown et al., 1987) 
7. Cabelli 1982 (Cabelli et al., 1979, Cabelli et al., 1982, Cabelli et al., 1983, Cabelli et al., 1975b, Cabelli et al., 1975a, 
Cabelli, 1983, Ktsanes et al., 1981) 
8. Calderon 1982 (Calderon and Mood, 1982) 
9. Charoenca 1995 (Charoenca and Fujioka, 1995) 
10. Colford 2005 (Colford et al., 2007, Colford Jr et al., 2005) 
11. Colford 2012 (Colford et al., 2012) 
12. Corbett 1993 (Corbett et al., 1993) 
13. Dale 2009 (Dale et al., 2009) 
14. Dwight 2004 (Dwight et al., 2004) 
15. Fewtrell 1994 (Fewtrell et al., 1994) 
16. Fleisher 2010 (Fleisher et al., 2010, Fleming et al., 2008, Sinigalliano et al., 2010, Abdelzaher et al., 2011) 
17. Fleming 2004 (Fleming et al., 2004) 
18. Gammie 1997 (Gammie et al., 2002, Gammie and Wyn-Jones, 1997) 
19. Haile 1999 (Haile et al., 1999, Haile et al., 1996) 
20. Harder-Lauridsen 2013 (Harder-Lauridsen et al., 2013) 
21. Harding 2015 (Harding et al., 2015) 
22. Harrington 1993 (Harrington et al., 1993) 
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Study ID References 
23. Hoque 2002 (Hoque et al., 2002) 
24. Ihekweazu 2006 (Ihekweazu et al., 2006) 
25. Kay 1994 (Fleisher et al., 1993, Fleisher and Kay, 2006, Fleisher et al., 1996, Fleisher et al., 1998, Jones et al., 1991, 
Kay et al., 1994, Pike, 1994, Pike, 1992, Pike, 1990) 
26. Kocasoy 1995 (Kocasoy, 1995, Kocasoy, 1989) 
27. Lepesteur 2006 (Lepesteur et al., 2006) 
28. McBride 1998 (McBride et al., 1998) 
29. Morens 1994 (Morens et al., 1994) 
30. Nelson (Nelson and Williams, 1997)  
31. New Jersey State 
Department of Health 
(NJSDH) 1988 
(New Jersey State Department of Health, 1988) 
32. Papastergiou 2011 (Papastergiou et al., 2012, Papastergiou et al., 2011) 
33. Prieto 2001 (Prieto et al., 2001) 
34. Reed 2006 (Reed et al., 2006) 
35. Roy 2004 (Roy et al., 2004) 
36. Soraas 2013 (Soraas et al., 2013) 
37. UNEP 1991 (Marino et al., 1995, UNEP and WHO, 1991) 
38. Wade 2010 (Wade et al., 2010a) 
39. Wade 2013 (Wade et al., 2013, Wade et al., 2010b, Wade et al.) 
40. Yau 2014 (Yau et al., 2014) 
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Figure 28: Results of a meta-analysis on the risk of experiencing cases of ear infections among bathers compared to non-bathers. 
Studies have been restricted to those published from 2003 onwards. 
NOTE: Weights are from random effects analysis
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Figure 29: Results of a meta-analysis on the risk of experiencing sensitive cases of gastrointestinal illness among bathers compared to 
non-bathers. Studies have been restricted to those published from 2003 onwards. 
NOTE: Weights are from random effects analysis
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Figure 30: Results of a meta-analysis on the risk of experiencing single symptom cases of gastrointestinal illness among bathers 
compared to non-bathers. Studies have been restricted to those published from 2003 onwards. 
NOTE: Weights are from random effects analysis
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Figure 31: Results of a meta-analysis on the risk of experiencing specific cases of gastrointestinal illness among bathers compared to 
non-bathers. Studies have been restricted to those published from 2003 onwards.  
NOTE: Weights are from random effects analysis
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Figure 32: Funnel plot to assess publication bias in the systematic review 
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Table 30: Methods used to match water quality data to survey participants’ 
responses 
Survey responders were asked to name beaches that they had visited in week 1 and week 2 of the past two weeks. These were open-
ended questions, and responders were free to provide as many beach names as they wanted. Beach names provided by participants were 
looked up on the EA website to assess which designated beaches they visited. The names of the designated beaches they visited were 
recorded and the water quality during the period of time on which people were responding were obtained. If the name of the beach couldn’t 
be found on the EA website, it was assumed that the person had visited an undesignated beach, for which there would be no water quality.  
In the EA water quality database acquired from DataShare services (http://www.geostore.com/environment-
agency/WebStore?xml=environment-agency/xml/ogcExternalDataDownload.xml), samples taken in 2014 were sorted based on E. coli and 
intestinal enterococci densities. Those failing the revised Bathing Water Directive during the weeks the survey collected information on 
were identified. The date of this failure was then used to find people who had visited that beach in the same week as the failure, using the 
table below: 
Wave Date individual responded Dates relating to week 1 of recall Dates relating to week 2 of recall 
W
a
v
e
 1
 
W
e
e
k
 1
 
re
s
p
o
n
d
e
rs
 02/06/14 19/05/14 – 25/05/14 26/05/14 – 01/06/14 
03/06/14 20/05/14 – 26/05/14 27/05/14 – 02/06/14  
04/06/14 21/05/14 – 27/05/14 28/05/14 – 03/06/14 
05/06/14 22/05/14 – 28/05/14 29/05/14 – 04/06/14 
06/06/14 23/05/14 – 29/05/14 30/05/14 – 05/06/14 
07/06/14 24/05/14 – 30/05/14 31/05/14 – 06/06/14 
08/06/14 25/05/14 – 31/05/14 01/06/14 – 07/06/14 
W
e
e
k
 2
 
re
s
p
o
n
d
e
rs
 09/06/14 26/05/14 – 01/06/14 02/06/14 – 08/06/14 
10/06/14 27/05/14 – 02/06/14  03/06/14 – 09/06/14 
11/06/14 28/05/14 – 03/06/14 04/06/14 – 10/06/14 
12/06/14 29/05/14 – 04/06/14 05/06/14 – 11/06/14 
13/06/14 30/05/14 – 05/06/14 06/06/14 – 12/06/14 
14/06/14 31/05/14 – 06/06/14 07/06/14 – 13/06/14 
15/06/14 01/06/14 – 07/06/14 08/06/14 – 14/06/14 
W
a
v
e
 2
 
W
e
e
k
 1
 
re
s
p
o
n
d
e
rs
 19/08/14 04/08/14 – 10/08/14 11/08/14 – 17/08/14 
20/08/14 05/08/14 – 11/08/14 12/08/14 – 18/08/14 
21/08/14 06/08/14 – 12/08/14 13/08/14 – 19/08/14 
22/08/14 07/08/14 – 13/08/14 14/08/14 – 20/08/14 
23/08/14 08/08/14 – 14/08/14 15/08/14 – 21/08/14 
24/08/14 09/08/14 – 15/08/14 16/08/14 – 22/08/14 
25/08/14 10/08/14 – 16/08/14 17/08/14 – 23/08/14 
W
e
e
k
 2
 
re
s
p
o
n
d
e
rs
 26/08/14  11/08/14 – 17/08/14 18/08/14 – 24/08/14 
27/08/14 12/08/14 – 18/08/14 19/08/14 – 25/08/14 
28/08/14 13/08/14 – 19/08/14 20/08/14 – 26/08/14 
29/08/14  14/08/14 – 20/08/14 21/08/14 – 27/08/14 
30/08/14  15/08/14 – 21/08/14 22/08/14 – 28/08/14 
31/08/14 16/08/14 – 22/08/14 23/08/14 – 29/08/14 
01/09/14 17/08/14 – 23/08/14 24/08/14 – 30/08/14 
W
a
v
e
 3
 
W
e
e
k
 1
 
re
s
p
o
n
d
e
rs
 10/11/14 27/10/14 – 02/11/14 03/11/14 – 09/11/14  
11/11/14 28/10/14 – 03/11/14 04/11/14 – 10/11/14 
12/11/14 29/10/14 – 04/11/14 05/11/14 – 11/11/14 
13/11/14 30/10/14 – 05/11/14 06/11/14 – 12/11/14 
14/11/14 31/10/14 – 06/11/14 07/11/14 – 13/11/14 
15/11/14 01/11/14 – 07/11/14 08/11/14 – 14/11/14 
16/11/14 02/10/14 – 08/11/14 09/11/14 – 15/11/14 
W
e
e
k
 2
 
re
s
p
o
n
d
e
rs
 17/11/14 03/11/14 – 09/11/14  10/11/14 – 16/11/14  
18/11/14 04/11/14 – 10/11/14 11/11/14 – 17/11/14 
19/11/14 05/11/14 – 11/11/14 12/11/14 – 18/11/14 
20/11/14 06/11/14 – 12/11/14 13/11/14 – 19/11/14 
21/11/14 07/11/14 – 13/11/14 14/11/14 – 20/11/14 
22/11/14 08/11/14 – 14/11/14 15/11/14 – 21/11/14 
23/11/14 09/11/14 – 15/11/14 16/11/14 – 22/11/14 
W
a
v
e
 4
 
W
e
e
k
 1
 
re
s
p
o
n
d
e
rs
 13/04/15 30/03/15 – 05/04/15 06/04/15 – 12/04/15 
14/04/15 31/03/15 – 06/04/15 07/04/15 – 13/04/15 
15/04/15 01/04/15 – 07/04/15 08/04/15 – 14/04/15 
16/04/15 02/04/15 – 08/04/15 09/04/15 – 15/04/15 
17/04/15 03/04/15 – 09/04/15 10/04/15 – 16/04/15 
18/04/15 04/04/15 – 10/04/15 11/04/15 – 17/04/15 
19/04/15 05/04/15 – 11/04/15 12/04/15 – 18/04/15 
W
e
e
k
 2
 
re
s
p
o
n
d
e
rs
 20/04/15 06/04/15 – 12/04/15 13/04/15 – 19/04/15 
21/04/15 07/04/15 – 13/04/15 14/04/15 – 20/04/15 
22/04/15 08/04/15 – 14/04/15 15/04/15 – 21/04/15 
23/04/15 09/04/15 – 15/04/15 16/04/15 – 22/04/15 
24/04/15 10/04/15 – 16/04/15 17/04/15 – 23/04/15 
25/04/15 11/04/15 – 17/04/15 18/04/15 – 24/04/15 
26/04/15 12/04/15 – 18/04/15 19/04/15 – 25/04/15 
For example, if a water sample failed E. coli or intestinal enterococci levels on the 22nd May 2014 at a certain beach, bathers responding 
to the survey between the 2nd June and 5th June that reported visiting that beach were recorded as having visited a beach when it was 
polluted. Assigning data on CSO spills was done in the same way.  
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Table 31: The mechanisms by which each of the 14 potential confounders might act upon participants in terms of exposure and 
outcome 
Confounder Exposure Outcome 
Age Some older adults might avoid going to the beach 
or going in the water due to mobility issues and 
reduced fitness.  
Commonly adjusted for in previous studies in this 
research area.  
Immunosenescence: the reduced ability of the immune 
system to combat infections as we age.  
Gender: Can’t tell how gender might impact a participant’s tendency to go bathing, or to report ill health. However, gender is a suspected 
confounder, commonly adjusted for in previous studies in this area 
Level of education – a 
measure of socioeconomic 
status (SES) 
Limited resources to access the beach among 
participants residing inland would affect their 
exposure to seawater 
Socioeconomic status is known to be associated with 
various health outcomes (possibly related to diet, 
environment, etc.) 
Repeat responder People responding to multiple rounds of the 
survey might have a particular interest in water 
sports (and/or the coastal environment) 
Increased awareness of issues affecting the coastal 
environments might affect people’s reporting of illnesses.  
Chronic illnesses  (relating to 
the digestive tract, respiratory 
tract, skin, allergies, and 
other) 
Experiencing symptoms caused by chronic 
disease might keep people away from the beach, 
and from going in the sea 
People might report symptoms caused by chronic 
disease 
Immunosupression People receiving treatment that suppresses the 
immune system are advised to avoid people (and 
places) from whom (from where) they might 
contract an infection. 
People with suppressed immune systems are at a 
greater risk of contracting infections due to a less active 
immune system. They might report symptoms of ill 
health that they have contracted elsewhere. 
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Confounder Exposure Outcome 
Household illness People living with someone who has recently 
been ill might stay at home to look after the sick 
person 
Person-to-person transmission of infections within the 
home environment might cause the symptoms reported 
by individuals 
Diet (consumption of 
shellfish, mayonnaise, food 
purchased from a takeaway, 
chicken, eggs, cold meat 
pies, salad and BBQ). 
Consumption of any of these 
food items was considered to 
be a risk factor for 
gastrointestinal illness 
A commonly investigated confounder among 
studies investigating the risk of experiencing 
gastrointestinal illnesses/symptoms and 
exposure to coastal waters.  
These foods are suspected causes of food poisoning, 
and producing symptoms of gastrointestinal illness 
similar to those supposed to be contracted from 
exposure to seawater 
Perceived risk (if the 
responder reported being 
worried about any of: oil 
spills, objects floating in the 
water, chemical pollution, 
sewage pollution, rip currents, 
algal blooms and/or weaver 
fish. 
If people who are aware of the health risks that 
exposure to seawater might cause, these people 
may be less likely to go into the sea or to the 
beach for fear of becoming ill.  
These people may be more likely to report ill health if 
they suspect to be at increased risk of being sick 
following exposure to the beach/sea water.  
Recreational water (has the 
participant had any contact 
with recreational water that 
weren’t the sea in the past 
two weeks? E.g. swimming in 
a lake or river) 
This could indicate an interest in outdoor water 
sports, and therefore regular exposure to 
pathogens carried by natural waters.  
 
 
These people could have contracted illness from 
exposure to fresh natural water (e.g. river, lake) rather 
than from the sea.  
206 
 
Confounder Exposure Outcome 
Animal ownership For example, dog ownership might encourage 
people to visit the beach to walk and play with 
their pet.  
Several zoonotic infections can be passed from animals 
to owners through close contact and cause symptoms of 
ill health 
 
Eyes: allergies to some animals could cause sore, 
irritated or itchy eyes 
Skin: allergies to some animals could cause itchy skin 
Smoking Unknown  Smoking is a known risk factor for multiple diseases, 
particularly diseases responsible for symptoms of the 
respiratory system.  
Travel Unknown Travel, particularly to low- and middle-income countries 
with poor sanitation is a known risk factor for infections, 
especially those relating to the gastrointestinal system.  
Regular bather (defined as a 
bather who reported going in 
the sea on average every 
week during the bathing 
season and every month 
outside the bathing season) 
Habitual use of seawater will increase people’s 
exposure to coastal waters, and/or make them a 
more practiced, more skilled at their sport, 
potentially falling in less, or swallowing less 
water.  
People who are regularly and repeatedly exposed to 
disease-causing microbes in bathing waters have 
developed immunity, and are therefore less likely to 
report symptoms of illness 
These variables were tested for collinearity before assessing the potential importance of each confounder.  No collinearity was detected: All variance inflation 
factors were small (≤1.05), and tolerance values high (>0.95), and overall a small condition number (<1.3.).For each major category of illness, the maximum 
number of confounders that we would be able to adjust for (to avoid over-fitting the model) have been recorded, and the confounders to be adjusted for have 
been prioritised in order of their supposed importance based on their mechanism and/or appearance in the literature as a confounder. These methods and 
confounders have been reviewed and approved by a medical statistician, as well as a clinical physician.  
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Table 32: Number (%) of incident cases of ill health among beach-going non-bathers compared to community controls  
Health outcome  Non-bathers 
(412) 
Community 
controls (526) 
Crude 
risk ratio  
Crude 
odds ratio 
Adjusted odds ratio (95% 
confidence intervals), P-value 
Gastrointestinal illness 
All waves 8/398 (2.0%) 17/508 (3.3%) 0.60 0.59 0.58 (0.25 to 1.36), P = 0.207 
Bathing season (wave 1+2) 1/130 (0.8%) 9/232 (3.9%) 0.20 0.19 0.17 (0.02 to 1.38), P = 0.098 
Out of season (wave 3+4) 7/268 (2.6%) 8/276 (2.9%) 0.90 0.90 0.86 (0.31 to 2.40), P = 0.770 
Wave 1  1/98 (1.0%) 3/162 (1.9%) 0.55 0.55 (0.06 to 5.33), P = 0.603 
Wave 2 0/32 (0%) 6/69 (8.7%) 0 1 (undefined) 
Wave 3 2/90 (2.2%) 3/132 (2.3%) 0.98 0.98 (0.16 to 5.97), P = 0.980 
Wave 4 5/178 (2.8%) 5/144 (3.5%) 0.81 0.80 0.78 (0.22 to 2.75), P = 0.697 
Acute Respiratory Febrile Illness 
All waves 3/405 (0.7%) 2/521 (0.4%) 1.93 1.94 (0.32 to 11.6), P = 0.470 
Bathing season (wave 1+2) 0/136 (0%) 0/234 (0%) .  1 (undefined) 
Out of season (wave 3+4) 3/269 (1.1%) 2/286 (0.7%) 1.59 1.60 (0.27 to 9.66), P = 0.607 
Wave 1 0/102 (0%) 0/165 (0%) . 1 (undefined) 
Wave 2 0/34 (0%) 0/69 (0%) . 1 (undefined) 
Wave 3 0/92 (0%) 0/138 (0%) . 1 (undefined) 
Wave 4 3/177 (1.7%) 2/148 (1.4%) 1.25 1.26 (0.21 to 7.63), P = 0.803 
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Health outcome  Non-bathers 
(412) 
Community 
controls (526) 
Crude 
risk ratio  
Crude 
odds ratio 
Adjusted odds ratio (95% 
confidence intervals), P-value 
Skin ailments  
All waves 3/399 (0.8%) 6/510 (1.2%) 0.64 0.64 (0.16 to 2.56), P = 0.525 
Bathing season (wave 1+2) 0/132 (0%) 3/230 (1.3%) 0 1 (undefined) 
Out of season (wave 3+4) 3/267 (1.1%) 3/279 (1.1%) 1.04 1.05 (0.21 to 5.23), P = 0.957 
Wave 1 0/101 (0%) 2/161 (1.2%) 0 1 (undefined) 
Wave 2 0/31 (0%) 1/69 (1.4%) 0 1 (undefined) 
Wave 3 0/92 (0%) 1/136 (0.7%) 0 1 (undefined) 
Wave 4 3/175 (1.7%) 2/143 (1.4%) 1.23 1.23 (0.20 to 7.46), P = 0.822 
Ear ailments 
All waves 5/400 (1.3%) 4/518 (0.8%) 1.62 1.63 (0.43 to 6.10), P = 0.471 
Bathing season (wave 1+2) 1/135 (0.7%) 1/235 (0.4%) 1.74 1.75 (0.11 to 28.1), P = 0.694 
Out of season (wave 3+4) 4/265 (1.5%) 3/283 (1.1%) 1.42 1.44 (0.32 to 6.45), P = 0.641 
Wave 1 1/102 (1.0%) 0/164 (0%) . 1 (undefined) 
Wave 2 0/33 (0%) 1/70 (1.4%) 0 1 (undefined) 
Wave 3 0/91 (0%) 2/136 (1.5%) 0 1 (undefined) 
Wave 4 4/174 (2.3%) 1/147 (0.7%) 3.38 3.43 (0.38 to 31.1), P = 0.272 
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Health outcome  Non-bathers 
(412) 
Community 
controls (526) 
Crude 
risk ratio  
Crude 
odds ratio 
Adjusted odds ratio (95% CI), P-
values 
Eye ailments 
All waves 2/408 (0.5%) 4/520 (0.8%) 0.64 0.64 (0.12 to 3.49), P = 0.602 
Bathing season (wave 1+2) 1/135 (0.7) 1/234 (0.4%) 1.73 1.73 (0.11 to 27.9), P = 0.697 
Out of season (wave 3+4) 1/273 (0.4%) 3/286 (1.0%) 0.35 0.35 (0.04 to 3.35), P = 0.360 
Wave 1 0/102 (0%) 1/164 (0.6%) . 1 (undefined) 
Wave 2 1/33 (3.0%) 0/69 (0%) . 1 (undefined) 
Wave 3 0/92 (0%) 2/140 (1.4%) 0 1 (undefined) 
Wave 4 1/181 (0.6%) 1/146 (0.7%) 0.81 0.81 (0.05 to 13.0), P = 0.879 
Any symptoms of illness 
All waves 20/337 (5.9%) 34/413 (8.2%) 0.72 0.70 0.71 (0.39 to 1.30), P = 0.269 
Bathing season (wave 1+2) 5/109 (4.6%) 21/183 (11.5%) 0.40 0.37 0.41 (0.14 to 1.16), P = 0.094 
Out of season (wave 3+4) 15/228 (6.6%) 13/230 (5.7%) 1.16 1.18 1.23 (0.57 to 2.67), P = 0.597 
Wave 1 5/86 (5.8%) 13/135 (9.6%) 0.60 0.58 0.57 (0.20 to 1.67), P = 0.306 
Wave 2 0/23 (0%) 8/47 (17.0%) 0 1 (undefined) 
Wave 3 4/78 (5.1%) 5/106 (4.7%) 1.09 1.09 (0.28 to 4.21), P = 0.898 
Wave 4 11/150 (7.3%) 8/124 (6.5%) 1.14 1.15 1.14 (0.44 to 2.93), P = 0.785 
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Table 33: Confounders to be adjusted for have been prioritised in order of their supposed importance based on their mechanism 
and/or appearance in the literature as a confounder  
Gastrointestinal  AFRI Skin Ear Eye Any  
1. Diet 
2. Chronic 
(digestive illness) 
3. Household illness  
4. Regular bather 
5. Perceived risk 
6. Recreational 
water 
7. Gender 
8. Age 
9. SES 
10. Immuno-
suppression 
11. Animal ownership 
12. Smoking 
13. Travel 
14. Repeat 
responder 
1. Chronic (respiratory 
illness) 
2. Smoking 
3. Gender 
4. Age 
5. SES 
6. Regular bather 
7. Immuno-suppression  
8. Household illness 
9. Perceived risk 
10. Recreational water 
11. Repeat responder 
12. Animal ownership 
13. Chronic (allergies) 
14. Travel  
1. Chronic (allergies) 
2. Immuno-suppression 
3. Animal ownership 
4. Diet 
5. Age 
6. SES 
7. Chronic (skin 
ailments) 
8. Household illness  
9. Gender 
10. Regular bather  
11. Perceived risk 
12. Recreational water 
13. Smoking 
14. Travel 
15. Repeat responder 
1. Regular bather  
2. Gender 
3. Immuno-
suppression 
4. Age 
5. SES 
6. Household 
illness 
7. Perceived risk 
8. Recreational 
water 
9. Animal 
ownership 
10. Smoking 
11. Travel 
12. Diet 
13. Chronic (other) 
14. Repeat 
responder 
1. Chronic 
(allergies) 
2. Regular bather 
3. Age 
4. SES 
5. Household 
illness  
6. Perceived risk 
7. Gender 
8. Immuno-
suppression 
9. Recreational 
water 
10. Animal 
ownership 
11. Smoking 
12. Travel 
13. Diet 
14. Repeat 
responder 
1. Chronic (any) 
2. Regular bather 
3. Diet 
4. Age 
5. SES 
6. Household 
illness  
7. Gender 
8. Perceived risk 
9. Immuno-
suppression 
10. Recreational 
water 
11. Animal 
ownership 
12. Smoking 
13. Travel 
14. Repeat 
responder 
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Table 34: Number (%) of incident cases among bathers and participants who did not report any water contact, separated by wave 
of data collection 
Health outcome  Bathers Unexposed 
participants (non-
bathers and 
community controls) 
Crude risk 
ratio  
Crude 
odds ratio 
Adjusted odds ratio (95% 
confidence intervals), P-value 
Gastrointestinal illness 
Wave 1 17/464 (3.7%) 4/260 (1.5%) 2.38 2.43 2.40 (0.80 to 7.22), P = 0.119 
Wave 2 25/343 (7.3%) 6/101 (5.9%) 1.23 1.24  1.09 (0.43 to 2.76), P = 0.861 
Wave 3 15/285 (5.3%) 5/222 (2.3%) 2.34 2.41 2.46 (0.88 to 6.90), P = 0.086 
Wave 4 23/480 (4.8%) 10/323 (3.1%) 1.55 1.58  1.53 (0.71 to 3.32), P = 0.277 
Acute Respiratory Febrile Illness  
Wave 1 3/487 (0.6%) 0/267 (0%) . 1 (undefined) 
Wave 2 5/380 (1.3%) 0/103 (0%) . 1 (undefined) 
Wave 3 5/309 (1.6%) 0/230 (0%) . 1 (undefined) 
Wave 4 8/497 (1.6%) 5/326 (1.5%) 1.05 1.05 1.04 (0.34 to 3.21), P = 0.946 
Skin ailments  
Wave 1 9/473 (1.9%) 2/262 (0.8%) 2.49 2.52  2.57 (0.55 to 12.0), P = 0.231 
Wave 2 6/353 (1.7%) 1/100 (1.0%) 1.70 1.71 (0.20 to 14.4), P = 0.621 
Wave 3 7/288 (2.4%) 1/228 (0.4%) 5.54 5.65 (0.69 to 46.3), P = 0.106 
Wave 4 14/470 (3.0%) 5/319 (1.6%) 1.90 1.93 1.95 (0.69 to 5.46), P = 0.206 
Ear ailments 
Wave 1 16/451 (3.5%) 1/266 (0.4%) 9.44 9.75 10.1 (1.28 to 79.4), P = 0.028 
Wave 2 12/339 (3.5%) 1/103 (1.0%) 3.65 3.74 1.71 (0.19 to 15.6), P = 0.634 
Wave 3 12/293 (4.1%) 2/227 (0.9%) 4.65  4.80 4.46 (0.83 to 23.8), P = 0.081 
Wave 4 18/475 (3.8%) 5/322 (1.6%) 2.44 2.50 2.88 (0.98 to 8.48), P = 0.054 
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Health outcome  Bathers Unexposed 
participants (non-
bathers and 
community controls) 
Crude risk 
ratio  
Crude 
odds ratio 
Adjusted odds ratio (95% 
confidence intervals), P-value 
Eye ailments 
Wave 1 9/469 (1.9%) 1/266 (0.4%) 5.10  5.18  5.18 (0.65 to 41.2), P = 0.120 
Wave 2 8/358 (2.2%) 1/102 (1.0%) 2.28 2.31 (0.29 to 18.7), P = 0.433 
Wave 3 5/295 (1.7%) 2/232 (0.9%) 1.97 1.98 (0.38 to 10.3), P = 0.416 
Wave 4 10/484 (2.1%) 2/328 (0.6%) 3.39 3.44 3.52 (0.76 to 16.2), P = 0.106 
Any symptoms of illness 
Wave 1 71/307 (23.1%) 18/211 (8.1%) 2.84 3.39 3.39 (1.82 to 6.31), P < 0.0001 
Wave 2 57/224 (25.4%) 8/70 (11.4%) 2.23 2.65 1.70 (0.67 to 4.32), P = 0.262 
Wave 3 44/188 (23.4%) 9/184 (4.9%) 4.78 5.94 5.69 (2.34 to 13.9), P < 0.0001 
Wave 4 86/356 (24.2%) 19/275 (6.9%) 3.50 4.29 3.97 (2.17 to 7.26), P < 0.0001 
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Table 35: Number (%) of incident cases of individual symptoms (all four waves combined) among bathers compared to participants 
who reported no contact with coastal water 
Health outcome  Bathers Unexposed 
participants (non-
bathers and 
community controls) 
Crude risk 
ratio  
Crude 
odds ratio 
Adjusted odds ratio (95% 
confidence intervals), P-value 
Vomiting 18/1669 (1.1%) 10/932 (1.1%) 1.01 1.01 1.01 (0.46 to 2.20), P = 0.978 
Diarrhoea 67/1586 (4.2%) 21/912 (2.3%) 1.83 1.87 1.75 (1.01 to 3.04), P = 0.005 
Indigestion 46/1610 (2.9) 10/918 (1.1%) 2.62 2.67 2.53 (1.21 to 5.32), P = 0.014 
Nausea 69/1598 (4.3%) 15/907 (1.7%) 2.61 2.68 2.25 (1.21 to 4.19), P = 0.011 
Fever 28/1656 (1.7%) 8/919 (0.9%) 1.94 1.96 1.82 (0.82 to 4.04), P = 0.139 
Headache  108/1510 (7.2%) 40/860 (4.7%) 1.54 1.58 1.27 (0.83 to 1.95), P = 0.272 
Body aches  74/1540 (4.8%) 26/888 (2.9%) 1.64 1.67 1.43 (0.86 to 2.38), P = 0.167 
Fatigue 87/1547 (5.6%) 24/882 (2.7%) 2.07 2.13 2.09 (1.26 to 3.47), P = 0.004 
Loss of appetite 31/1661 (1.9%) 5/913 (0.5%) 3.41 3.45 3.55 (1.36 to 9.26), P = 0.010 
Sore throat 130/1478 (8.8%) 28/865 (3.2%) 2.71 2.88 2.36 (1.49 to 3.75), P < 0.001 
Runny nose 112/1477 (7.6%) 29/873 (3.3%) 2.28 2.39 1.89 (1.18 to 3.04), P = 0.008 
Dry cough 52/1601 (3.2%) 19/902 (2.1%) 1.54 1.56 1.73 (0.96 to 3.10), P = 0.069 
Productive cough 47/1617 (2.9%) 11/903 (1.2%) 2.39 2.43 2.33 (1.18 to 4.59), P = 0.014 
Ear ache 88/1558 (3.7%) 9/918 (1.0%) 3.80 3.91 3.39 (1.59 to 7.22), P = 0.002 
Ear discharge 7/1674 (0.4%) 3/932 (0.3%) 1.30 1.30 1.45 (0.33 to 6.35), P = 0.624 
Red, painful eyes 32/1606 (2.0%) 6/928 (0.6%) 3.08 3.12 2.12 (0.81 to 5.53), P = 0.125 
Eye discharge 6/1681 (0.4%) 3/934 (0.3%) 1.11 1.11 (0.28 to 4.46), P = 0.881 
Skin rash 15/1654 (0.9%) 3/925 (0.3%) 2.80 2.81 2.88 (0.83 to 9.99), P = 0.095 
Skin ulcer 4/1679 (0.2%) 1/933 (0.1%) 2.22 2.26 (0.25 to 19.9), P = 0.475 
Skin irritation 28/1616 (1.7%) 7/919 (0.8%) 2.27 2.30  2.34 (1.02 to 5.38), P = 0.046 
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Table 36: Breakdown of extent of immersion (head immersion and swallowing water) by reported activity 
Activity Bathers reported doing Reported head immersion Reported swallowing water 
Surfing 1,071 896 (81.1%) 687 (64.1%) 
Body boarding 299 239 (79.9%) 163 (54.5%) 
Stand up paddle boarding 249 151 (60.6) 69 (27.7%) 
Windsurf 106   85 (80.2%) 55 (51.9%) 
Swimming 794 642 (80.9%) 350 (44.1%) 
Snorkel 77   70 (90.9%) 33 (42.9%) 
Scuba 20   15 (75.0%) 4 (20.0%) 
Paddle 579   57 (9.8%) 17 (2.9%) 
Canoe 212 69 (32.5%) 26 (12.3%) 
Other (total) 95 57 (63.3%) 34 (35.8%) 
Coasteering or cliff jumping 15 13 (86.7%) 9 (60.0%) 
Bodysurfing or hand planing 13 12 (92.3%) 9 (69.2%) 
Belly boarding or skim boarding 2 2 (100.0%) 1 (50.0%) 
PWC (jet ski) 3 3 (100.0%) 1 (33.3%) 
Rowing or rafting 11 0 (0%) 0 (0%) 
Wakeboarding or water-skiing 8 7 (87.5%) 5 (62.5%) 
Other sailing (dingy) 2 1 (50.0%) 0 (0%) 
Fishing 4 0 (0%) 0 (0%) 
Spearfishing 2 2 (100.0%) 1 (50.0%) 
Free diving 3 3 (100.0%) 1 (33.3%) 
Lifesaving or rescue training 6 4 (66.7%) 2 (33.3%) 
Surf kayaking or surf boating 2 0 (0%) 0 (0%) 
Coaching surfing 12 6 (50.0%) 4 (33.3%) 
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Table 37: Number (%) of incident cases of major health outcomes (all four waves combined) among bathers who reported head 
immersion compared to participants who reported no contact with coastal water 
 Head immersion 
bathers 
Non-
bathers 
Risk ratio Odds ratio Adjusted odds ratio (95% confidence intervals), 
P-value 
Gastrointestinal 
illness 
83/1628 (5.1%) 22/850 
(2.6%) 
1.97     2.02 1.85 (1.09 to 3.14), P = 0.022   
Acute Respiratory 
Febrile Illness 
21/1734 (1.2%) 5/865 
(0.6%) 
2.10  2.11 2.09 (0.78 to 5.56), P = 0.141 
Skin ailments 36/1637 (2.2%) 9/856 
(1.1%) 
2.09 2.12  2.15 (1.03 to 4.50), P = 0.041   
Ear ailments 59/1617 (3.6%) 8/859 
(0.9%) 
3.92 4.03  3.46 (1.57 to 7.64), P = 0.002 
Eye ailments 32/1664 (1.9%) 6/870 
(0.7%) 
2.79   2.82 1.84 (0.70 to 4.82), P = 0.212 
Any symptoms of 
illness 
260/1115 (23.3%) 52/710 
(7.3%) 
3.18 3.85 3.59 (2.52 to 5.11), P = 0.000     
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Table 38: Number (%) of incident cases of individual respiratory symptoms among beach-going non-bathers and community 
controls 
Symptom Number (%) cases 
in beach-going 
non-bathers  
Number (%) cases 
in community 
controls  
Crude risk 
ratio 
Crude odds 
ratio 
Adjusted odds ratio (95% CI), 
P-value 
Fever 5/400 (0.8%) 5/519 (1.0%) 0.78 0.78 (0.18 to 3.27), P = 0.731 
Headache 13/375 (3.5%) 27/485 (5.6%) 0.62 0.61 0.57 (0.28 to 1.13), P = 0.108 
Body aches 5/387 (1.3%) 21/501 (4.2%) 0.31 0.30 0.30 (0.11 to 0.81), P = 0.018 
Fatigue 9/390 (2.3%) 15/492 (3.0%) 0.76 0.75  0.77 (0.33 to 1.78), P = 0.536 
Loss of appetite 2/399 (0.5%) 3/514 (0.6%) 0.86  0.86 (0.14 to 5.16), P = 0.867 
Sore throat 14/384 (3.6%) 14/481 (2.9%) 1.25 1.26 0.94 (0.15 to 5.69), P = 0.943 
Runny nose 12/385 (3.1%) 17/488 (3.5%) 0.89 0.89 0.93 (0.43 to 1.98), P = 0.844 
Dry cough 10/397 (2.5%) 9/505 (1.8%) 1.41 1.42 1.43 (0.58 to 3.56), P = 0.457 
Productive cough 5/399 (1.3%) 6/504 (1.2%) 1.05 1.05 1.05 (0.32 to 3.49), P = 0.931 
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Table 39: Compilation of water ingestion rates reported in the literature for various water sports 
Study Type of water Recreational Activity Volume of water ingested  
(mean has been reported where 
available) 
Method of estimation 
(Staley et al., 
2012a) 
Different types 
(estuarine, 
marine, tannic, 
lake, river) 
Swimming 18.6 ml  Methods of estimation not 
reported 
(Department of 
Environmental 
Affairs, 2012) 
Coastal water Water recreation (not 
specified) 
200 ml per day or 100 ml per session Methods of estimation not 
reported.  
(Schets et al., 
2011) 
Seawater Swimming 26 -36 ml/hour Questionnaire (self-report) 
(Dorevitch et al., 
2011) 
Swimming pool 
(chlorinated) 
Swimming 
Wading/splashing 
10 ml  
3.7 ml 
Questionnaire (self-report) 
Surface water 
(freshwater) 
Boating 3.7 ml/hour 
*2.1 ml/h 
Canoeing (combined 
capsized and did not 
capsize) 
3.9 ml/hour 
*2.3 ml/h 
Fishing 3.6 ml/hour 
*2.0 ml/h 
Kayaking (combined 
capsized and did not 
capsize) 
3.8 ml/hour 
*2.3 ml/h 
Rowing(combined capsized 
and did not capsize) 
3.9 ml/hour 
*2.3 ml/h 
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Study Type of water Recreational Activity Volume of water ingested  
(mean has been reported where 
available) 
Method of estimation 
(Stone et al., 
2008a) 
Seawater Surfing 170.6 ml /day 
*34.4 ml/day 
Questionnaire (self-
reported)  
(Schijven and 
Husman, 2006) 
Seawater  
(coastal) 
Diving (sports divers, 
ordinary facemask) 
9.9 ml/dive Questionnaire (self-
reported) 
Open sea  7.7 ml/dive 
Open sea + 
coastal water  
 9.0 ml/dive 
Fresh 
recreational 
water 
 13 ml/dive 
Canals and 
rivers 
 3.4 ml/dive 
City canals  2.8 ml/dive 
Canals, rivers, 
city canals  
 3.2 ml/dive 
Swimming pool  20 ml/dive 
(Evans et al., 
2006) 
Swimming pool 
(chlorinated) 
Swimming Adults: 24 ml/hr 
Children: 47ml/hr 
Measured cyanuric acid in 
the urine of people that had 
swum in a treated 
swimming pool 
Unable to access full report 
for quality appraisal 
(Dufour et al., 
2006)
Swimming pool 
(chlorinated) 
Swimming Adults: 16 ml/45 min 
Children: 37 ml/45 min 
 
Measured cyanuric acid in 
the urine of 53 people that 
had actively swum in a 
treated swimming pool 
Unspecified Swimming 10 ml per day References Shuval 1975, 
but unable to access this 
paper 
Unspecified Swimming 10 ml per event References Streeter 1951, 
but unable to access this 
paper 
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Study Type of water Recreational Activity Volume of water ingested  
(mean has been reported where 
available) 
Method of estimation 
(Westrell, 2004) Swimming Swimming (recreational) 50 ml Not primary research 
References (Westrell et al., 
2004) 
(Shuval, 2003a) Seawater Swimming 10-100ml per 20 or 30 minute event Methods of estimation not 
reported 
(World Health 
Organization, 
2003) 
Unspecified Swimming Adults: 100 ml per session, 200 ml per 
day 
Children: 250 ml per session 
Methods of estimation not 
reported 
(United States 
Environmental 
Protection Agency, 
2003) 
Unspecified Non-competitive swimming Adults: 25 ml/h 
Children: 50 ml/h 
Methods of estimation not 
reported 
(Georgiou, 2002) Seawater Bathing 10-15ml  Methods of estimation not 
reported 
(Haas et al., 1999) Unspecified Swimming (with head 
immersion) 
100ml per event  
 
Methods of estimation not 
reported.  
(Rijal et al., 2011) Unspecified Full contact swimming  30 ml/h References Crabtree 1997, 
but unable to access this 
paper 
(Department of 
Water Affairs and 
Forestry, 1996) 
Not specified Water recreation (not 
specified) 
100ml per session Methods of estimation not 
reported.  
(Eisenberg et al., 
1996) 
Reclaimed 
water in a 
swimming pool 
Swimming 30 – 50 ml/h Methods of estimation not 
reported. References 
(Asano and Sakaji, 1990), 
US EPA 1988 and  (Haas, 
1983) 
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Study Type of water Recreational Activity Volume of water ingested  
(mean has been reported where 
available) 
Method of estimation 
(Marino et al., 
1995) 
Seawater Bathing 
 
10 – 15 ml per session Methods of estimation not 
reported 
(United States 
Environmental 
Protection Agency, 
1989, United 
States 
Environmental 
Protection Agency, 
1995) 
Surface water 
(unspecified) 
Swimming 50 ml/hour  Methods of estimation not 
reported Wading  Adults: 10 ml/hour  
Wading  Children: 50 ml/h 
(Boland et al., 
1993) 
Unspecified Swimming 100 ml per event Methods of estimation not 
reported 
(Philipp et al., 
1985) 
Unspecified Swimming 10-50ml/session Methods of estimation not 
reported 
(Allen et al., 1982) Swimming pool 
(outdoor, 
chlorinated) 
Swimming 161 ml per hour  Measurement of CYA in 
long-distance recreational 
swimmers  
5 non-adult participants 
(aged 9-17) 
Swimming pool 
(outdoor, 
chlorinated) 
Soaking 3 – 3.6 ml in 2 hours 
*median values reported 
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Table 40: Calculation of population-level estimates of exposure to third-generation cephalosporin resistant E. coli 
Activity 
Average 
number of 
sessions per 
person per 
year (EFTEC, 
2002) 
Population 
(Office for 
National 
Statistics, 
2013b) 
Total 
number of 
water sport 
sessions 
Number of sessions occurring in each water 
quality category 
Number of sessions involving 
3GCREC ingestion in each water 
quality category 
 
Total 
number of 
sessions 
    
High 
(83.3%) 
Mandatory (15.4%) Fail (1.3%) High Mandatory Fail  
Swimming 
(adults) 
1.2 
43,802,500 
* 
52,563,000 43,784,979 8,094,702 683,319 175,140 590,913 608,837 1,374,890 
Swimming 
(children) 
1.2 12,765,300 15,318,360 12,760,194 2,359,027 199,139 114,842 396,317 199,139 710,298 
Surfing/ 
water-
skiing/ 
windsurfing
¥ 
0.4 56,567,800 22,627,120 18,848,391 3,484,576 294,153 829,329 2,707,516 294,153 3,830,998 
Diving ƚ 0.2 56,567,800 11,313,560 9,424,195 1,742,288 147,076 28,273 78,403 45,005 151,681 
Boating 0.5 56,567,800 28,283,900 23,560,489 4,355,721 367,691 23,560 74,047 75,744 173,351 
Canoeing/ 
jet skiing ≠ 
0.2 56,567,800 11,313,560 9,424,195 1,742,288 147,076 9,424 31,361 31,916 72,701 
Fishing Not reported - - - - - - - - - 
Kayaking Not reported - - - - - - - - - 
Rowing Not reported - - - - - - - - - 
Wading/ 
splashing 
Not reported - - - - - - - - - 
Total   164,046,620      6,313,919 
*Total number of children in England and Wales (combined males and females) aged 0 – 18 as reported by (Office for National Statistics, 2013b) 
** Total number of adults in England and Wales (combined males and females) aged 19 – 90+ as reported by (Office for National Statistics, 2013b) 
¥ Assume similar volumes of water are ingested during windsurfing and water-skiing sessions as during surfing 
ƚ Assume similar volumes of water are ingested while snorkelling as during diving 
≠ Assume similar volumes of water are ingested while jet skiing as during canoeing.  
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Table 41: Mean number of antibiotic resistant E. coli ingested per average session of each water sport 
Activity Guideline Mandatory Fail 
Swimming (adults) 0.943 
(0.923 - 0 .962) 
16.755 
  (15.931 - 17.579) 
205.014 
(185.722 - 224.307) 
Swimming (children) 2.180 
 (2.134 - 2.225) 
38.745 
(36.840 - 40.651) 
474.096 
(429.483 - 518.709) 
Surfing 10.050 
(9.840 - 10.261) 
178.648 
(169.862 - 187.433) 
2185.967 
(1980.263 - 
2391.670) 
Diving 0.583 
(0.571 - 0.595) 
  10.367 
(9.857 - 10.877) 
126.853 
(114.916 - 138.790) 
Boating 0.218 
(0.213 - 0.223) 
3.875 
(3.684 - 4.065) 
47.410 
(42.948 - 51.871) 
Canoeing 0.230 
(0.225 - 0.235) 
4.084 
(3.883 - 4.285) 
49.972 
(45.270 - 54.675) 
Fishing 0.212 
(0.208 - 0.217) 
3.770 
(3.584 - 3.955) 
46.128 
(41.787 - 50.469) 
Kayaking 0.224 
(0.219 - 0.229) 
3.979 
(3.784 - 4.175) 
48.691 
(44.109 - 53.273) 
Rowing 0.206 
(0.202 - 0.211) 
3.665 
(3.485 - 3.845) 
44.847 
(40.627 - 49.067) 
Wading/ splashing 0.218 
(0.213 - 0.223) 
3.875 
(3.684 - 4.065) 
47.410 
(42.948 - 51.871) 
On average, 27.6% of E. coli isolated from surface waters in the bathing season were resistant to at least one of the antibiotics tested by 
Blaak et al. (2011). This prevalence was used to calculate the mean number of antibiotic resistant E. coli ingested per water sport 
session in 2012, using the methods described in the main text. 
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Table 42: Calculation of population-level estimates using the prevalence of antibiotic resistant E. coli reported elsewhere (Blaak et al., 
2011) 
 
 
 
Activity 
Average 
number of 
sessions per 
person per 
year (EFTEC, 
2002) 
Population 
(Office for 
National 
Statistics, 
2013b) 
Total number of 
water sport 
sessions 
Number of sessions occurring in 
each water quality category 
Number of sessions involving 
3GCREC ingestion in each water 
quality category 
Total number 
of sessions  
    
High 
(83.3%) 
Mandatory 
(15.8%) 
Fail 
(0.13%) 
High Mandatory Fail  
Swimming 
(adults) 
1.2 
43,802,500 
* 
52,563,000 43,784,979 8,094,702 683,319 41,269,922 8,094,702 683,319 50,047,943 
Swimming 
(children) 
1.2 12,765,300 15,318,360 12,760,194 2,359,027 199,139 12,760,194 2,359,027 199,139 15,318,360 
Surfing/ 
waterskiing/ 
windsurfing 
0.4 56,567,800 22,627,120 18,848,391 3,484,576 294,153 18,848,391 3,484,576 294,153 22,627,120 
Diving 0.2 
56,567,800 11,313,560 9,424,195 1,742,288 147,076 5,496,269 1,742,288 147,076 7,385,634 
Boating 0.5 
56,567,800 28,283,900 23,560,489 4,355,721 367,691 5,135,402 4,355,721 367,691 9,858,813 
Canoeing/ 
jet skiing 
0.2 
56,567,800 11,313,560 9,424,195 1,742,288 147,076 2,165,197 1,742,288 147,076 4,054,561 
Total 
 
 164,046,620 
 
     109,292,431 
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Table 43: Lab methods for the Beach Bum Survey 
Each envelope contained: 
 A completed questionnaire and consent form sealed in a Ziploc bag 
 A rectal swab in Fecal Transwab tube (Medical Wire Equipment), sealed 
in a separate Ziploc bag 
 
1. Check the validity of returned swabs 
Overview: samples of the rectal swab were plated out onto LB agar (Miller?) 
containing no antibiotics to make sure that a sufficient sample of viable cells is 
available for analysis. Media was made according to manufacturer’s 
instructions.   
 
1. Envelopes were opened and contents removed in a CAT II hood. 
2. The outside of the tube was sprayed with ethanol to sterilise it to reduce 
cross-contamination between samples. The unique identifying number from 
the questionnaire that accompanied the Fecal Transwab tube (top left hand 
corner) was transcribed on the tube.  
3. The quality of the specimen received was noted in the results table (poor = 
no visible material on the swab; moderate = a small amount of material 
visible on the swab; good = lots of material visible on the swab). 
4. Each Fecal Transwab tube was vortexed for 30 s to suspend any faecal 
material in the liquid medium. 
5. 100 µl of the liquid medium was plated onto LB agar containing no 
antibiotics, which was labelled with the sample’s unique identifying number. 
6. Plates were incubate overnight (18 – 20 h) at 37oC. 
7. The next day the plates were inspected for any bacterial colony growth. If 
there was no visible growth, the swab was marked as invalid in the results 
table. Any negative results returned from the next stages of lab work were 
therefore likely to be false negatives.  
 
2. Enrichment stage 
Overview: samples of the rectal swabs were enriched in LB broth containing 
Ampicillin to improve selection of resistant colonies at the next stage. Media 
was made according to manufacturer’s instructions.   
 
Amount of selective LB broth (per swab): 10 ml LB broth + 10 µl Ampicillin  
1. 1 ml of the liquid medium from the vortexed Fecal Transwab tube was added 
to the selective LB broth. The container was labelled with the sample’s 
unique identifying number and vortexed. 
2. Containers were incubated overnight at 37oC, shaking at 160 rpm.  
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3. Isolating resistant colonies 
Overview: enriched samples were plated out onto Chromocult® coliform 
Enhanced Selectivity agar (CCA) (Merck) containing antibiotics, as well as a 
plate containing CCA and no antibiotics. Media was made according to 
manufacturer’s instructions. 
   
1. Enrichments were vortexed and 50 µl of the enrichment pipetted into 450 µl 
fresh LB broth and vortexed again.  
2. 100 µl of this was pipetted onto each of the 4 CCA plates:  
3. 100 µl onto CCA containing cefotaxime (1 mg/L),  
4. 100 µl onto CCA containing meropenem (4mg/L),  
5. 100 µl onto CCA containing temocillin (4 mg/L),  
6. 100 µl onto CCA containing no antibiotics.  
Using a sterile spreader, cell suspension was spread onto labelled plates until 
dry, and the plates were incubated overnight at 37oC.  
7. The next day, plates were inspected for the presence of blue (presumptive 
E. coli) colonies and pink (presumptive non-E. coli coliform) colonies.  
 
Quality control: Bacteria containing known resistance profiles from the Public 
Health England Culture collection were plated out onto plates containing 
antibiotics. This was done to make sure that the antibiotics are still effective and 
at the correct concentration to discern between resistant and susceptible 
phenotypes. 
 Cefotaxime resistant control: CTX-M 
 Meropenem resistant control: Klebsiella pneumoniae strain NCTC 13443, 
contains NDM-1 metallo-beta-lactamase 
 Temocillin resistant control: Klebsiella pneumoniae strain NCTC 13442, 
contains OXA-48  
 Susceptible control: Escherichia coli strain NCTC 10418 
 
4. Freezer stocks (enriched samples) 
Overview: freezer stocks were made of the enriched samples and stored in the 
freezer. 
 
500 µl 40% glycerol was pipetted into cryovial tubes and 500 µl of the enriched 
samples added. Cryovial tubes were then labelled, vortexed and stored at -80oC.  
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5. Colony PCR for detection of blaCTX-M and blaOXA-48 
 
Overview: resistant bacteria were tested for the presence of important mobile 
genetic elements (CTX-M among cefotaxime resistant bacteria, and OXA-48 
among temocillin resistant bacteria) 
 
1. Single colonies were picked from the CCA plates (a maximum of 5 blue 
colonies and a maximum of 5 pink colonies per swab) using a sterile 
toothpick and spotted onto LB agar containing the antibiotic to which they 
were resistant. Plates were labelled and incubated at 37oC overnight. 
2. At the same time, the picked colony was spotted into an Eppendorf tube 
containing 1 ml LB broth containing the antibiotic to which they were 
resistant. Eppendorf tubes were incubated at 37oC shaking overnight, and 
freezer stocks of the enrichments were made as described above.  
3. Once the colonies were grown on LB agar (see part 1), PCR reagents were 
assembled on ice: 
For 1 reaction (total volume = 15 µl): 
 5.85 µl nuclease-free water  
 0.15 µl Bovine Serum Albumin (BSA) 
 1.5 µl universal primer for CTX-M genes (forward and reverse primers were 
mixed at a ratio of 1:1)  
 7.5 µl Master Mix (New England BioLabs One Taq Hot Start Quick-Load 2x 
Master Mix with standard buffer) 
15 µl of the reaction was pipetted into a PCR tube. Single colonies from the LB 
agar were spotted into the reagents using a sterile toothpick. PCR tubes were 
labelled with the corresponding sample unique identifying number. 
 
4. PCR was performed in a 96 well thermal cycler (Applied Biosystems) under 
the following conditions:  
Stage 1 (denaturation): 95oC for 3 min (1 cycle) 
Stage 2 (annealing): 95oC for 30 s, 54oC for 30 s, 72oC for 1min (30 cycles) 
Stage 3 (final extension): 72oC for 10 min (1 cycle) 
Stage 4 (storage): 10oC  
OXA-48: PCR reaction conditions were the same as those reported by Poirel et 
al. (2004). (Poirel et al., 2004): 
Stage 1 (denaturation): 95oC for 3 min (1 cycle) 
Stage 2 (annealing): 95oC for 30 s, 54oC for 30 s, 72oC for 1min (30 cycles) 
Stage 3 (final extension): 72oC for 10 min (1 cycle) 
Stage 4 (storage): 10oC  
 
5. 10 µl of the PCR products were run on 1.0% agarose gel stained with 
ethidium bromide, along with a 1kb gene ladder (Fisher BioReagents 
exACTGene 1kb Plus DNA Ladder 100bp – 10,000bp). Gels were run at 100 
V for 30 min.  
6. Gel results were viewed under UV on GENESys software and 
absence/presence of the gene of interest were recorded for each sample in 
the spreadsheet.  
 
Quality control: positive and negative controls for each PCR reaction (i.e. CTX-
M positive strain or OXA-48 positive strain) and negative controls (Escherichia 
coli strain NCTC 10418) were included to make sure that the PCR has worked – 
i.e. that a band is produced for the known gene of interest, and that no band is 
produced from a strain that does not carry the gene of interest, indicating 
contamination of the reactions.  
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6. Phylogrouping E. coli colonies by quadruplex PCR 
Overview: blaCTX-M- bearing E. coli were tested for the presence of genes that 
assign them to one of 8 phylogenetic groups within E. coli according to the 
methods described by Clermont et al., 2013. 
 
1. Bacterial lysates were made by pipetting 100 µl sterilise distilled water into a 
labelled Eppendorf tube and spotting in a sample of the colony to be tested 
using a sterile toothpick. Eppendorf tubes were boiled at 100oC for 5 minutes to 
lyse the bacterial cells.  
2. PCR reagents were assembled on ice: 
 For 1 reaction (total volume = 20 µl): 
 2.8 µl nuclease-free water 
 0.2 µl BSA 
 1 µl primers for chuA (all primers were manufactured by Integrated DNA 
Technologies, and forward and reverse primers were combined at a ratio of 
1:1) 
 1 µl primers for yjaA 
 1 µl primers for TspE4.C2 
 1 µl primer for arpA 
 10 µl Master Mix  
17 µl of the reagents were pipetted into a PCR tubes. Then 3 µl of the bacterial 
lysate was added to the PCR tube and labelled with the sample Id number.  
PCR was performed in a 96 well thermal cycler (Applied Biosystems) under the 
following conditions: 
Stage 1 (denaturation): 94oC for 4 min (1 cycle) 
Stage 2 (annealing): 94oC for 5 s, 59oC for 20 s (30 cycles) 
Stage 3 (final extension): 72oC for 5 min (1 cycle) 
Stage 4 (storage): 10oC  
 
3. 15 µl of the PCR products were run on 2.0% agarose gel stained with 
ethidium bromide, along with a 1kb gene ladder (Fisher BioReagents 
exACTGene 1kb Plus DNA Ladder 100bp – 10,000bp). Gels were run at 100 
V for 1 h.  
4. Gel results were viewed under UV on GENESys software and 
absence/presence of the gene of interest were recorded for each sample in 
the spreadsheet. Phlyogroups were determined according to the table 
below: 
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Quality control: a negative control (sterilised distilled water) also underwent 
PCR and gel electrophoresis. 
 
 7. Identification of O25b-ST131 clone of E. coli by PCR 
 
Overview: blaCTX-M-bearing E. coli were tested for the presence of a gene that 
indicates whether it belongs to the clone O25b-ST131: a highly virulent strain of 
E. coli. Methods described by Johnson et al., (2009).   
 
1. PCR reagents were assembled on ice: 
For 1 reaction (total volume = 20 µl): 
 2.8 µl nuclease-free water 
 0.2 µl BSA 
 2 µl primer mdh36 
 2 µl primer gyrB47 
 10 µl Master Mix 
17 µl of the reagents were pipetted into PCR tubes. Then 3 µl of the bacterial 
lysate was added to the PCR tube and labelled with the sample Id number.  
PCR was performed in a 96 well thermal cycler (Applied Biosystems) under the 
following conditions: 
Stage 1 (denaturation): 95oC for 10 min (1 cycle) 
Stage 2 (annealing): 94oC for 30 s, 65oC for 30 s, 68oC for 2 min (32 cycles) 
Stage 3 (final extension): 68oC for 7 min (1 cycle) 
Stage 4 (storage): 10oC  
 
15 µl of the PCR products were run on 2.0% agarose gel stained with ethidium 
bromide, along with a 1kb gene ladder (Fisher BioReagents exACTGene 1kb 
Plus DNA Ladder 100bp – 10,000bp). Gels were run at 100 V for 45 min.  
Gel results were viewed under UV on GENESys software and absence or 
presence of the genes of interest were recorded for each sample in the 
spreadsheet. Samples that produced PCR products of 275 bp (mdh) and 132 
bp (gyrB) were considered to be E. coli ST131.  
Quality control: a positive control, EC958, was provided by Mathew Upton 
(University of Plymouth), which also underwent PCR and gel electrophoresis.  
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8. Characterisation of non-E. coli coliforms (NEC) 
Overview: NEC that were resistant to meropenem or were found to contain 
CTX-M gene were analysed to identify what species of bacteria they were. PCR 
was conducted to isolate the dnaJ gene, according to methods described by 
Pham et al. (2007). These projects were cleaned and sent off for sequencing. 
Sequencing results were compared to the BLAST database to name the 
identities of CTX-M-bearing NEC. 
 
A. PCR 
PCR reagents were assembled on ice: 
For 1 reaction (total volume = 40 µl): 
1. 12.6 µl nuclease-free water 
2. 0.4 µl BSA 
3. 4 µl primer dnaJ 
4. 20 µl Master Mix 
17 µl of the reagents were pipetted into a PCR tubes. Then 3 µl of the bacterial 
lysate was added to the PCR tube and labelled with the sample Id number.  
PCR was performed in a 96 well thermal cycler (Applied Biosystems) under the 
following conditions: 
Stage 1 (denaturation): 95oC for 3 min (1 cycle) 
Stage 2 (annealing): 94oC for 30 s, 50oC for 30 s, 72oC for 1 min (35 cycles) 
Stage 3 (final extension): 72oC for 7 min (1 cycle) 
Stage 4 (storage): 10oC  
 
6 µl of the PCR products were run on 1.2% agarose gel stained with ethidium 
bromide, along with a 1kb gene ladder (Fisher BioReagents exACTGene 1kb 
Plus DNA Ladder 100bp – 10,000bp). Gels were run at 100 V for 30 min.  
Gel results were viewed under UV on GENESys software. PCR products that 
produced a band of approximately 758 bp underwent PCR clean up (see 
below).  
 
Quality control: a negative control (sterilise distilled water) also underwent PCR 
and gel electrophoresis. 
 
B. PCR clean up 
Nucleospin® Gel and PCR Clean-up (Macherey-Nagel) was used according to 
the manufacturer’s instructions to purify the PCR products. 1 µl was tested for 
concentration and purity using Nanodrop 2000 UV-Vis Spectrophotometer. 
Samples producing purity ratio (260/280 nm) values of less than 0.8 were 
considered to be too poor to send for sequencing.  
 
C. Sequencing and interpretation of sequence data 
Purified DNA was sent to GATC for sequencing and nucleotide sequences were 
analysed using BLAST 
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9. Confirmation of presumptive E. coli as E. coli 
Overview: cefotaxime resistant E. coli underwent qPCR to detect the gene uidA, 
which is unique to E. coli, using methods described by (Srinivasan et al., 2011) 
 
1. qPCR reagents were assembled: 
 4.4 ul nuclease-free water 
 0.2 ul BSA 
 2 ul primer uidA 
 0.4 ul dye 
 10 ul Mast mix (sybr green master mix) 
17 ul of reagent were pipetted into a 96-well plate. 3 ul of bacterial lysate was 
added to each well. qPCR was performed in a StepOne Real-Time PCR 
System (Life Tecnologies) using the following program: 95oC for 6 s, 58oC for 8 
s, 72oC for 8 s.  
 
Quality control: A number of known E. coli (E. coli K12, E. coli NCTC 10418, 
and E. coli BL21 Star) and non-E. coli coliforms (Enterobacter cloacae, and 
Pantoea dispersa) also underwent qPCR. Average CT values were calculated 
for these known E. coli and known non-E. coli. CT values for the unknown 
samples were viewed and if they were below 21.9, samples were identified as 
being E. coli. If CT values for the unknown samples were above 28, these were 
identified as non-E. coli coliforms.  
 
10. Characterisation of CTX-M 
Overview: CTX-M-bearing enteric coliforms (both E. coli and NEC) underwent 
PCR to amplify the blaCTX-M gene, which is then cleaned and sent for 
sequencing. Sequencing results are compared by BLAST and GenBank.  
The regions located upstream of the blaCTX-M genes were amplified with primers 
annealing to ISEcp1 and to orf513 (876bp) 
 
A. PCR 
PCR reagents were assembled on ice: 
For 1 reaction (total volume = 40 µl): 
 12.6 µl nuclease-free water 
 0.4 µl BSA 
 4 µl primer CTX-M 
 20 µl Master Mix 
Pipette 17 µl of the mixture into individual PCR tubes. Then add 3 µl of the 
bacterial lysate to each tube and label.  
PCR was performed in a 96 well thermal cycler (Applied Biosystems) under the 
following conditions: 
Stage 1 (denaturation): 95oC for 3 min (1 cycle) 
Stage 2 (annealing): 95oC for 20 s, 54oC for 30 s, 72oC for 1 min 30 s (35 
cycles) 
Stage 3 (final extension): 72oC for 10 min (1 cycle) 
Stage 4 (storage): 10oC  
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6 µl of the PCR products were run on 1.0% agarose gel stained with ethidium 
bromide, along with a 1kb gene ladder (Fisher BioReagents exACTGene 1kb 
Plus DNA Ladder 100bp – 10,000bp). Gels were run at 100 V for 30 min.  
Gel results were viewed under UV on GENESys software. PCR products that 
produced a band of approximately 758 bp underwent PCR clean up (see 
below). 
 
Quality control: a negative control (sterilised distilled water) also underwent 
PCR and gel electrophoresis to ensure samples or reagents had not been 
contaminated. 
 
B. PCR clean up 
Nucleospin® Gel and PCR Clean-up (Macherey-Nagel) was used according to 
the manufacturer’s instructions to purify the PCR products. 1 µl of the resultant 
exudate was tested for concentration and purity using Nanodrop 2000 UV-Vis 
Spectrophotometer. Samples producing a purity ratio values (260/280 nm) of 
less than 0.8 were considered to be too poor to send for sequencing.  
 
C. Sequencing and interpretation of sequence data 
Purified DNA was sent to GATC for sequencing and nucleotide sequences were 
analysed using BLAST. 
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Table 44: Primer sequences used for PCRs conducted in the beach bum study.  
 
Primer pair sequences PCR 
product 
size 
(bp) 
References 
Universal primer pair for CTX-M genes 
CTX-F: TCTTCCAGAATAAGGAATCCC 
CTX-R: CCGTTTCCGCTATTACAAAC 
909 (Kiratisin et 
al., 2008) 
OXA-48 
OXA-48A: TTGGTGGCATCGATTATCGG 
OXA-48B: GAGCACTTCTTTTGTGATGGC 
 
740  (Poirel et 
al., 2004) 
Phylogrouping E. coli primers  
chuA.1b: ATGGTACCGGACGAACCAAC 
chuA.2: TGCCGCCAGTACCAAAGACA 
288 (Clermont et 
al., 2013) 
yjaA.1b:CAAACGTGAAGTGTCAGGAG 
yjaA.2b: AATGCGTTCCTCAACCTGTG  
211 
TspE4C2.1b: CACTATTCGTAAGGTCATCC 
TspE4C2.2b: AGTTTATCGCTGCGGGTCGC 
152 
AceK.f: AACGCTATTCGCCAGCTTGC 
ArpA1.r: TCTCCCCATACCGTACGCTA 
400 
Group E 
ArpAgpE.f: GATTCCATCTTGTCAAAATAT 
GCC 
ArpAgpE.r: GAAAAGAAAAAGAATTCCCAA 
GAG 
301 
Group C 
trpAgpC.1: AGTTTTATGCCCAGTGCGAG 
trpAgpC.2: TCTGCGCCGGTCACGCCC 
219 
ST131 primers 
Mdh36_forward: TTTAACGTTAACGCCGGT 
Mdh36_reverse:GGTAACACCAGAGTGACCA 
275 (Johnson et 
al., 2009) 
gyrB47_forward: CGCGATAAGCGCGAC 
gyrB47_reverse: CCGTCTTTTTCGGTGGAA 
132 
Primers for dnaJ gene 
DN1-1F: GATYTRCGHTAYAACATGGA 
DN1-2R: TTCACRCCRTYDAAGAARC 
758 (Pham et 
al., 2007) 
Primers for amplifying and sequencing entire 
genes: 
For CTX-M-1 group genes 
CTXprom: TGCTCTGTGGATAACTTGC 
ORF477R: CCGATGACTATGCGCACTGGG 
 
 
876 (Poirel et 
al., 2002, 
Geser et al., 
2012) 
PROM+: TGCTCTGTGGATAACTTGC 
PRECTX-M: CCGTTTCCGCTATTACAAAC 
(if no product, replaced PROM+ with IS26ENDF) 
IS26ENDF: GTACGGCCCACAGAATGATGTC 
 (Dhanji et 
al., 2011, 
Poirel et al., 
2002)  
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Primers for amplifying UidA gene using qPCR 
UidA: 
AATGGTGATGTCAGCGTTACACTCTGTCCGGCTT
TTG 
6FAM-TTGCAACTGGACAAGGCA 
CCAGC-BBQ 
NA (Srinivasan 
et al., 2011) 
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Figure 33: Results of the phylogenetic analysis to identify variants of blaCTX-M 
genes isolated from Beach Bum Survey participants.  
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Table 45: Plausible estimates of the true prevalence of faecal carriage of CTX-
M-producing enteric coliforms among surfers, given a range of possible values 
for the prevalence of community carriage.  
Percentage 
of the 
community 
colonised by 
coliforms 
harbouring 
CTX-M  
Percentage of 
surfers colonised by 
coliforms producing 
CTX-M (% 
difference) 
Lower estimate of 
the percentage of 
surfers colonised 
by coliforms 
producing CTX-M 
(% difference) 
Upper estimate of 
the percentage of 
surfers colonised by 
coliforms producing 
CTX-M (% 
difference) 
0.5% 2.05% (+1.55%) 0.51% (+0.01%) 8.20% (+7.70%) 
1.0% 4.09% (+3.09%) 1.02% (+0.02%) 16.40 % (+15.40%) 
1.54%  6.30% (+4.76%) 1.57% (+0.03%) 25.26% (+23.72%) 
5.0% 20.45% (+15.45%) 5.10% (+0.10%) 82.00 % (+77.00%) 
8.1% 33.13% (+25.03%) 8.26% (+0.16%) 100.00% (+91.9%) 
10.0% 40.90% (+30.90%) 10.20% (+0.20%) 100.00% (+90.00%) 
11.1% 45.40% (+34.30%) 11.32% (+0.22%) 100.00% (+88.90%) 
15.0% 61.35% (+46.35%) 15.30% (+0.30%) 100.00% (+85.00%) 
20.0% 81.80% (+61.80%) 20.40% (+0.40%) 100.00% (+80.00%) 
22.8% 93.25% (+70.45%) 23.26% (+0.46%) 100.00% (+77.20%) 
25.0% 100.00% (+75.00%) 25.50% (+0.50%) 100.00% (+75.00%) 
30.0% 100.00% (+70.00%) 30.60% (+0.60%) 100.00% (+70.00%) 
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Table 46: Results of previous studies reporting the percentage of subjects with faecal samples testing positive for CTX-M-producing 
Enterobacteriaceae.  
Exposure of interest Country Years studies 
were conducted 
% in exposed 
group 
% in unexposed 
group 
Crude risk 
ratio 
Study  
Hospitalisation Hungary 2009-2010 1.53% * 3.58%* 2.05 (Ebrahimi et al., 2014) 
International travel The 
Netherlands 
 6.76% (post-
travel) 
1.62% (pre-travel) 4.17 (Paltansing et al., 2013)  
Global origin of high 
prevalence area 
(proxy for 
international travel)  
UK 2010 22.8%* (Global 
origin Middle 
East and South 
Asia) 
8.1%* (Global origin 
Europe) 
2.81 (Wickramasinghe et al., 2012) 
International travel Australia 2008-2009 17.7%* 2.00%* 8.82 (Kennedy and Collignon, 2010) 
Hospitalisation UK 2003 2.28% (hospital 
patients) 
1.42% (community 
patients) 
1.61 (Munday et al., 2004) 
0.25%* 1.42%* 0.18 
Hospitalisation Spain 2003 3.75% 1.85% (healthy 
volunteers)  
2.03 (Valverde et al., 2004) 
*=CTX-M-bearing E. coli only.  
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Figure 34: Estimating the number of newly colonised individuals contributed to 
the community by surfing and by healthcare settings.  
 
Term  Proportion Population Value Notes 
A The number of 
individuals 
colonised after 
surfing 
11.1% + 
6.7% = 
17.8% 
500,0001 89,000 6.7% = risk difference 
between surfers and non-
surfers of colonisation by 
CTX-M-bearing E. coli, 
see Table 19  
B The number of 
colonised 
individuals 
going surfing 
11.1% 500,000 55,500 11.1% = proportion of 
community harbouring 
CTX-M-bearing E. coli 
reported by 
Wickramasinghe et al., 
2012 
A-B Net contribution of surfing to community 
carriage of CTX-M-producing E. coli 
33,5000 
C The number of 
individuals 
colonised after 
a hospital stay 
11.1% + 
0.89% = 
11.99% 
16 million 1918400 0.89% = risk difference 
between hospitalised 
patients and out patients 
colonised by ESBL-
producing 
Enterobacteriaceae 
(Munday et al 2004)7 
D The number of 
colonised 
individuals 
admitted to 
hospital 
11.1% 16 million 1776000 16 million hospital 
admissions in 2014/2015 
(NHS Confederation, 
2016) 
C-D Net contribution of hospitalisation to 
community carriage of CTX-M-producing 
E. coli 
142,400 
1 500,000 surfers are estimated to live and surf in the UK, according to a report 
on the economic impact of domestic surfing on the UK (Mills and Cummins, 
2013) 
 
                                                          
77 This was the only UK estimate of faecal carriage of CTX-M-producing E. coli among hospitalised and 
community-based subjects. A search was conducted to try and find a more recent estimate, but none 
were found. The estimate for CTX-M-producing Enterobacteriaceae was used as we assumed prevalence 
of the blaCTX-M genes are likely to have increased since 2003.  
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Appendix II - Systematic review documentation 
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The symptoms and illnesses considered in each of the health outcome categories (any, ear, gastrointestinal, eye, other, respiratory, skin, 
urogenital, specific) 
Any (A) Ear (E) Gastrointestinal 
(G) 
Eye (I) Other (O) Respiratory (R) Skin (S) Urogenital 
(U) 
Specific (Sp) 
Any illness Ear Abdominal pain/ 
cramps/stomach 
pain 
Conjunctivitis/ 
eye infection/ 
eye/ eye 
ailments/ eye 
symptoms 
Aching joints Acute febrile 
respiratory 
illness 
Cutaneous 
infection 
Urinary tract 
infection 
Giardia infection 
Any 
symptoms 
Ear 
ailments/ 
ear 
infection/ 
ear 
symptoms/ 
otitis 
Any 
gastro(intestinal) 
illness 
Eye discharge/ 
mucopurulent 
exudate/ tear 
secretion/ eye 
discharge 
Back ache Blocked nose Dermatitis/ 
skin infection 
Urogenital Echovirus infection 
One or 
more 
symptoms 
Ear 
discharge/ot
orrhoea/ 
runny ears 
Constipation Eye irritation/ 
Eye pain or 
burn/ sore or 
itchy eyes/ 
sore eyes 
Chills Breathing 
difficulties 
Dermatological 
/ skin ailments/ 
skin problems 
Vaginal 
infection / 
vaginitis 
Staphylococcal 
skin infection 
Illness Ear itching Diarrhoea Eye redness 
/red eyes 
Constitutional Breathing 
trouble 
Itchy skin  Cryptosporidiosis 
Total illness Ear pain/ 
ear ache/ 
sore ears 
Bloody 
diarrhoea 
 Cough + 
diarrhoea 
Chest pains Infected cut  Hepatitis A 
 Otitis 
externa 
Diarrhoea + 
fever 
 Cough + ears Cough Skin  Mycobacterium 
Avium Complex 
 Fullness in 
ears 
Enteric  Cough + skin Cold, flu, cough Skin rash  E. coli O157 
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Any (A) Ear (E) Gastrointestinal 
(G) 
Eye (I) Other (O) Respiratory (R) Skin (S) Urogenital 
(U) 
Specific (Sp) 
  Gastro(enteritis)  Cough + 
vomiting + 
diarrhoea  
Cough + phlegm   Extended-spectrum 
beta lactamase-
producing 
community 
acquired urinary 
tract infections 
  Highly credible 
gastrointestinal 
illness 
 Diarrhoea + 
skin 
Dry cough   Campylobacter 
  Indigestion  Dysphagia Highly credible 
respiratory 
illness 
  Giardia lambli 
  Loss of appetite  Ear, nose 
and throat 
Hoarseness   Diarrhoegenic E 
coli 
  Nausea  Fever Phlegm   Enteropathic E coli 
  Nausea or 
vomiting 
 Generally felt 
ill 
Respiratory 
illness 
  Enterotoxigenic E. 
coli 
  Nausea + 
diarrhoea 
 Headache Rheum    
  Nausea + 
diarrhoea + 
fever 
 Infected cut Runny nose    
  Stomach upset  Lack of 
energy 
Significant 
respiratory 
disease 
   
  Vomiting  Other 
condition 
Sore throat    
  Vomiting + 
diarrhoea 
 Otitis + 
conjunctivitis 
+ respiratory 
Throat    
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Any (A) Ear (E) Gastrointestinal 
(G) 
Eye (I) Other (O) Respiratory (R) Skin (S) Urogenital 
(U) 
Specific (Sp) 
  Vomiting + 
diarrhoea + 
fever 
 Sinus 
problems 
Upper 
respiratory 
   
  Vomiting + 
nausea 
 Skin + ears Wheezing    
    Toothache     
    Vaginal 
infection + 
skin 
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Example of a data extraction form for (a cohort study) 
BIBLIOGRAPHIC DETAILS 
Author(s):  
Year:  
Title:  
Citation:  
 
STUDY DETAILS 
Country:  
Year(s):  
Study design:  
Study objective(s): (e.g. association between faecal indicator 
bacteria and risk of gastrointestinal symptoms) 
Study size: Number recruited 
Number analysed 
Drop out: % 
Number of study sites:  
Type of water: Marine/Estuarine/Fresh 
Recreational exposure:  
Description of exposure:  
Comparator description:  
Method of exposure 
assessment: 
 
Hypothesised sources of 
pollution: 
 
Period of recruitment:  
Funding source:  
Notes:  
 
POPULATION 
Population 
description: 
(e.g. beach-goers aged between 5 and 64) 
Method of 
selection: 
 
Eligibility criteria:  
Method and 
duration of follow-
up: 
 
Notes:  
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HEALTH OUTCOMES MEASURED 
Health 
outcome 
Health outcome 
category  
Any, ear, eye, 
gastrointestinal, 
other, 
respiratory, skin 
or specific 
Definition Case 
definition 
category 
Specific, 
single, 
sensitive, or 
not reported 
Method of 
assessment 
Self-reported 
symptoms/ 
physician-
diagnosed/lab-
diagnosed 
     
     
     
     
     
     
     
Notes 
 
 
WATER QUALITY ASSESSMENT  
Location (or year):   
Indicator Geometric mean 
density (cfu/100ml) 
 Method of 
enumeration 
    
    
    
    
    
Location (or year):   
Indicator Geometric mean 
density (cfu/100ml) 
 Method of isolation/ 
enumeration 
    
    
    
    
    
 
Notes on method of isolation/measurement:  
When were water samples taken in relation to exposure?  
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 Exactly the same time and place as bather exposure 
 The same morning/afternoon as bather exposure 
 The same day as bather exposure 
 Over the study period 
 After bather exposure 
Notes: 
 
STATISTICAL METHODS SECTION 
Risk factors measured: 
Confounders adjusted for: 
Statistical tests used: 
 
RESULTS 
 
 
Outcome  Number 
of 
exposed  
Number of 
unexposed 
Number 
of cases 
among 
exposed 
Number of 
cases 
among 
unexposed 
Crude 
odds ratio 
(95%CI) 
calculated 
in STATA 
Other risk 
metric (95% 
CI) reported 
       
       
       
       
       
       
 
 
 
Quality appraisal – CASP 
Indicator Assessment: 
Yes/partially/no/can’t 
tell 
Comments 
Was the study population defined? 
 
  
Risk factors under study defined?   
Is it clear whether the study tried to detect a 
beneficial or harmful effect? 
  
   
Was the cohort recruited in an acceptable way   
Was the cohort representative of a defined 
population? 
  
Was everybody who should have been included?   
Were any subgroups excluded from the 
cohort/sampled population (e.g. children/adults, 
males/females, tourists/locals) 
  
Were there a sufficient number of participants?   
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Was the exposure clearly defined?   
Was exposure assessed using objective 
measures? 
  
Were methods used for exposure assessment 
accurate and confirmed or validated in any way? 
  
Were measurement methods exactly the same 
for cases as controls in the exposure 
assessment? 
  
Were the subjects blinded to the exposure of 
interest? 
  
Were the subjects blinded to the outcome of 
interest? 
  
Were the investigators blinded to the exposure of 
interest? 
  
Were the investigators blinded to the outcome of 
interest? 
  
Were the cases/outcomes of interest defined 
precisely? 
  
Were objective measurements used to measure 
the outcome(s) of interest? 
  
Were the methods to measure outcome(s) of 
interest accurate (have they been validated?) 
  
Is incidence measured?   
Is the timeframe (recall/follow-up period) of the 
study relevant to disease/ exposure? 
  
Were outcome measurement methods similar in 
the different groups (cases and controls)? 
  
Was the follow up of subjects complete enough? 
i.e. was the response rate high? 
  
Was loss to follow- up similar across 
cases/controls/unexposed/exposed? 
  
What confounding/risk factors have the authors 
measured? 
  
What important confounding/risk factors have 
been missed? 
  
Which confounders have been used to adjust risk 
metrics? 
  
Have the authors taken account of confounders 
in the design stage of the study? 
  
Have the authors taken account of these 
confounders in the analysis stage?  
  
Have the authors investigated the effect of non-
response/loss to follow-up? 
  
Is the analysis appropriate to the design?   
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What are the bottom line results?   
Have they reported rate or proportion between 
exposed/unexposed, the ratio/rate difference? 
  
How strong is the association between exposure 
of interest and outcome? How precise are the 
results? 
  
Might confounding still explain the association?   
Has adjustment made a big difference to the 
odds ratio/relative risk? 
  
Are the design and methods of this study 
sufficiently flawed to make the results unreliable? 
  
Bradford Hill’s criteria (criteria for causation)  
Time sequence   
Dose-response   
Strength of association   
Biological plausibility   
Consistency   
Specificity   
Experimental   
Coherence   
Analogy   
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Using the CASP quality appraisal rating system: Interpretation of criteria and rationale for quality appraisal 
 
Part A: are the results of the study valid?   
 
Does the study address a focused issue? 
Things to consider and their importance in 
evaluating quality 
Yes/Good Partially/moderate No/poor Can’t 
tell/NA 
Was the study population defined? 
 
Study population well defined in terms 
in terms of either location (source) 
and/or time. Inclusion/exclusion criteria 
have been stated.   
Study population 
defined but not 
well   
Study population not 
defined 
 
Risk factors (or intervention in the case of 
randomised control trials) under study defined? 
Note: this question is explored further in section 
2 and section 3.  
Exposure and important risk factors of 
interest have been well-defined in the 
research question/study aims 
E.g. swimming at the beach, swimming 
in water of poor quality, swimming for 
more than X minutes 
Risk factors 
mentioned but not 
well defined 
Study does not 
report any risk 
factors under 
investigation 
 
Is it clear whether the study tried to detect a 
beneficial or harmful effect? 
Illness (e.g. symptoms)  It is not clear 
whether the study is 
investigating a 
harmful or beneficial 
effect.  
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Section 1: Were participants recruited in an acceptable way to minimise bias? 
 
Do you have reason to believe that the population of interest is different to that in the study?  
 
Things to consider and their importance in 
evaluating quality  
Yes/Good Partially/ 
Moderate 
No/ Poor Can’t 
tell/N
A  
CASE-CONTROL:   
Are the cases representative of a defined 
population?  
 
CASE-CONTROL 
Study has defined the population (in 
terms of either location and/or time) and 
cases are likely to representative of the 
population of interest.  
 
Authors might have compared their 
sample to characteristics of the source 
population.  
 
 
 
 Study population has 
been defined, but 
cases are unlikely to 
be representative of 
the population of 
interest, e.g. certain 
groups are over-
represented 
Study 
popul
ation 
has 
not 
been 
defin
ed or 
can’t 
tell if 
cases 
are 
repre
senta
tive  
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Was there an established, reliable system 
for detecting all the cases? 
 
There was a reliable system in place for 
detecting and recruiting all cases 
E.g. population surveillance 
 
 
 There was not a 
reliable system in 
place 
E.g. cases reporting 
to a Dr or clinic where 
healthcare is not free 
of charge. These 
samples are likely be 
made up of people 
from higher 
socioeconomic strata 
and exclude people 
from lower strata 
 
Was a sufficient number of cases selected?  
Note: A sample size or power calculation may help 
decide if the sample size was adequate, but if this 
is not reported, need to consider the size of 
effect/difference between the two groups. Power 
can be increased by recruiting more controls than 
cases.  
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COHORT:  
Was the cohort recruited in an acceptable 
way? 
 
 
 
COHORT 
The population has been defined and 
acceptable recruitment methods have 
been employed. 
E.g. study population of interest are 
beach-goers, and the investigators have 
approached people on the beach. They 
might have used quota sampling to make 
sure that sufficient numbers for the 
comparator group were recruited to the 
study. Random sampling 
 
   
Was the cohort representative of a defined 
population? 
 
The authors have reported sampled 
population’s key demographic information 
(e.g. gender) that might give some 
indication of representativeness, e.g. 
~50% cohort male, 50% female 
 Sampled population 
is not likely to be 
representative of the 
population of interest.  
 
For example, cash 
incentives offered for 
participation is likely 
to select for people 
from lower 
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socioeconomic 
backgrounds 
Was everybody included who should have 
been included? 
 
Note: the method of follow-up may exclude some 
people from the study e.g. if conducting follow-up 
interviews by telephone, this would exclude people 
who do not own phones or who are unhappy giving 
information over the phone. 
 
 
Yes 
E.g. used multiple methods for follow-up 
(e.g. postal, as well as telephone 
interview) 
E.g. method 
of follow up is 
likely  to allow 
most people 
to take part 
(e.g. 
telephone 
surveys in 
countries 
where a high 
% of the 
population 
have phones) 
but exclude a 
small 
proportion.  
No 
E.g. method of follow 
up likely to exclude a 
large number of 
people (postal usually 
have very low 
response rates) 
 
Were any subgroups excluded from the cohort? 
i.e. where there any exclusion criteria? It is not 
necessarily a bad thing to have exclusion criteria: 
they can remove people whose outcome might be 
influenced by other exposures, but it does affect 
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the generalizability of the results to wider 
populations.  
 
 
Were there a sufficient number of participants?  
Note: A sample size or power calculation may help 
decide if the sample size was adequate, but if this 
is not reported, need to consider the size of 
effect/difference between the two groups. 
 
    
 
Section 2: Were the exposures and outcomes accurately measured to minimise bias?  
Consider the different aspects of exposure: activity, extent (time, immersion of body parts, swallowing water), water quality. Water 
contact/going to a beach can encompass a huge range of activities, accurately assessing these can reduce misclassification bias. Also 
consider who is providing information on exposure/outcome: participants self-report, or parents/guardians reporting on behalf of family 
members.  
 
Things to consider and their importance in 
evaluating quality  
Yes/Good Partial/Moderate No/Poor Can’t  
tell 
Was the exposure clearly defined and 
accurately measured? 
Exposure was clearly defined and 
accurately measured. 
Exposure was 
defined but not 
clearly. Method of 
Exposure was defined poorly  
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Misclassification bias 
 
 
Example of clear exposure 
definition: swam for X minutes and 
immersed head 
 
Example of accurate measurement 
of exposure:  investigator observed 
participant in the water. 
 
If investigating the effect of water 
quality on rates of illness, 
investigators have attempted to 
assign (as closely as possible) water 
quality to individuals (e.g. by having 
swimmers collect their own water 
samples, by noting which water 
sampling point swimmers were 
closest to) 
 
assessment not 
accurate.  
 
Example of 
unclear definition 
of exposure: 
swimming 
 
 
Method of assessment not 
accurate 
 
Example of a poorly defined 
exposure: “seawater contact”: 
this encompasses a wide 
range of activities.  
 
Example of inaccurate 
assessment: 
Water samples were 
collected at one time point or 
at one place but was applied 
to individuals who were 
exposed at a different time or 
place.  
 
Appendix II - Systematic review documentation 
254 
 
Did the authors use subjective or objective 
measurements of exposure?  
 
Used objective measurements to 
assess exposure.  
 
Example:  
 Quantification of water quality 
indicator measurement – e.g. by 
culture-based methods 
Example: 
 Investigators timed participants’ 
time in the water.  
 
Used a mixture of 
subjective and 
objective 
measurements  
to assess 
exposure 
 
Example:  
respond to a 
questionnaire on 
extent of water 
contact, and 
measurement of 
water quality at 
the time of 
exposure 
Used subjective 
measurements to assess 
exposure 
 
E.g. respond to a 
questionnaire on level of 
water exposure.  
 
 Do the exposure measures truly reflect 
what they are supposed to measure 
(have they been validated?) 
 
 
  
All methods used were accurate and 
confirmed or validated 
 
E.g. investigators watched 
participants enter the sea, timed 
Methods used 
were reasonably 
accurate 
 
E.g. participants 
self-reported on 
Methods used were unlikely 
to be accurate and were not 
validated. 
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participants in the water, observed 
their activities 
 
Water quality: 
Quantification of causal organisms 
in water samples to which 
individuals were exposed  
 
Investigators use a questionnaire 
that has been piloted before use  
the day of 
exposure 
 
E.g. 
measurement of 
faecal indicator 
organisms as a 
proxy for the 
presence of 
faecally 
transmitted 
pathogens.  
 
E.g. participant (or family 
member) reported exposure 
several days after exposure 
 
E.g. Results of water quality 
assessment were averaged 
over space and or time, 
leading to misclassification of 
exposure.  
 Were the exposure measurement 
methods similar in the cases and 
controls/ exposed and unexposed?  
Recall bias 
Temporal matching  
The same methods used to 
measure exposure were used for 
cases and controls/exposed and 
unexposed.  
 
Case-control: Measurement 
methods were exactly the same in 
cases as controls 
 Measurement methods were 
not the same in cases as for 
controls 
 
Case-controls: cases were 
interviewed about their 
exposure a long time after 
cases were interviewed about 
their exposure  
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In addition, there was temporal 
matching (i.e. cases and controls 
were interviewed about their 
exposures at a similar time, such 
that cases were not interviewed a lot 
closer to the exposure event, and 
controls a lot later or vice versa) 
 
Cohort: all subjects were classified 
into exposure groups using the 
same procedure/criteria  
Cohorts: Participants were 
not classified into exposure 
groups using the same 
criteria/procedure.  
 
  
Were the subjects and/or investigators 
blinded to the exposure and outcomes of 
interest?  
Interviewer bias 
Responder bias 
Social desirability response bias 
 
Study reports blinding where 
feasible 
Example: interviewers collecting 
symptoms/physicians or lab 
technicians who were diagnosing 
subjects were blinded to subjects 
exposure status 
Participants were unaware of the 
case definitions of the outcomes 
under investigation 
Study reports 
some blinding 
where feasible 
Subjects were aware of 
outcomes under 
investigation, interviewers 
were aware of subjects status 
(case/control or 
exposed/unexposed) when 
collecting data on 
symptoms/exposure  
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Were the cases/ outcomes of interest 
defined precisely 
Misclassification bias 
Diagnostic criteria were given for all 
health outcomes investigated 
 
Example 1: a person was 
considered to have diarrhoea if they 
reported ≥3 loose stools in a 24 h 
period 
 
Example 2: cut-off between positive 
and negative results was set at a 
value of 300.  
Diagnostic criteria 
were given for 
some but not all 
health outcomes 
investigated 
Diagnostic criteria were not 
given 
 
Did they use subjective or objective 
measurements for outcome measurement? 
Note: fever in particular is difficult for people 
to self-diagnose (do people over or 
underestimate their fever?)  
Social desirability response bias 
Objective measurements were used  
 
Laboratory diagnosis where 
outcome has been quantified, e.g. 
levels of antibody, temperature 
measured to assess fever, 
enumeration of cysts/oocysts in 
faecal samples.  
A mixture of 
objective and 
subjective 
 
Subjective  
 
Example: participants self-
report symptoms experienced 
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Do the measures of outcome truly reflect 
what you want them to? I.e. were the 
methods used to assess cases/outcomes 
appropriate/validated? Etc.  
Validity 
 
Methods used to assess outcomes 
are gold-standard/have been 
validated 
 
E.g. gold standard diagnostic test, 
physician-confirmed 
 
Self-reported 
symptoms have 
been collected by 
trained 
personnel/ 
computer-
assisted 
telephone 
interviews 
 
Cases are pre-
defined by a 
standard 
combination of 
symptoms 
(international 
classification of 
diseases). 
 
Methods used to assess 
outcomes are not validated 
 
Respondents self-report 
individual symptoms. 
Parents/guardians/head of 
family reporting on behalf of 
others.  
 
Is incidence or prevalence measured? 
Important for establishing temporal 
sequence i.e. exposure precedes outcome 
Incidence (number of new cases or 
newly diagnosed cases) measured 
over a given time period 
NA Prevalence measured (the 
number of cases (old and 
new) in a population at a 
given point in time 
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Is the timeframe (recall/follow-up period) of 
the study relevant to disease/exposure? 
Consider incubation period of illnesses  
Exposures investigated for average 
length of incubation period or 
longer.  
 
In absence of a specific pathogen 
10-14 days for the majority of short-
term illnesses commonly 
investigated in studies where causal 
organism isn’t known 
In absence of a 
specific pathogen 
3-9  
Duration of recall/follow up 
too short to allow all cases to 
emerge/capture exposure, or 
too long for people to recall 
exposure accurately.  
In absence of a specific 
pathogen 
<3 days 
 
Were the outcome measurement methods 
similar in the different groups? 
Temporal matching 
Case-control: outcome was 
assessed in the control group using 
the same method as case 
assessment 
Cohort: the same methods were 
used to measure outcome(s) in 
exposed and the unexposed group 
 Different methods were used 
to measure outcome in cases 
and controls, or cases were 
not assessed for the outcome 
under investigation.  
Cohort: different methods 
were used to measure 
outcome in exposed and 
unexposed groups.  
 
Was the follow up of subjects complete 
enough? Was the non-response rate high? 
Attrition bias 
<25% lost to follow up/ refusal to 
participate 
Authors have reported loss to follow 
up across groups (i.e. 
50%- 25% lost to 
follow up 
 
>50% lost to follow up – 
reason for missing outcome 
data likely to be related to 
true outcome, with either 
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cases/controls or 
exposed/unexposed)  and the rates 
are similar in the groups 
 
And/or authors have investigated 
the effect of loss to follow up in a 
sensitivity analysis  
Authors have 
reported loss to 
follow up across 
groups and the 
rates are not 
similar 
imbalance in numbers or 
reasons for missing data 
across intervention groups.  
RANDOMISED CONTROL TRIALS: 
Was the assignment to 
treatment/intervention randomised? How 
was this carried out?  
Described as random, and the 
authors have described appropriate 
methods used to randomise 
participants into each exposure 
group.  
Examples of appropriate 
randomisation: block randomisation, 
stratified randomisation.  
 
 
Described as 
random, but 
authors do not 
specify methods 
used to 
randomise 
participants into 
each exposure 
group, or use 
Simple 
randomisation  
  
 
 
 
 
Appendix II - Systematic review documentation 
261 
 
Section 3: Analysis: Confounding factors and risk factors/ loss to follow up 
Things to consider and their importance in 
evaluating quality 
Yes/Good Partial/Moder
ate 
No/Poor Can’t 
tell 
What confounding* factors/risk factors have the 
authors measured? 
 
Some confounders or risk factors studies might 
investigate are: age, sex, measure of 
socioeconomic status  (SES), local vs 
tourist/visitors≠ 
Exposure to other sources of pathogens 
(international travel, animal contact, secondary 
transmission, consumption of risky 
foods/beverages*, exposure to other natural or 
recreational waters*),  
Alternative explanations for symptoms reported 
(e.g. pre-existing medical conditions (clinical 
susceptibility bias, protopathic bias), smoking/living 
with a smoker, use of sunscreen/insect repellent, 
risk perception)  
 
Detailed list the confounders (and risk 
factors) that have been collected in the 
study  
 
List of confounders and risk factors 
includes all ones  we consider to be 
important for any health outcome: 
- Age 
- Sex 
- Other beach visits 
- Pre-existing medical condition or 
chronic illness 
In addition: 
For enteric illness: food/beverages 
consumed likely to cause  food poisoning 
For respiratory: smoking/living with a 
smoker,  
Some 
important 
confounders/r
isk factors 
collected, but 
some missing 
or insufficient 
detail 
provided for 
some 
Example: 
“some 
demographic 
information 
was 
collected”. 
No confounders/risk 
factors measured.  
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*Some of these may have a temporal aspect: e.g. 
symptoms of food poisoning can appear 1-5 days 
after food consumption 
≠ local residents may have immunity to local 
pathogens so if there is a high % of locals in 
sampled population, this may produce a lower risk 
estimate 
For skin: use of sunscreen etc.  
 
Note that important risk 
factors/confounders will be different for 
specific outcomes e.g. giardia.  
What important confounding/ risk factors have 
been missed? 
 
 
None of these important confounders 
missed 
A few 
important 
confounders 
missed 
All confounders 
missed 
 
Which confounders have been used to adjust risk 
metrics? 
 
Authors have described criteria/results for 
variables considered to be confounders, 
and have adjusted accordingly.  
 
Note that some studies may not have 
adjusted risk estimates, because none fit 
their criteria for adjustment. 
Authors have 
adjusted but 
have not 
justified 
adjusting for 
certain 
confounders 
Risk estimates have 
not been adjusted, 
and no explanation 
for why  
 
Have the authors taken account of confounders in 
the design stage? 
Yes  No   
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 Example 1: controls and cases/exposed 
and unexposed have been matched 
based on age and/or sex etc. 
 
Example 2: Eligibility criteria exclude 
people who have been swimming in the 
week before day of exposure.  
No matching, no 
exclusion criteria 
Have the authors taken account of these 
confounders in the analysis stage? 
Stratification, adjusting for confounding factors 
Yes: this has included stratification and/or 
adjusting for confounding factors 
 No. results have not 
been investigated for 
different subgroups of 
the population or 
adjusted for 
confounders 
 
Have the authors investigated the effect of non-
response/loss to follow up? 
Attrition bias 
 
The authors have compared the 
differences between characteristics of 
responders and non-responders/missing 
data, and the effect of non-response/loss 
to follow up on the results was 
investigated in a sensitivity analysis. 
 
A sensitivity analysis might look at the 
difference to risk it might make if all non-
The authors 
have 
compared the 
differences 
between 
characteristic
s of 
responders 
and non-
responders/m
issing data, 
No  
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responders had been ill, or all well. Or 
adjusting risks for unmeasured 
confounders.  
but have not 
investigated 
or 
commented 
on the effects 
on the results 
of this 
Is the analysis appropriate to the design? 
Data bias 
Consider study objectives and study design – is 
the study design and are the analytical methods 
geared to answer the research question(s)? 
How many confounders have they adjusted for? If 
the number of confounders >10% of the number of 
people reporting the symptom, then there is the 
potential for over-fitting the model.  
Have correct tests been used for 
continuous/categorical data/distribution of the 
data? 
In the calculation of risk metrics, have appropriate 
referent groups been used?  
Yes Partially 
I.e. some 
parts of the 
analysis are 
appropriate, 
but not all.  
No  
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Are the methods in any multivariate analyses 
appropriate? 
Randomised control trials: were patients analysed 
in the groups to which they were randomised? 
 
Part B: results and interpretation 
Things to consider and their importance in 
evaluating quality 
Yes/Good Partial/Moder
ate 
No/Poor Can’t  
tell 
What are the bottom line results? 
Which findings have the authors highlighted in the 
abstract? 
Are the conclusions they’ve drawn correct based 
on the data they’ve represented. 
What are the results for each outcome 
investigated? 
 
Research question/aims answered and 
the results reported in the paper support 
the conclusions the authors present in the 
abstract/discussion 
 The results do not 
answer the study’s 
questions and/or the 
authors draw 
conclusions that are 
not supported by the 
results presented in 
the paper 
NA 
Have they reported rate or proportion between 
exposed/unexposed, the ratio/rate difference? 
Yes. Authors have reported the number 
(and/or proportion) of cases in each 
exposure group – i.e. enough information 
to calculate a risk metric with 95% 
confidence intervals.  
Authors have 
either 
reported 
number 
and/or 
Not reported number 
or proportion of 
cases/controls in 
each exposure group. 
I.e. there is not 
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Authors have also reported a point 
estimate (either adjusted or crude) for a 
risk metric (e.g. odds ratio, relative risk) 
along with 95% confidence intervals 
 
percentage of 
cases/control
s in each 
exposure 
group 
Or they have 
reported a 
risk estimate 
(adjusted/cru
de) 
enough information to 
calculate risk.  
Authors have not 
reported a risk metric. 
How strong is the association between exposure of 
interest and outcome?  
Look at reported odds ratio/risk ratio/relative risk/ 
absolute risk reduction (aka risk difference). Use 
adjusted estimates if available.  
 
How precise are the results? 
Large odds ratio/relative risk/absolute risk 
reduction 
Confidence intervals are small, and do 
not include the null value.  
Moderate risk 
metric. 
Confidence 
intervals do 
not include 
the null value.  
Small risk metric 
Confidence intervals 
are large, and include 
the null value 
 
 
 
Might confounding still explain the association? 
Inaccurately measured confounders or 
unmeasured confounders could explain the 
association observed/ mask any association 
All confounders and risk factors 
considered to be important for the 
outcome under investigation have been 
collected and analysed for their effects on 
risk. 
Some but not 
all important 
confounders 
and risk 
factors were 
Confounders/risk 
factors were not 
measured or 
assessed for their 
effects on risk  
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Check the confounders list: have they fully 
investigated potential risk factors for the outcome 
that has demonstrated significance?  
Note: It is possible for authors to conduct 
sensitivity analyses to investigate the effect of 
unmeasured confounders, but this is not common 
in these studies.  
collected and 
analysed for 
their effects 
on risk.   
 
Has adjustment made a big difference to the odds 
ratio/relative risk? 
A difference of ≥10% between crude and 
adjusted point estimates.  
And/or 
crude estimates (&95% CI) did not 
indicate an effect, but adjusted estimates 
did (or vice versa)  
 Adjustment has made 
a small difference 
<10% to the point 
estimate, and 
interpretation of the 
95%CI do not change 
the conclusions 
drawn.  
 
Are the design and methods of this study 
sufficiently flawed to make the results unreliable? 
No. Results are reliable Some results 
could be 
reliable, but 
some are not.  
Yes. Results are 
unreliable 
 
Consider Bradford Hill’s criteria : criteria for 
causation 
  Prevalence 
measured, so can’t 
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Time sequence - exposure precedes outcome (if 
there is an expected delay between the cause and 
expected effect, then the effect must occur after 
that delay) 
Incidence measured, correct sequence of 
events, timeframe is appropriate for 
exposure and outcome 
tell if exposure 
preceded outcome.  
Time frame is 
inappropriate for 
exposure/outcome 
Dose-response gradient – increasing exposure 
(e.g. duration of activity, intimacy of contact with 
water, level of pollution) increases risk of illness 
  
Increase in time, frequency or exposure 
to water quality indicators produces a 
larger risk of illness. Size of increase has 
been measured, reported, or tested.  
Increase in 
time, 
frequency or 
exposure to 
water quality 
indicators 
indicates an 
increase in 
risk, but this 
has not been 
sufficiently 
tested for 
significance.  
Increase in time, 
frequency or 
exposure to water 
quality indicators 
does not produce a 
larger risk of illness.  
 
Strength – the size of the risk. If it is large and 
precise, hard to ignore 
Size of adjusted risk estimates large (see 
above) and 95% confidence intervals to 
not include the value 1.  
 Size of risk estimate 
small and/or 95% 
confidence intervals 
include the value 1.  
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Biological plausibility – association agrees with 
current understanding- a plausible mechanisms 
between cause and effect is helpful (although 
knowledge of mechanisms is limited by current 
knowledge) 
Results in line with findings on 
ingestion/direct contact/inhalation of 
infective doses of pathogens 
For some of 
the outcomes 
under 
investigation 
  
Consistency – similar results found in different 
settings, by different people, at different times and 
using different methods. This strengthens the 
likelihood of an effect. Do the results agree or 
contradict the findings from other studies? 
Results of this study fit with other 
available evidence 
 Results contradict 
other available 
evidence 
 
Specificity – causation is likely if a specific 
population at a specific site and disease with no 
other likely explanation.   
    
Experimental – occasionally it is possible to collect 
experimental evidence e.g. Randomised exposure 
trial 
RCT (with appropriate control group) NA Other study design  
Coherence – association should be compatible 
with existing theory and knowledge. Coherence 
between epidemiological and laboratory evidence 
increases the likelihood of an effect  
NA NA NA  
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Analogy – analogous associations between similar 
factors and similar diseases. E.g. drinking water 
and diarrhoeal illness 
Skin: schistosomiasis from contact with faecally 
polluted fresh water, mycobacterium marinum  
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Number (%) of prevalent cases of health outcomes among bathers and participant who reported not going in the sea (non-bathers and 
community controls).  
 Bathers 
(1,693) 
Participants who didn’t 
go in the sea (938) 
Crude 
risk ratio  
Crude 
odds ratio 
Adjusted odds ratio (95% CI), 
P-value 
Gastrointestinal illness 
All waves 201 (11.9%) 57 (6.1%) 1.95 2.08 1.76 (1.24 to 2.48), P = 0.001 
Bathing season  113 (12.9%) 23 (6.1%) 2.09 2.25 1.86 (1.11 to 3.10), P = 0.018 
Outside the bathing season  88 (10.8%) 34 (6.0%) 1.79 1.89 1.45 (0.88 to 2.39), P = 0.140 
Wave 1 46 (9.3%) 14 (5.2%) 1.80 1.88 1.66 (0.84 to 3.26), P = 0.144 
Wave 2 67 (17.4%) 9 (8.7%) 2.01 2.22 1.90 (0.85 to 4.22), P = 0.117 
Wave 3 43 (13.7%) 16 (6.9%) 2.00 2.16 1.26 (0.58 to 2.73), P = 0.566 
Wave 4 45 (9.0%) 18 (5.4%) 1.65 1.71 1.77 (0.93 to 3.35), P = 0.080 
Acute Respiratory Febrile Illness 
All waves 41 (2.4%) 17 (1.8%) 1.34 1.34 1.42 (0.79 to 2.55), P = 0.243 
Bathing season  19 (2.2%) 4 (1.1%) 2.02 2.05 2.03 (0.69 to 6.02), P = 0.200 
Outside the bathing season  22 (2.7%) 13 (2.3%) 1.17 1.18  1.29 (0.63 to 2.63), P = 0.489 
Wave 1 9 (1.8%) 3 (1.1%) 1.64 1.65 1.65 (0.44 to 6.14), P = 0.457 
Wave 2 10 (2.6%) 1 (1.0%) 2.70 2.75 2.73 (0.35 to 21.6), P = 0.341 
Wave 3 9 (2.9%) 3 (1.3%) 2.23 2.27 2.27 (0.61 to 8.49), P = 0.224 
Wave 4 13 (2.6%) 10 (3.0%) 0.86 0.85 0.85 (0.37 to 1.97), P = 0.706 
Skin ailments 
All waves 145 (8.6%) 38 (4.1%) 2.11 2.22 1.55 (1.02 to 2.35), P = 0.038 
Bathing season  67 (7.6%) 15 (4.0%) 1.90 1.98 1.86 (1.03 to 3.36), P = 0.039 
Outside the bathing season  78 (9.6%) 23 (4.1%) 2.35 2.49 1.59 (0.91 to 2.78), P = 0.100 
Wave 1 29 (5.9%) 10 (3.7%) 1.59 1.62 1.66 (0.79 to 3.47), P = 0.180 
Wave 2 38 (9.9%) 5 (4.8%) 2.05 2.17 2.20 (0.84 to 5.77), P = 0.107 
Wave 3 32 (10.2%) 6 (2.6%) 3.97 4.31 4.34 (1.77 to 10.6), P = 0.001 
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Wave 4 46 (9.2%) 17 (5.1%) 1.78 1.86 1.90 (1.06 to 3.41), P = 0.031 
 Bathers 
(1,693) 
Participants who didn’t 
go in the sea (938) 
Crude 
risk ratio  
Crude 
odds ratio 
Adjusted odds ratio (95% CI), 
P-value 
Ear ailments 
All waves 193 (11.4%) 29 (3.1%) 3.69 4.03 3.07 (1.99 to 4.74), P < 0.0001 
Bathing season  116 (13.2%) 7 (1.9%) 7.06 7.98 5.57 (2.49 to 12.5), P < 0.0001 
Outside the bathing season  77 (9.4%) 22 (3.9%) 2.42 2.57 2.03 (1.15 to 3.58), P = 0.014 
Wave 1 58 (11.8%) 5 (1.9) 6.35 7.07 5.33 (2.02 to 14.1), P = 0.001 
Wave 2 58 (15.1%) 2 (1.9%) 7.83 9.05 6.71 (1.53 to 29.5), P = 0.012 
Wave 3 32 (10.2%) 8 (3.4%) 2.98 3.20 2.34 (0.87 to 6.27), P = 0.091 
Wave 4 45 (9.0%) 14 (4.2%) 2.12 2.23 1.97 (0.99 to 3.93), P = 0.053 
Eye ailments 
All waves 119 (7.0%) 16 (1.7%) 4.12 4.36 3.29 (1.86 to 5.81), P < 0.0001 
Bathing season  68 (7.7%) 8 (2.1%) 3.62 3.84  2.95 (1.33 to 6.50), P = 0.008 
Outside the bathing season  51 (6.3%) 8 (1.4%) 4.41 4.64 3.42 (1.50 to 7.82), P = 0.004 
Wave 1 33 (6.7%) 5 (1.9%) 3.61 3.80 3.44 (1.26 to 9.40), P = 0.016 
Wave 2 35 (9.1%) 3 (2.9%) 3.15 3.37 2.50 (0.70 to 8.89), P = 0.157 
Wave 3 23 (7.3%) 3 (1.3%) 5.71 6.08 6.66 (1.78 to 24.9), P = 0.005 
Wave 4 28 (5.6%) 5 (1.5%) 3.69 3.85 2.96 (1.05 to 8.34), P = 0.040 
Any symptoms of illness 
All waves 876 (51.7%) 242 (24.8%) 2.01 3.08 2.81 (2.27 to 3.48), P < 0.0001 
Bathing season  475 (54.1%) 109 (29.1%) 1.86 2.87 2.53 (1.86 to 3.44), P < 0.0001 
Outside the bathing season  401 (49.2%) 133 (23.6%) 2.09 3.14 2.85 (2.08 to 3.90), P < 0.0001 
Wave 1 257 (52.1%) 67 (24.8%) 2.10 3.30 3.20 (2.17 to 4.72), P < 0.0001 
Wave 2 218 (56.6%) 42 (40.3%) 1.40 1.93 1.50 (0.87 to 2.59), P = 0.149 
Wave 3 169 (54.0%) 58 (24.9) 2.17 3.54 3.48 (1.99 to 6.06), P < 0.0001 
Wave 4 232 (46.2%) 75 (22.7%) 2.04 2.93 2.65 (1.79 to 3.93), P < 0.0001 
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Number (%) of prevalent cases of individual symptoms among bathers and participant who reported not going in the sea (non-bathers 
and community controls) 
 Bathers 
(1,693) 
Participants who didn’t 
go in the sea (938) 
Crude risk ratio  Crude odds 
ratio 
Adjusted odds ratio (95% CI), 
P-value 
Vomiting 42 (2.5%) 16 (1.7) 1.45 1.47 1.03 (0.53 to 2.01), P = 0.922 
Diarrhoea 174 (10.3%) 47 (5.0%) 2.05 2.17 1.86 (1.28 to 2.70), P = 0.001 
Indigestion 129 (7.6%) 0230 (3.2%) 2.38 2.50 2.01 (1.27 to 3.16), P = 0.003 
Nausea 164 (9.7%) 46 (4.9%) 1.98 2.08 1.94 (1.32 to 2.84), P = 0.001 
Fever 65 (3.8%) 27 (2.9%) 1.33 1.35 1.27 (0.76 to 2.14), P = 0.361 
Headache  291 (17.2%) 118 (12.6%) 1.37 1.44 1.16 (0.88 to 1.53), P = 0.278 
Body aches  227 (13.4%) 76 (8.1%) 1.65 1.76 1.31 (0.96 to 1.80), P = 0.087 
Fatigue 233 (13.8%) 80 (8.5%) 1.61 1.71 1.46 (1.07 to 1.98), P = 0.016 
Loss of appetite 63 (3.7%) 30 (3.2) 1.16 1.17 1.48 (1.09 to 2.01), P = 0.013 
Sore throat 345 (20.4%) 101 (10.8%) 1.89 2.12 1.87 (1.42 to 2.47), P < 0.0001 
Runny nose 328 (19.4%) 94 (10.0%) 1.93 2.16 1.83 (1.38 to 2.43), P < 0.0001 
Dry cough 144 (8.5%) 55 (5.9%) 1.45 1.49 1.36 (0.94 to 1.96), P = 0.106 
Productive cough 123 (7.3%) 46 (4.9%) 1.48 1.52 1.07 (0.71 to 1.61), P = 0.751 
Ear ache 193 (11.4%) 29 (3.1%) 3.69 4.03 3.07 (1.99 to 4.74), P < 0.0001 
Ear discharge 26 (1.5%) 9 (1.0%) 1.60 1.61 1.13 (0.47 to 2.68), P = 0.787 
Red, painful eyes 119 (7.0%) 16 (1.7%) 4.12 4.36 3.29 (1.86 to 5.81), P < 0.0001 
Eye discharge 18 (1.1%) 7 (0.7%) 1.42 1.43 1.24 (0.47 to 3.31), P = 0.665 
Skin rash 54 (3.2%) 16 (1.7%) 1.87 1.90 2.02 (1.14 to 3.58), P = 0.016 
Skin ulcer 18 (1.1%) 6 (0.6%) 1.66 1.67 1.72 (0.68 to 4.37), P = 0.251 
Skin irritation 105 (6.2%) 26 (2.8%) 2.24 2.32 1.58 (0.96 to 2.58), P = 0.070 
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Number (%) of prevalent cases of illness reported by bathers exposed to known pollution compared to bathers not exposed to known 
pollution 
 
Health outcome  Bathers exposed to 
known pollution 
(221) 
Bathers not 
exposed to known 
pollution (1,472) 
Crude 
risk ratio  
Crude 
odds 
ratio 
Adjusted odds ratio (95% CI), 
P-value 
Gastrointestinal illness 18 (8.1%) 183 (12.4%) 0.66 0.62 0.57 (0.33 to 0.96), P = 0.035 
Acute Respiratory Febrile Illness 7 (3.2%) 34 (2.3%) 1.37 1.38 1.40 (0.29 to 2.33), P = 0.428 
Skin ailments 24 (10.9%) 121 (8.2%) 1.32 1.36 1.36 (0.84 to 2.22), P = 0.212 
Ear ailments 33 (14.9%) 160 (10.9%) 1.37 1.44 1.43 (0.94 to 2.17), P = 0.096 
Eye ailments 19 (8.6%) 100 (6.8%) 1.27 1.29 1.33 (0.79 to 2.24), P = 0.288 
Any symptoms of illness 121 (54.8%) 755 (51.3%) 1.07 1.15 1.11 (0.81 to 1.51), P = 0.515 
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The Beach Bum Survey 
 
 INFORMATION SHEET FOR PARTICIPANTS 
Please read this information sheet carefully before deciding whether or not to take 
part in the survey. Whether or not you decide to participate, we thank you for 
considering our request.  
What is the aim of the project? 
This project is investigating bacteria that live in people’s gut which are resistant 
to antibiotics. We want to study the bacteria in the guts of healthy adults that 
frequently surf or body board in the UK and compare this to healthy adults who 
do not have frequent contact with seawater. This project aims to investigate if 
there is an association between the recreational use of UK coastal waters and 
gut colonisation by antibiotic resistant bacteria. The project is being undertaken 
as part of a PhD in Medical Sciences.  
Description of participants required 
We require two kinds of participants with different levels of exposure to seawater:  
1. Surfers and body boarders: Adults who live in England, Wales or Northern 
Ireland who are frequently exposed to seawater by surfing or body boarding 
on average at least 3 times per month  
2. Comparison group: Adults who live in England, Wales or Northern Ireland who 
do not surf or body board and have minimal contact with seawater (on average 
less than once a month) 
You will NOT be able to take part in this study if you answer ‘yes’ to any of the 
following questions: 
1. Are you under the age of 18? Yes 
☐ No ☐ 
2. Do you have a long-term health condition that requires 
frequent hospitalisation or makes you susceptible to 
infections (i.e. do you have a condition or receive treatment 
for a condition that suppresses your immune system? For 
example, high-dose steroids, chemotherapy, transplanted 
organ recipient, HIV/AIDS) 
Yes 
☐ No ☐ 
3. Do you live outside England, Wales or Northern Ireland? Yes 
☐ No ☐ 
4. Have you lived anywhere outside the UK in the past 12 
months? 
Yes 
☐ No ☐ 
5. In the past 6 months have you:   
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a. Travelled outside Europe? Yes 
☐ No ☐ 
b. Participated in any watersports (e.g. surfing, 
swimming) outside the UK? 
Yes 
☐ No ☐ 
c. Stayed in a hospital for 24 hours or more? Yes 
☐ No ☐ 
d. Received a course of treatment involving 
antibiotics? 
Yes 
☐ No ☐ 
Why me? 
 Surfers and body boarders 
As a regular surfer or body boarder, we are approaching you to take part in this 
survey because surfers and body boarders are highly exposed to seawater which 
may contain antibiotic resistant bacteria. 
 Comparison group 
As someone who does not surf or body board, or have regular exposure to 
seawater (i.e. not more than once a month), you have been approached to take 
part in this study as part of the comparison group. The information you provide 
us with will be compared with information provided by surfers and body boarders. 
This will enable us to investigate the impact of recreational exposure to seawater 
on gut colonisation by antibiotic resistant bacteria.   
What will I be asked to do? 
1. You will be asked to collect your own rectal swab and to complete a short 
questionnaire. The rectal swab will collect a small amount of stool 
containing bacteria that live in your gut which we will be able to test for 
resistance to antibiotics. We will provide you with a rectal swab collection 
kit with full instructions and a short questionnaire to complete. These need 
to be returned by post in the envelope provided as soon as possible. 
2. Only surfers and body boarders will be asked to identify a person who 
does not surf or body board to take part in this study as part of the 
comparison group (see ‘Instructions for the recruitment of subjects for the 
comparison group’). 
Why is this research important? 
The spread of antibiotic resistant bacteria is a serious health problem because 
infections caused by antibiotic resistant bacteria do not respond to treatment. 
Understanding how these bacteria enter human populations is essential for 
controlling the spread of antibiotic resistant bacteria, and the environment could 
be an important source of these bacteria. Recreational contact with seawater is 
unlikely to result in life-threatening disease in healthy individuals, but gut 
colonisation by antibiotic resistant bacteria could contribute to the spread of 
resistant bacteria in the community. This project will not be able demonstrate a 
causal link between recreational contact with seawater and gut colonisation by 
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antibiotic resistant bacteria, but may provide evidence suggesting that one exists 
which can be explored in future research. This may also have implications for 
how we view the regulation of coastal water quality.  
What are the risks? 
Risks and discomfort associated with participation in this study are minor. 
Damage to the rectal wall is extremely rare but possible. Therefore, please make 
sure you follow the instructions provided on how to collect your rectal swab safely. 
Medical concerns 
If you do experience illness, or are concerned about your health following 
participation in this study, we recommend that you contact a member of the 
research team on 07960531500.  
Time commitment  
It should take less than 15 minutes to collect the swab and complete the 
questionnaire. 
Can I change my mind and withdraw from the Project? 
Your participation is entirely voluntary, and you may withdraw from the project at 
any time. 
What information will be collected and what use will be made of it? 
What information will be collected?  
Rectal swabs are being used to collect bacteria that live in the gut. The swabs 
will be tested for the presence of bacteria that are resistant to antibiotics. These 
swabs will not provide us with any other information about your health (e.g. 
colorectal cancer, the presence of disease-causing microorganisms, etc.). The 
questionnaires will collect information on factors that may be associated with 
antibiotic resistant bacteria living in your gut (e.g. exposure to human or animal 
waste), as well as some personal information, such as your age and sex. All data 
collected will be anonymous.  
What will the information be used for? 
Results of this project may be published but any data included will be anonymous. 
Surfers Against Sewage will be provided with a copy of the final report and survey 
participants may request copies from the European Centre for Environment and 
Human Health website (www.ecehh.org) or from Surfers Against Sewage. 
How will my information be stored? 
Surfers Against Sewage will not have access to your data. The data collected will 
be anonymous and will be securely stored in such a way that only researchers 
involved in this project at the University of Exeter Medical School will be able to 
gain access to it. Data will be retained in secure storage for 5 years after the end 
of this project.    
Can I find out the results of my swab? 
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We will not be informing individual participants whether antibiotic resistant 
bacteria have been found on their swabs. This is because in most cases, gut 
colonisation by antibiotic resistant bacteria clears by itself after a short time, and 
usually does not cause any health problems in healthy individuals. Additionally, 
there is currently no recommended treatment for the elimination of antibiotic 
resistant bacteria that are not causing illness. The proportion of colonised people 
in the surfer/body boarder group and in the comparison group will be written up 
in a report which will be available on the European Centre for Environment and 
Human Health’s website (www.ecehh.org), and from Surfers Against Sewage. 
However, results of individuals will not be identifiable. If you have any concerns 
about your health, we recommend that you seek the advice of your GP.  
What if I have any questions? 
If you have any questions about our project, either now or in the future, please 
feel free to contact a member of the research team:- 
 
Anne Leonard 
PhD researcher 
European Centre for Environment and Human Health (ECEHH) 
University of Exeter Medical School (UEMS) 
Tel: 01872 258 174 or 01326 259 468 (available Mon-Fri 9am-5pm) 
Tel: 07960531500 (out-of-office hours) 
Email: afcl202@exeter.ac.uk 
 
Dr Will Gaze Dr Ruth Garside 
ECEHH, UEMS ECEHH, UEMS 
Tel: 01872 258 149 Tel: 01872 258 148 
w.h.gaze@exeter.ac.uk r.garside@exeter.ac.uk 
 
This project has been reviewed and approved by the 
University of Exeter Medical School Research Ethics Committee 
 
 University of Exeter Medical School Research Ethics Committee Reference 
Number:  15/02/067 
VERSION NUMBER 3: DATE 19/11/14 
 
If you have any complaints about the way in which this study has been carried 
out please contact the Chair of the University of Exeter Medical School 
Research Ethics Committee:- 
 
Peta Foxall, PhD 
Chair, UEMS Research Ethics Committee 
Email : P.J.D.Foxall@exeter.ac.uk 
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The Beach Bum Survey 
CONSENT FORM FOR PARTICIPANTS 
 I have read and understood the Information Sheet Version Number 3 [dated 
19/11/14] concerning this project. All my questions have been answered to my 
satisfaction. I understand that I am free to request further information at any 
stage. 
I know that: 
1. My participation in the project is entirely voluntary;    Y/N 
   
2. I am free to withdraw from the project at any time;    Y/N 
   
3. The data will be retained in secure storage for five years;    Y/N 
   
4. The results of the project may be published but my anonymity 
will be preserved. 
 
 
   Y/N 
I agree to take part in this project. 
 
 
................................................. ………….……………………………….. 
 ............................. 
(Printed name of participant)      (Signature of participant) 
 (Date) 
 
 
This project has been reviewed and approved by the University of Exeter 
Medical School Research Ethics Committee 
 
 
 
UEMS REC REFERENCE NUMBER:  15/02/067 
VERSION NUMBER: 3 
DATE 19/11/14 
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4. The questionnaire 
The Beach Bum Survey  
7. QUESTIONNAIRE 
 
This questionnaire has 6 sections (A-F) which will collect some personal 
information as well as information on aspects of your life that might influence 
whether antibiotic resistant bacteria are in your gut. 
Please complete the questionnaire and return it with your swab and signed 
consent form.  
Section A: About you 
1. Sex (Please choose one) 
☐   Male           ☐   Female 
2. Age (Please choose one) 
          ☐   18-24           ☐   25-34         ☐   35-44         ☐   45-54        ☐   55-64        
☐   65+ 
3. What is your ethnic group? (Please choose one option that best describes 
your ethnic group or background) 
White 
☐ English/ Welsh/ Scottish/ Northern 
Irish/ British 
☐ Irish 
☐ Gypsy or Irish Traveller 
☐ Any other White background 
 
Asian/ Asian British 
☐ Indian 
☐ Pakistani 
☐ Bangladeshi 
☐ Chinese 
☐ Any other Asian background 
Mixed/ Multiple ethnic groups 
☐ White and Black Caribbean 
☐ White and Black African 
☐ White and Asian 
☐ Any other Mixed/ Multiple ethnic 
background 
 
Black/ African/ Caribbean/ Black 
British 
☐ African 
☐ Caribbean 
☐ Any other Black/ African/ 
Caribbean background 
Other ethnic group 
☐ Arab 
☐ Any other ethnic group 
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4. Please tell us in which UK County you live 
         ________________________________________ 
5. What is the highest level of qualification you have completed?   
(Please choose one)  
☐   No formal qualifications 
☐   Level 1: 1-4 GCSEs or equivalent qualifications 
☐   Level 2: 5 or more GCSEs or equivalent qualifications 
☐   Apprenticeship 
☐   Level 3: 2 or more A-levels or equivalent qualifications 
☐   Level 4: Bachelor’s degree or equivalent, higher qualifications 
☐   Other qualification 
Full list of qualifications in each level 
No Qualifications: No academic or professional qualifications 
Level 1 qualifications: 1-4 O Levels/CSE/GCSEs (any grades), Entry Level, 
Foundation Diploma, NVQ level 1, Foundation GNVQ, Basic/Essential Skills 
Level 2 qualifications: 5+ O Level (Passes)/CSEs (Grade 1)/GCSEs (Grades 
A*-C), School Certificate, 1 A Level/ 2-3 AS Levels/VCEs, 
Intermediate/Higher Diploma, Welsh Baccalaureate Intermediate Diploma, 
NVQ level 2, Intermediate GNVQ, City and Guilds Craft, BTEC First/General 
Diploma, RSA Diploma 
Apprenticeship 
Level 3 qualifications: 2+ A Levels/VCEs, 4+ AS Levels, Higher School 
Certificate, Progression/Advanced Diploma, Welsh Baccalaureate Advanced 
Diploma, NVQ Level 3; Advanced GNVQ, City and Guilds Advanced Craft, 
ONC, OND, BTEC National, RSA Advanced Diploma 
Level 4+ qualifications: Degree (for example BA, BSc), Higher Degree (for 
example MA, PhD, PGCE), NVQ Level 4-5, HNC, HND, RSA Higher Diploma, 
BTEC Higher level, Foundation degree (NI), Professional qualifications (for 
example teaching, nursing, accountancy) 
Other qualifications: Vocational/Work-related Qualifications, Foreign 
Qualifications (Not stated/ level unknown). 
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Section B: Watersports 
6. Are you taking part in this study as a surfer/body boarder or as someone 
who has little contact with seawater? (Please choose one) 
☐   As a surfer/body boarder 
☐   As someone who has little contact with seawater 
7. Do you participate in any of the following watersports in water bodies that 
are not the sea (i.e. swimming pools, rivers) on a regular basis? (Please 
choose one for each activity) 
 
Swimming Diving Rowing/boating Canoeing/kayaking Other 
☐   Yes   
☐   No 
☐   Yes   
☐   No 
☐   Yes   
☐   No 
☐   Yes  
☐   No 
☐   Yes  
☐   No 
  
8. When was the last time you went in the sea in the UK? (Please choose 
one) 
☐   Less than 7 days ago 
☐   In the past month 
☐   More than a month ago  
☐   More than a year ago    
9. How many times in the past 6 months have you been in the sea? (Please 
choose one) 
☐   Never  
☐   Between 1 – 5 times 
☐   Between 6 – 10 times  
☐   Between 11 – 15 times 
☐   Between 16 – 20 times 
☐   Between 21 – 25 times 
☐   More than 25 times  
10. In the past month, have you done any of the following activities at the 
beach in the UK? (Please choose one for each activity) 
Walking/running 
Rock 
pooling 
Fishing 
Sun bathing/ 
sitting on the 
beach 
Playing in the 
sand 
☐   Yes   
☐   No 
☐   Yes   
☐   No 
☐   Yes 
☐   No 
☐   Yes  
☐   No 
☐   Yes  
☐   No 
 
 
11. The remaining questions in this section are for surfers and body boarders 
only. If you are responding to this questionnaire as someone who has little 
contact with seawater, please continue to Question 12 in Section C (on 
the next page). 
 
a) In which UK County do you usually go surfing/body boarding?  
__________________________________ 
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b) How much time do you spend in the water (on average) each time you 
go surfing/body boarding? (Please choose one) 
☐   Less than 1 hour    
☐   Between 1 and 3 hours 
☐   More than 3 hours 
c) How many times have you been surfing/body boarding in the past 
month? (Please choose one) 
☐   Less than 3 times  
☐   3 – 7 times 
☐   More than 7 times 
d) How often do you look for information* on the water quality at beaches 
before you go surfing/body boarding? (Please choose one) 
☐    Always 
☐    Often 
☐    Rarely 
☐    Never 
*Information on the water quality at beaches can be found on water quality 
apps, beach signs, news, social media, online, word of mouth, etc. 
e) Do you avoid surfing/body boarding at beaches if you know warnings 
are in place that the water is polluted? (Please choose one) 
☐    Always 
☐    Often 
☐    Rarely 
☐    Never 
☐    Not applicable 
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Section C: Travel 
12.   Have you travelled within Europe in the past 6 months? (Do not 
include travel within the UK) 
☐   Yes                 ☐   No 
 
Section D: Diet 
13.   Do you eat the following foods on a regular basis (i.e. do you eat 
them at least once a month)?  
Beef Pork Lamb Chicken Fish Salad 
☐   Yes 
☐   No 
☐   Yes 
☐   No 
☐   Yes 
☐   No 
☐   Yes 
☐   No 
☐   Yes 
☐   No 
☐   Yes 
☐   No 
 
14. Is your tap water at home from a private source? (i.e. not supplied by 
mains) 
☐   Yes                  ☐   No 
 
 
Section E: Your household 
 
15. Do you, or anyone you live with, own a pet or domestic animal?  
☐   Yes                   ☐   No 
16. To your knowledge, is there anyone in your household who works in a 
healthcare setting? 
☐   Yes                   ☐   No 
17. To your knowledge, is there anyone in your household who works with 
animals (e.g. farmer, butcher)?  
☐   Yes                   ☐   No 
18. To your knowledge, is there anyone in your household who has been 
hospitalised (spent 24 hours or more in hospital) in the past 6 months? 
☐   Yes                   ☐   No 
19. To your knowledge, is there anyone in your household who has taken 
antibiotics in the past 6 months? 
☐   Yes                  ☐   No 
20. Is there anyone in your household who has spent time abroad in the 
past 6 months?  
☐   Yes                  ☐   No 
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Section F: Your occupation or voluntary work 
21. Do you work in a healthcare setting (e.g. hospital, nursing home)? 
☐   Yes         ☐   No 
22. Does your work involve contact with animals?  
☐   Yes         ☐   No 
 
Please tell us the date and time that you collected your rectal swab: 
Date (dd/mm/yy): ____/____/____ 
Time: ____:_____ am / pm (please delete as appropriate) 
 
End of survey 
 
Please put your completed survey in the large grip seal bag provided along with 
your signed consent form, and place in the addressed envelope.   
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